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Abstract 
 The phylum molluska represents one of the largest and most diverse groups of 
marine animals and are considered to be an important source to derive bioactive 
compounds. Mollusks contain rich nutrients that are beneficial to people of all ages. Large 
populations, particularly those living in coastal areas relied on these animals for a 
substantial portion of their diet and few reports available in the public domain deal with 
the traditional use of mussels against diseases. The consumption of mollusks as popular 
seafood has increased steadily over the past decades and extensive research efforts 
initiated to derive bioactive molecules that promote health in that field. Bivalve mollusks 
and cephalopods are widely used in different parts of the world for various studies, but 
only recently they have been recognized as potential sources for bioactive compounds. 
Free radicals and other reactive species are constantly generated in the human 
body. Uncontrolled generation of free radicals is associated with lipid and protein 
peroxidation, resulting in cell structural damage, tissue injury, or gene mutation and 
ultimately led to the development of various health disorders. The roles of antioxidants are 
to neutralize the excess of free radicals, to protect the cells against their toxic effects, and 
to contribute to disease prevention. Antioxidant defense systems scavenge, and minimize 
the formation of, reactive oxygen species, but they are not fully effective. ROS mediated 
inflammation is treated mainly by non-steroidal anti-inflammatory drugs (NSAIDs) that 
exert anti-inflammatory actions by inhibiting cyclooxygenase and lipoxygenase enzymes. 
Therefore, in recent years, there are interests in finding naturally occurring antioxidant 
and anti-inflammatory compounds in food or medicine to replace synthetic products. 
Nutrient antioxidants belong to the exogenous antioxidants compounds, which cannot be 
produced in the body, and must be provided through foods or supplements. As mollusks 
live in the permanent pro-oxidant conditions, greater levels of antioxidant defenses are 
generally measured in these species. 
Bivalves comprising one of the major marine fishery resources, and consumption 
of bivalve mollusks, particularly the south Malabar area has increased in the recent years 
in response to the higher availability under wild and cultured conditions. The cephalopods 
represent important economic seafood for human consumption due to their nutritional and 
market value, cephalopod aquaculture has also shown an increase during the past few 
years. Among the bivalves, Perna viridis and Crassostrea madrasensis constitute an 
important part of marine fishery and aquaculture at the south west coast of India and are 
the preferred food items among the people living in this area. Octopus dolffusi is 
predominant among the cephalopod species and therefore, these candidate species have 
been taken into account to isolate and characterize the bioactive molecules with reference 
to their antioxidant and anti-inflammatory potential. This work relates to the isolation and 
characterization of bioactive antioxidant and anti-inflammatory components of marine 
mollusks, and further contemplated to develop enriched antioxidant and anti-
inflammatory formulation(s) with individual or combination of natural ingredients with 
potential antioxidant properties to form a stabilized anti-inflammatory formulation.  
The present study provides insights in different biochemical and fatty acid 
variation of three different mollusks collected from different geographical locations on 
the south-western coast of India. This work also explored the influence of the growth 
conditions on the essential nutritional compositions of the bivalves harvested from 
different sites in south western coast of India. It is apparent that spacial and growth 
conditions play a vital role in physiological mechanisms of bivalves, guiding fatty acid 
metabolism. High levels of PUFA including n-3 PUFAs and low levels of n-6 PUFA and 
relatively high n-3/n-6 PUFA ratio values characterized P. viridis and C. madrasensis. 
The nutrient profiling of octopus indicated that O. dolffusi collected south-west coasts 
during the post-monsoon season have superior quality with respect to their nutritional and 
fatty acid profile, especially as a protein source with low in fat content.  
The natural environment has provided a wealth of chemically diverse, bioactive 
compounds that are responsible for over half of the medications currently available for a 
multitude of diseases. Extracts both aqueous and solvent fractions of different polarities 
were generated from these species and screened for the promising antioxidant and anti-
inflammatory activities. The ethylacetate extracts of the mollusks were found to possess 
higher antioxidant and anti-inflammatory potential than other solvent extracts when the 
in-vitro and in-vivo antioxidant and anti-inflammatory properties were considered. These 
crude extracts were subjected to undergo repeated purifications with the aid of various 
chromatographic techniques and a total of ten compounds with potential antioxidant and 
anti-inflammatory activities were isolated from these mollusks. The chemical structures 
of the pure compounds, as well as their relative stereochemistries, were established by 
means of detailed spectroscopic experiments. Chromatographic separation of P. viridis 
extract led to the isolation of six new derivatives. The molecular structures of the purified 
compounds was proposed on the basis of comprehensive analysis of the 
1
H NMR, 
13
C NMR, 
including 2D-NMR experiments (
1
H-
1
H-COSY, HMQC, HMBC, and NOESY), and mass 
spectra. The compounds belonging to  phenanthrenone derivatives, such as 3-hydroxy-13-
vinyl-dodecahydro-11-phenanthrenone (1) and 4,4,9-trimethyl-13-vinyl-dodecahydro-2-
phenanthrenone (2), chromene derivatives such as 11,20-dihydroxy-6,6-dimethyl-
decahydro-5H-benzo[h]naphtho[1,2-c]chromene-16-carbaldehyde (3) and 16-acetyl-20-
hydroxy-6,6-dimethyl-dodecahydro-5H-benzo[h]naphtho[1,2-c]chromen-12-one (4) and 
compounds such as cholest-5-en-3β-3-yl-(30-hydroxy-3-methyl-36-methyleneundeca-
30E,34E-dienoate (5) and cholest-5-en-3β-3-yl-((E)-33-oxooct-31-enoate (6) were 
isolated from the chloroform partioned methanolic  extract of P. viridis. These 
compounds were demonstrated to possess potential antioxidative anti-inflammatory 
properties. In the present study, it was observed that these derivatives can inhibit anti-
inflammatory enzymes, and suggested that the compounds substantiate the wet lab 
experiments. The ethylacetate-methanol extract of Crassostrea madrasensis was 
fractionated chromatographically to yield methyl-3-(26-phenylacetyloxy)-icosahydro-19-
hydroxy-4,4,20-trimethylpicene-23-carboxylate (7) and methyl-3-(26-phenylacetyloxy)-
icosahydro-1,19-dihydroxy-4,4,20-trimethylpicene-23-carboxylate (8). The  ethylacetate-
methanol extract of Octopus dolffusi yielded two pure compounds, namely, cholesta-5-en-
3β-yl-(32-methyl-(30-((E)-34-amino-36-ethyl-39-oxohept-36-enyl)-pentanedioate (9) and 
7-ethyl-9-vinyl-octahydroazuleno[1,8-bc]pyran-3,12-dione (10).  The effective 
antioxidant and anti-inflammatory properties of these compounds indicated that they have 
potential as natural lead molecules in the food industry. The anti-inflammatory potential 
of these compounds are proved to be comparable to the synthetic anti-inflammatory 
agents, aspirin and indomethacin. 
Marine-derived bioactive components have excellent potential as functional food 
ingredients as they possess advantageous physiological effects, with medicinal 
characteristics and added health benefits such as anticancer or anti-inflammatory 
activities. Considering the importance and easy availability of P. viridis, compared with 
other species, an anti-inflammatory concentrate from P. viridis, for use as nutraceuticals 
or functional food, in combating oxidative stress-induced and inflammatory diseases has 
been formulated. The harmful reactive oxygen species (ROS), which attack the biological 
macromolecules were arrested  by  natural antioxidants in different compositions of 
oleoresins (Rosmarinus officinalis (ROO) and Curcuma longa(CLO) and other natural 
antioxidant additives in different proportions were blended with mussel extract (FDPE) in 
different combinations and were subjected to accelerated shelf life study for a period of 
90 days (d90) to find their individual and synergistic effects, which were able to reduce the 
free radicals causing oxidation reactions thereby deteriorating the nutritional 
compositions of the mussel extract. 
The present work involved the extraction and isolation of anti-inflammatory 
principles from P. viridis. Specifically the polysaccharides and anti-inflammatory lecithin 
along with glycolipoprotein and n-3 polyunsaturated fatty acids were isolated from this 
bivalve mollusk in an attempt to enrich the anti-inflammatory activity of the formulations. 
The oligosaccharide (11) characterized as di-(N-acetyl-β-D-mannosamine) -(1→4)-2-N-
acetyl-β-D-galactosamine-(1→) - (4-N-acetyl p-phenoxyl) motifs. IR spectrum of (→4)-
2, 4 Di-(N-acetyl-b-D-mannosamine) -(1→4)-2-N-acetyl-b-D-galactosamine-(1→) - (4-
N-acetyl p-phenoxyl) unit was isolated from the aqueous extract of P. viridis. The down 
field-shifts in carbon signals of the sugar units compared to the native glucan might suggest 
the possible linkage information of the compound. The linkage information of the sugar units 
were further confirmed by NOESY and HMBC experiments. In the HMBC spectrum, the 
intra- and inter-residual connectivities of both anomeric protons and carbons of each of the 
glycosyl residues. The compound 12 contain C-28 carbon lysolecithin isolated from the 
chloroform-methanol extract of green mussel has been assigned to the choline and 
glycerol systems. Its mass spectrum exhibited a molecular ion peak at m/z 550 
(C28H57NO7P). 
1
H NMR in conjugation with 
13
C NMR recorded the signature peaks of 
choline, glycerol and fatty acid portion of the lysolecithin. 
13
C NMR spectra displayed 
three close peaks at δ 54.31(C-1), δ 54.21(C-2) and δ 53.56(C-3) that were attached to the 
nitrogen represented singlet at δ 3.19 (s) with an integral value of 9.  The potential anti-
inflammatory combination was enriched with bioactive components, isolated from P. 
viridis which was found to possess higher anti-inflammatory activity as compared to other 
mollusks extracts. A time-dependent accelerated shelf life studies were conducted in order 
to find the effects of different compositions of additives in the enriched anti-inflammatory 
composition. Significant in vivo activities also indicates better therapeutic profile and 
fewer side effects of the anti-inflammatory combination as compared to the synthetic non-
steroidal anti-inflammatory drugs. 
The anti-inflammatory combination formulated in this study, were found to be an 
effective alternative to the synthetic non-steroidal anti-inflammatory drugs used against 
inflammatory diseases in the mammalian model. The optimized procedure to prepare the 
stabilized anti-inflammatory combinations developed in the present study would 
contribute to the commercial application to produce the stabilized anti-inflammatory as 
nutraceuticals and dietary supplements. 
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1.1 Importance of mollusks 
Marine organisms are considered as vast untapped resources of 
bioactive molecules having enormous pharmaceutical potential, which led to 
the growing interest in investigation of useful therapeutics. Among different 
marine organisms, mollusks are widely distributed, and have many 
representatives in the marine and estuarine ecosystems. The phylum Molluska 
comprises highly diverse group of invertebrates, with 50,000 to 1,20,000 
reported species, and form the largest marine phylum, comprising about 23% 
of the named marine organisms (Chapman, 2009).The total annual production 
of mollusks has been estimated as 1.4 lakh tonnes, which is 10% of total 
marine fish landing (CMFRI, 2014). Cephalopods, bivalves and gastropods are 
the principal groups of mollusks exploited from coastal, estuarine and 
backwater environments. The annual landing of octopus, bivalves and 
gastropods were 9761, 6015 and 2005 tonnes, respectively during 2012 and 
constitute a valuable fishery resource in various sectors of coastal India 
(CMFRI, 2014). Mollusks have been used as highly palatable and nutritious 
food source for humans. Mollusks were also reported to be one of the important 
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sources to derive bioactive compounds that exhibit antitumor, antimicrobial, 
anti-inflammatory and antioxidant activities (Chellaram et al., 2009). Marine 
bivalves belong to the class Bivalvia of phylum Molluska, and are widely 
distributed in the coastal sea beds.  
The commercially important bivalves along the Indian sea coasts are 
clams, mussels, edible oysters, and pearl oysters. The bivalves were exploited 
for shell, meat, industrial purposes and for the pearl.  The edible bivalves 
became more popular and the average quantity of bivalve products exported per 
annum was 580 tonnes during the year 1995-1999. Clams and cockles form 
73.8%, followed by oysters (12.5%), mussels (7.5%) and windowpane oysters 
(6.2%) (Appukuttan, 2008). They are good source of proteins and novel 
bioactive compounds. They are cultured to large numbers in coastal waters as 
a source of food, and for the identification of novel molecules.  
Cephalopod mollusks constitute squid, cuttlefish, octopus, and are the 
most neurologically advanced of all invertebrates. Cephalopods make up only a 
small proportion (nearly 3 %) of the world capture fisheries landings, but there 
have been substantial increase during the last three decades. Cephalopods are 
landed in all the maritime states in India, and the state of Kerala ranked first 
among others, accounting for 37.70 % of the total cephalopod landings followed 
by Maharashtra (28.98 %) and Tamil Nadu (13.8 %) during 1992 
(Appukuttan,2008). Cephalopods are generally carnivorous, highly versatile, and 
active predators at all stages of their life consuming mostly crustaceans, mollusks, 
and to a lesser extent other invertebrates or fish (Rodhouse and Nigmatullin, 
1996). Due to their ecological importance, greater nutritional and market value, 
excellent palatability and increasing demand throughout different regions of the 
world, cephalopods have received considerable attention in recent years.  
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1.2 Marine environment as a potential source of bioactive compounds 
Marine environment encompasses a massively complex ecosystem with 
diverse assemblage of life forms and extreme variations in pressure, salinity, 
thermal stress and exposure to ultraviolet radiation. The extreme environment 
can be stressful to the resident organisms, and are able to withstand up to certain 
limits. The increased stress can be highly toxic to aquatic organisms including 
mollusks, often resulting in oxidation of lipids in membranes, protein oxidation 
and DNA damage. The adaptation to these stress factors could involve efficient 
defense strategies that allow them to limit the harmful consequences of 
oxidative stress. Absence of oxidative damage in the stress-induced biochemical 
parameters suggested that their cells are equipped with powerful anti-stress 
secondary metabolites. These inhabitants are known to possess bioactive 
compounds, formed as a part of highly toxic defense mechanisms, which is a 
reflection of the highly competitive and solute environment in which the 
organisms reside. Moreover, considering its great taxonomic diversity, 
investigations related to the search of new bioactive compounds from the marine 
environment can be seen as an almost unlimited field. 
1.3 Antioxidant and anti-inflammatory potentials to compact 
plurality of disorders 
1.3.1 Free radicals as major causative agent of life threatening diseases  
Free radicals are highly reactive molecules with one or more unpaired 
electrons, produced as part of normal cellular function, can cause damage to 
cell structures and consequently may adversely affect immune functions. 
Reactive oxygen species (ROS) is a collective term that includes all reactive 
forms of oxygen, both radical and non-radical species that are oxidizing agents 
or can be easily converted into radicals. The sources of ROS includes 
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endogenous free radicals, that are generated from immune cell activation, 
inflammation, mental stress, excessive exercise, ischemia, infection, cancer 
and aging. Endogenous antioxidant systems dysfunction is due to the low 
amount of non-enzymatic antioxidants such as gluthatione, vitamins A, C and 
E, reduced enzymatic activity. Exogenous ROS result from air and water 
pollution, cigarette smoke, alcohol, heavy or transition metals (Cd, Hg, Pb, Fe, 
As), certain drugs (cyclosporine, tacrolimus, gentamycin, bleomycin), 
industrial solvents, cooking (smoked meat, used oil, fat) and radiation. After 
penetration into the body by different routes, these exogenous compounds are 
decomposed or metabolized into free radicals. ROS, comprising the 
superoxide anion radical, the peroxide anion and singlet oxygen, are highly 
reactive entities, produced from molecular oxygen by the gain of electrons, or 
the realignment of the electron spins. The hydroxyl radical, the highly reactive 
species of ROS, is formed by dismutation of peroxide catalysed by Fe2+. The 
mechanisms of oxidative cellular damage are summarized in Fig 1.1. 
 
Fig 1.1  Mechanisms of oxidative cellular damage. Free radicals are reduced into water with the 
cooperation of the three main antioxidant enzymes: SOD, catalase, and GSHPx. The generation 
of hydroxyl radicals from hydroperoxide produces the development of oxidative cell injury: DNA 
damage; carboxylation of proteins; and lipid peroxidation, including lipids of mitochondrial 
membranes. By these pathways, oxidative damage leads to cellular death. 
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Uncontrolled generation of free radicals is associated with lipid and 
protein peroxidation, resulting in cell structural damage, tissue injury, or gene 
mutation and ultimately led to the development of various health disorders. The 
ROS are the mediators of inflammation, and through this their interaction with 
platelets, neutrophils, macrophages and other cells can involve the synthesis of 
eicosanoids and the activation and release of various cytokines, propagating the 
inflammatory process from one organ system (liver) to another (kidney, lungs, 
etc.). (The Fig 1.2 illustrates the free radical induced diseases in human).  
 
Fig 1.2 Free radical induced diseases in humans 
These often results in tissue oxidative stress and multiple-system organ 
failure (Parke and Parke, 1995). The ROS-mediated inflammation is involved 
in immune and autoimmune diseases, for example, rheumatoid arthritis and 
inflammatory bowel disease (Parke et al., 1991), cancer (Witz, 1991; Ames et 
al., 1993), atherosclerosis (Halliwell, 1994), hepatitis (Elliot and Strunin, 
1993), AIDS (Baruchel and Wainberg, 1992), Alzheimer’s dementia (Evans, 
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1993), multiple-system organ failure (Fry, 1992; Parke and Parke, 1995), and 
respiratory distress syndrome (ARDS). Molecular mechanisms of ROS toxicity 
and ROS-mediated disease include: (i) oxidation of vital thiol compounds to 
disulphides, (ii) loss of tissue GSH, (iii) impairment of energy generation (ATP, 
NADH, NADPH), (iv) inhibition of Ca2+ transport and electrolyte homeostasis, 
(v) oxidation of cytochromes (vi) DNA strand cleavage, and (vii) the initiation 
and promotion of mutations and carcinogenesis (Parke and Parke, 1995). 
1.3.2 Biological defense against ROS injury 
The body has several mechanisms to counteract oxidative stress by 
producing antioxidants, either naturally generated in situ (endogenous 
antioxidants), or externally supplied through foods (exogenous antioxidants). 
The enzymatic and non-enzymatic antioxidants defenses overwhelmed the 
ROS production resulting in the adaptation and prevention of diseases are 
illustrated in Fig 1.3. 
 The roles of antioxidants are to neutralize the excess of free radicals, to 
protect the cells against their toxic effects, and to contribute to disease 
prevention. The human body constantly quenches excessive oxidants through 
various scavenging mechanisms, such as, use of antioxidant enzymes and 
molecules. The major antioxidant enzymes directly involved in the 
neutralization of ROS are: superoxide dismutase (SOD), catalase (CAT), 
glutathione peroxidase (GPx) and glutathione reductase (GRx). SOD, the first 
line of defense against free radicals, catalyzes the dismutation of superoxide 
anion radical (O2•–) into hydrogen peroxide (H2O2) by reduction. The oxidant 
formed (H2O2) is transformed into water and oxygen (O2) by catalase (CAT) 
or glutathione peroxidase (GPx). The endogenous antioxidant are produced in 
the body, such as lipoid acid, glutathione, L-ariginine, coenzyme Q10, 
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melatonin, uric acid, bilirubin, metal-chelating proteins, transferring, and a 
variety of nutritional factors, primarily the antioxidant vitamins. These 
antioxidants could attenuate the oxidative damage of a tissue indirectly by 
increasing cells natural defenses or directly by scavenging the free radical 
species. The resulting increased oxidative damage to biomolecules may play 
an important role in the pathology of several human diseases, and is amenable 
to therapeutic intervention with appropriate antioxidants. 
 
Fig 1.3  Reactive oxygen species (ROS) are derived from multiple sources (endogenous and 
exogenous) and are counterbalanced by enzymatic and non-enzymatic antioxidants. The 
antioxidant defenses are overwhelmed ROS production resulting in prevention of 
diseases. 
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1.3.3 Natural alternatives  
Free radicals and other reactive species are constantly generated in the 
human body. Antioxidant defense systems scavenge, and minimize the 
formation of, reactive oxygen species, but they are not fully effective. Free 
radicals are known to take part in lipid peroxidation in foods, which is 
responsible for rancid odors and flavors, which decrease the nutritional quality. 
Antioxidant defenses minimize the damage levels of food ingredients containing 
unsaturated fatty acids that are quite susceptible to quality deterioration, 
especially under oxidative stress. Therefore, synthetic antioxidants, such as, 
butylated hydroxyanisole (BHA), butylated hydroxytoluene (BHT) and tert-
butylhydroquinone (TBHQ) are widely used in the food industry as potential 
inhibitors of lipid peroxidation. They are extensively used to control rancidity in 
lipid-containing foods, and formation of peroxidation products, cosmetic, and 
pharma industries. Synthetic antioxidants are associated with side effects. 
BHT was reported to react with other ingested substances to cause the 
formation of carcinogens. BHA and BHT accumulate in the body and result in 
liver damage and carcinogenesis. ROS mediated inflammation is treated 
mainly by non-steroidal anti-inflammatory drugs (NSAIDs) that exert anti-
inflammatory actions by inhibiting COX-2, which induces the  pro-
inflammatory agents such as TNF-α, LPS and tumor-promoting factors (Jaggi 
et al., 2004). The main undesirable side-effects of NSAIDs are due to the 
inhibition of COX-1 (constitutive isoform), along with COX-2. The side 
effects of these drugs are often deleterious, which include gastrointestinal 
ulcers, cardiovascular diseases, drug dependency etc (Quan et al., 2008). 
Therefore, in recent years, there are interests in finding naturally occurring 
antioxidant and anti-inflammatory compounds in food or medicine to replace 
synthetic products. This trend has increased considerably as the synthetic 
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antioxidants are being restricted due to the consumer preference for natural 
products, and concern about the potential toxic effects of synthetic medicines 
(Zheng et al., 2001). These natural antioxidants prevent oxidation of proteins, 
lipid peroxidations and prevent generation of ROS, thus act as upstream 
therapeutic barrier to oxidation stress. 
1.3.4 Nutritional antioxidants 
The nutritional antioxidants take care of the nutritional part along with 
the defense mechanisms to suppress various metabolic disorders. Nutrient 
antioxidants belong to the exogenous antioxidants compounds, which cannot 
be produced in the body, and must be provided through foods or supplements. 
Dietary antioxidants namely, phenolic compounds and low molecular mass 
antioxidants (Se, Zn, vitamins E, C, & A) were found to arrest the oxidation 
process by ROS (Fang et al., 2002; Gorinstein et al., 2002). The various 
mechanisms for nutritional defense and disease prevention are: scavenging of 
ROS; reduction of peroxides and repair of per oxidized biological membranes; 
sequestration of iron to decrease the formation of ROS; utilization of dietary 
lipids for rapid energy production; scavenging of ROS by short-chain fatty 
acids, scavenging of ROS by cholesteryl esters and alternative biological 
pathways as occur in stomach cancer, multiple system organ failure and 
diabetes. The potential of dietary antioxidants to reduce the risk of coronary 
vascular disease (CVD) and inflammation, is gaining a great deal of interest in 
the medical and scientific communities. In this contest the concept of 
nutraceuticals having antioxidant and anti-inflammatory potential play a vital 
role in eliminating the disorders associated with the free radicals. Marine-
derived nutrients and other marine bioactive components have great potential 
as functional food ingredients as they possess advantageous physiological 
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effects, with medicinal characteristics and added health benefits, such as, 
anticancer or anti-inflammatory activities. 
1.4 Mollusks as potential sources of bioactive compounds 
The marine invertebrate species are one of the most interesting phyla 
with diverse chemical classes to biosynthesize pharmacologically active 
marine compounds. Among different marine invertebrates, mollusks are the  
potential sources of bioactive substances . Bivalve mollusks and cephalopods 
possess protective antioxidative defense mechanisms to avoid the cellular 
damage in the structural components of cells. The protective mechanisms 
against oxidative stress include specific antioxidant systems (e.g., vitamins, 
antioxidant enzymes, glutathione, etc.) and nonspecific molecules which 
provide competitive advantages against various oxidative stress factors leading 
to the development of harmful reactive oxygen species. As mollusks live in the 
permanent pro-oxidant conditions, greater levels of antioxidant defenses are 
generally measured in these species. The absence of cellular damage in the 
structural components of bivalve mollusks and cephalopods implies that their 
cells possess protective antioxidative defense mechanisms. This makes them 
specific for prevention of free radical accumulation, supporting the immune 
system in eliminating the proliferation of radicals. These sessile species are the 
richest natural sources of bioactive compounds, many of which belong to 
novel chemical classes not found in terrestrial the sources Therefore it is 
imperative to explore these organisms for potential antioxidant molecules. 
The nutritional antioxidants are of particular interest in the case of 
marine invertebrates particularly bivalve mollusks. Bivalves are preferred food 
items in the Malabar region of India. Among various bivalves, green mussel is 
a delicious food item for the people living in this region from the time 
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immemorial. These species constitute a major source of nutritional elements, 
such as, fatty acid, amino acid, proteins, vitamins and minerals along with the 
vitamin E, K and Se etc. The seasonality related variations were reported for 
antioxidant activities (Power & Sheehan, 1996). Bivalves were reported to 
repair the oxidative damage caused by ROS by increasing the expression of 
antioxidant molecules. This makes them specific for prevention of free radical 
accumulation, supporting the immune system in eliminating the proliferation 
of radicals. Various studies on bioactive compounds from mollusks exhibiting 
antitumor, anti-leukemic, antibacterial and antiviral activities have been 
reported worldwide (McPhee et al., 2007). Although the coastline of South 
Indian subcontinent is bestowed with large assemblage of mollusks and 
cephalopods, have not been explored in detail regarding their potential to be 
used against inflammatory and oxidative stress induced disorders. Marine 
mollusks have evolved biochemical and physiological mechanisms for the 
production of bioactive compounds against oxidative stress. Hence mollusks 
can be considered as an important source to derive bioactive compounds with 
anti-inflammatory and antioxidant activities. 
1.5  Antioxidant and anti-inflammatory potentials of mollusks and 
cephalopods 
Bivalve mollusks and cephalopods are widely used in different parts of 
the world for various studies, but only recently they have been recognized as 
potential sources for bioactive compounds. Bivalve mollusks and cephalopods 
are abundant in the coastal brackishwater and sea. The culturing of these 
mollusks is initiated on a commercial scale, and experimental farming 
methods of a number of species have been carried out and suitable farming 
techniques evolved (Kuriakose and Appukuttan, 1980; Narasimham, 1980). 
Marine bivalves are virtually untapped resource for the discovery of novel 
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bioactivities and were reported to contain abundance of bioactive principles 
(Chellaram et al., 2004). Ziconotide isolated from the cone snail Conus magus 
venom was approved to treat chronic pain. Ziconotide shows its effect by 
blocking N-type voltage gated Ca2+channels (Schroeder et al., 2004). In recent 
years, the n-3 PUFAs from bivalve mollusks provide an almost unlimited 
variety of long chain PUFAs, with beneficial roles in human health (Nestel, 
2000; James et al., 2000; Emelyanov et al., 2002). The antioxidant potential of 
mollusks measures the biological resistance towards ROS, thus providing 
useful indications to predict oxyradical-mediated adverse effects on the 
physiological condition of the organisms. Bivalve mollusks and cephalopods 
are rich sources of structurally diverse bioactive compounds with valuable 
pharmaceutical and biomedical potential. These compounds frequently 
produce structural and functional changes in lipids, proteins and other 
biomolecules, and are derived from the partial reduction of O2. However, no 
detailed chemical studies to identify the active principle(s) have been reported 
from the bivalve mollusks and cephalopods available from the south western 
coast of India. Further investigations intending to purify these active 
compound(s) should be considered to invent their chemical nature responsible 
for the target bioactivities. Therefore, a systematic search for the development 
of new sources of chemical compounds from bivalve mollusks and 
cephalopods will be helpful for the isolation of anti-inflammatory and 
antioxidant molecules. 
In the present study we have considered Perna viridis and Crassostrea 
madrasensis among the bivalves and Octopus dolffusi as the candidate 
cephalopod. These species are abundantly available at the south west coast of 
India and are the preferred food items among the people living in the Malabar 
coast. Based on this background, the present work is focused in the isolation of 
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potential anti-inflammatory and antioxidant principles from these candidate 
bivalve mollusks and cephalopods, and their characterization them by different 
spectroscopic techniques. The products containing active anti-inflammatory 
and antioxidant principles with suitable stabilizers are developed from the 
candidate bivalve mollusks and cephalopods in an attempt to deliver potent 
medication and nutraceutical supplements. 
Based on this background the objectives of the thesis are as follows: 
1) To develop an optimized procedure for the extraction of antioxidant 
and anti-inflammatory substances from bivalve mollusks, such as, 
Perna viridis and Crassostrea madrasensis and cephalopods, such as, 
Octopus dolffusi available in the south-west coast of India.  
2) To document the in vitro antioxidant and anti-inflammatory potential 
of the crude extracts from these mollusk species. 
3) To purify the active principles by bioassay-guided chromatography, and 
to elucidate the structure of purified molecules by spectroscopic 
experiments.  
4) To develop a product containing the active principles from selected 
bivalve mollusks and cephalopods with antioxidant and anti-
inflammatory activities as nutraceutical supplements and medication.  
1.6 Thesis outline 
Based on the above objectives the present thesis is summarized into a 
total of seven chapters. The importance of the study on the nutritional and 
bioactive properties of mollusks and cephalopods, with objectives, were 
discussed and explained in the introduction under Chapter 1. Chapter 2 deals 
with the detailed review of the works carried out regarding the significance of 
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mollusks and cephalopods as potential sources particularly the antioxidative and 
anti-inflammatory bioactivities have been considered to explain the 
pharmaceutical and medicinal values of these species. Subsequently Chapter 3 
described the nutritional parameters of the candidate species to understand the 
seasonal and spacial variation in the nutritional constrains. Chapter 4 described 
the evaluation of the anti-oxidant and anti-inflammatory potentials of Perna 
viridis, Crassostrea madrasensis and Octopus dolffusi to assess the in-build 
antioxidant and anti-inflammatory capacity to inhibit free radical formation and 
inflammation in the body. The isolation and characterization of secondary 
metabolites responsible for antioxidant and anti-inflammatory activities for the 
development of new sources of bioactive pharmacophores from these mollusks 
has been described in Chapter 5. A stabilized anti-inflammatory formulation for 
use as nutraceutical supplement has been developed from P. viridis was 
described in Chapter 6. The summary of the work carried out along with the 
major research findings from the present study were summarized in Chapter 7.  
…………??………… 
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Background of the study 
Mollusks are heterogenous group of animals both in shape and 
diversity, and are mainly represented by amphineura, gastropods, bivalves, 
cephalopods and scaphopods. Most of the mollusks inhabit the marine 
environment and very few dwells in the terrestrial and freshwater habitats. The 
Indian coast is blessed with number of ecosystems, such as, coral reefs, 
mangroves, lagoons, estuaries, sandy beaches and rocky shores. Among these, 
the coral reef and rocky shores have rich assemblage of molluskan fauna. They 
are the largest and most diverse phylum in the tropical seas (Venkatraman and 
Venkataraman, 2012). The majority of mollusks inhabit marine biotopes, and 
they occur from the backwater zone, mangroves, intertidal, shelf and down to 
deeper waters. The mollusks are abundant in rocky shores, as it provides a 
better substratum, and act as a feeding and breeding ground, ensuring a 
favorable environment for their survival. A total of 80,000 to 100,000 species 
of mollusks recorded from various parts of the world. An aggregate number of  
3271 mollusks are known to occur in coastal Indian waters, belonging to 220 
families and 591 genera, of which 1900 were reported as gastropods 
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(Venkatraman and Venkataraman, 2012). Although many species of the 
phylum molluska are  indigenous to the continent, the most important classes 
of commercial interest are the bivalves (oysters, clams, scallops and mussels), 
gastropods (conchs, whelks, abalones and periwinkles) and cephalopods 
(cuttle fish, squid and octopus) (Periyasamy, 2012).  
 
Fig 2.1 Abundance of bivalves along the coastal waters of the Indian subcontinent 
 
Fig 2.2 Cephalopods in Fortkochi harbor, collected from coastal waters of the Indian   subcontinent 
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2.1 Marine environment as a prolific source of bioactive compounds 
Marine environment is a rich source of both biological and chemical 
diversity. Marine ecosystem covers a wide thermal, pressure and nutrient 
ranges, and it has extensive photic and non-photic zones. These marine 
organisms live in complex habitats, and are exposed to the extreme conditions 
and intensive ecology pressure. The mollusks are soft - bodied, heterogeneous 
group of animals with great antiquity and diversity (Venkatraman and 
Venkataraman , 2012). Despite the presence of a shell in some molluskan 
groups, all mollusks are essentially soft-bodied, making them vulnerable to 
predators and pathogens. Mollusks often live in microbial rich habitats, such 
as, soil and leaf litter on land and amongst marine benthic sediments and hard 
reef communities (Benkendorff et al., 2009). As they thrive in a different kind 
of climate and habitat, these organisms develop certain adaptation 
mechanisms, which may be useful for their defense, and this result in the 
production of bioactive metabolites, which cannot be found in other organisms 
(Ira Bhatnagar et al., 2010). The marine environment, which contains a vast 
array of organisms with unique biological properties, is one of the most 
underutilized biological resources. Moreover, considering its great taxonomic 
diversity, investigation related to the search of new bioactive compounds from 
the marine environment has seen in almost unlimited field (Rasmussen et al., 
2007, Plaza et al., 2008).  
Marine invertebrates synthesize primary and secondary metabolites. 
The primary metabolites include amino acids, simple sugars, nucleic acids, 
and lipids, whilst secondary metabolites are alkaloids, terpenoids, and other 
compounds, have known bioactivities and biological functions. Mollusks are 
considered as one of the important sources to harbor valuable bioactive 
compounds that exhibit antitumor, antimicrobial, anti-inflammatory, and 
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antioxidant activities (Anbuselvi et al., 2009; Chellaram and Edward, 2009b; 
Benkendorff et al., 2011). These animals usually produce structurally diverse 
substances to form a chemical defensive system, representing a different 
source of bioactive compounds from marine organisms. A series of 
metabolites with complex structures and intriguing biological activities have 
been isolated from mollusks (Zhen and Yue, 2012). Compounds isolated from 
mollusks were also used in the treatment of rheumatoid arthritis and 
osteoarthritis (Chellaram and Edward, 2009a). Mollusk extracts also exhibited 
antiviral and antibacterial activity against fish pathogenic bacteria, and 
therefore may be applied in aquaculture other than medicinal purpose (Defer et 
al., 2009). Compounds isolated from marine organisms even show promising 
activities within the nanomolar range, and can be developed as drug 
candidates and lead pharmacophores.  
2.2 Bivalves and Cephalopods 
Bivalves are highly abundant group of organisms in majority of coastal 
and marine environments. Till date about 7500 bivalves were identified and 
found from the intertidal zone to the abyssal. They inhabit different marine 
ecosystems including temperate, tropical and polar seas, brackish estuary, 
hydrothermal vent etc. Kerala, a coastal state in the southwestern peninsula, 
dominates in the production of bivalves, which include oysters, mussels and 
clams. The fishing of bivalves is pursued as a small-scale activity, mostly at 
subsistence level in various estuaries and inshore seas. The total bivalve 
production in the Malabar region of India was estimated at 9695 t during 2007 
(Fig. 2.3). The annual average clam production is about 57,000 t, oysters about 
18,800 tonnes, and mussels about 14,900 tonnes (CMFRI, 2007-08). Mollusks 
are important for marine ecology and human diet, and considered to be an 
important source of nutrients. 
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Fig 2.3 Total bivalve production (%) in Malabar region during 2007-08 
Class Cephalopoda represents the most advanced class of the phylum 
Molluska, and include some intriguing individuals like squids, octopods, cuttle 
fishes and so forth. These species are exclusively marine, and are distributed 
throughout the seas of the world. The vast majority of them are free swimming 
shallow water predators described by rapid growth. More than 700 species are 
depicted today, and their number has a tendency to expand consistently as the 
researcher discovers new species, especially in the tropical and polar oceans 
(Sweeney et al., 1998). These species occupy a leading place among the 
exploited marine fishery resource on the planet, and are receiving greater 
importance due to their increasing demand in export. The expanding interest 
of cephalopods in the global business sector is primarily because of the 
increased awareness of the nutritional qualities (Zlatanos et al., 2006). The 
cephalopods were accounted to be a rich source of long chain n-3 
polyunsaturated fatty acids, essential amino acids, which are deficient in 
cereals and pulses, along with rich antioxidants and minerals, for instance, 
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selenium, which could not be acquired from other sources. Notwithstanding 
this, their great sensory properties make them a favoured human delicacy. 
The progression of cephalopods as an imperative business fishery 
commodity in the global business occurred only during the recent decades 
(Boyle, 1990). Cephalopods are by far the most important group with an 
average annual production of about 1,05,000 tonnes. They are landed as by-
catch and as a targeted fishery mostly in mechanized trawlers operating up to 
200 m depth, and beyond in some areas. Cephalopod catch in Kerala during 
2007 was estimated at 23,392 tonnes and showed a decline of 25% compared 
to previous year (CMFRI, 2007-08).  
 
Fig 2.4  Cephalopod landing (%) in Kerala. Cuttlefishes contributed 59% followed by squids 
(30%) and octopus (11%) Sepia pharaonis, S. aculeate and Sepiella inermis (cuttlefish), 
Urothethis duvauceli,  Doryteuthis sibogae  (squids), Amphioctopus marginatus, O. dolfusi, 
Cystopus indicus were observed in the fishery.  
2.3 Nutritional importance of mollusks  
The knowledge on biochemical composition of any edible organisms is 
extremely important since the nutritive value is reflected in its biochemical 
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content. Phytoplanktons are considered as a main food source for bivalves and 
many studies looked at the influence of bivalves on phytoplankton community 
(Arapov et al., 2010).Bivalve mollusks and cephalopods are highly delicious 
seafood items because of their nutritive value next to finfishes and 
crustaceans. They are also very good source for biomedically important 
products (Shenoy, 1988). Mollusks, as well as the invertebrates, in general, 
constitute a source of lipidic bioactive compounds offering a variety of 
nutraceutical and pharmaceutical applications (Benkendorff  et al., 2010). 
Among them, the n-3 polyunsaturated fatty acids (PUFA), such as, 
eicosapentaenoic acid, 20:5n-3, and docosahexaenoic acid, 22:6n-3, are known 
for their beneficial effects on human health (Simopoulos et al., 2008). These 
long chain unsaturated n-3 fatty acids are widely known for their capacities for 
cardioprotection. They were reported to reduce triacylglycerol and cholesterol 
levels, and have anti-inflammatory and anticancer effects. Numerous 
experiments on animals confirmed the cancer preventive properties of n-3 
fatty acids from marine sources (Wendel et al., 2009; Candela et al., 2011). 
2.3.1 Nutritional importance of bivalves 
Bivalve mollusks are aquatic mollusks (Phylum: Molluska; Class: 
Pelecypoda or Bivalvia), and comprise major marine fishery resources, 
mussels being a prominent member (Murphy et al., 2002). Bivalves in coastal 
area are good sources of n-3 PUFAs, including the long-chained 
eicosapentaenoic acid (20:5n-3; EPA) and docosahexaenoic acid (22:6n-3; 
DHA) with valuable pharmaceutical and biomedical potential (Taylor and 
Savage, 2006). The consumption of bivalve mollusks in India, particularly 
south Malabar area has increased in the recent years in response to the higher 
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availability under wild and cultured conditions. Bivalves are considered vital 
next to the fish and prawns from the nutritive point of view. Bivalve mollusks 
were reported to contain bioactive lipids, which include fatty acids; 
sphingolipids, phytosterols, diacylglycerols, etc., and many of these can 
influence human health and diseases linked to alleviate the symptoms of 
inflammatory conditions (Li and Sinclair, 2007). The green mussel Perna 
viridis (family: Mytilidae) is a bivalve mollusk native of the Indian coast and 
available throughout the Indo-Pacific and Asia-Pacific (Benson et al., 2001). It 
forms a significant fishery and contributes nearly 50% to the total bivalve 
production of the area (Laxmilatha et al., 2011).  
 Mussels are consumed as seafood in several European countries including 
Belgium, the Netherlands, and France. In India, two species of mussels (green 
mussel P. viridis and brown mussel P. indica) support a traditional sustenance 
fishery in Malabar and Konkan areas of Penninsular India.  
The Malabar Coast of Kerala is popularly called as the ‘Mussel fishery 
zone of India’, which accounts for the bulk of the mussel production in the 
country. Mussels are commercially valuable species, easy to cultivate or 
collect in coastal areas. They are very important for marine ecology and for 
human diet, since they are an important source of nutrients (Astorga-Espana et 
al., 2007).  
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Fig 2.5  (A) Photographs of P. viridis (green mussel) with meat (B) P. viridis shells are kept near 
the seahore (C) P. viridis along the southwestern coast of Kerala 
The edible oyster Crassostrea madrasensis is a commercially important 
bivalve mollusk distributed all along the east and west coasts of India. The 
Indian Backwater Oyster (Crassostrea madrasensis) locally known as ‘Kadal 
muringa’ is found in the backwaters and estuarine regions of Kerala. 
Crassostrea madrasensis is endemic to brackishwaters, such as, estuaries, 
creeks, bays and backwaters (Rao and Nayar, 1956; Joseph and Joseph, 1983; 
Velayudhan et al., 1998). Crassostrea madrasensis is a good source of n-3 
PUFAs, including the long-chained eicosapentaenoic acid (20:5n-3; EPA) and 
docosahexaenoic acid (22:6n-3; DHA). Consumption of these bivalve 
mollusks provides an inexpensive source of protein with a high biological 
value, essential minerals and vitamins (Astorga-Espana, et al., 2007; 
Karakoltsidis et al., 1995). 
A  B
C 
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Fig 2.6  (A) Photographs of culturing sites of C. madrasensis (oyster), (B) C. madrasensis with 
meat inside the shell (C) C. madrasensis with shell and meat separately. 
2.3.2 Nutritional importance of cephalopods 
The cephalopods represent important economic seafood for human 
consumption and contribute to 14% of the world fisheries (FAO, 2004). This 
is due to its high nutritional and market value, excellent palatability, and 
increasing demand throughout different regions of the world. Cephalopods 
including cuttlefish, squid and octopus are now among the most interesting 
inhabitants of the seas for both scientific and economic reasons. They are 
considered as an important marine resource since they are rich in taste and 
have few inedible parts. These species are also cheap sources of well-balanced  
protein and lipid (Kreuzer, 1984; Sinanoglou & Miniadis-Meimaroglou, 1998; 
Sinanoglou & Miniadis-Meimaroglou, 2000; Zlatanos et al., 2006). According 
to Boucaud-Camou, cuttlefish is composed mainly of water (81%) and protein 
B
A 
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(16.1%); it has no carbohydrates and lesser than 1% lipids (Boucaud-Camou, 
1990). It is also a source of mineral salts and vitamins, and is highly digestible. 
Its nutritional profile, as a high protein and EPA/DHA lipid source, makes it 
one of the most suitable and healthy forms of human food. An overall increase 
in world cephalopod consumption is predicted, since an open market with high 
growing potential is foreseen in the future.  
 
Fig 2.7 Photographs of cephalopods collected from southwestern coast of Kerala 
Cephalopods are fairly good sources of protein with low in fat content 
and rich in n-3 polyunsaturated fatty acids (Sinanoglou and Miniadis-
Meimaroglou, 1998). The characteristic PUFAs were found to be 
docosahexaenoic acid (DHA; 22:6n−3) and eicosapentaenoic acid (EPA; 
20:5n−3), which ranged between 20% and 36%, and 8.3%, and 17.6% of total 
fatty acids, respectively (Culkin and Morris, 1970; Gibson, 1983; Sinanoglou 
and Miniadis-Meimaroglou, 1998). Passi et al. studied the fatty acid 
composition of several species of teleosts, cephalopods and crustaceans from 
the Mediterranean Sea and found that all of them had an n-3/n-6 ratio of more 
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than 1, confirming the great importance of these fish and shellfish as a dietary 
source of n-3 PUFA for humans (Passi et al., 2002). The essentiality of n-3 
highly unsaturated fatty acids (HUFA) in fish diets is directly related to their 
role as components of biomembrane phospholipids.  
Octopus and cephalopods in general are characterized by low lipid 
contents, with relatively large phospholipid and sterol fractions, and 
triacyglycerides as minor components (Nash et al., 1978; Hayashi and 
Yamamoto, 1987; Navarro and Villanueva, 2000). Thus, the changes in the 
fatty acid composition of total lipids observed in the octopus reflected those 
that occurred mainly in the composition of phospholipids. The nutritional 
composition of cuttlefish has been reported by some researchers (Thanonkaew 
et al., 2006; Villanueva et al., 2004; Ozyurt et al., 2006; Phillips et al., 2002). 
However, this composition could vary among species due to geographical 
differences of fishing grounds.  
2.4 Bioactive potentials of mollusks 
Mollusks are considered as one of the important sources to derive 
bioactive compounds that exhibit antitumor, antioxidant activities 
(Benkendorff et al., 2011; Anand et al., 2010). The bioactive compounds in 
mollusks were identified essentially as peptides, depsipeptides, sterols, 
sesquiterpenes, terpenes, polypropinates, nitrogenous compounds, macrolides, 
prostaglandins, fatty acid derivatives and alkaloids which exhibit specific 
types of bio-activities (Balcazar et al., 2006). Compounds isolated from 
mollusks were also used in the treatment of rheumatoid arthritis and 
osteoarthritis (Chellaram and Edward, 2009). Molluskan extracts also reported 
to exhibit antiviral and antibacterial activity against fish pathogenic bacteria 
(Defer et al., 2009).  
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2.4.1 Bioactive potentials of bivalves 
The antioxidant defense systems are of particular interest in the case of 
marine invertebrates particularly bivalve mollusks. Marine bivalves are 
virtually untapped resource for the discovery of novel bioactivities and were 
reported to contain abundance of bioactive principles, which were reported to  
influence human health (Chellaram  et al., 2004). Marine originated bioactive 
lipids have been reported to be linked in alleviating the symptoms of 
inflammatory conditions (Calder, 2004). Asian green mussel, Perna viridis, is 
abundant in C20-C22 n-3 PUFAs, particularly EPA and DHA, which are the 
precursors of anti-inflammatory resolvins (E- and D-series) (King et al., 
1990). Aerobic organisms including P. viridis maintain constitutive 
antioxidant defenses, detoxifying and scavenging the reactive oxygen species 
(ROS), including superoxide radical (.O2_), H2O2, peroxyl radical (.RO2) and 
hydroxyl radical (.OH) that are continuously produced as a by-product of 
aerobic metabolism (Santovito  et al., 2005). These compounds frequently 
produce structural and functional changes in lipids, proteins and other 
biomolecules, and are derived from the partial reduction of O2. Bivalves were 
reported to repair of oxidative damage caused by ROS by increasing the 
expression of antioxidant molecules (Demple, 1999). The seasonality-related 
variations were reported for antioxidant activities (Power and Sheehan, 1996). 
The aquatic environment particularly intertidal zone is characterized by 
significant variability of temperature and salinity, and pO2. Antioxidative 
indicators therefore are common biochemical markers of combating capability 
of mussels dwelling in the intertidal zone, against ROS. Several studies 
dealing with antioxidant defenses of M. edulis and M. galloproincialis 
demonstrated correlation between antioxidant defenses and seasonality with 
respect to the reproductive period and food availability (Sheehan and Power, 
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1999; Cancio et al., 1999). Dietary antioxidants, phenolic compounds and low 
molecular mass antioxidants (Se, Zn, vitamin E, C, & A) were found to arrest 
the oxidation process by ROS (Fang et al., 2002; Gorinstein et al., 2002).  
2.4.2 Bioactive potentials of cephalopods  
Cephalopods are considered to be a rich source of n-3 fatty acids that are 
responsible for anti-inflammatory activities (Russo and Tringali, 1983). 
Cephalopods were reported to be a goodt source of arachidonic acid along with 
sufficient n-3 PUFAs. PUFAs consisting of 20 carbon atoms (e.g. 20:3n-6, 
20:4n-6 and 20:5n-3) were reported in various cephalopods including squid and 
octopus, which have a wide range of physiological actions including immune 
and anti-inflammatory response, and were reported to have vital role in neural 
function and reproduction (Tocher, 1995; Miliou et al., 2006). The secondary 
metabolites derived from number of marine animals possess antibiotic, anti-
larvae, antiviral and anti-cancer activities (Simmons et al., 2005; Grabley et al., 
1999). The bioactive compounds isolated from the mollusks, in particular, from 
the gastropods are considered to have a role in the chemical defense of the 
animals against their predators. Many promising lead compounds have been 
reported from marine mollusk having anti-inflammatory activity (Morris et al., 
1990). Chemical composition of inks from different mollusks suggested 
convergent chemical defenses (Derby et al., 2007). Methanolic tissue extract of 
cephalopods in 100% concentration showed the maximum activity against 
human pathogens (Ramasamy et al., 2011). Significant antimicrobial activity 
was observed from the polysaccharides extracted from cuttle bone and 
methanolic extract of body tissue of Sepia parshadi, against ten human 
pathogenic bacteria and five fungi (Montgomery et al., 1992). Takaya et al., 
(1994) investigated the antitumour activity of a peptidoglycan fraction 
containing 7.8 % peptide, 57 % polysaccharide and 30 % pigment from the 
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squid (I. argentinus) ink against fibrosarcoma in mice. Mimura et al., (1985) 
reported the anti-inflammatory activity of squid ink that inhibits gastric 
secretion (Mimura et al., 1985). An angiotensin-converting enzyme purified 
from squid ink causes dilation of blood vessels, resulting in lower blood 
pressure. Cephalopod ink has antioxidant activity in both the melanin and 
melanin-free fractions of ink. This antioxidant activity was found to be may be 
related to anti-cancer effects, as established by in vitro studies of various cell 
types and cell lines (Debry, 2014). 
2.5 Compounds isolated from bivalves and cephalopods 
In recent years, many bioactive compounds have been extracted from 
marine invertebrates, such as, sponges, tunicates, bryozoans, and mollusks 
(Donia et al., 2003; Haefner et al., 2003). Marine invertebrates synthesize 
primary and secondary metabolites. Marine bivalve mollusks (Class 
Pelecypoda) settled along the shoreline of south coast of India constitute a 
major share of marine fauna, and were reported to possess structurally diverse 
anti-stress metabolites with respect to antioxidant and anti-inflammatory 
properties (Chandran et al., 2009). These animals usually produce structurally 
diverse substances to form a chemical defensive system, representing a 
different source of bioactive compounds from marine organisms. Of the few 
bio-evaluated for various bioactivities, some showed interesting biological 
activity with respect to antioxidant and anti-inflammatory properties (Kamboj, 
1999). Polar bivalves developed a battery of antioxidant defenses, which 
comprise of enzymes and low-molecular weight scavengers. Past studies have 
reported that polar bivalves are characterized by high antioxidant defenses 
(Lionel et al., 2005). 
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Cephalopods are commonly available throughout the world. These are 
important as a food resource as well as in scientific research (Ngoile, 1987). 
Among the invertebrates, the discovered bioactive compounds in mollusks were 
identified essentially as peptides, depsipeptides, sterols, sesquiterpenes, terpenes, 
polypropionates, nitrogenous compounds, macrolides, prostaglandins and fatty 
acid derivatives which presented specific types of activities (Balcazar et al., 
2006). The specific group of bioactive compounds derived and characterized from 
mollusks have been described under the following sub-sections.  
2.5.1 Polypropionates 
The most prominent source of marine polypropionates are mollusks. 
Marine polypropionates not only play defensive roles in mollusks, but also 
showed antimicrobial, antiviral, and cytotoxic activities. Among a variety of 
polypropionates, a new and two previously known metabolites possessing a 
polypropionate carbon skeleton have been isolated from the marine gastropod 
mollusk Siphonaria lessoni, collected at Chilean coasts (Rovirosa et al., 2006). 
Elysoidean sacoglossan and Placobranchus ocellatus from Indian coast were 
found to be rich sources of two new ɤ-pyrone propionates, possessing a bicyclo-
octane ring  together with the known propionates 9,10-deoxy-tridachione,  
photodeoxytridachione  (Ireland and Scheuer, 1979) , tridachiahydropyrone B and 
C (Fu et al., 2000)  and iso- 9,10-deoxy-tridachione.  Earlier Gavagnin et al., 
(1999) reported photodeoxy-tridachione from the same mollusk of Pacific region. 
These compounds are antioxidants and photodeoxy-tridachione has shown 
activity in an ichthyotoxicity assay at 5 ppm (Gavagnin et al., 1994). 
Siphonarienal was isolated from Siphonaria grisea, whereas other unusual 
pyrone-containing metabolite as siphonarin A was also isolated from S. zelandica.  
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Chemical studies on marine pulmonata of the Onchidiidae family focused 
on polypropionates and onchidione as the main metabolite, was characterized 
from the first collection of the Chinese marine pulmonate Onchidium sp, which 
was present both in the mucus and in the mantle (Carbone et al., 2009). Study on 
the second collection of the mollusk led to the isolation of onchidiol, 4-epi-
onchidiol and related alcohols of onchidione  (Wang et al., 2012).  
 
Fig 2.8 Examples of marine polypropionates isolated from mollusks 
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2.5.2 Nitrogen-containing compounds  
The nitrogen-containing compounds of marine mollusks were found to 
consist of phidianidines A and B obtained from Phidiana militaris, belonging 
to the Glaucidae family of mollusks (Carbone et al., 2011). The phidianidines 
were tested in a panel of tumor cell lines and non-tumor cell lines. These 
componds showed a strong and selective activity against tumor cell lines in 
nanomolar range. The chemical study of an actinocyclidae nudibranch resulted 
in the isolation of actisonitrile (found in the mantle of Actinocyclus papillatus) 
and a lipid based 1,3-propanediol ether skeleton. The compound exhibited 
high cytotoxicity against tumor and nontumor mammalian cell lines in in vitro 
assays (Manzo et al., 2011).  
 
Fig 2.9 Examples of nitrogen-containing compounds isolated from mollusks 
2.5.3 Cyclic peptides 
Kahalalide F, a cyclic depsipeptide isolated from the herbivorous marine 
mollusk, Elysia rufescens, has shown to be effective against cancer cell lines with 
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strong multidrug resistance and against cell lines resistant to topoisomerase II 
inhibitors. In vivo models have also confirmed anticancer activity in various solid 
tumor models (Pardo et al., 2008; Provencio et al., 2009).  
Dolastatin which is a cyclic depsipeptide isolated from D. auricularia was 
found to stabilize actin filaments as in the case of jaspakinolide/jaspamide 
(Umehara et al., 2012). Dolastatins and kahalalides were reported to be 
sequestered by the mollusks from the cyanobacterial diets. Kulokekahilide-2, a 
26-membered cyclodepsipeptide, was isolated from Hawaiian marine mollusk, 
which possesses potent cytotoxicity in mammalian tumor cells (Umehara et al., 
2012).  
 
Fig 2.10 Examples of cyclic peptides isolated from mollusks 
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2.5.4 Alkaloids 
Indole alkaloids from marine invertebrates have reported to possess 
potential anti-inflammatory properties. Manoalide, pseudopterosins, topsentins, 
scytonemin and debromohymenialdisine were isolated from mollusks and were 
found to exhibit anti-inflammatory activity (Chellaram and Edward, 2009a). 
Pseudopterosins have anti-inflammatory and analgesic activities, with a 
mechanism of action different from the common non-steroidal anti-inflammatory 
drugs.  Commercially, pseudopterosins are found in the skin creams as topical 
anti-inflammatory agents (Kohl and Kerr, 2003). An alkaloid lamellarin D (LAM-
D) was first isolated from the prosobranch mollusks of the genus Lamellaria, and 
subsequently obtained from Didemnid ascidians (Andersen et al., 1985). 
Lamellarin was reported to exhibit cytotoxicity against many different tumor cell 
lines and is cytotoxic (Reddy et al., 1999). An isoquinoline alkaloid, jorumycin 
was isolated from the nudibranch  J. funebris collected off the Indian coasts  
(Fontana et al., 2000). Irvalec® and Zalypsis®, are the derivatives of jorumicin, 
and formulated from the lead molecules isolated from opisthobranchs,  Elysia 
rufescens and  Jorunna funebris, respectively (Reyes et al., 2009). The diacetyl 
derivative of ecteinascidin-637, was isolated from the nudibranch  Phidiana 
militaris from the south China sea (Menchaca et al., 2003). The study of different 
Chromodoris species from the South China Sea confirmed the already described 
spongiane diterpenoids and their antiproliferative activities against murine 
lymphoma and human epidermoid carcinoma cell lines (Miyamoto, 1996). 
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Fig 2.11 Examples of alkaloids isolated from mollusks 
2.5.5 Terpenes 
The study on the South China Sea nudibranch Tritoniopsis elegans led 
to the isolation of four diterpenes, tritoniopsins A-D, which displayed an 
unprecedented pyran ring in the cladiellane framework representing a novel 
cladiellane-based diterpene family. Both tritoniopsins A and B were 
discovered from T. elegans and C. krempfi, but the major compound in this 
mollusk was tritoniopsin A, which was found to possess antiproliferative 
activity on tumor and nontumor cell lines (Ciavatta et al., 2011). Two 
formamide-containing pupukeanane sesquiterpenoid congeners were reported 
from the tubercle nudi- branch Phyllidia coelestis (Jaisamut et al., 2013). 
Moderate to strong cytotoxicity towards tumour cell lines was observed for 
these terpenoids. 
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Fig 2.12 Examples of terpenes isolated from mollusks 
2.5.6 Other compounds 
The indole derivatives tyrindoleninone, tyrindolinone, 6-bromoisatin and 
6, 6′-dibromoindirubin were isolated from the Muricidae family of marine 
gastropods and were reported to have anti-cancer properties (Benkendorff et al., 
2011; Vine et al., 2007; Westley et  al., 2010). Tyrindoleninone and 6-
bromoisatin are indole derivatives from marine mollusk Dicathais orbita that 
were found to induce apoptosis in female reproductive cancer cell lines 
(Edwards et al., 2012). These indole compounds inhibited cell growth in solid 
tumour cell lines obtained from the colon and breast, and induced apoptosis and 
necrosis in T-cell lymphoma cells (Benkendorff et al., 2011). 
Dolastatin-10, and Dolastatin 15, derived from the shell-less 
mollusk Dolabella auricularia (Pettit et al., 1987), was reported to have anti-
tumour activity against breast and liver cancer in phase-I clinical trials (Tran et 
al., 1997). Two novel fatty acids pinnaic Acid and tauropinnaic acid extracted 
from Pinna muricata with phospholipase A2 (cPLA2) inhibitory activity 
(Uemura et al., 1996). 
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Two new molecules, 9-chloro-phorbazole D and N1-methyl-phorbazole 
A, co-occurring with the known related phorbazoles A, B and D have been 
isolated and characterized from A. andersoni mollusk. These compounds 
display similar in vitro growth inhibitory activity in the five human cancer cell 
lines, and it mainly relates to cytostatic effects in both human SKMEL-28 
melanoma and U373 glioblastoma cells (Genoveffa et al., 2012). 12-
Deacetoxy-12-oxo-deoxoscalarin, and a series of related scalaranes, most 
likely derived from dietary scalaradial, were isolated from the mollusk, thus 
proving the ability of Glossodoris rufomarginata to modify dietary molecules 
(Gavagnin et al., 2004; Fontana et al., 1999). 
 
Fig 2.13 Examples of other compounds isolated from mollusks 
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2.5.7 Compounds isolated from bivalves  
The marine mussels are not only a cheap source of protein for human 
consumption but also found to possess some complex bioactive compounds, 
which have tremendous potential in medical science. Brown mussel hydrolysate is 
available for human use in the Russian market with trade names Viramid and 
Midel as antiviral drugs. Potentially interesting HIV-virus-inhibiting compound 
have been isolated from the green mussel Perna viridis, and it has been patented 
(Mitra and Chatterji, 2002). Epidioxysterol (EDS) is the compound, which is 
responsible for inducing apoptosis was isolated from hard clam by ethyl acetate 
extraction (Min-Hsiung et al., 2007). Zinc diprolinate isolated from black clam 
was found to be an inhibitor of HIV-1 replication with potential therapeutic 
importance (Pereira et al., 2000). Extracts prepared from economically important 
estuarine clam (Meretrix casta), black clam (Villorita cyprinoides) and mud clam 
(Polymesoda erosa) were found to possess high antiviral activity when tested with 
influenza virus strains type-A (A/Missisipi 1/85/H3N2) and type-B (B/Harbin 
7/94) (Chatterji et al., 2002). Villorita cyprinoides (black clam) having 
agglutination potency on trypsin-treated rabbit erythrocytes (Learnal and Prakash, 
2014). The compound, ES-285–HCl originally isolated from the clam Spisula 
polynyma, has shown selective anticancer properties against several cancer cell 
lines in vitro and against solid hepatocellular, prostate and renal tumours in 
vivo (Den Brok et al., 2006). Saxitoxin has been isolated from several marine 
organisms, such as, the Californian mussels Mytilus californiananus, alaskan 
butter clams Saxidomus giganteus. Saxitoxin produced effects on the 
cardiovascular system, and a marked hypotensive effect at a very low 
concentration. 
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The antioxidant activity detected in Japanese samples of the Pacific oyster 
(Crassostrea gigas) was attributed to 3,5-dihydroxy-4-methoxybenzyl alcohol 
(Watanabe et al., 2012). Carotenoids were isolated from Mytilus galloprovincialis 
(Black Sea, Ukraine), with absolute configurations attributed to and via 
comparison of ECD spectra with previously reported data (Maoka et al., 2011). 
Bathymodiolamides were isolated from the mussel Bathymodiolus 
thermophilus collected at 1700 m depth near the hydrothermal vents on the Mid-
Atlantic Ridge, and were found to inhibit tumour cell growth. Variety of bioactive 
fatty acid derivatives have been isolated from marine organisms, and the most 
unusual example is a highly chlorinated sulfolipid, isolated as a cytotoxic 
principle from the mussel Mytilus galloprovincialis (White et al., 2004). The ω-
conotoxin peptide known as ziconotide (Prialt®) was isolated from the fish-
hunting marine mollusk, Conus magus, and found utility as a therapeutic for 
severe pain. Ziconotide functions through binding as an antagonist to N-type 
voltage-gated calcium channels (Teichert and Olivera, 2010) 
New onchidioneanalogues ilikonapyrone esters with potential 
cytotoxicity were reported from different mollusks belonging to Onchidium 
species. A halogenated tyrosine derivative was isolated from the marine 
mollusk Buccinum  undatum (Hunt and  Breuer, 1971).   
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Fig 2.14 Examples of compounds isolated from bivalves 
2.5.8 Compounds isolated from cephalopods 
Cyclophosphamine, a well-known chemotherapeutic drug induced 
hemopoietic injuries, has been extracted from the squid ink (Zhong, 2009). 
Cyclophosphamide is commonly used to treat cancers and autoimmune diseases. 
Cytotoxic tyrosinase was isolated from the ink of the cuttlefish Sepia officinalis 
(Russo et al., 2003). A cardioactive peptide was isolated from the brain of the 
common octopus, Octopus vulgaris (Kanda & Minakata, 2006). Baker & 
Murphy (Baker & Murphy, 1981) reported the occurrence of aromatic amino 
acids, noradrenaline and some benzoquinols from cephalopods. 
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Fig 2.15 Examples of compounds isolated from cephalopods 
2.5.9 Polysaccharides isolated from mollusks 
Polysaccharides and polysaccharide–protein complexes have been found 
as common polymers in shellfish, and received considerable attention in recent 
years because of their anti-inflammatory, antioxidant, antitumor and 
immunoregulatory activities (Liu et al., 2008, Liu et al., 2007). Polysaccharides 
have been used for decades to stimulate the immune system, and to fight against 
cancer. A glycogen complex extracted from Perna canaliculus, was reported to 
pssess anti-inflammatory activity (Miller et al., 1993). Bioactive lipids, and 
specifically phospholipids are important part of the intestinal mucus (Kao, 1991), 
and an important regulator of epithelial function during inflammation by 
inhibiting cytokine tumor necrosis factor (TNF-α). Green lipped mussel from 
New Zealand hab been shown to contain unique n-3 fatty acids, which appear to 
act as dual inhibitor of arachidonic acid oxygenation by both cycloxygenase and 
lipoxygenase pathways (Tiffany et al., 2002), thus decreasing prostaglandin and 
leukotriene synthesis and downregulating the inflammatory sequence. 
Polysaccharides are potentially useful, and are biologically active ingredients for 
pharmaceutical uses due to diverse biological activities, such as, immunological, 
anti-radiation, anti-blood coagulation, anti-cancer, anti-human immunodeficiency 
virus (HIV), and hypoglycemic activities (Yoon et al., 2003; Yang et al., 2005). 
The activity of polysaccharides is closely related to their structure-related aspects, 
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such as, molecular mass, degree of substitution, degree of branching, sugar 
component and the structure of main chain and branches (Bohn and BeMiller, 
1995). Qin (Qin, 1993) found that Misgurnus anguillicaudatus polysaccharide 
(MAP) played an important role in the prevention of oxidative damage in the 
living systems. Polysaccharide isolated from the cuttlebone of Sepia aculeata and 
Sepia brevimana were found to possess potential antibacterial and antifungal 
activity (Shanmugam et al., 2008).  
2.6 Functional foods from marine sources 
Naturally occurring bioactive extracts or single compounds are believed 
to benefit human health and research resulting in substantial advances in 
nutritional knowledge. There is also growing awareness that dietary source and 
form of food may affect overall health. Suitably, the role of food as an agent for 
improving health has been recognized, initiating the development of new classes 
of compound from marine environment. The added bioactive compounds are 
usually referred to as functional ingredients, and they are responsible for the 
functional bioactivities. The marine ecosystem is an untapped reservoir of 
biologically active compounds, which have considerable potential to supply 
food ingredients towards the development of new functional foods. 
2.6.1 Free radicals 
Oxidation is an essential process for all living organisms for the 
production of energy necessary for biological processes (Duan et al., 2006). The 
most common reported cellular free radicals are singlet oxygen, hydroxyl (OH·), 
superoxide (O2–·) and nitric monoxide (NO·). Also, some other molecules, such 
as, hydrogen peroxide (H2O2) and peroxynitrite (ONOO–) were reported to 
generate free radicals in living organisms through various chemical reactions 
(Halliwell, 2006). Under normal circumstances, cells are able to defend 
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themselves against ROS induced damage with enzymatic antioxidants, such as, 
superoxide dismutase, catalase, glutathione peroxidase and non-enzymatic 
antioxidants such as vitamin E, C and glutathione. The equilibrium between the 
production and the scavenging of ROS may be perturbed by various biotic and 
abiotic stress factors, such as, salinity, UV radiation, drought, heavy metals, 
temperature extremes, nutrient deficiency, air pollution, herbicides and pathogen 
attacks. 
These disturbances in equilibrium lead to sudden increase in the 
intracellular levels of ROS, which can cause significant damage to cell 
structures (Gill and Tuteja, 2010). This is associated with the onset of a variety 
of chronic diseases, such as, cancer and free radical induced degenerative 
diseases. Antioxidant molecules present in different mollusks were found to 
prevent cell damage from oxidative reaction in our body (Nagash et al., 2010). 
Furthermore, the radicals also play a significant role in the process of ageing 
and carcinogenesis (Cuzzocrea et al., 2001).  
2.6.2 Free radicals and inflammation 
Reactive oxygen species (ROS) are important mediators that initiate 
and propagate inflammatory responses by stimulating release of pro-
inflammatory cytokines such as interleukin-1β (IL-1β) and tumour necrosis 
factor (TNF-α) (Geronikaki and Gavalas, 2006). Inflammation is part of the 
complex biological response of vascular tissues to harmful stimuli, such as, 
pathogens, damaged cells, or irritants. The signs of acute inflammation are 
pain, heat, redness, swelling, and loss of function. Inflammatory diseases 
include rheumatoid arthritis, atherosclerosis, Alzheimer dementia, asthma, 
psoriasis, multiple sclerosis, and inflammatory bowel diseases (Gautam et al., 
2009, Rang et al., 2012). Chronic inflammatory diseases constitute a major 
Chapter 2 
44 
cause of mortality and the World Health Organization (WHO) reported 
chronic noncommunicable conditions to be the leading cause of mortality in 
the world, representing 35 million deaths during 2005 (Tunstall, 2006). 
The harmful action of the free radicals can, however, is blocked by 
antioxidant substances, which scavenge the free radicals and detoxify the 
organism. Endogenous antioxidants in the human body act through different 
types of mechanisms,  such as, reducing the ROS generation, stopping the 
ROS formation chain reaction, scavenging ROS with antioxidant enzymes and 
reparing lesions caused by ROS via specific enzymes, such as, endonucleases, 
peroxidases, lipases, etc. All these antioxidant systems act differently, 
depending on their structure and properties, their hydrophilic or lipophilic 
characters, and also depending on their localization (intracellular or 
extracellular, in cell or organelles membrane, in the cytoplasm, etc.).  
 
Fig.2.16 Antioxidant defenses against ROS to eliminate free radicals  
The antioxidant defenses against ROS have been explained in Fig 16. 
SOD is considered a first-line defense against ROS. This enzyme is present in 
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nearly all cells, and converts •O2 - into H2O2. Mitochondrial and bacterial SOD 
contains Mn, while cytosolic SOD is a dimer containing Cu and Zn. As the 
H2O2 may still react with other ROS, it needs to be degraded by either one of 
the other two antioxidant enzymes, GSH-Px or catalase. GSH peroxidase is 
located in the mitochondria. It catalyzes the degradation of H2O2 by reduction, 
where two gluthathione (GSH) molecules are oxidized to glutathione disulfide 
(GSSG). Regeneration of GSH by GSH-reductase, requires NADPH, which is 
oxidized to NADP+. Catalase, on the other hand, is localized primarily in 
peroxisomes, and detoxifies the H2O2 that diffuses from the mitochondria to 
the cytosol, converting it into water and molecular O2. There are also 
nonenzymatic antioxidant mechanisms, which help to regenerate GSSG back 
into GSH (Maria-Luisa et al., 2013). 
Current research in free radicals has confirmed that foods rich in 
antioxidants might play an essential role to prevent cardiovascular diseases, 
cancers, neurodegenerative diseases, including Parkinson’s and Alzheimer’s 
diseases, as well as inflammation and problems caused by cell and cetaceous 
aging (Li et al., 2007). Hence, consumption of antioxidants has been 
advocated to be useful for health as they are found to help neutralize these 
excess free radicals produced in the body. 
2.6.3 Natural and synthetic anti-oxidants 
Currently, reactive oxygen species in the food industry is being controlled 
or minimized by the addition of commercial synthetic antioxidants like BHA 
(butylated hydroxyanisol), BHT (butylated hydroxytoluene) and tBHQ (tert-butyl 
hydroquinone), which are able to reduce the free radicals causing oxidation 
reactions. Recently, much attention is being paid to screen natural molecules to 
prevent several clinical situations, such as, carcinogenicity (Kim et al., 2002). In 
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the search of new antioxidants, exploration of marine habitats has led to the 
discovery that marine plants and invertebrates, as potential reservoirs of 
antioxidants.  
2.6.4 Current symptomatic treatment of inflammation 
Current symptomatic treatment of inflammation is mainly by non-
steroidal anti-inflammatory drugs (NSAIDs) that exert anti-inflammatory 
activities by inhibiting cycloxygenase (COX) enzymes, which exist as two 
isoforms: COXI and COXII (Jaggi et al., 2004). COX is a bi-functional enzyme 
containing a site that converts arachidonic acid (ARA) to prostaglandin G2 
(PGG2), and another site that reduces PGG2 to prostaglandin H2 (PGH2) 
(Fernandes et al., 2004). Prostaglandins are potent mediators of inflammation 
that result in edema, pain and vasodilation.  
2.6.5 Drawbacks of current treatment of inflammation 
NSAIDs produce intestinal tract ulcers (with potential internal 
bleeding) in 10-30 percent of long-term users, and erosions of the stomach 
lining and intestinal tract in 30-50 percent of cases (McPhee et al., 2007). 
Selective COXII inhibitors (coxibs) have come to attention in recent years, 
although they too exhibit side effects, most notably in relation to 
cardiovascular disturbances. As a result, medical researchers are looking for 
safer, more efficacious alternatives to both the traditional NSAIDs and the 
coxibs. There is a tradition of using shellfish supplements as a remedy for 
arthritis among indigenous people, notably in Western Mexico and throughout 
the South Pacific (Whitehouse et al., 1997). Freeze-dried extract of New 
Zealand green-lipped mussel Perna canaliculus (Seatone®) was shown to be 
useful to inhibit experimentally induced inflammation in the treatment of 
rheumatoid arthritis and osteoarthritis (McPhee et al., 2007). 
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2.6.6 Natural alternatives from marine sources 
The marine world, due to its phenomenal biodiversity, is a rich natural 
resource of many biologically active compounds, such as, polyunsaturated fatty 
acids (PUFAs), sterols, proteins, polysaccharides, antioxidants, and pigments. 
Marine-based bioactive food ingredients can be derived from many sources, 
including marine plants, microorganisms, and sponges, all of which contain 
their own unique set of biomolecules (Rasmussen et al., 2007). However, these 
naturally occurring bioactive substances has defined health benefits on the 
human body. Increasing knowledge regarding the impact of diet on human 
health along with the state-of-the-art technologies has led to significant 
nutritional discoveries, product innovations, and mass production on 
unprecedented scale.  
Research on the bioactive compounds in marine mollusks has provided 
interesting leads for the development of a range of complementary and 
alternative medicines, with potential pharmaceutical values. Mollusk-derived 
secondary metabolites have yielded a number of approved therapeutic drugs, as 
well as compounds which are still in clinical trials. Molluskan derived 
compounds in clinical use or final stage clinical trials include the analgesic 
zinconotide (Prialt®); a synthetic-conotoxin peptide from the cone snail Conus 
magus and the anti-lymphoma Brentuximab vedotin Dolstatin-10. Other novel 
mollusk compounds in the clinical trial include anti-tumor depsipeptide 
kahalalide F, isolated from the sea slug Elysia rufescens  and anti-tumor agent 
ES-285, obtained from the clam Mactromeris polynima (Rudd and Benkendorff, 
2014). Freeze-dried extract of New Zealand green-lipped mussel Perna 
canaliculus (Seatone®) was shown to be useful to inhibit experimentally 
induced inflammation in the treatment of rheumatoid arthritis and osteoarthritis 
(McPhee et al., 2007). Lyprinol, a commercially available preparation of P. 
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canaliculus, is the mussel oil obtained by CO2 supercritical fluid extraction, 
which showed potential anti-inflammatory activity (Whitehouse et al., 1997). 
The coastline of South Indian subcontinent is bestowed with large assemblage 
of P. viridis, although they have not been explored in detail regarding their 
potential to be used as nutritional supplement. Considering the importance of 
this species, the present study is envisaged to prepare a freeze-dried concentrate 
from P. viridis collected from the South West coast of India. 
 
Fig. 2.17 P. viridis along the southwestern coast of Kerala  
However, the lipidic ingredients including LC-PUFAs in  the freeze-dried 
concentrate are susceptible to peroxidation (or oxidation) due to the presence of 
olefinic bonds in their structure resulting in low molecular weight aldehydes, 
ketones, and deleterious free radical species under shelf, and are major risk factors 
for cardiovascular and inflammatory diseases. This very important phenomenon is 
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often overlooked by the producers and consumers because we cannot visualize 
their effect immediately, though these undesirable oxidation products and trans-
fatty acids will lead to a cascade of immunosystem compromising diseases in 
long run. It is, therefore, imperative to arrest the oxidation of these fatty acids by 
the addition of antioxidants, and to retain its nutritional properties for a longer 
time period in shelf. In recent years, the use of antioxidants of natural origin is 
considerably enhanced by the concern about the adverse side effects of these 
popularly used synthetic antioxidants and other analogues. Hence we focused to 
explore the natural alternatives to arrest the degradation of vital nutrients with 
respect to long chain polyunsaturated fatty acids (PUFAs) of the P. viridis 
concentrate. Keeping these facts as background information, the present study has 
attempted to prepare functional foods from marine derived bioactive compounds 
for the prevention and treatment of anti-inflammatory and chronic diseases. 
…………??………… 
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Background of the study 
Mollusks are widely distributed throughout the world, and have many 
representatives in the marine and estuarine ecosystems, namely, bivalve 
mollusks and cephalopods. The estuarine representatives are subjected to both 
diurnal and seasonal changes in the hydrological parameters of aquatic 
organisms. The impact of this will be more on resident species particularly 
oysters, clams and mussels etc. (Ansell, 1974a.). Location specific variations 
in growth and survival of bivalves have been demonstrated for Mytilus edulis 
(Incze et al., 1980), Mya arnaria (Appeldoorn, 1983), Crassostrea virginica 
(Mallet and Haley, 1983), Crassostrea gigas (Brown and Hartwick, 1988a) 
and Ostrea edulis (Utting, 1988). 
Bivalve mollusks and cephalopods are highly delicious seafood because of 
their nutritive value next to fin fishes and crustaceans. Bivalves in coastal area are 
fairly good sources of n-3 PUFAs, including the long-chained eicosapentaenoic 
acid (20:5n-3; EPA) and docosahexaenoic acid (22:6n-3; DHA) with valuable 
pharmaceutical and biomedical potentials (Taylor and Savage, 2006). The 
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consumption of bivalve mollusks in India, particularly south Malabar area has 
increased in the recent years in response to the greater availability under wild and 
cultured conditions. Bivalve mollusks were reported to contain bioactive lipids, 
which include fatty acids, sphingolipids, phytosterols, diacylglycerols etc. and 
many of these can influence human health.  
The green mussel Perna viridis (family: Mytilidae) is a bivalve mollusk 
which is native of the Indian coast and throughout the Indo-Pacific and Asia-
Pacific (Benson et al., 2001). It forms a significant fishery and contributes 
nearly 50 percent to the total bivalve production of the area (Laxmilatha et al., 
2011).   
The edible oyster Crassostrea madrasensis is a commercially important 
bivalve mollusk distributed all along the east and west coasts of India. This 
Indian backwater oyster (Crassostrea madrasensis) locally known as ‘Kadal 
muringa’ is found in the backwaters and estuarine regions of Kerala 
Cephalopods are valued marine organisms due to their nutritional, 
commercial and ecological importance. Mediterranean countries are top 
consumers of cephalopods being only equalled or surpassed by some Asian 
countries (FAO, 2012). The main reasons for the increasing demand of the 
cephalopods in international market are due to the fact that, these species are 
good source of protein and essential lipids (Sinanoglou and Miniadis-
Meimaroglou, 2000), and represents an alternative to the exploited fish 
resources. Biochemical analyses of octopus tissues could provide valuable 
information regarding nutritional requirements and nutritional qualities for 
human consumption. 
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Fig 3.1. A: P. viridis samples collected from Kozhikode; B: Wild C. madrasensis samples from 
Cochin; C: O. dolffusi samples from Fortkochi; 
The present investigation was therefore carried out to provide complete 
information on different nutritional qualities of Perna viridis, Crassostrea 
madrasensis and Octopus dolffusi. The present study also correlated the impact 
of seasonal and spacial variation on the essential nutritional compositions with 
respect to amino acids, cholesterol, proteins, lipids, and fatty acids of these 
mollusks harvested from south west coast of Kerala.  
3.1 Methods 
3.1.1 Proximate composition 
The proximate composition analyses of the edible portion of the 
mollusks were performed as follows: Moisture was determined by oven drying 
at 105°C to constant weight (AOAC, 1990). Dried samples were used for 
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determination of crude fat, crude protein and ash contents. All analyses were 
done in triplicate. The crude protein was determined by the Kjeldahl method 
(AOAC, 1990). Crude fat was extracted from the dried tissues using Bligh and 
Dyer (Bligh and Dyer, 1959) method. The fat content was gravimetrically 
determined. Ash was determined gravimetrically in a muffle furnace by 
heating at 550 ºC constant weight (AOAC, 1990). 
3.1.2 Lipid and fatty-acid profile of the candidate mollusks 
3.1.2.1 Estimation of total lipids  
The edible portion of each species (100 g) were left to extract lipids 
overnight in the dark in 1:1 of chloroform:methanol (2:1, v/v) and distilled 
water (200 mL). The lipid extracts were washed according to the Folch 
procedure (Folch et al., 1957) and the organic layer containing lipids was 
evaporated in vacuo. The lipid content was determined gravimetrically in 
triplicate and expressed as percent (w/w) of the edible portion. 
3.1.2.2 Fatty acid profiling by gas-chromatographic analysis 
The fatty acid compositions of the lipids were performed by GLC 
according to the established procedure (Chakraborty & Paulraj, 2008; 
Chakraborty & Paulraj, 2009). The fatty acid converted to fatty acid methyl 
esters (FAMEs) were recorded on a Perkin-Elmer (USA) AutoSystem XL gas 
chromatograph (HP 5890 Series II) connected with a SP 2560 (crossbond 5 
percent diphenyl- 95 percent dimethyl polsiloxane) capillary column (100 m X 
0.25 mm i.d., 0.50ìm film thickness, Supelco, Bellfonte, PA) using a flame 
ionization detector (FID) equipped with a split/splitless injector, which was 
used in the split (1:15) mode. The analyses were accomplished using an oven 
temperature ramp program: 140°C for 1 min, rising at 30°C / min to 250°C, 
where it was held for 1.0 min, followed by an increase of 25°C /min to 285°C, 
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where it was held for 2.0 min, until all peaks had appeared. The injector and 
detector were held at 285°C and 290°C, respectively. Nitrogen (ultra high 
purity > 99.99 percent) was used as the carrier gas with a pressure of 5.6 x 103 
kg/m2 and flow rate of 25 mL /min. The flow rate of hydrogen (45 mL/min) 
and air (450 mL/min) were maintained at a pressure of 3.5 x 104 kg/m2. The 
injection volume was 0.2 µL FAMEs were identified by comparing the 
retention time of the samples and appropriate FAME standards and the relative 
percentage of the area was obtained by using the subsequent formula: Percent 
of total fatty acid (percent TFA) = (Area of the methyl esters / Total area of 
the chromatogram) X100; where. Peak areas lower than 0.1percent of the total 
area was not considered. Three replicate injections were performed and the 
mean results were expressed as percent of total fatty acids (percent TFA) ± 
standard deviation.  
3.1.2.3 Evaluation of fatty acid based nutritional indices 
The different nutritional indices with respect to fatty acids, such as, n-
3/n-6, n-6/n-3, DHA/EPA, PUFA/SFA and LA/ALA ratios were calculated in 
order to allow comparisons with the United Kingdom department of health 
recommendations (HMSO, 2001). The indices of atherogenicity (AI) and 
thrombogenicity (TI) (Ulbricht & Southgate, 1991) have been calculated as: 
AI = (4 * 14:0 + 16:0 + 18:0) / (MUFA + n-3 PUFA + n-6 PUFA) ; TI = (14:0 
+ 16:0 + 18:0) / [(0.5 * MUFA) + (0.5 * n-6 PUFA) + (3 * n-3 PUFA) + (n-3 
PUFA/n-6 PUFA). The hypercholesterolaemic (HH) ratio were determined as, 
HH= (18:1n-9 + 18:2n-6 + 20:4n-6 + 18:3n-3 + 20:5n-3 + 22:5n-3 + 22:6n-3)/ 
(14:0 + 16:0) (Santos-Silva et al., 2002).  
3.1.3 Determination of true protein and amino acids 
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The protein contents of the mollusks were estimated by the established 
method (Lowry et al., 1951). The absorbance of the protein aliquot was 
measured at 660 nm in a UV-visible spectrophotometer within 15 min against 
the reagent blank. The protein content of the sample was calculated from the 
standard curve of bovine serum albumin, and expressed as g 100g-1 edible 
portion. Amino acid content of the mollusks was measured using Pico-Tag 
method as described earlier Heinrikson and Meredith (Heinrikson and 
Meredith, 1984) using suitable modifications. The sample (0.1 g) was 
hydrolysed for 24 h at 110°C with 6 M HCl in sealed glass tubes filled with 
nitrogen. The hydrolyzed samples were treated with redrying reagent (MeOH 
95percent: water:triethylamine, 2:2:1 v/v/v), and thereafter pre-column 
derivatization of hydrolysable amino acids was performed with 
phenylisothiocyanate (PITC, or Edman’s reagent) to form phenylthiocarbamyl 
(PTC) amino acids. The reagent was freshly prepared, and the composition of 
derivatizing reagent (methanol 95percent: triethylamine: phenylisothiocyanate, 
20  μL, 7:1: l v/v/v). The derivatized sample (PTC derivative, 20 μL) was 
diluted with sample diluent (20 μL, 5 mM sodium phosphate NaHPO4 buffer, 
pH 7.4: acetonitrile 95:5 v/v) before being injected into reversed-phase binary 
gradient HPLC fitted with a packed column (dimethylocatadecylsilyl- bonded 
amorphous silica; Nova-Pak C18, 3.9 X 150 mm) maintained at 38±1°C in a 
column oven which connected to a Waters 2487 dual absorbance detector 
(ëmax 254 nm). The mobile phase eluents used were eluents A and B, whereas 
eluent A comprises sodium acetate trihydrate (0.14 M, 940 mL, pH 6.4) 
containing triethylamine (0.05percent)., mixed with acetonitrile (60 mL), and 
eluent B used was acetonitrile : water (60:40, v/v). A gradient elution 
programme, with increasing eluent B was employed for this purpose. An 
additional step of 100percent eluent B is used to wash the column prior to 
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returning to initial conditions. Standard was run prior to sample injection. 
Samples (PTC amino acid derivatives) were injected in triplicate, and the 
output was analyzed using BREEZE software (Waters Corporation, Milford, 
MA 01757). The quantification of amino acids was carried out by comparing 
the sample with the standard, and the results were expressed in g 100g-1 edible 
portion. The total essential amino acids (TEAA), total non-essential amino 
acids (TNEAA), total amino acids (TAA) and the ratio of total essential amino 
acid to the total non essential amino acid (EAA/NEAA) were calculated. 
3.1.4 Total cholesterol content 
The total cholesterol content in the edible portion of the mollusks were 
determined spectrophotometrically (Varian Cary, USA) as described 
elsewhere (Wanasundara and Shahidi, 1999) with suitable modification using 
o-phthalaldehyde (50 mg dL-1 in glacial acetic acid). The total cholesterol 
content of the samples were calculated from the standard curve of cholesterol, 
and expressed as mg/ 100g edible portion (mg/ 100g EP). 
3.1.5 Estimation of minerals 
The estimation of minerals was carried out by atomic absorption 
spectrophotometer (AAS) following the di-acid (HNO3/HClO4) digestion 
method with suitable modifications (Astorga-Espana et al., 2007). In brief, the 
edible portions of mollusks (2 g) were placed in digestion tubes, to which 
concentrated HNO3 (7 mL) was added, and the content was kept for overnight 
digestion in a fume hood until no brown fumes appeared. The digestion was 
continued over the sand bath with HClO4 (6 mL) until the color of the solution 
became pale yellow to colorless. The solution was thereafter cooled and 
filtered through Whatman No. 1 filter paper. The filtrate was diluted with 
distilled water (50 mL) to be injected in atomic absorption spectrophotometer 
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Se, continuous flow hydride generator coupled with atomic absorption 
spectrometer was used. Phosphorus content was analyzed by alkalimetric 
ammonium molybdophosphate method as described in AOAC official method 
964.06 (AOAC, 2005). The Macro minerals (Na, K, Ca and P) are represented 
in mg 100g
-1 
edible portion and the micro minerals (Fe, Mn, and Zn) are 
represented in mg 100g
-1 
edible portion  
3.1.6 Estimation of vitamins 
The estimation of fat soluble vitamins (A, D3, E and K1) in the edible 
portions of the mollusks was carried out using a modified method of Salo- 
Vaananen et al. (Salo- Vaananen et al., 2000). The stock solutions of vitamin 
standards were prepared °C (1, 10, 25, 50, & 100 ppm) to construct the 
standard curve by HPLC. All the stock solutions were stored at -20°C except 
vitamin D3 where the stock solutions were stored at 4°C. The lipids were 
extracted using the procedure described in 3.1.2.1, which was hydrolyzed, 
with KOH/MeOH (0.5N, 2 mL) at 60°C for 30 min to furnish the hydrolyzed 
mixture, which (2 mL) was thereafter extracted with petroleum ether (12 mL), 
and washed with distilled water (2 x 8mL) to make it alkali-free. The 
nonsaponifiable matter (8 mL) was concentrated using a rotary evaporator 
(50°C), reconstituted in MeOH, and filtered through nylon acrodisc syringe 
filter (0.2 μm) to be injected (20 μL) in HPLC equipped with a C18 column 
(Phenomenex, 250 mm length, 4.6 mm I.D., 5ìm) in a column oven (32°C). 
The run time was 45 min, and the eluents were detected at 265 nm (UV-VIS 
detector) using the gradient programme as follows: 20percent MeOH upto 3 
min, which was increased to 100percent in next 5 min and held for 37 min. 
The flow rate was 1 mL/min. The vitamins A, D3, E, K1 were expressed as μg 
100g
-1
  edible portion. The water soluble vitamin, ascorbic acid, was 
determined based upon the quantitative discoloration of 2, 6-dichlorophenol 
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indophenol titrimetric method as described AOAC (AOAC, 2005). The 
vitamin C was expressed as μg 100g-1 edible portion. 
3.1.7 Statistical analyses 
Statistical evaluation was carried out with the Statistical Program for 
Social Sciences 13.0 (SPSS Inc, Chicago, USA, ver. 13.0). Descriptive 
statistics were calculated for all the studied variables. Analyses were carried 
out in triplicate, and the means of all parameters were examined for 
significance (p = 0.05) by analysis of variance (ANOVA). The Pearson 
correlation test was used to assess correlations between means. The level of 
significance for all analyses was P<0.05. 
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3A. Nutrient profiling of green mussel (Perna viridis L.) from 
southwest coast of India  
General 
The green mussel, P. viridis, is a bivalve mollusk (family Mytilidae) 
which is found in the coastal sea beds in the Arabian Gulf in south Malabar 
waters along the west coast of Peninsular India. In India, two species of mussels 
(green mussel P. viridis and brown mussel P. indica) support a traditional 
sustenance fishery in Malabar and Konkan areas of Penninsular India. India has 
risen to one among the top ten cultured mussel producing nations in Asia, with 
an annual production of 10,060 tonnes (Kripa & Mohammed, 2008). The 
consumption of bivalve mollusks in India, particularly south Malabar area has 
increased in the recent years in response to the higher availability from wild and 
cultured conditions.  
The potential health benefits related to marine mussel consumption are 
due to the presence of inexpensive source of protein/amino acid with high 
biological value and polyunsaturated fatty acids (PUFAs) especially long-
chain n-3 PUFAs containing mainly eicosapentaenoic acid (20:5n-3; EPA) and 
docosahexaenoic acid (22:6n-3; DHA) which have valuable pharmaceutical 
and biomedical potential (McLean & Bulling, 2005) Proteins, lipids, minerals 
and fatty acids, contribute to the nutritional value and organoleptic 
characteristics of P. viridis. In addition, it contributes to the intake of essential 
minerals and trace metals and certain vitamins (Astorga et al., 2007).Recently, 
after the importance of P. viridis as a potential health food had been realized, 
studies on its biochemical composition began to receive considerable 
attention. It is anticipated that the determination of the essential nutritional 
composition of wild P. viridis vis-à-vis cultured one will provide the necessary 
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information concerning the nutrient value of this seafood for both to the 
consumers and to the researchers working on nutrient tables.  
Among the different parameters of quality, biometric measurements and 
chiefly meat yield are important aspects of mussel marketability. Biochemical 
changes in the mussel from different sites and growth conditions may result 
from fluctuations of environmental parameters, viz., temperature, salinity, 
oxygen levels, and to the physiological status of the animals, depending on food 
availability, gametogenic cycle, and spawning (Livingstone, 2001). Earlier 
studies indicated the influence of environmental and nutritional conditions on 
the composition of bivalves (Khan et al., 2006; Murphy et al., 2002). 
No reports have yet been published about the essential nutritional 
composition of the green mussel under wild and cultured condition. The data 
will provide useful information for food industries and mussel aquaculture. 
Therefore, considering the promising perspective for the utilization of P. viridis, 
and the need for knowledge of its biochemical composition, this work explores 
the influence of the growth conditions on the essential nutritional compositions 
of P. viridis harvested from different sites in south western coast of India.  
3A.1 Samples collection and processing 
3A.1.1 Samples collection 
P. viridis (green mussel) samples (wild and cultured) were collected from 
two different sites (Cochin and Kozhikode) along the southwest coast of India. 
The sample collection sites of green mussel (P. viridis) (wild and cultured) from 
two different sites (Cochin and Kozhikode) are depicted in Fig.3A.1. The first one 
is a relatively clean site on intertidal rocky shore of the Sattar island at Cochin 
(UST: 1141160E, 221200N) (Lat: 9
058’N; Long: 76016’E) in the southwestern 
coast of India, predominantly influenced by oceanic water from the Arabian Sea. 
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During the same period P. viridis samples were collected from Elathur (Lat: 
11054’11.6”N; 750 12’. 21.8’’E), located about 10 km north of Kozhikode city 
and is  bounded by the Arabian Sea on the west and the Korapuzha River (Elathur 
River) on the north along the Southwestern coast of India. Fig 3A.1 illustrates the 
sampling locations of P. viridis. P. viridis from both sites were collected at 
comparable depths (2 m below the surface) to avoid confounding effects of depth 
on the fatty acid composition. Cultured mussels were stripped from the 1/4" rope, 
at each site and transported for analyses following the protocol. Gender 
differences of the representative samples (n = 3 at each determination) were not 
treated. All live samples thus collected were immediately placed on ice for 
transportation, in isothermic boxes. Upon return, these samples were cleaned of 
fouling organisms and placed in filtered (1.0 mm) seawater at the ambient 
temperature The tissues of mussels from the two sites were combined, minced, 
and the samples were stored in low temperature (-20°C) until further use for 
biochemical characterization.  
 
Fig.3A.1  Sample collection site of green mussel (P. viridis) (wild and cultured) from two 
different sites (Cochin and Kozhikode) along the Southwestern coast of India. Sattar 
island at Cochin (UST: 1141160E, 221200N) (Lat: 9
058’N; Long: 76016’E) and Elathur (Lat: 
11054’11.6”N; 750 12’.21.8’’E) were selected as respective collection sites of P. viridis. 
3A.1.2  Biometric parameters, condition indices, and meat yield of P. viridis  
P. viridis thus collected were measured for their biometrical parameters, 
viz., length, width, and thickness. Length (maximum measure along the anterior-
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posterior axis), width (maximum lateral axis), and thickness (depth of the 
maximum longitudinal axis) of 235 randomly selected mussels, were measured 
using a vernier calliper. The mussels were then weighed, opened by cutting the 
adductor muscle with a scalpel, and the wet meat and shell weight were noted. 
The tissues were oven dried for 48 h at 60°C, and the dry weight determined. 
Condition indices are used to characterize the apparent health and quality of a 
biological entity. Three condition indices (CI) were taken into account in this 
study are as follows: (1) Economic CI (Imai and Sakai, 1961) as thickness X [0.5 
(length+width)]
-1; (2) Booth’s CI (Booth, 1983) flesh weight X total weight-1. (3) 
Ecophysiological CI (Walne, 1976) as dry flesh weight / dry shell weight. The dry 
weight of the shells was determined by oven-drying at 80
o
C for 12 h. In brief, the 
whole weight of mussels was obtained on an electronic balance, before the meat 
was sucked. The dimensions of shells were measured using a vernier calliper, and 
weighed. The meat from each mussel was weighed to obtain wet weight and dry 
weight, the latter after desiccation kept in a freeze-dryer for 24 h at −100°C.  
3A.2 Results and discussion 
The present study provided a detailed biochemical profile of the green 
mussel, Perna viridis collected from the wild and cultured conditions, for the 
first time, from two prominent mussel beds from different geographical 
regions of the south-western coast of India (Cochin and Kozhikode). 
Considering the production trend of edible bivalves, where the contribution of 
cultured P. viridis showing an increasing trend, information on the food 
qualities of cultured with reference to the wild ones is of importance. 
Differential growth conditions (wild and cultured) of P. viridis were therefore 
studied to understand their effect on nutritional indicators. This is essentially 
to develop the P. viridis nutritional biomarkers with respect to the collection 
area and growth condition for use in human food and nutrition.  
Nutritional importance of Perna viridis, Crassostrea madrasensis and Octopus dolffusi 
65 
3A.2.1 Biometric characteristics, percent meat yield and condition index (CI) 
The commercial quality and physiological state of bivalve mollusks are 
adequately described by Condition Index (CI), a parameter of economic 
relevance reflecting the ecophysiological conditions and the health of P. viridis. 
The wild samples collected from Kozhikode showed significantly higher 
(P<0.05) Imai and Sakai's CI than cultured samples (3.1). The Booth’s CI 
registered maximum value for cultured samples, collected from Kozhikode. A 
low value of CI for both wild and cultured samples collected from Cochin 
indicates that a major biological effort has been expended, either as maintenance 
energy under poor environmental conditions or disease, or in the production and 
release of gametes during spawning. The values obtained in this study indicated 
that cultured samples from Kozhikode were in good condition than Cochin 
samples. In Goa region of south-western coast of India, P. viridis were reported 
to grow faster on ropes compared to those in natural beds (Qasim et al., 
1977).Wild samples collected from Cochin exhibited significantly higher (P< 
0.05) meat yield than recorded in cultured samples. The variations of percent 
meat and CI of P. viridis were statistically significant (P<0.05). CI and meat 
content of green mussels were registered to be affected by a variety of 
environmental and endogenous factors, viz., water temperature, salinity, food 
availability, and gametogenic cycle of animals (Okumus and Stirling, 1998). 
However, the parameters of meat yield and condition index from wild and 
cultured P. viridis are within the range as reported earlier (Okumus and Stirling, 
1998), and, therefore, appeared to be in good condition for consumption. 
Principle component analyses (PCA) were carried out to gain an overview of the 
similarities and differences among the various parameters of wild and cultured 
P. viridis collected from different geographical locations (Cochin and 
Kozhikode). The major nutritional and biochemical parameters of P. viridis vis-
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à-vis different sampling locations/growth conditions were included as variables 
in a PCA model and illustrated under Fig 3A.2. The loading plot obtained by 
performing PCA on conditional indices viz., Imai and Sakai (IS), Walne, Booth 
and meat yield, which were included as variables, were shown in Fig 3A.2. The 
formation of group A which comprises conditional indices of Walne, meat yield 
(wild from Cochin and cultured from Kozhikode) and Booth (cultured from 
Cochin and wild from Kozhikode) showed a high positive correlation with PC 1 
(64.56%). PC 2 describes the remaining variability (35.44%). Correlation 
between various nutritional and antioxidative parameters of wild and cultured P. 
viridis from two geographical locations by loading plot diagrams (A-F) of 
various components (PC-1 and PC-2) in rotated space. 
 
 
Fig 3A.2 The loading plot diagram (in PCA plot) showing the correlation of various condition 
indices (Imai and Sakai (IS), Walne, and Booth) vis-à-vis meat yields. Here, cCoc and 
cKoz signify cultured P. viridis from Cochin and Kozhikode, respectively, whereas 
wCoc and wKoz imply wild P. viridis from Cochin and Kozhikode, respectively.  
3A.2.2 Proximate composition  
The proximate compositions of mussels are characterized by phases of 
accumulation and depletion of food reserves, reflecting the stage of gonadal 
development, and availability of food. There was no marked variation in the 
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contents with respect to fat, crude fibre, and ash from different regions of the 
experimental area, as well as growth conditions (cultured and wild). The crude 
protein content varied from 7.14 -13.1%; the minimum of 7.14% was recorded 
in Cochin (wild) and maximum of 13.1% in samples collected from 
Kozhikode (wild) (Table 3A.1). Proximate composition analyses in Mytilus 
galloprovincialis from different Spanish origins revealed moisture content as 
79-83g 100g
-1
, lipid 1.4-2.1 g 100g
-1
, and protein 6.5-10 g 100g
-1
 (Fuentes et 
al., 2009). An inverse relationship between moisture and protein content was 
apparent between Kozhikode and Cochin samples. Crude fat and ash recorded 
significant difference (P<0.05) between wild and cultured samples, and their 
fluctuations were also coincident with those of the crude protein. There 
appeared to be no significant differences in acid insoluble ash content of 
cultured samples collected from Cochin and Kozhikode (P>0.05). A positive 
correlation between CI and biochemical constituents of bivalves has been 
reported in different mollusk species (Orban et al., 2004).  
Table 3A.1 Biometric measurements, condition index, meat yields (percent), proximate, lipid, 
protein, cholesterol, and mineral compositions of P. viridis collected from Cochin 
and Kozhikode 
 Cochin 
 
Kozhikode 
  wild cultured wild cultured 
Length (cm) 6.00±0.01a 8.10±0.03b 9.40±0.07b 6.33±0.01a 
Width (cm) 2.59±0.03a 3.14±0.03b 4.10±0.01c 2.40±0.14a 
Thickness (cm) 2.88±0.09a 3.96±0.04b 5.10±0.01c 1.90±0.04d 
Meat yield (%) 28.4±0.03a 24.5±0.04b 27.9±0.03a 34.0±0.01c 
Condition  indices 
Imai and Sakai  0.63 ±0.02a 0.65±0.05a 0.86±0.01b 0.60±0.02a 
Booth 0.28±0.01a 0.24±0.04b 0.28±0.04a 0.34±0.02c 
Walne 0.06±0.02a 0.07±0.01a 0.06±0.01a 0.08±0.01a 
Proximate composition (g 100g-1 wet sample) 
Dry matter 10.68 ± 0.01a 17.86 ± 0.01b 20.6±0.02c 16.8±0.01b 
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Moisture 89.32 ± 0.52a 82.14 ± 0.61b 79.3±0.60b 83.1±0.84b 
Crude protein 7.14 ± 0.07a 12.02 ± 0.05b 13.1±0.18b 11.9±0.04b 
Crude fat 1.27 ± 0.04a 1.90 ± 0.02b 1.96±0.02b 1.72±0.03b 
Crude ash 1.42 ± 0.03a 1.71 ± 0.002b 1.65±0.02b 0.99±0.008d 
Crude fiber 0.012 ± 0.002a 0.014 ± 0.001b 0.08±0.01c 0.07±0.007d 
Carbohydrates (soluble) 0.84 ± 0.12a 2.22 ± 0.072b 3.78±0.31c 2.08±0.05b 
Acid insoluble ash 0.61 ± 0.01a 0.09 ± 0.002b 0.13±0.01c 0.07±0.01b 
Lipid (%) 1.47± 0.10a 2.63±0 .19b 2.00±0.13c 1.70±0.16d 
Cholesterol (mg 100g-1) 96.6±0.78a 65.1±0.32b 58.61±0.42c 36.28±0.42d 
Protein (mg 100g-1) 183.06±3.9a 236.6±5.38b 103.9±0.67c 220.3±1.83d 
Macronutrients (mg 100g-1  wet sample) 
Na 1967.25± 14.32a 1942.00±26.05a 2136.5±1.59b 1195±2.12c 
K 1450.50±84.73a 1563.25±87.24b 1532.2±3.80b 697.5±1.96c 
Ca 287.00±13.41a 427.65±36.28b 280.92±0.53a 1095±9.2d 
Mg 64.33±2.05a 353.58±8.49b 69.2±0.72a 515±1.45c 
Micronutrients (mg 100g-1  wet sample) 
Cr ND 0.17± 0.02a 0.365±0.07b ND 
Zn 1.55± 0.11a 2.57± 0.19b 3.03±0.01c 3.19±0.01c 
Mn ND 0.84± 0.05b 0.27±0.09b ND 
Cu 0.05± 0.01a 0.12± 0.01b 0.26±0.06c 0.22±0.01c 
Fe 6.10± 0.08a 4.48± 0.25b 10.19±0.81c 4.61±0.07b 
Se 0.04± 0.00a 0.03± 0.001b 0.04±0.01a ND 
Fat soluble vitamins 
Retinol (A)/IU 11.89±1.16a 12.71± 0.85a 8.20±0.15b 5.31±0.08c 
Cholecalciferol (D3)/IU 410.0±17.1a 442.0 ± 6.3b 352.5±4.3c 412.8±2.5a 
Tocopherol (E)/IU 0.15±0.01a 0.14± 0.02a 0.13±0.01a 0.12±0.01a 
Phylloquinone (K1) (μg 100g-1) 2.72±0.18a 2.65± 0.21a 1.26±0.02b 2.2±0.14c 
Water soluble Vitamins 
Ascorbic acid (C)/IU 12.14±0.95a 9.28± 0.56b 12.74±0.15a 9.89±0.08b 
All samples were analyzed in triplicate (n=3) from a pooled samples (20 numbers), and expressed 
as mean ± standard deviation. Means followed by the same letter within the same row are not 
significantly different, and different letters indicate significant differences (P<0.05). ND: non 
detectable.  
3A.2.3 Protein, lipid and total cholesterol contents of P. viridis 
Bivalve mollusks were reported to provide an inexpensive source of 
lipid and protein with high biological value (Astorga et al., 2007). The 
cultured samples collected from both the sites were found to possess the 
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significantly higher protein content (P<0.05) than their wild counterparts 
(Table 3A.1). The variations in protein contents appeared to be due to the 
differential availability of food (microalgae), which were reported to be major 
food sources of filter feeders viz., bivalve mollusk P. viridis (Fernández-Reiriz 
et al., 1989). P. viridis from both locations and growth conditions were found 
to be rich in proteins with a low calorie count; they may therefore form an 
essential part of a healthy diet. 
The cultured P. viridis harvested from Cochin registered higher lipid 
content (> 2. % than wild samples (<1.5%) (Table 3A.1). It is generally accepted 
that water temperature and differences in salinities are principal environmental 
factors affecting growth and gonadal development of marine bivalves (Pazos et 
al., 1996), which is a major reason for the differences in lipid content. The 
marginal differences in the lipid content of tissues of P. viridis apparently depend 
on the variation in the availability of food, temperature and microclimatic 
conditions. The higher relative percentage of diatoms (Thalassiosira subtilis, 
Nitzschia seriata, Baciallria paradoxa, and Biddulphia mobilensis) and 
dinoflagellates in their diet (Ceratium furca, C. tripos, Gonyaulax spinifera, and 
Peridinium biconicum) with high lipid content appeared to contribute to the lipid 
pool of P. viridis. The total lipid content of P. viridis in this study are in good 
agreement with earlier studies with Mytilus edulis and Perna canaliculus 
(Murphy et al., 2002), in which the total lipid content varied from 1.06 -1.97% 
(wet weight). 
Wild samples recorded significantly higher cholesterol content than 
cultured samples (P<0.05) both in Kozhikode as well as Cochin, respectively. 
Though significant differences in cholesterol contents were observed between 
wild and cultured samples collected from Cochin and Kozhikode, the values are 
well within the limits, and considered to be safe for consumption. Plankton is 
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the predominant diet of mussels, which contains various sterols, and they can be 
incorporated into mussel tissues, and some sterols viz., cholesterol can be 
synthesized from plankton cholesterol precursors (Li et al., 2007). Earlier 
studies reported cholesterol as predominant sterol present in mussels (Li et al., 
2007). Cholesterol was the major sterol in Mytilus edulis (30%) and Perna 
canaliculus (29%) (Murphy et al., 2002). The loading plot of cholesterol was 
analyzed by PCA (Fig 3A.3). Cholesterol of cultured origin from both sampling 
locations (Cochin and Kozhikode) is the dominant features in PC 1 (74.2%). 
 
 
Fig 3A.3  The loading plot diagram showing the correlation of cholesterol content in cultured 
and wild (wCholKoz, wCholCoc, cCholCoc and cCholKoz) P. viridis. 
 
3A.2.4 Mineral composition  
Minerals are nutrients that are conserved by the body and play 
significant role in metabolism in the human body. The present study revealed 
that Ca and Mg were higher than those reported in the literature for bivalve 
mollusks (Astorga et al., 2007). The cultured green mussels registered 
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significantly higher content of the macronutrients (Ca, Mg) than wild samples 
from both experimental locations (P<0.05). Cultured samples collected from 
Kozhikode recorded significantly higher Mg content than cultured Cochin 
samples (P<0.05). Ca and Mg are extremely important minerals that are often 
out of balance in persons with arteriosclerosis and thyroid diseases. 
Imbalances of these minerals can result in irregular heart rate. A normal 
person needs a Ca/Mg ratio of about 2:1. Alterations in the metabolism of Ca 
and Mg have been implicated in the pathogenesis of primary hypertension 
(Kisters et al., 2004).  The cultured samples from Kozhikode was found to be 
superior to another in terms of the Ca/Mg ratio (2.13), and therefore may be 
referred to be an ideal diet for good health. The cultured samples from 
Kozhikode registered significantly lower (P< 0.05) Na than other samples, and 
therefore, rated high as health food. Reports linking excessive Na intake to the 
genesis of hypertension and other related diseases like changes in vascular 
reactivity, and changes in the renin–angiotensin system are well-known 
(Santos et al., 2006).The micronutrient element, Zn was found to be 
significantly higher in samples collected from Kozhikode than Cochin. The 
cultured P. viridis was found to possess higher content of Zn than either the 
wild samples from both locations. Zn was found to be the second most 
abundant trace element in P. viridis (after Fe), and its role in the 
pathophysiology of disease is stimulating a great deal of interest (Coudray et 
al., 2006). Copper (Cu), which is also receiving growing attention for its role 
in alleviating oxidative stress, was found to be higher in samples collected 
from Kozhikode (~0.2 mg 100g
-1
).Se, the antioxidant mineral element was 
found to vary between 30-40 µg 100g
-1 
this species is a valuable natural 
resource to combat free-radical induced disorders in the body. The variation of 
mineral content appeared to be due to the influence of several factors including 
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food availability and differences in metal regulation. In addition, the 
differences in the mineral concentrations of the surrounding seawater could 
also influence their levels in P. viridis (Astorga et al., 2007).
 
3A.2.5 Vitamin and unsaponifiables 
The contents of fat soluble vitamins (A, D3, E & K1) and water soluble 
vitamin (vitamin C) were recorded in Table 3A.1. All trans-retinol underwent 
highly insignificant fluctuations reaching maxima in cultured samples and 
minima in wild samples from Cochin. The levels of α-tocopherol, a vitamin 
with anti-oxidant properties, in P. viridis were low, and showed insignificant 
fluctuations between wild and cultured samples collected from the 
experimental locations (P>0.05). Significant differences were apparent in 
phylloquinone (K1) content between wild and cultured samples collected from 
Kozhikode (P<0.05). Similarly, significant differences in cholecalciferol (D3) 
content were realized between the wild and cultured samples collected from 
two different locations (P<0.05). The Vit C The loading plot of vitamins (Fig 
3A.4) indicates that the vitamin E variables of both wild and cultured origin 
from Kozhikode are the dominant features in PC 1 accounting for 53.2% of the 
total variability. The highest loadings on the second component (PC 2) were 
defined by vitamin D3 of both growth conditions (wild and cultured) of P. 
viridis from Cochin, representing 46.8% of the total variance. The values of 
trans retinol content are within the limits to impart their beneficial effects. 
Vitamin D precursors constitute a large proportion of the unsaponifiable 
fraction of mollusk lipids. Among minor unsaponifiable components, HPLC 
analyses showed that oxygenated carotenoids, characterized by typical 
absorption spectra, were prevalent over the less polar, late-eluting, α-carotene 
and β-carotene. Due to the lack of suitable standard compounds, the early-
eluting xanthophylls were not identified. 
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Fig 3A.4: The loading plot diagram of fat soluble and water soluble vitamins A, D3, E, K1, C 
collected from Cochin and Kozhikode 
3A.2.6 Amino acid composition  
A total of seventeen amino acids was identified and quantified in the 
samples of cultured and cultured P. viridis collected from two different locations 
is shown in Table 3A.2. The cultured samples were found to possess higher 
essential amino acids than wild samples, and present in quantities required for 
balanced nutrition. It is to be noted that the cultured samples collected from 
Kozhikode exhibited significantly higher essential amino acid content than wild 
samples (P<0.05). Among the wild samples from Kozhikode, the most abundant 
essential amino acid was found to be phenylalanine followed by arginine and 
leucine. The study indicated that Kozhikode samples have significantly higher 
methionine content (1.15-0.93g 100g
-1
) than Cochin (0.26-0.43g 100g
-1
) samples. 
In general, the amino acid lysine is absent in cereals and this amino acid 
constitutes a major share to the total essential amino acid pool in cultured P. 
viridis from both experimental locations. Threonine, another essential amino acid 
deficient in cereals, was found to be more in P. viridis from Kozhikode as 
compared to the samples collected from Cochin. This was supported by earlier 
works of Wesselinova (Wesselinova, 2000), who reported that the amounts and 
 
 
 
C 
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types of amino acids in fish muscle were affected by location. It is, therefore, 
anticipated that cultured P. viridis is a good source to supplement the deficient 
amino acids in cereals. Iwasaki and Harada (Iwasaki and Harada, 1985) similarly 
reported lysine as one of the major amino acids in the muscles from marine origin. 
Among the non-essential amino acids in Kozhikode samples, negatively charged 
amino acid glutamate was observed to be the predominant. Glycine was found to 
constitute a major share, thereby signifying the potential capability of this species 
to withstand salinity and adverse stress. The results obtained from this study 
showed that cultured P. viridis have well-balanced and high-quality protein source 
in the respect of EAA/NEAA ratio. Any ratio of EAA/NEAA amino acids higher 
than 1.0 is considered to be excellent, and therefore it can be concluded that, P. 
viridis collected from Kozhikode is a good sources of well-balanced proteins and 
high-quality protein source in respect of EAA/NEAA ratio. The percentages of 
the major amino acids of P. viridis from different growth conditions (wild and 
cultured) and geographical locations were included as variables in a principal 
component analysis (PCA) and given as a loading plot in (Fig 3A.5). The 
parameters included in the loading plot are aspartic acid, glutamic acid, lysine, 
arginine, ΣEAA, ΣNEAA, ΣTAA and EAA/NEAA ratio (Fig 3A.5). The highest 
loadings on the first component (PC 1) were defined by variables viz., glutamic 
acid, EAA/NEAA ratio of both growth conditions (wild and cultured) of P. viridis 
from the different geographical locations (Kozhikode and Cochin), lysine, aspartic 
acid, and TAA from P. viridis of wild and cultured origin from Kozhikode 
representing 73.3 % of the total variability. Lysine, EAA of cultured origin from 
Cochin dominates in PC 2 explaining 26.7 % of the total variance of the dataset.  
Table 3A.2  Amino acid composition (g 100g
-1
 wet tissue) of wild and cultured P. viridis collected 
from Cochin and Kozhikode. 
Amino acids Cochin Kozhikode 
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 wild cultured wild cultured 
Essential amino acids (EAA) 
His 0.38±0.01a 0.29± 0.01b 0.76±0.01c 0.12± 0.05d 
Arg 1.70±0.01a 2.45± 0.06b 1.88±0.01c 4.44±0.09d 
Thr* 0.61 ±0.06a 0.83± 0.02b 1.53±0.04c 1.66±0.02d 
Val* 0.59 ±0.04a 0.62± 0.04a 0.96±0.03b 1.55±0.06c 
Met* 0.25± 0.04a 0.43± 0.01b 1.14±0.07c 0.92±0.03d 
Ile* 0.52± 0.05a 0.44± 0.01b 0.84±0.02c 1.45±0.05d 
Leu* 1.16± 0.04a 1.28 ± 0.07b 1.82±0.01c 2.84±0.01d 
Phe* 0.63± 0.06a 0.54± 0.01b 2.02±0.02c 1.39±0.03d 
Lys* 0.91± 0.01a 1.74 ± 0.06b 1.64±0.03c 2.03±0.09d 
EAA 6.75 a 8.54b 12.59c 16.36d 
Non-essential amino acids (NEAA) 
Asp 1.79±0.03a 2.43± 0.01b 2.23±0.04c 3.86±0.02d 
Glu 2.42±0.06a 3.05± 0.05b 3.08±0.03b 6.35±0.03c 
Ser 0.92± 0.05a 1.36± 0.05b 2.06±0.07c 2.23±0.06d 
Gly 1.85±0.03a 2.01±0.07b 1.66±0.05c 4.24±0.04d 
Ala 0.87±0.01a 1.31±0.08b 1.10±0.08c 2.45±0.07d 
Pro 0.77±0.05a 0.47±0.03b 1.36±0.05c 1.64±0.00d 
Tyr 0.30±0.07a 0.41± 0.08b 1.42±0.02c 0.87±0.01d 
Cys 0.03± 0.01a 0.03± 0.01a 0.25±0.01b 0.39±0.04c 
NEAA 8.95a 11.07b 13.16c 22.03d 
EAA/ NEAA 0.75a 0.77a 0.95b 0.74a 
Reversed-phase binary gradient high performance liquid chromatograph (HPLC, Waters RP PICO.TAG 
amino acid analysis system), fitted with a packed column (dimethylocatadecylsilyl bonded amorphous 
silica; Nova-Pak C18, 3.9 X 150 mm maintained at 38±1°C in a column oven) was used to analyse 
hydrolysable amino acids by their UV absorbance (λmax 254 nm). The mobile phase eluents used were A 
and B, eluent A comprises sodium acetate trihydrate (MeCOONa, 0.14 M, 940 mL, pH 6.4) containing 
TEA (Me3N, 0.05percent), mixed with CH3CN (60 mL); and eluent B used was acetonitrile:water 
(60:40, v/v). Data are means of duplicate analysis of pooled homogenates. Note. Tryptophan was not 
determined, *Essential amino acid for humans. 
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Fig 3A.5:  The loading plot of amino acids (asp, glu, lys, arg) vis-à-vis ΣEAA, ΣNEAA, ΣTAA and 
EAA/NEAA ratio. 
3A.2.7 Fatty acid composition  
The percentage compositions of fatty acids in P. viridis, collected from 
different sites were given in Table 3A.3. The different groups of fatty acids 
are illustrated in the following section.  
3A.2.7.1 Saturated fatty acids (SFAs) 
Cultured samples collected from Kozhikode recorded significantly lower 
(P<0.05) total SFAs than wild samples. Mussel fatty acid profiles usually 
contain about ~30-40% SFA (Alkanani et al., 2007), a level which was found in 
the present study. The predominant SFA was recorded to be 16:0 (21-28% of 
total fatty acids, TFA), with a maximum recorded in samples collected from 
Cochin (≥28% TFA) and minimum in those from Kozhikode (~21% TFA). 
Palmitic acid (16:0) is the major SFA in mussels (Alkanani et al., 2007; Orban 
et al., 2002) and appeared to be insignificant, between the samples collected 
from cultured or wild condition (Table 3A.3) (P>0.05).SFAs are used for 
Nutritional importance of Perna viridis, Crassostrea madrasensis and Octopus dolffusi 
77 
energy storage, and therefore, their concentration increases during periods of 
enhanced feeding activity (Gockse et al., 2004). Growth of mussels in the 
presence of readily available non phytoplanktonic organic material can too 
result in the accumulation of a higher proportion of SFAs (Freites et al., 2002).  
3A.2.7.2 Monounsaturated fatty acids (MUFAs) 
The wild samples collected from Cochin recorded significantly higher 
total MUFAs than cultured samples (P<0.05) (Table 3A.3). However, no 
significant differences were apparent between wild and cultured samples 
harvested from Kozhikode (P>0.05). MUFA was found to be highly 
dependent on 18:1n-9, the primary constituent that contributed a major share 
to total MUFA pool, registering maxima in wild samples (16-18% TFA), and 
minima (14-15% TFA) in cultured samples. The total content of MUFAs was 
found to be highly dependent on 18:1n-9, the primary constituent registered 
maximum in wild samples. The earlier studies reported that the fatty acid 
16:1n-7 is believed to be a diatom marker (Alkanani et al., 2007) whereas 
18:1n-9 is not restricted to a single phytoplankton group. This further supports 
the fact that a food ingested by P. viridis by filter feeding is directly reflected 
in their fatty acid composition. In an earlier study, Orban et al (Orban et al., 
2002) too did not observe consistent fluctuations of the MUFAs, particularly 
16:1n-7.The other MUFA detected as16:1n-7, which is abundant in diatoms, 
and significant differences were apparent between those of wild and cultured 
samples (P<0.05). The share of this fatty acid was found to be lower than 
those reported in literature (16:1n-7, 11-14%) (Alkanani et al., 2007). 
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3A.2.7.3 Polyunsaturated fatty acids (PUFAs) 
PUFAs are considered as single most important nutritional indicator 
dictating the quality of P. viridis. The prevalence of PUFAs, amounting to 
about 24-34% of total fatty acids, over the MUFAs (18-24%) is evident in P. 
viridis harvested from both locations and growth conditions. These results 
were in accordance in mussels from different studies (Orban et al., 2004). 
Although other authors (Orban et al., 2002) have reported that the PUFA in 
mussels predominated over the SFAs, a wide range of variation in the 
percentages of these compounds in these mollusks has been detected, ranging 
from 29-48% for PUFA, 16–32% for MUFAs, and 23–45% for SFAs. The 
wild samples collected from Cochin showed insignificant differences in total 
PUFA content than cultured samples (P>0.05) (Table 3A.3). Interestingly, the 
samples collected from Kozhikode registered significantly higher total PUFA 
content (31-35%) than those from Cochin (24-25%, P>0.05). However, it is of 
note that a level of >20% PUFA with LC-fatty acids are a source of balanced 
nutrition, and, therefore, the samples from Cochin too satisfies the requirement 
of balanced nutrition. The marginal variability in fatty acid composition is due 
to the fact that the lipid levels and composition of marine bivalves depend on 
the biochemical and environmental conditions of seed development, 
environmental conditions, including the phytoplankton resources available 
(Fuentes et al., 2009).  
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Table 3A.3  Fatty acid composition of P. viridis collected from two different growth conditions (wild 
and cultured) and locations (Cochin and Kozhikode) of south west coast of India. 
 Fatty acids (% total fatty acids, TFA) 
Fatty acids Cochin  Kozhikode  
 wild cultured wild cultured 
Saturated fatty acids 
16:0 28±0.02a 28.3±0.09a 21.25±1.4b 20.68±0.04b 
17:0 1.32±0.02a 1.37±0.06a 0.12±0.08b 0.06±0.12c 
18:0 8.84±0.76a 8.54±0.15a 4.83±0.42b 1.56±0.58c 
20:0 0.22±0.41a 0.32±0.36b 1.09±0.01c 0.72±0.04d 
22:0 ND 0.04±0.02a 2.11±0.01b 2.26±0.02b 
24.0 1.18±0.01a 1.16±0.01a 2.68±0.02b 1.83±0.07c 
Σ SFA 39.56a 39.73a 34.15c 29.61d 
Monounsaturated fatty acids 
14:1n-7 0.22±0.01a 0.84±0.01b 1.57±0.01c 1.4±0.02d 
16:1n-7 3.26±0.05a 2.95±0.07b 1.21±0.18c 1.39±0.14d 
18:1n-9 17.6±0.01a 13.7±0.04b 15.49±0.3c 14.91±0.49d 
22:1n-9 ND ND 2.47±0.04a 3.74±0.15b 
24:1n-9 0.55±0.15a 0.42±0.26b 3.38±0.05c 2.14±0.03d 
Σ MUFA 21.63a 17.91b 24.03c 23.57c 
Polyunsaturated fatty acids 
18:2n-6 1.54±0.02a 1.03±0.01b 1.09±0.83b 1.17±0.04c 
18:3n-6 0.55±0.01a 0.46±0.01b 0.85±0.001c 1.03±0.15d 
18:3n-3 1.68±0.15a 1.48±0.16b 1.03±0.82c 0.86±0.01d 
18:4n-3 0.11±0.01a 0.98±0.02b 0.3±0.05c 0.42±0.05d 
18:4n-6 1.01±0.08a 1.12±0.17b 1.15±0.03b 1.98±0.01c 
20:2n-6 0.09±0.03a 1.05±0.04b 0.12±0.08c 0.39±0.08d 
20:3n-6 0.77±0.1a 0.7±0.02a 0.54±0.06b 1.92±0.04c 
20:4n-6 1.32±0.03a 0.26±0.05b 1.19±0.02c 0.86±0.18d 
20:3n-3 0.21±0.01a 0.2±0.02a 0.25±0.09a 0.27±0.03a 
20:5n-3 7.95±0.46a 7.38±0.65a 12.68±0.05b 12.84±0.05b 
22:5n-3 0.55±0.11a 0.42±0.06b 2.41±0.06c 3.01±0.03d 
22:6n-3 9.6±0.05a 8.96±0.06a 9.6±0.16a 9.87±0.03a 
Σ PUFA 25.38a 24.04a 31.13c 34.58d 
∑ C18PUFA 4.89a 5.07a 4.42b 5.46c 
∑ C20PUFA 10.34a 9.59b 14.70c 16.24d 
∑ n-3 20.1a 19.42a 26.27b 27.27b 
∑ n-6 5.28a 4.62b 4.94a 7.35c 
n-3/n-6 3.81a 4.20b 5.30c 3.70d 
∑ PUFA/∑ SFA 0.64a 0.61a 0.91b 1.17c 
22:6n-3/20:5n-3 1.21a 1.21a 0.76b 0.77b 
ΣSFA: total saturated fatty acids; ΣMUFA: total monounsaturated fatty acids; ΣPUFA: total 
polyunsaturated fatty acids; Data presented as mean values of three samples (mean ± SD). 
These values do not total 100percent because minor fatty acids are not reported. ND implies 
non detectable (or fatty acids present below 0.05percent). *a,b,c,d values for each sample with 
different letters in the same row are significantly different at P<0.05.  
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3A.2.7.4 n-3 polyunsaturated fatty acids (n-3 PUFAs) 
The PUFA composition of P. viridis was characterized by the 
predominance of n-3 PUFAs (Fig 3A.6) particularly 20:5n-3(EPA) and 22:6n-
3(DHA), which constitute >80% of total PUFAs. The total content of n-3 
PUFAs was recorded to be significantly higher (26-27%) in P. viridis collected 
from Kozhikode than those collected from Cochin (19-20%) (P<0.05). 
Presence of higher amount of 20:5n-3 and 22:6n-3 in Kozhikode samples than 
Cochin samples largely reflects the composition of the planktonic diet (De 
Moreno et al., 1980). EPA content was found to be significantly higher in 
samples collected from Kozhikode than those recorded in Cochin samples, and 
no significant differences (P>0.05) were apparent between wild and cultured 
samples (Fig 3A.7). No significant differences (P>0.05)were realized in the 
share of DHA to the total fatty acid pool as registered in the samples collected 
from Cochin and Kozhikode under two different growth conditions (Fig 
3A.7). It is to be noted that 20:5n-3 content of >5% is good to provide a 
balanced nutrition with respect to fatty acids, and thereby indicating the P. 
viridis collected from Cochin is equally good as Kozhikode with respect to 
fatty acid composition. Kharlamenko et al (Kharlamenko et al., 1995) reported 
a high 20:5n-3 content is a fatty acid marker characteristic of diatoms. The 
PUFA composition also concurs with numerous studies of mussels and other 
bivalve species (Alkanani et al., 2007; Orban et al,. 2002).Bivalves are filter 
feeders with diets consisting largely of phytoplanktons that contain a high 
proportion of long-chain n-3 PUFAs, such as 22:6n-3 and 20:5n-3 (Li et al., 
2007; Murphy et al., 2002).Phytoplankton is the most important food resource 
for mollusks, and can be considered to be the most important source of 
unsaturated fatty acids, viz., C20:5 and C22:6 (De Moreno et al., 1976). 
Therefore, the quantitative and qualitative availability of food influences the 
unsaturation level and composition of fatty acids (Freites et al., 2002), even if 
green mussels are able to convert 20:5 and 22:6 fattyacids, as observed by 
Orban et al (Orban et al., 2002). The variations of 20:5n-3 and 22:6n-3 
Nutritional importance of Perna viridis, Crassostrea madrasensis and Octopus dolffusi 
81 
(P<0.05), the fatty acids known to be synthesized by diatoms and 
dinoflagellates, may be related to the type of food ingested by P. viridis during 
their growth. The fact that lipids in mussel tissue are rich in C20-22 PUFAs 
seems to suggest that, food consists of phytoplankton elements. The New 
Zealand mollusk P.canaliculus reported to contain a similar PUFA profile, 
dominated by 20:5n-3 and 22:6n-3.  
A significantly higher proportion of C18 PUFAs were recorded in 
cultured P. viridis collected from Kozhikode than in wild samples (P<0.05). A 
higher proportion of C18 PUFAs in cultured samples from both locations (>5%) 
than in wild (<5%) apparently indicated that they feed on the water column. 
This conclusion is supported by the fact that Dunaliella sp., a chlorophytan 
microalga, which is characterized by C18 PUFAs (Volkman et al., 1998), is 
present in the water column. Interestingly the cultured P. viridis recorded lower 
20:4n-6 than those in wild counterparts. The n-3/n-6 fatty acid ratio is of P. 
viridis were found to be about 3.7-5.3, which is considerably higher than the 
health foods available in the market, and therefore may P. viridis may serve as 
an effective alternative to balance the higher intake of n-6 fatty acids.  This ratio 
was also found to be directly proportional to the anti-inflammatory activities due 
to the fact that 20:5n-3 is a precursor to anti-inflammatory lipid mediators (E-
series of resolvins, RvE1), whereas docosanoids (DHA, 22:6n-3) to the D-series 
of resolvins (RvD1) and protectins (neuroprotectin D1, NPD1). Proper balance 
of dietary n-3/n-6 PUFAs is integral to prevent chronic diseases including 
cardiovascular diseases by reducing ventricular arrhythmias, serum 
triacylglycerol concentrations, and atherosclerotic plaque growth. Reversing the 
n-3/n-6 ratio in a favourable manner is the need of the hour to retain disease-free 
healthy populace. An earlier study conducted in this line concluded that a 20% 
reduction in overall mortality and a 45% reduction in sudden death were 
reported in subjects with pre-existing cardiovascular diseases when given 850 
mg n-3 fatty acids (Cordain et al., 2005). It is, therefore, apparent that higher 
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dietary intakes of P. viridis, with n-3/n-6 ratio of 4-5 as realized in the present 
study may favourably alter the ratio resulting in preventing inflammatory and 
autoimmune diseases. This is potentially important because the ratios of these 
fatty acids in the tissues are determined largely by their ratios in the diet 
(Cleland et al., 2006).  
 
 
Fig 3A.6: Polyunsaturated fatty acid profiles of wild and cultured samples of Perna viridis 
collected from Cochin and Kozhikode. Differential compositions of Σn-3 and Σn-6 
PUFAs in the representative samples. 
 
  
Fig 3A.7: EPA and DHA content of wild and cultured samples of P.  viridis collected from Cochin 
and Kozhikode.  
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3A.2.7.5  n-6 polyunsaturated fatty acids (n-6 PUFAs) 
The total content of n-6 PUFAs were recorded to be comparatively 
higher in cultured samples collected from Kozhikode than those collected wild 
(Table 3A.3). This is apparently due to the fatty acids 18:4n-6 and 20:3n-6, 
which contributed a major share to the total n-6 PUFA pool. Among the n-6 
PUFAs, 20:4n-6, 18:2n-6 and 20:3n-6 was the dominant fatty acids. 
Interestingly the wild samples collected from the experimental locations 
recorded significantly higher 20:4n-6 than those collected under cultured 
condition (P<0.05).  However, it is of note that the n-6 fatty acids, particularly 
20:4n-6 was reported to have an important role in stress tolerance. Higher 
content of 20:4n-6 of wild P. viridis (>1%) than that in cultured ones (<1%) 
revealed the ability of the former to withstand adverse stress conditions 
prevailing in a wild environment. The fatty acid AA (20:4n-6), the 20 carbon n-
6 PUFA was reported to be the key link between PUFAs and eicosanoid family 
of inflammatory mediators (series-4 leucotrienes LTB4 and series-2 
prostaglandins PGE2) and pro-inflammatory cytokines (TNF-α) in a cascade of 
metabolic processes involving 5-lipoxygenase (5-LOX) and cyclooxygenase-2 
(COX-2)(Calder, 2006) and PUFAs. A family of anti-inflammatory mediators 
such as resolvins derived from n-3 LC-PUFAs viz., EPA and DHA produced 
via the COX-2 reaction, and are considered to be anti-inflammatory (Calder, 
2006).  
3A.2.7.6 Ratios of different families of PUFAs and their correlation analyses  
Low levels of n-6 (5-7%) and high levels of n-3 PUFAs (19-27%) in P. 
viridis, were apparent in the present study (Table 3A.3). The average n-3/n-6 
ratio was recorded as ~4 in samples collected from Cochin, and 4-5 in 
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Kozhikode samples (Table 3A.3). No significant differences (P>0.05) in the 
ratio between ∑PUFA/∑SFA were realized in the P. viridis collected from 
Cochin under wild or cultured conditions. The higher ∑PUFA/∑SFA ratio in 
cultured samples collected from Kozhikode was mainly contributed by n-3 
fatty acids particularly 20:5n-3, 22:5n-3, and 22:6n-3 (Table 3A.3). The 
loading plot which includes ΣPUFA, Σn3, Σn6, EPA, and DHA when analysed 
by PCA were shown in Fig. 3A.8. The first principal component (PC 1) 
accounted for 68.3% of the variability in the data set. The second principal 
component (PC 2) accounted for 31.7% of the variance in the data set.  This 
revealed a high correlation between ΣPUFA and an important n-3 fatty acid, 
DHA of green mussel collected from Cochin, despite different growth 
conditions. The higher negative loadings of the PC 1 are for variables n-6, 
lipid of wild origin from Cochin, DHA of wild origin from Kozhikode, and 
EPA of cultured origin from Kozhikode, which are grouped as C, highlighting 
its inverse relationship with other components. 
 
Fig.3A.8: Loading plot diagrams showing the correlation of fatty acids (ΣPUFA, Σn-3, Σn-6, 
EPA, DHA) and Σcarotenoids of P. viridis. 
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The present study provides insights in different biochemical and fatty 
acid variation of P. viridis collected from two different geographical locations 
on the south-west coast of India (Cochin and Kozhikode), and under different 
growth conditions (cultured and wild). No significant differences in different 
nutritional and biochemical parameters under observation were apparent 
between P. viridis collected from different locations of the south-western coast 
of India, and the cultured samples were found to equal or sometimes better than 
their wild counterparts in terms of this food quality indicators. The higher PUFA 
content of the samples collected from this mussel harvesting area also contribute 
to their potential to exhibit anti-inflammatory activities. P. viridis, by virtue of 
realizing a balanced EAA/NEAA ratio with considerable amount of lysine and 
threonine, is a well-balanced and high-quality protein source, and a candidate 
species to supplement these amino acids of cereals. The optimum and balanced 
quantities of vitamins, mineral nutrients, and low cholesterol contents added to 
the good qualities of this particular species, and therefore, proved to be a 
desirable item in the human diet in the south-western region of India.  
3B) Nutrient profiling of edible oysters (Crassostrea madrasensis L.) 
from Southwest coast of India 
General 
Oysters are one of the most valued seafood as they constitute a rich 
source of fatty acids, amino acids, and minerals, which are essential for 
providing a balanced diet (Nagabhushanam and Bidarkar, 1978).The edible 
oyster, Crassostrea madrasensis, is a bivalve mollusk (family Ostreidae); 
found in the coastal sea beds in the Arabian Gulf in south Malabar waters 
along the west coast of Peninsular India. The oyster fishery of Kerala is 
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limited to backwaters like Dharmodam, Kayamkulam, Ashtamudi, Paravoor, 
Kadalundi where C. madrasensis is the most prominent species (Harikumar et 
al., 2007), but the culture operations are possible only for six months during 
the pre-monsoon period (Appukuttan, 2007). 
Considering the promising perspective for the utilization of C. 
madrasensis, as a potential health food, studies on its biochemical composition 
began to receive considerable attention. This work anticipated the influence of 
the growth conditions on the essential nutritional compositions of C. 
madrasensis harvested from south western coast of India. No reports have yet 
been published about the essential nutritional composition of this species 
under wild and cultured condition. The present study also directed to elucidate 
the effect of various climatological parameters on the nutritional profile of C. 
madrasensis. The data will provide useful information for seafood industries 
and oyster aquaculture. The integration with the nutritional composition and 
climatological factors was attempted to focus for a more holistic assessment of 
the overall biological significance of wild and cultured C. madrasensis. 
3B.1 Sample collection and processing  
3B.1.1 Collection of wild and cultured C. madrasensis samples 
The samples (wild and cultured) were collected on April - May (pre 
monsoon season) from a relatively clean site in intertidal rocky shore of Sattar 
island at Cochin, south west coast of India (UST: 1141160E, 221200N) (Lat: 
9
058’N; Long: 76016’E), which is predominantly influenced by oceanic water 
from the Arabian Sea.  
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Fig 3B.1: Sampling locations of C. madrasensis (A) Sample collection site of edible oyster (C. 
madrasensis) (wild and cultured) along the Southwestern coast of India. Sattar island 
at Cochin (UST: 1141160E, 221200N) (Lat: 9
058’N; Long: 76016’E) was selected as the 
collection sites of C. madrasensis; (B) A site of culture of C. madrasensis by rack 
method; (B1) Cultured C. madrasensis on rack; (C) Wild C. madrasensis; (D) C. 
madrasensis; (D1) Shell with meat and (D2) Meat portion of C. madrasensis. 
Fig.3B.1 illustrates the sampling location of C. madrasensis. Sattar island 
region was selected considering the abundance of C.madrasensis and preferable 
environmental parameters for successful development of commercial bivalve 
culture and this region is a natural bed of this particular species. Peak water 
temperature was observed in pre-monsoon season (before May) with an average 
monthly temperatures of 30.0°C (±2.18) measured with thermistor temperature 
recorders. The samples were collected from comparable depths (2 m below the 
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surface) to avoid confounding effects of depth on the fatty acid composition. 
Cultured oysters were stripped from the 1/4" rope, at each site. All live samples 
thus collected were immediately and transported to the laboratory after proper 
washing. 
3B.1.2  Determination of biometric parameters, condition indices, and meat 
yield of C. madrasensis 
The samples of C. madrasensis were cleaned of fouling organisms and 
then measured for their biometrical parameters, viz., length, width, and 
thickness to determine the condition indices as described in section 3.1.2.2.1  
3B.2 Results and discussion 
The present study provided a detailed biochemical profile of oysters, 
Crassostrea madrasensis collected from the wild and cultured conditions, from 
the most prominent oyster bed along the south-western coast of India (Sattar 
island). The samples of C. madrasensis were collected in May as there is a drop 
of salinity after May due to the monsoon. The periods of faster growth from 
April to May (pre-monsoon season) coincided with high chlorophyll-a levels. 
The chlorophyll-a peaks indicate an increase in primary production by May, 
associated with the increase in water temperature (Sasikumar et al., 2007).It is 
reasonable to assume that October-May period, when the environmental 
conditions are relatively stable, should be favorable for oyster culture (Purushan 
et al., 1983).Therefore this particular period has been chosen to collect both the 
wild and cultured samples of this target species. 
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3B.2.1  Morphometric characteristics of C. madrasensis in wild and cultured 
conditions 
Biometric measurements, condition indices and meat yield (percent) of 
wild & cultured C. madrasensis samples are given in Table 3B.1.The current 
study indicated that there was substantial variation in the condition index of 
wild and cultured oysters. CI and meat content of mollusks were registered to 
be affected by a variety of environmental and endogenous factors, viz., water 
temperature, salinity, food availability, and gametogenic cycle of animals 
(Okumus and Stirling 1998). There was no significant difference in CI of 
Walne and Booth between wild and cultured oysters. A significant difference 
(P<0.05) in meat yield was recorded between oysters in different growth 
conditions, wild and cultured, with higher values were observed for cultured 
oysters. Positive correlations between meat yield and chlorophyll-a levels in 
cultured oysters (Fig 3B.2, r
2 
=0.88) and negative correlation with wild 
oysters (r
2 
=0.13) indicated that, food availability and relatively high stocking 
densities are the important factors governing the increased growth of cultured 
oysters. The decreased growth rate of wild C. madrasensis may be due to 
some environmental factors such as disturbances in sites, competition for 
space and slow water movement (Rajagopal et al., 2002). Maximum values of 
CI and meat yield was due to the seasonal blooms in Sattar island waters.  
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Table 3B.1 Biometric measurements, condition indices, meat yield (percent), cholesterol, vitamins and 
mineral compositions of wild & cultured C. madrasensis. 
  Wild Cultured 
Meat Yield 12.16±0.09a 12.98±0.08b 
Length (cm) 10.5±0.12a 10.7±0.31a 
Thickness (cm) 3.90±0.06a 3.80±0.02a 
Width (cm) 8.5±0.06a 8.6±0.01a 
Condition  indices 
Imai and Sakai 0.41±0.01a 0.39±0.02a 
Booth 0.12±0.01a 0.13±0.02a 
Walne 0.02±0a 0.03±0.01a 
Moisture(%) 81.2±0.67a 82.0±1.27a 
Cholesterol (mg 100g-1) 34.5±0.96a 43.3±0.72b 
Fat soluble Vitamins 
Retinol (A)/IU 5.35±0.16a 4.26±0.08a 
Cholecalciferol (D2)/IU 439.9±1.33a 459.2±0.8b 
Tocopherol (E)/IU 0.20±0.00a 0.15±0.02b 
Phylloquinone (K1)(μg 100g-1) 1.50±0.01a 0.95±0.01b 
Water soluble Vitamins 
Ascorbic acid (C)/IU 9.76±0.30a 9.78±0.03a 
Macronutrients (mg 100g-1 wet sample) 
Na 185.6±3.93a 146.5±4.73b 
K 265.4±4.48a 515.4±2.21b 
Ca 174.7±1.36a 120.8±0.16b 
P 319.1±1.53a 530.2±4.97b 
Micronutrients (mg 100g-1 wet sample) 
Fe 3.14±0.01a 4.23±0.01b 
Mn ND ND 
Zn 3.66±0.16a 4.48±0.14b 
Se 0.04±0.00a 0.03±0.00a 
Na/K 0.5815 a 0.2725 b 
Ca + P 493.9 a 643.46 b 
Σ micro nutrients 6.85 a 9.10 b 
All samples were analysed in triplicate (n=3) from pooled samples (30 numbers), and 
expressed as mean ± standard deviation. Means followed by the same letter within the same 
row are not significantly different, and different letters indicate significant differences 
(P<0.05). ND: non detectable. 
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Fig.3B.2  Correlation between various nutritional indices and chrophyll-a of wild and cultured 
oysters collected from Cochin. (A) Correlation plot (negative correlation) between meat 
yield and chlorophyll-a levels in wild oysters (r2 =0.13). (B) Correlation plot (positive 
correlation) between meat yield and chlorophyll-a levels in cultured oysters (r2 =0.88).  
3B.2.2 Lipid content and fatty acid composition of C. madrasensis in different 
growth conditions  
Lipid content and fatty acid composition of C. madrasensis were 
recorded in Table 3B.2.No significant difference in lipid content was observed 
among wild and cultured oysters (P>0.05). The fatty acid and lipid 
composition of marine bivalves depend on the biochemical and environmental 
conditions of seed development, environmental conditions, including the 
phytoplankton resources available (Fernandez-Reiriz et al., 1989).  
Table 3B.2  Lipid and fatty acid composition of C. madrasensis collected from two different 
growth conditions (wild and cultured). 
  Wild Cultured 
Lipid (%) 7.04±0.38a 5.63±0.01b 
Saturated fatty acids 
C 12:0 0.14±0.02a 0.2±0.03b 
C 14:0 4.36±0.09a 7.84±0.37b 
C 15:0 0.92±0.30a 1.28±0.27b 
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C 16:0 19.9±0.10a 23.7±0.28b 
C 17:0 6.95±0.08a 3.83±0.51b 
C 18:0 5.81±0.07a 7.63±0.37b 
C 20:0 2.12±0.70a 0.28±0.01b 
C 22:0 0.43±0.02a 0.2±0.01b 
C 24:0 0.04±0.01a 0.85±0.56b 
∑ SFA 40.7±0.60a 45.9±0.67b 
Monounsaturated fatty acids 
C14:1 n-7 0.54±0.02a 1.20±0.13b 
C16:1 n-7 3.50±0.20 a 5.38±0.35b 
C18:1 n-7 ND ND 
C18:1 n-9 4.14±0.20a 5.79±0.43b 
C20:1 n-9 0.43±0.08a 0.21±0.01b 
C22:1 n-9 4.58±0.16a 6.35±0.20b 
C24:1 0.04±0.01a 0.26±0.06b 
∑ MUFA 13.2±0.05a 19.2±0.50b 
Polyunsaturated fatty acids 
C 18:2n-6 ND ND 
C 18:3n-6 ND ND 
C 18:3n-3 4.27±0.34a 4.42±0.10a 
C 18:4n-3 1.85±0.10a 1.28±0.04b 
C 18:4n-6 0.68±0.32a 0.73±0.11a 
C 20:2n-6 ND ND 
C 20:3n-6 1.88±0.11a 0.72±0.19b 
C 20:4n-6 3.32±0.04a 2.23±0.06b 
C 20:3n-3 1.52±0.09a 1.57±0.23b 
C 20:5n-3 9.38±0.07a 6.76±0.20b 
C 22:5n-3 1.33±0.08a 0.59±0.02b 
C 22:6n-3 11.5±0.10a 6.48±0.15b 
Σ PUFA 35.8±0.08a 24.8±0.78b 
∑ n-3 21.7±0.25a 14.5±0.47a 
∑ n-6 12.7±0.29a 10.2±0.31 b 
∑ C18PUFA 6.80±0.08a 6.44±0.06a 
∑ C20PUFA 15.6±0.78a 11.2±0.57b 
n-3/n-6 1.70±0.14a 1.42±0.02b 
n-6/n-3 0.59±0.02a 0.70±0.01a 
∑ PUFA/ 
0.81±0.09a 0.55±0.02a 
∑ SFA 
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DHA/EPA 1.18±0.11a 0.96±0.03b 
AI 2.53 3.56 
TI 0.53 0.8 
HH 1.35 0.83 
ΣSFA: total saturated fatty acids; ΣMUFA: total monounsaturated fatty acids; ΣPUFA: total 
polyunsaturated fatty acids AI: Atherogenic index; TI: thrombogenic index; HH: 
hypocholesterolaemic/ hypercholesterolaemic ratio;Data presented as mean values of three 
samples  (mean ± SD). These values do not total 100percent because minor fatty acids are not 
reported. ND implies non detectable (or fatty acids present below 0.05percent). *ab values for 
each sample with different letters in the same fraction are significantly different at P<0.05. 
Within a row, values not sharing the same superscript are significantly different (P<0.05). 
Data for each species are the mean of nine individual animals, representing three animals from 
each of three sites. 
3B.2.2.1 Saturated fatty acids (SFAs) 
Cultured samples recorded significantly lower (P<0.05) total SFAs than 
wild samples (Table 3B.2). Palmiticacid (C16:0) was the primary SFA found 
in both wild and cultured oysters contributing 40% to the total SFA content in 
wild and 45.9% to the total SFA content in cultured samples. The presence of 
readily available non-phytoplanktonic organic material in the cultured 
condition resulted in the accumulation of higher proportion of SFAs (Freites et 
al., 2002) 
3B.2.2.2 Monounsaturated fatty acids (MUFAs) 
The predominant MUFA was found to be C18:1n-9, was significantly 
(P<0.05) greater in cultured oysters than wild ones. Significantly greater 
MUFA content was observed for cultured samples than wild 
samples(P<0.05).The greater amount of MUFA content in cultured oysters 
may probably due to the greater content of monoenoic fatty acids in the food 
of the cultured oysters. The total MUFA in wild samples ranged from 13.2% 
in wild and 19.2% in cultured samples. The second abundant MUFA detected 
was 16:1n-7, a diatom marker, registered significantly greater values (P<0.05) 
in cultured samples (P<0.05). Significantly great levels of 16:1n-7 and 18:1n-
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9 was registered in phytoplanktons (diatoms and dinoflagellates) and this 
further supports the fact that foods ingested by bivalves by filter feeding are 
directly reflected in their fatty acid composition. 
3B.2.2.3  Polyunsaturated fatty acids (PUFAs) and ratios of different families of 
PUFAs  
PUFAs are very important biochemical indicators of bivalves 
contributing to their nutritional quality. A wide range of variation in the 
percentages of PUFA compounds in this mollusk has been detected between 
wild and cultured ones, 35%t for wild and 25% for cultured ones. The wild 
samples recorded significantly greater PUFA content (P<0.05) than cultured 
samples. The total content of n-6 PUFAs and n-3 PUFAs (EPA and DHA) 
were recorded to be significantly greater (P<0.05) in wild oyster samples. 
Wild oysters recorded positive correlations between chlorophyll-a and PUFA 
composition (r
2 
= 0.997) and maximum values of C18 PUFA and C20 PUFA 
indicated that, besides gametogenic cycle influences, the blooming of different 
planktonic populations may affect the lipid profile of those organisms, like 
bivalves, relying on plankton as the main food source (Albentosa et al., 1996). 
Docosahexaenoic acid (DHA, C22:6n-3) and EPA were the prominent 
PUFAs in wild and cultured oysters followed by 18:3n-3 and 20:4n-6.Diatoms 
contain considerable amounts of 20:5n-3 (EPA) and 22:6n-3 (DHA), 
respectively. Therefore, the ratio of DHA: EPA can be used as an indicator of 
the predominant phytoplankton class assimilated by the mussels. The 
DHA/EPA ratio was also insignificant among wild and cultured oysters (P> 
0.05). Ratios > 1 indicate a dominance of dinoflagellates in the diet, while 
ratios < 1 reflect a dominance of diatoms (Budge & Parrish, 1998). A good 
correlation was observed between EPA, DHA and chlorophyll-a concentration 
in wild samples (r
2 
=0.96) (r
2 
=0.99) respectively. Various algal species 
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including dinoflagellates, cryptomonads, and certain thraustochytrids as well 
as zooplankton are known to contain elevated levels of DHA (Murphy et al., 
2002). The n-3/n-6 ratio was 1.70 in wild samples and 1.42 in cultured 
samples. Also, the n-6/n-3 ratio was 0.59 in wild samples and 0.70 in cultured 
samples. No significant differences were observed in both this ratio among 
wild and cultured oysters (P>0.05). The UK Department of health 
recommends an ideal ratio of n-6/n-3 of 4.0 at maximum (HMSO, 1994) and 
the values greater than 4.0 are considered harmful to health and may promote 
cardiovascular diseases. Among n-6 PUFAs, 20:4n-6, 18:2n-6 and 20:3n-6 
was the dominant fatty acids. The total content of n-6 PUFAs presumably 
associated with a high 18:2n-6 intake which is probably contributed to by a 
microbial diet (Abad, et al.,  1995). 
The atherogenic and thrombogenic indexes were found to be greater in 
the cultured samples compared with wild samples (Fig.3B.3), which gives an 
indication of the attitude of a composite diet or a single food to protect from 
atherosclerosis and platelets aggregation. The greater n-3 fatty acid content and 
consequently the greater n-3/n-6 fatty acid ratio in the wild samples apparently 
contributed to lower atherogenic and thrombogenic indices. It has been 
reported that due to the anti-atherogenic and anti-thrombogenic properties, the 
n-3 PUFAs play a major role to protect human beings from atherosclerosis and 
platelets aggregation (Barrento et al., 2010). The ideal HH ratio noted in the 
oysters also contributed towards its qualities to be judged as desirable from the 
consumer health perspective. 
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Fig.3B.3 Differential compositions of health indices of wild and cultured oysters collected from Cochin.  
 
3B.2.3 Total cholesterol composition 
The cultured samples exhibited significantly, greater cholesterol 
content (43.3 mg 100g
-1
) than wild samples (34.5 mg 100g
-1
) (Table 3B.1). 
The cholesterol content of wild samples showed very good positive correlation 
with PUFA content (Fig 3B.4, r
2 
=0.83). Cholesterol generally ranges from 
around 2-90% of total sterols in various mollusks. Plankton is the predominant 
diet, which contains various sterols, and they can be incorporated into its 
tissues, and some sterols viz., cholesterol can be synthesized from plankton 
cholesterol precursors (McLean & Bulling, 2005).The wild samples were 
found to possess greater essential amino acids, than cultured samples, although 
the difference appeared to be insignificant and present in quantities required 
for balanced nutrition. 
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Fig.3B.4. Correlation plot between cholesterol (mg 100g
-1
) and total PUFA (percent) in wild 
oysters collected from cochin. 
3B.2.4  Amino acid composition of cultured and wild C. madrasensis 
Seventeen amino acids (expressed as g 100g
-1
 protein) were identified 
and quantified in both the wild and cultured oysters (Table 3B.3). Wild samples 
exhibited significantly greater (P<0.05) amount of total essential (ΣEAA) and 
non-essential (ΣNEAA) amino acid content than cultured samples. The most 
abundant essential amino acid (EAA) was found to be arginine in both wild and 
cultured (2.30 -3.31 g 100g
-1
 protein) oysters, followed by leucine and lysine. 
Among non-essential amino acids (NEAA), glutamic acid constitutes major 
share followed by glycine in both wild (2.91 g 100g
-1
 protein) and cultured (2.20 
g 100g
-1
 protein) oysters. The total amino acid content (ΣAA) was found to be 
significantly greater (P<0.05) for wild oysters (~ 20 g 100g
-1
 protein) compared 
to their cultured counterparts (~ 13 g 100g
-1
 protein). The richness of amino 
acids in wild oysters was also been related to the maximum ripeness (Dridi et 
al., 2007).Alanine, glycine and arginine, which are normally contained at a 
relatively high level in marine mollusks, are crucial in energy metabolism by 
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maintaining glycolysis through the formation of opines under hypoxic 
conditions(Lei et al., 2013).  
Table 3B.3 Amino acid composition (g 100g
-1
 protein) of C. madrasensis collected from two 
different growth conditions (wild and cultured) along the south west coast of India. 
 Wild Cultured 
Essential amino acids (E) 
His* 0.55±0.01a 0.38±0.07b 
Arg* 3.31±0.03a 2.30±0.04b 
Thr* 0.77±0.09a 0.57±0.02b 
Val* 0.65±0.08a 0.50±0.03b 
Met* 0.48±0.02a 0.26±0.09b 
Ile* 0.62±0.03a 0.39±0.01b 
Leu* 1.56±0.01a 1.06±0.04b 
Phe* 0.87±0.09a 0.51±0.02b 
Lys* 1.46±0.02a 0.90±0.04b 
Non-essential amino acids (NE) 
Glu 2.91±0.02a 2.20±0.11b 
Ser 1.50±0.04a 0.92±0.07b 
Gly 2.73±0.07a 1.26±0.04b 
Ala 1.42±0.04a 1.06±0.04b 
Pro 0.85±0.02a 0.65±0.01b 
Tyr 0.44±0.02a 0.47±0.04a 
Cys 0.40±0.06a 0.06±0.04b 
EAA 10.27±2.05a 6.87±0.11b 
NEAA 10.25±0.01a 6.62±0.41b 
EAA/NEAA 1.0±0.01a 1.04±0.02a 
Reversed-phase binary gradient high performance liquid chromatograph (HPLC, Waters RP 
PICO.TAG amino acid analysis system), fitted with a analyse hydrolysable amino acids by 
their UV absorbance (λmax 254 nm). The mobile phase eluents used were A and B, eluent A 
comprises sodium acetate trihydrate (MeCOONa, 0.14 M, 940 mL, pH 6.4) containing TEA 
(Me3N, 0.05percent), mixed with CH3CN (60 mL); and eluent B used was acetonitrile:water 
(60:40, v/v). Data are means of duplicate analysis of pooled homogenates. Note. Tryptophan 
was not determined, 
*
Essential amino acid for humans. 
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The slight difference in the ΣEAA and ΣNEAA among wild and cultured 
oysters appeared to be due to the different environmental and nutritional 
conditions. This demonstrates the potential capability of C. madrasensis, 
growing in wild condition, to withstand salinity and adverse stress conditions 
during summer, because glycine or its conjugate (glycine betaine) that was 
earlier reported to have unique osmolytic property (Eklund et al., 2005) and 
helps to protect the cells during summer against osmotic injury. Any ratio of 
EAA/NEAA amino acids greater than 1.0 is considered to be excellent, and 
therefore it can be concluded that, C. madrasensis are good sources of well-
balanced proteins and high-quality protein. 
3B.2.5  Vitamin and unsaponifiable composition of maricultured and wild C. 
madrasensis 
The fat soluble vitamins A, D3, E, K and water soluble vitamin C were 
recorded in Table 3B.1. The cultured samples exhibited significantly greater 
(P<0.05) content of cholecalciferol than wild counterparts .The levels of α-
tocopherol, a vitamin with anti-oxidant properties, (0.20 IU in wild & 0.15 in 
cultured) showed significant difference (P<0.05) among wild and cultured 
samples. As only plants synthesize α-tocopherol, algae, either direct or 
indirectly, are the ultimate source of this compound for oysters. Phylloquinone 
(K1) registered significantly high values (P<0.05) in wild samples than cultured 
ones. The values of trans retinol content are within the limits to impart their 
beneficial effects. Vitamin D precursors constitute a large proportion of the 
unsaponifiable fraction of mollusk lipids. Among minor unsaponifiable 
components, HPLC analyses showed that oxygenated carotenoids, characterized 
by typical absorption spectra, were prevalent over the less polar, late-eluting, α-
carotene and β-carotene. Due to the lack of suitable standard compounds, the 
early-eluting xanthophylls were not identified 
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3B.2.6  Mineral composition of cultured and wild C. madrasensis 
Minerals are nutrients that are conserved by the body and play 
significant role in metabolism in the human body. Table 3B.1 shows the trace 
mineral composition (mg 100g
-1 
wet edible tissue) of cultured and wild C. 
madrasensis. The comparison between cultured and wild oysters revealed that 
there was significant greater (P<0.05) concentrations of Na and Ca in wild 
oysters (Na = 185.6 mg 100g
-1
; Ca = 174.7 mg 100g
-1
) and K and P in cultured 
oysters (K = 515.4 mg 100g
-1
; P = 530.2 mg 100g
-1
). The cultured samples 
recorded lower Na and Ca than wild samples, and therefore rated high as a 
health food. The results in the present study agree with other studies, which 
reported mussels to be a good source of Ca, Zn and Fe (Astorga et al., 
2007).In general, the present study revealed that cultured C. madrasensis 
samples exhibited greater micronutrient contents than wild samples. Se, the 
antioxidant element was found to be 0.04 mg/ 100g wet sample for wild and 
0.03 mg 100g
-1 
wet sample for cultured samples. The concentration of trace 
minerals in oysters is influenced by a number of factors such as seasonal and 
biological differences (size, age, sex and sexual maturity), food source and 
environment  water chemistry, salinity, temperature and contaminants; (Lal, 
1995). The variation of mineral content between wild and cultured oysters 
appeared to be due to the influence of several factors including food 
availability and differences in metal regulation (Astorga et al., 2007). In 
addition, the differences in the mineral concentrations of the surrounding 
seawater could also influence their levels in bivalves (Peaz et al., 1995).  
No significant difference was observed between wild and cultured 
collected from southwestern coast of India and the minor differences in 
biochemical indicators could be attributed to the differential feeding patterns of 
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oysters grown under wild and cultured conditions. Growth conditions play vital 
role in physiological mechanisms of oysters guiding fatty acid metabolism. High 
levels of PUFA (21.7-36.4%) including n-3 PUFAs (12.5-23.2 %), low levels of 
n-6 PUFA (maximum of 7% of total fatty acids) observed in both wild and 
cultured oysters. The ratios of essential/non-essential amino acids (EAA/NEAA) 
indicated that both oyster tissues are good sources of well-balanced proteins. 
The cholesterol content in wild oysters is low (<35 mg 100g
-1
) compared to 
cultured samples (>40 mg 100g
-1
).The well optimised contents added to the 
good qualities of this particular species, therefore proved to be a desirable item 
in the human diet in this region of India. 
3.C Nutrient profiling of  Octopus dolffusi collected from south west 
coast of Kerala 
General 
Cephalopods are considered as the most active and specialized class of 
mollusks. Octopus is one of the main cephalopod species, representing about 
8.8 percent of cephalopod world catches. Octopus has received more attention 
in recent years due to its high nutritional and market value, excellent 
palatability and increasing demand throughout different regions of the world. 
Cephalopods are carnivorous, active predators, and the shallow water species 
are characterized by rapid growth because they have very high feeding rates 
and most part of the elements can be incorporated in the diet. Due to their 
rapid growth and market value, the culture of cephalopods is an area of 
increasing interest (Walsh et al., 2002; García García et al., 2004; 
Nabhitabhata et al., 2005; Sykes et al., 2006; Cerezo Valverde et al., 2008; 
Rosas et al., 2007, 2008). 
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Octopus and cephalopods in general are characterized by low lipid 
contents, with relatively large phospholipid and sterol fractions, and 
triacyglycerides as minor components (Nash et al., 1978; Hayashi and 
Yamamoto, 1987; Navarro and Villanueva, 2000). The lipid of cephalopods 
contain a high percentage of PUFA, such as eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA), which are particularly high in paralarval and 
juvenile cephalopods (Navarro and Villanueva, 2000, 2003; Hamasaki and 
Takeuchi, 2001; Moxica et al., 2002; Okumura et al., 2005; Almansa et al., 
2006; Kurihara et al., 2006; Seixas et al., 2008). The high levels of EPA and 
DHA in marine lipids imply the presence of a strong antioxidant system in 
marine animal tissues. Dietary supplementation with EPA and DHA is 
expected to attenuate inflammatory responses by reducing the content of 
arachidonate or inhibiting eicosanoid production (Ramesha and Pickett, 1986). 
Cephalopods contain low level of lipid with large amounts of polyunsaturated 
fatty acids (Sinanoglou and Miniadis-Meimaroglou, 1998). 
From the nutritional point of view, less attention has been paid to the 
nutritional profile of cephalopods. Recently, octopus is finding more 
acceptances because of its extraordinary nutritional qualities. Therefore, 
proper understanding about the biochemical constituents of this species has 
become a primary requirement for the nutritionists and dieticians. Biochemical 
changes in the octopus in different seasons may result from fluctuations of 
environmental parameters, viz., temperature, salinity, oxygen levels, and to the 
physiological status of the animals, depending on food availability, 
gametogenic cycle, and spawning. The nutritional compositions vary among 
species due to geographical differences of fishing grounds and cause difficulty 
to recommend a suitable preventive diet. Therefore, considering the promising 
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perspective for the utilization of octopus, and the need for knowledge of its 
chemical composition, this work determined the seasonal variations (winter 
and postmonsoon) of essential nutritional compositions with respect to amino 
acids, cholesterol, proteins, lipids, and fatty acids of P. viridis harvested from 
south western coast of India to assess possible seasonal differences in 
nutritional composition.  
3C.1. Sample collection and processing  
3C.1.1 Collection of O. dolffusi samples  
Octopus dolffusi samples were collected from the Fort Kochi, area of 
Kerala along the South-west coast of India in different seasons as winter 
(January-February) and post-monsoon (August-September). The samples were 
cleaned and the edible tissues were minced for analyses. Although, age and sex 
differences in nutritional composition could occur, we regarded the octopus 
samples as a whole food source, which was representative of the market, and 
thus totally used by the local population, without any age or sex differences.  
 
Fig.3C.1 Sample collection site of O. dolffusi, along the Southwestern coast of India. 
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3C.1.2 Biometric parameters and meat yield of O. dolffusi 
O. dolffusi samples were measured for their biometrical parameters, viz., 
length, width, and thickness. Length, width and thickness of randomly selected 
samples were measured using a vernier caliper. The samples were then weighed 
and the tissues were oven dried for 48 h at 60°C, and the dry weight was also 
determined.  
3C.2 Result and discussion 
3C.2.1 Biometric characteristics and percent meat yield of O. dolffusi 
The octopus samples collected in winter season recorded significantly 
greater (P< 0.05) meat yield than samples collected during postmonsoon (Table 
3C.1). The length and weight of octopus collected in postmonsoon season is 
significantly higher compared to octopus collected in winter season The size and 
weight of cephalopods are dependent on growth stage, temperature, salinity, 
oxygen, light, food, competition, social interaction and sex (Forsythe et al., 2002; 
Okuzumi and Fujii, 2000). 
Table 3C.1 Biometric parameters, meat yields (percent), proximate, lipid, protein, cholesterol, 
and mineral compositions of O. dolffusi collected from Cochin  
 Winter Postmonsoon 
Length (cm) 25.6±0.05a 34.8±0.25b 
Weight (gm) 13.8 ±0.92a 15.6±0.56b 
Meat yield (%) 21.5±0.65a 25.4±0.32b 
Proximate composition (g 100g-1 wet sample) 
Dry matter   
Moisture 80.1±0.84a 85.2±1.43b 
Crude protein 12.42±0.22a 10.11±0.04b 
Crude fat 2.46±0.17a 2.41±0.08a 
Crude ash 1.01±0.04a 0.96±0.04a 
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Crude fiber 0.03±0.01a 0.02±0.00a 
Lipid (%) 4.56±0.17a 5.16±0.13b 
Cholesterol (mg 100g-1) 98.6±0.47a 105.3±0.29b 
Protein (mg 100g-1) 215.1±2.56a 197.6±6.10b 
Macronutrients (mg 100g-1  wet sample) 
Na 283.±1.46a 197.7±0.95b 
K 518.±4.35a 376.5±2.46b 
Ca 4.72±0.28a 4.52±0.24a 
Mg 19.3±0.57a 18.56±0.16a 
P 310.±1.64a 301.3±1.56b 
Na/K 0.54±0.02a 0.49±0.00a 
Ca+P 315.±1.32a 294.5±1.84b 
Micronutrients (mg 100g-1  wet sample) 
Cr 0.15±0.01a 0.12±0.01a 
Zn 0.72±0.01a 0.65±0.00a 
Mn 0.2±0.01a 0.1±0.00a 
Cu 0.22±0.01a 0.16±0.01b 
Fe 5.69±0.54a 4.91±0.05b 
Se 0.37±0.01a 0.31±0.02a 
Fat soluble Vitamins 
Retinol (A)/IU 0.32±0.01a 0.37±0.06a 
Cholecalciferol (D3)/IU 410.1±0.81a 394.5±2.57b 
Tocopherol (E)/IU 0.17±0.06a 0.16±0.01a 
Phylloquinone (K1) (μg 100g-1) 1.14±0.02a 1.21±0.15a 
Water soluble Vitamins 
Ascorbic acid (C)/IU 0.76±0.25 a 0.84±0.13 b 
All samples were analyzed in triplicate (n=3) from a pooled samples (20 numbers), and 
expressed as mean ± standard deviation. Means followed by the same letter within the same 
row are not significantly different, and different letters indicate significant differences 
(P<0.05). ND: non detectable 
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3C.2.2 Inter seasonal variability in proximate composition of O. dolffusi 
The seasonal variations in the proximate compositions of octopus 
collected in two different seasons were shown in Table 3C.1.The proximate 
compositions of octopus recorded ~12% crude protein and 2.5% crude fat in 
winter season whereas in post-monsoon season the values were 10% and 2% 
respectively. The results of protein analysis indicated no significant variation 
throughout the seasons. Moisture content of octopus significantly fluctuated 
(P<0.01) across the season. There was no marked variation in the crude fibre 
and ash content of octopus samples. These results were in accordance with the 
results of other cephalopod species of Mediterranean origin, which revealed 
moisture content as 78-83g 100g
-1
, and crude ash as 1.2-2.1 g 100g
-1
 (Yesim et 
al., 2008).  
3C.2.3 Inter seasonal variability in protein and total cholesterol contents of O. 
dolffusi 
The octopus samples collected during the winter season were found to 
possess significantly greater protein and cholesterol content (P<0.05) than 
samples collected in post-monsoon season. The level of cholesterol in octopus 
samples collected in winter and post-monsoon season were 98 mg 100g
-1 
and 
105 mg 100g
-1
,
 
respectively (Table 3C.1). Okuzumi and Fujii (Okuzumi and 
Fujii, 2000) reported that the cholesterol content in several cephalopods 
species as, 123 mg 100g
-1 
in cuttlefish, 180 mg 100g
-1 
 in squid and139 mg 
100g
-1 
 in octopus. The protein content of octopus samples recorded 215.1 mg 
100g
-1 
in winter season and 197.6 mg 100g
-1 
during post-monsoon season. 
Contrary to fish and crustaceans, the cephalopods exclusively use protein for 
both growth and energy supply. Cephalopods are composed mainly of protein 
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(75-85% dry weight) (Iwasaki and Harada, 1985; Boucaud-Camou, 1990). The 
main reason for the increasing demand in cephalopods is that, they are a good 
source of balanced protein with essential lipids (Sinanoglou and Miniadis-
Meimaroglou 2000). 
3C.2.4 Inter seasonal variability in lipid content and fatty acid composition 
of O. dolffusi  
The lipid content and fatty acid composition of octopus were recorded 
in Table 3C.2. Significant differences in lipid content were observed among 
octopus samples collected during different seasons (P>0.05). Lipid content of 
octopus increased in post-monsoon season (5.2 %) compared to that during the 
winter (4.6 %). The direct mobilization of muscle protein provides metabolic 
energy during periods of starvation and the direct use of protein as an energy 
reserve may account for the lack of major glycogen or lipid reserves in 
cephalopod tissues (Storey and Storey, 1983; O’Dor et al., 1984). The major 
factor affecting the lipid content in cephalopods was the abundance of food 
(Ackman, 1995; Robards et al., 1999; Rosa et al., 2002). The high lipid 
content in post-monsoon season might be due to the availability of more 
nutrients in monsoon season than in other seasons. It has also been indicated 
that the lipid content of fish changes due to species, gender, geographical 
origin and season (Rasoarahona et al., 2005). The low level of lipids in 
cephalopod was due to the poor absorption of lipids (O’Dor et al., 1984) and 
consequent poor utilization by the animal’s metabolism (Ballantyne  et al., 
1981). 
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Table 3C.2 Fatty acid composition of O. dolffusi collected in winter and postmonsoon season 
Fattyacids(percent total fatty 
acids, (TFA)) 
Winter Postmonsoon 
Saturated fatty acids 
C12:0 1.92±0.05a 2.85±0.03b 
C14:0 2.32±0.01a 2.91±0.02b 
C15:0 1.18±0.54a 1.23±0.61a 
C16:0 15.9±0.02a 16.7±0.01b 
C17:0 0.46±0.32a 1.23±0.24b 
C18:0 8.59±0.11a 6.46±0.09b 
C22:0 0.36±0.01a 0.58±0.01b 
C24:0 1.03±0.01a 1.99±0.01b 
∑ SFA 31.8±1.07a 34.0±1.02b 
Monounsaturated fatty acids 
C16:1 n7 2.48±0.05a 2.69±0.08b 
C18:1n7 4.17±0.01a 4.15±0.02a 
C18:1 n9 10.1±0.74a 9.58±0.29b 
C20:1 n9 9.62±0.03a 8.49±0.01b 
C22:1 n9 3.12±0.05a 4.19±0.02b 
C24:1 0.57±0.01a 0.67±0.01b 
∑ MUFA 30.1±0.89a 29.7±0.34b 
Polyunsaturated fatty acids 
C18:2n-6 2.16±0.18a 2.24±0.08b 
C18:3n-6 2.94±0.13a 2.65±0.02b 
C18:3n-3 1.11±0.01a 1.55±0.03b 
C18:4n-3 0.75±0.01a 1.61±0.01b 
C20:2n-6 1.16±0.01a 0.25±0.01b 
C20:3n-6 1.38±0.02a 0.11±0.01b 
C20:4n-6 3.35±0.14a 4.68±0.05b 
C20:5n-3 6.93±0.21a 5.94±0.06b 
C22:5n-3 1.92±0.05a 2.84±0.03b 
C22:6n-3 15.7±0.54a 13.3±0.07b 
Σ PUFA 37.4±1.3a 35.1±1.12b 
∑ C18PUFA 6.96±0.12a 8.05±0.02b 
∑ C20PUFA 12.8±0.09a 10.9±0.11b 
∑ n-3 26.4±0.35a 25.2±0.42b 
∑ n-6 10.9±0.21a 9.93±0.06b 
n-3/n-6 2.41±0.05a 2.54±0.01b 
∑ PUFA/∑ SFA 1.17±0.02a 1.03±0.01b 
22:6n-3/20:5n-3 2.27±0.04a 2.24±0.08a 
AI 1.59±0.00a 1.60±0.00a 
TI 0.42±0.00a 0.43±0.00a 
HH 2.26±0.64a 2.04±0.16a 
ΣSFA: total saturated fatty acids; ΣMUFA: total monounsaturated fatty acids; ΣPUFA: total 
polyunsaturated fatty acids AI: Atherogenic index; TI: thrombogenic index; HH: 
hypocholesterolaemic/ hypercholesterolaemic ratio; Data presented as mean values of three 
samples (mean ± SD). These values do not total 100percent because minor fatty acids are not 
reported. ND implies non detectable (or fatty acids present below 0.05percent). *a,b values for 
each sample with different letters in the same row are significantly different at P<0.05.   
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3C.2.4.1 Saturated fatty acids (SFAs) 
The total saturated fatty acid composition of octopus recorded 31.8% in 
winter season and 34 % in post-monsoon season (Table 3C.2). The highest 
proportions of saturated fatty acids in cephalopods were due to myristic acid 
(C14:0, 1–3%), palmitic acid (C16:0, 15.5–25.2%), heptadecanoic acid 
(C17:0, 1.05–2.6%), stearic acid (C18:0, 4.32–10%).The results of fatty acid 
analysis in octopus are within the range of previous studies.(Ozyurt et al., 
2006; Reale et al., 2006; Rosa, Pereira, & Nunes, 2005; Zlatanos et al., 2006). 
Palmitic acid was the abundant fatty acid in marine lipids, and recorded 16% 
in the samples. Palmitic acid was found to be  20% of the total fatty acids in 
the cephalopod tissues (Passi et al., 2002; Phillips et al., 2002). Studies have 
shown that SFA was positively associated with the total cholesterol levels and 
coronary heart diseases (Caggiula and Mustad, 1997). 
3C.2.4.2 Monounsaturated fatty acids (MUFAs) 
MUFA are believed to reduce the incidence of cardiovascular diseases 
by decreasing low density lipoprotein (LDL) cholesterol in blood (Appel et al., 
2005; Chow, 2008; Kris-Etherton, 1999). No significant difference was 
observed between the MUFA content of octopus samples collected in two 
different seasons (P<0.05). Octopus samples revealed 30 % of MUFA content 
in both seasons (Table 3C.2). Consumption of cephalopods would contribute 
the intake of MUFA (Ozogul et al., 2008). Inclusion of higher dietary MUFA 
has been suggested by NCEP (2001) due to their beneficial effects on 
cardiovascular heart disease (Kalogeropoulus et al., 2004; Keys et al., 1986). 
The predominant MUFAs were oleic acid (C18:1n-9) and cis-11-eicosenoic 
acid (C20:1), which were found to be greater in the samples collected during 
winter than in post-monsoon season. It was also observed that the proportion 
of these fatty acids changed significantly throughout the seasons (Ozogul et 
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al., 2008). The variation of fatty acid composition depends on species, food 
availability, age, geographical area, season and salinity (Ozogul and Ozogul, 
2005; Ozyurt et al., 2006).  
3C.2.4.3  Polyunsaturated fatty acids (PUFAs) and ratios of different families of 
PUFAs  
PUFA are the predominant fatty acids of octopus, and these long-chains 
fatty acids are beneficial in preventing health problems but with their own 
specialized and distinctive functions. Significant differences in total PUFA 
content was observed between the samples collected during different seasons 
(P>0.05). The samples collected in winter season (37.4 %) recorded greater 
total PUFA content than in the post-monsoon samples (Table 3C.2). The 
variation of fatty acid composition depends on species, food availability, age, 
geographical area, season and salinity (Ozogul and Ozogul, 2005; Ozyurt et al., 
2006). Cephalopods contain large amounts of polyunsaturated fatty acids (52.9–
56.3% of total fatty acids) (Sinanoglou and Miniadis-Meimaroglou, 1998). EPA 
(20:5n−3) and DHA (22:6n−3) were the most abundant fatty acids found in the 
lipids of O. vulgaris, as has been reported for many cephalopod species 
(Jangaard and Ackman, 1965; Culkin and Morris, 1970; Nash et al., 1978). The 
major polyunsaturated fatty acids identified in octopus are eicosapentaenoic acid 
and docosahexaenoic acid. The highest EPA and DHA proportions were 
obtained for octopus samples collected in winter (16% and 7% respectively) 
whereas post-monsoon samples recorded only 13% and 6% respectivelyin that 
order  (Fig.3C.2). These fatty acids are the precursors of the eicosanoids and are 
necessary for maintaining the impermeability barrier of the skin, and are also 
involved in cholesterol transport and metabolism (Tarley et al., 2004; Osman et 
al., 2001). The most characteristic PUFAs were found to be docosahexaenoic 
acid (20% and 36%) and eicosapentaenoic acid (8% and 18%), in the octopus 
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species (Culkin and Morris, 1970; Gibson, 1983; Sinanoglou and Miniadis-
Meimaroglou,1998). Polyunsaturated fatty acids with 20 carbon atoms (e.g. 
20:3n-6, 20:4n-6 and 20:5n-3) are known precursors of eicasonoids, which have 
a wide range of physiological actions, such as, assisting in blood clotting, the 
immune response, the inflammatory response, cardiovascular tone, renal 
function, neural function, and reproduction (Tocher, 1995). Dietary 
supplementation with EPA and DHA is expected to attenuate inflammatory 
responses by reducing arachidonic acid content or inhibiting eicosanoid 
production (Ramesha and Pickett, 1986). Cephalopods contained small amounts 
of fat and high amount of EPA and DHA as reported earlier (Kalogeropoulus et 
al., 2004; Ozyurt et al., 2006; Reale et al., 2006; Zlatanos et al., 2006). DHA 
was known to be an important constituent of the building blocks of the 
biological membranes in the brain and retina affecting cognitive and visual 
functions (Chow, 2008; Connor, 2000). EPA is more efficient in reducing 
cellular inflammation preventing depression disorders (Martins, 2009), and in 
the reduction of serum triacylglycerols (formerly known as triglycerides). The 
EPA and arachidonic acid (AA) concentration in the octopus indicated an 
inverse relationship, where decreased EPA levels resulted in respective 
increased AA levels. 
No significant difference was observed between the n-3/n-6 and 
DHA/EPA content of octopus samples collected during two different seasons 
(P<0.05). The recommended n-3/n-6 ratio was reported to be greater than 1.0 
(Chow, 2008). The fatty acid composition of several species of teleosts, 
cephalopods and crustaceans were studied by Passi et al (Passi et al., 2002), and 
found that the edible muscle had an n−3/n−6 ratio of greater than 1, confirming 
the  importance of octopus as an ideal dietary source of n-3 PUFA for humans. 
Samples collected in winter season exhibited greater n-3 PUFA content required 
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for maintaining the structural and functional integrity of cell and more 
importantly for the development and survival of fast growing cephalopods 
(Navarro and Villanueva, 2000). Cardiovascular mortality was noted to be 
inversely proportionate to the intake of n-3 fatty acids (Kafatos et al., 1997). 
Moreover, they play an important role in the neurodevelopment of infants and in 
fat glycemic control (Caponio et al., 2011). 
 
Fig.3C.2. Differential compositions of n-3/n-6 PUFAs, ∑ PUFA/∑ SFA, 22:6n-3/20:5n-3 of O. 
dolffusi collected during winter and post monsoon season.  
The changes in the fatty acid composition of total lipids observed in the 
octopus reflected to those that occurred mainly in the composition of 
phospholipids.  No significant difference was observed in atherogenic and 
thrombogenic indices for samples collected during winter and post-monsoon 
season. The greater PUFA content and consequently the higher PUFA/SFA 
fatty acid ratio were apparent in the samples collected in winter, contributed to 
lower atherogenic and thrombogenic indices.   
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3C.2.5 Amino acid composition of O. dolffusi 
Samples collected during winter exhibited greater amount of total 
essential (ΣEAA) amino acids than those collected in pre-monsoon season 
(Table 3C.3). The amino acid content could vary among organisms due to 
geographical differences, species, age and physiological condition (Capillas et 
al., 2002). The abundant essential amino acids (EAA) were found to be 
arginine and proline in winter as well as post-monsoon samples. Arginine and 
proline were reported as the main substrates amino acid catabolism for energy 
in the cephalopods (Hochachka and Fields, 1983). Arginine (1.6g 100g
-1
) and 
proline (1.5g 100g
-1
) were found to be significantly greater in the samples 
collected in post-monsoon season. This is because the arginine available is 
condensed with glucose-derived pyruvate to form octopine, the main 
anaerobic end product that accumulates in adult cephalopods during periods of 
exercise and stress (Hochachka et al., 1977; Storey and Storey, 1978). Proline 
is involved in oxidative metabolism in cephalopods and during exercise 
(Villanueva et al., 2004). The ability of cephalopods to absorb amino acids by 
the integument fluids also exists in other mollusks (Manahan, 1990) and might 
represent a phylogenetic remnant for this group of exclusively carnivorous 
animals. The non-essential amino acid recorded greater values in post-
monsoon season. Proline and alanine (non-essential amino acid) in the diet 
must be reinforced, given the fact that both amino acid represent one of the 
most important energy resources in cephalopods with a production not 
sufficient to cover catabolic demands (Lee, 1994). 
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Table 3C.3 Amino acid composition (mg 100g
-1
 wet tissue) of O.dolffusi collected in winter and 
post-monsoon season 
Amino-acids Winter Post-monsoon 
Essential amino acids (E) 
His 0.79±0.01a 0.84±0.02b 
Arg 1.72±0.16a 1.59±0.01b 
Thr* 0.58±0.01a 0.74±0.05b 
Val* 0.89±0.01a 0.81±0.07a 
Met* 0.66±0.01a 0.94±0.05b 
Ile* 0.77±0.02a 0.82±0.03a 
Leu* 1.41±0.04a 1.35±0.12b 
Phe* 0.82±0.02a 0.98±0.02b 
Lys* 1.04±0.05a 1.16±0.09b 
Σ EAA 8.68±0.33a 9.23±0.46b 
Non-essential amino acids (NE) 
Glu 0.86±0.09a 0.95±0.09b 
Ser 0.89±0.06a 0.76±0.05b 
Gly 0.74±0.04a 0.82±0.07b 
Ala 1.01±0.03a 1.31±0.06b 
Pro 1.55±0.01a 1.51±0.02a 
Tyr 0.73±0.02a 0.76±0.07a 
Cys 0.23±0.01a 0.37±0.01b 
Σ NEAA 6.01±0.01a 6.48±0.37 b 
Σ EAA/ Σ NEAA 1.44±0.01a 1.42±0.01a 
TAA 14.6±0.28a 15.71±0.83b 
 Reversed-phase binary gradient high performance liquid chromatograph (HPLC, Waters RP 
PICO.TAG amino acid analysis system), fitted with a packed column (dimethylocatadecylsilyl 
bonded amorphous silica; Nova-Pak C18, 3.9 X 150 mm maintained at 38±1°C in a column 
oven) was used to analyse hydrolysable amino acids by their UV absorbance (λmax 254 nm). 
The mobile phase eluents used were A and B, eluent A comprises sodium acetate trihydrate 
(MeCOONa, 0.14 M, 940 mL, pH 6.4) containing TEA (Me3N, 0.05percent), mixed with 
CH3CN (60 mL); and eluent B used was acetonitrile:water (60:40, v/v). Data are means of 
duplicate analysis of pooled homogenates. Note. Tryptophan was not determined, 
*
Essential 
amino acid for humans. 
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3C.2.6  Vitamin and unsaponifiables of O. dolffusi 
The fat soluble vitamins A, D3, E, K and water soluble vitamin C were 
recorded in Table 3C.1. Among the vitamins, A and E play a major roles in 
growth, reproduction and embryonic development. Vitamin A is present in 
many forms including the free alcohol form of retinol. Vitamin E, being the 
most bioactive component, is present in two structural types: as tocopherols 
and tocotrienols, and the levels of α-tocopherol (0.16 IU) were found to be 
greater in samples collected during winter season, and showed no significant 
difference (P>0.05) among samples collected in various seasons. The α-
tocopherol is a lipid-soluble antioxidant, known for its ability to protect 
sensitive molecules, such as, unsaturated fatty acids against oxidation, by its 
ability to neutralize free radicals and reduce lipid peroxidation (Pazos et al., 
2005) The α-tocopherol concentration exhibited proportional content with n-3 
PUFAs as also supported by earlier studies (Chow, 2008). Phylloquinone (K1) 
and cholecalciferol (D3) registered significantly high values (P<0.05) in 
samples collected in winter than during the post-monsoon season. Seasonal 
variation in retinol and tocopherol contents was observed in squid Watasenia 
scintillans, especially in relation to spawning period (Motoe et al., 1997). 
3C.2.7 Mineral composition of O. dolffusi 
Minerals are required for the maintenance of normal metabolic and 
physiological functions of living organisms. The absorption of minerals from 
seawater also could take place by osmotic uptake through the gills and the 
body surface as the cephalopods live in the hypoosmotic environment 
(Nurjanah et al., 2012). Table 3C.1 showed the trace mineral composition (mg 
100g
-1 
wet edible tissue) of O. dolffusi. The major functions of essential 
elements in the body include the formation of skeletal structure, maintenance 
of colloidal systems, as well as regulation of acid base equilibrium. They are 
important components of hormones, enzymes and structural proteins (Lall, 
2002; Villanueva and Bustamante, 2006). Zn is involved in numerous protein 
functions, such as, the carbonic anhydrase and is efficiently absorbed in the 
samples collected during winter (0.72 mg 100g
-1
) than those in post-monsoon  
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(0.65 mg 100g
-1
). Sodium (283.1 mg 100g
-1 
 and potassium (518.2 mg 100g
-1
) 
concentrations were found to be greater in the octopus samples collected 
during  winter. These elements and are required for maintaining homeostasis 
and the acid-base balance. No significant difference was apparent in the 
contents of P and Ca which are required for the formation of skeletal structure 
of the body (Lall, 2002). High Na/K ratio (0.54) was recorded in the edible 
tissues of the samples collected during the post-monsoon season. The values 
of Ca+P ratio obtained in the samples varied 295 – 315 mg 100g-1. Minerals 
were reported to be absorbed by the digestive gland of octopus, they swallow 
massive quantities of sea water during feeding (Wells and Wells, 1989). Se, 
the antioxidant element was found to be greater in the samples collected 
during the winter season as compared to that in post-monsoon season. 
The present work elucidated the importance of O. dolffusi as balanced 
sources of amino acid, fatty acid, mineral and vitamin. O. dolffusi is a fairly 
good source of well-balanced proteins with good ratio of essential to 
nonessential amino acids.  The balanced nutritional profile of O. dolffusi, makes 
it one of the most suitable and healthy forms of human food. 
3.2 Conclusions 
Octopus was found to be the good protein source with low in fat 
content, and considered as the most interesting inhabitants of the seas. Greater 
levels of EPA and DHA in the lipids implied the presence of antioxidant 
system in the edible muscle of O. dolffusi. Greater levels of PUFA including n-
3 PUFAs, important in the human diet for their platelet anti-aggregating and 
blood pressure-reducing properties, lesser levels of n-6 PUFA, and relatively 
high n-3/n-6 PUFA ratio values characterized P. viridis. The higher PUFA 
content also contributed to their potential to exhibit anti-inflammatory 
activities, and therefore, proved to be a highly desirable item for use as food 
and nutrceutical supplement.   
…………………… 
 
Bioactive potentials with respect to anti-oxidative and anti-inflammatory properties of Perna …………. 
117 
 
 
 
Background of the study 
Free radicals are continuously produced in our body due to the 
utilization of oxygen which results in the generation of a series of reactive 
oxygen species (ROS) and non-free radical species. Reactive oxygen species 
are highly reactive and can easily react with the vital biological molecules 
including proteins, lipids, lipoproteins and DNA. These free radicals are 
naturally scavenged by antioxidant mechanism in mammalians. However 
uncontrolled generation of free radicals is associated with lipid and protein 
peroxidation, resulting in cell structural damage, tissue injury, or gene 
mutation which ultimately lead to a various pathophysiological disorders, such 
as, arthritis, diabetes, inflammation, cancer and genotoxicity (Kourounakis et 
al., 1999). The human body constantly quenches excessive oxidants and free 
radicals through various scavenging mechanisms, such as, use of antioxidant 
enzymes and molecules. In certain circumstances, the body's natural defence 
mechanism becomes inefficient, which makes mandatory dietary intake of 
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antioxidant compounds as an alternative, suggesting that there is an inverse 
relationship between dietary intake of antioxidants and the incidence of 
diseases caused by the deficiency of these substances. The commercially 
available synthetic antioxidants are used to reduce the deleterious effect of 
oxidative-induced reactions in food and biological systems. However, the 
potential toxicity of these synthetic antioxidants has aroused an increased 
interest in identifying alternative natural and safe sources of antioxidants, and 
the search for natural antioxidants, especially of marine origin, has notably 
increased during the recent years. 
Marine organisms are considered as unique biostore of active 
compounds, having enormous therapeutic potential, which led to the growing 
interest in investigation of natural products for the discovery of immuno-
stimulatory activity, such as, antioxidant, anti-inflammatory and antimicrobial 
compounds. Among marine organisms, mollusks are widely distributed 
throughout the world, and have many representatives in the marine and 
estuarine ecosystems, namely, slugs, whelks, clams, mussels, oyster, scallops, 
squids and octopus. Bivalves and cephalopods are considered to be a valuable 
food items as they constitute rich source of antioxidants, essential for 
providing a balanced diet. They are also very good source of biomedically 
important products. Bivalves were reported to repair of oxidative damage by 
ROS, by increasing the expression of antioxidant molecules (Santovito et al., 
2005). Mollusks are considered as one of the important sources to derive 
bioactive compounds that exhibit antimicrobial, anti-inflammatory, and 
antioxidant activities (Anbuselvi et al., 2009; Chellaram and Edward, 2009b; 
Benkendorff et al., 2011). Many bioactive compounds have been extracted, 
characterized and purified from the bivalves and cephalopods. Compounds 
isolated from mollusks were used in the treatment of rheumatoid arthritis and 
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osteoarthritis (Chellaram and Edward, 2009a). Cephalopods are considered to 
be a rich source of n-3 fatty acids that are responsible for anti-inflammatory 
activities (Russo and Tringali, 1983). Long chain fatty acids consisting of 20 
carbon atoms (eg., 20:3n6, 20:4n6 and 20:5n3) were reported in various 
cephalopods including squid and octopus, which have a wide range of 
physiological actions including immune and anti-inflammatory responses, and 
were reported to have vital role in neural function and reproduction (Tocher, 
1995; Miliou et al., 2006). Polyunsaturated fatty acids (PUFAs) are important 
constituents of the phospholipids of all cell membranes. Changes in fatty acid 
composition of cell membranes influence inflammation, and these 
compositions can modify the membrane fluidity, cell signalling leading to 
altered gene expression, and the pattern of lipid mediator production. Cells 
involved in the inflammatory response are typically rich in the n-6 fatty acid 
(arachidonic acid), and eicosanoids produced from arachidonic acid have roles 
in inducing inflammation. Long-chain n-3 PUFAs also gives rise to 
eicosanoids, and these may have differing properties from those of arachidonic 
acid-derived eicosanoids. Long-chain n-3 PUFAs give rise to a family of anti-
inflammatory mediators, termed resolvins, which are anti-inflammatory and 
inflammation resolving, through the pathways involving cyclooxygenase and 
lipoxygenase enzymes. Thus, n-3 PUFAs are potent anti-inflammatory agents, 
and have therapeutic efficacy in a variety of acute and chronic inflammatory 
settings.  
The present study attempted to highlight the promising antioxidant and 
anti-inflammatory activities of bivalves and cephalopods using different in-
vitro antioxidant assays. Antioxidants from natural sources play a paramount 
role in helping endogenous antioxidants to neutralize the oxidative stress. The 
natural antioxidants have lesser toxicity, and were proved to be effective in 
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scavenging free radicals and avoiding the excess ROS formation in the body 
(Youdim et al., 2001). The study designed to evaluate the antioxidant and anti-
inflammatory capacities of freeze dried extract and different solvent fractions 
and aqueous fractions of selected species such as Perna viridis, Crassostrea 
madrasensis and Octopus dolffusi. This is particularly important to assess the 
in-build antioxidant and anti-inflammatory capacities to inhibit free radical 
formation and inflammation in the body, and to evaluate their potentials to 
isolate bioactive molecules.  
4.1 Materials and methods 
4.1.1 Instrumentation 
A bench top refrigerated high – speed microprocessor controlled 
centrifuge equipped with asynchronous motor and programmable micro-
controlled variable frequency controller (Superspin Plasto Crafts R-V/Fm, 
Mumbai, India) was used for centrifugation. Crude solvent extracts were 
concentrated using a rotary vacuum evaporator (Heidolph Instruments GmbH 
& Co. KG Schwabach, Germany). All spectrophotometric data were acquired 
using Varian Cary 50 UV-visible spectrophotometer (Varian Cary, USA).  
4.1.2 Determination of antioxidant and anti-inflammatory potential of the 
aqueous and solvent fractions of the mollusks 
4.1.2.1 In vitro antioxidant assays 
4.1.2.1.1  2, 2 -Azino-bis-3-ethylbenzothiozoline-6-sulfonic acid diammonium salt 
(ABTS) radical scavenging activity  
ABTS (2, 2′-azino-bis-3ethylbenzothiozoline-6-sulfonic acid diammonium 
salt) assay was performed by the method of Arnao et al. (Arnao et al., 2001) with 
some suitable modifications. The samples (1 mg) were allowed to react with the 
ABTS+ solution (2850 mL) for 2h in dark. The absorbance was recorded at 734 
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nm using the spectrophotometer, and expressed relative trolox (6-hydroxy-2, 5, 7, 
8-tetramethylchroman-2-carboxylic acid) in terms of %TEAC (trolox equivalent 
antioxidant capacity, 6-hydroxy-2, 5, 7, 8-tetramethylchroman-2-carboxylic acid).  
Briefly, ABTS was dissolved in deionized water to 7 mM concentration, 
and potassium persulfate (K2S2O8) was added to a concentration of 2.45 mM. 
The reaction mixture was kept at room temperature overnight (12-16 h) in dark 
condition. The resultant intensely colored ABTS.+ radical cation was diluted 
with methanol to give an absorbance of ~0.70 at 734 nm. The crude extracts (50 
μL) of different concentrations (0.1 – 0.5 μg/mL) was diluted 100 times with the 
ABTS.+ solution to a total volume of 5 mL. Absorbance was measured 
spectrophotometrically at different concentrations (0.1-0.5 μg/mL) for each 
extract results of the assay were expressed as percent  radical scavenging ability. 
The assay was performed in triplicate. Fresh stocks of ABTS.+ solution were 
prepared before analyses. 
4.1.2.1.2  2, 2’-Diphenyl-1-picryl hydrazil (DPPH•) radical scavenging activity  
The free radical scavenging activities of the samples were determined 
by 2, 2’-diphenyl -1- picryl hydrazyl (DPPH) free radical scavenging activity 
(Moreira et al., 2013). The radical scavenging activity was expressed as 
percent inhibition of DPPH formation using the formula: percent inhibition of 
DPPH free radical = {(absorbance of control- absorbance of sample) × 100}/ 
absorbance of control. Butylated hydroxyl toluene (BHT) was used as the 
standard.  
Briefly, DPPH solution was prepared (80 μg/mL) in methanol, and an 
equal volume of sample solution (2.5 mL) and DPPH solution (2.5 mL) were 
added at different concentrations (0.5-1 mg/mL). The mixture was shaken 
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vigorously, and allowed to stand at room temperature for 30 min, and the 
absorbance was measured at 517 nm. The lesser absorbance of the reaction 
mixture indicated greater free radical scavenging activity. The percentage 
DPPH radical scavenging activity was calculated using the following formula: 
DPPH· scavenging effect (%) = 100 (A0 - A1/A0), where A0 was the 
absorbance of the control reaction and A1 was the absorbance in the presence 
of the standard sample or crude extract. 
4.1.2.2 In vitro anti-inflammatory assays 
4.1.2.2.1 Cycloxygenase (COX) inhibition assay 
Cycloxygenase (COX-1 and COX-2) inhibition assays were performed 
using 2, 7-dichlorofluorescein method with suitable modifications. In brief, leuco-
2, 7-dichlorofluorescein diacetate (5 mg) was hydrolyzed at room temperature in 
1 M NaOH (50 μL) for 10 min followed by the addition of 1 M HCl (30 μL) to 
neutralize the excess of NaOH before the resulting leuco-dichlorofluorescein (1-
DCF) was diluted in 0.1 M tris-buffer (pH 8). COX enzyme (COX-1 and COX-2) 
was diluted in 0.1 M tris-buffer (pH 8), so that a known aliquot gave an 
absorbance change of 0.05/min in the test reaction. The test samples (or the 
equivalent volume of MeOH, 20 μL) were pre-incubated with the enzymes at 
room temperature for 5 min in the presence of hematin. Premixed phenol, 1-DCF 
and arachidonic acid were added to the enzyme mixture to begin the reaction, and 
to give a final reaction mixture of arachidonic acid (50 μM), phenol (500 μM), 1-
DCF (20 μM) and hematin (1 μM) in 1 mL final volume of 0.1 M tris-buffer (pH 
8). The reaction was recorded spectrophotometrically over 1 min at 502 nm. A 
blank reaction mixture was analyzed in the spectrophotometer reference cell 
against each test reaction to account for any non-enzymatic activity attributed to 
the test sample. This blank consisted of the reaction mixture without the addition 
of the enzyme.  
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4.1.2.2.2 Lipoxygenase 5 (5-LOX) inhibition assay 
The 5-lipoxygenase (5-LOX) inhibition assay was carried out using the 
principle of 1-4 diene (linoleic acid) oxidations to 1- 3-diene (Baylac and 
Racine, 2003) with modification. Briefly, an aliquot of the stock solution (50 
µL, in DMSO and tween 20 mixture; 29:1, w/w) of each test sample was 
placed in a 3 mL cuvette, followed by addition of pre-warmed 0.1 M 
potassium phosphate buffer (2.95 mL, pH 6.3) and linoleic acid solution (48 
µL). Thereafter, ice-cold buffer (potassium phosphate) (12 µL) were added 
with 5-LOX (100 U) before being recorded spectrophotometrically at a 
wavelength of 234 nm. Prior to 5-lipoxygenase (LOX) inhibition assay, two 
samples were prepared as mentioned above but only with the mixtures of 
DMSO and tween 20, to serve as controls (no enzyme inhibition).  
4.1.2.3 In vivo anti-inflammatory assay  
The in vivo carrageenan-induced mice paw edema experiment was 
carried out as previously described (Winter et al., 1962).Thirty female 
BALB/c mice (20-30 g, 6–8 weeks old) were used in this study and those were 
housed under normal laboratory conditions (24 – 26ºC and 60 -75% RH), 
under a 12h light/dark cycle by fasting with distilled water. The animals were 
divided into 5 groups of 6 animals each. A 1% solution of carrageenan in 
saline (0.1 mL/mice) was injected subcutaneously into the right hind paw 30 
min after the test samples (250 mg/kg mice) had been administered orally. The 
control group (aspirin, 200 mg/kg mice) received normal saline as the vehicle. 
Paw volumes were measured at 0, 1, 2 and 4h after injection, and the thickness 
of the edema was measured with an electronic micrometer (aerospace; 0-25 
mm range, least count: 0.001 mm). Percentages of inhibition were obtained 
using the formula: (Tt −To) X 100/ To, where Tt is the average thickness for 
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each group after treatment in different time intervals and To is the average 
thickness obtained for each group before any treatment (zeroth  hour).  
4.1.3 Statistical analysis 
Statistical evaluation was carried out with the Statistical Program for 
Social Sciences 13.0 (SPSS Inc, Chicago, USA, ver. 13.0). Descriptive 
statistics were calculated for all the studied traits. Analyses were carried out in 
triplicate and the means of all parameters were examined for significance 
(p<0.05) by analysis of variance (ANOVA). The Pearson correlation test was 
used to assess correlations between means. The mean variance in the data set 
was detected using principal component analysis (PCA). All data were mean 
centered and scaled to equal unit variance prior to PCA. 
4A.  Antioxidative and anti-inflammatory activities of the solvent and 
aqueous fractions of Perna viridis  
4A.1 Description of study area and preparation of P. viridis extract 
Green mussel P. viridis (10 kg) were collected from their natural 
habitat at Elathur (Lat: 11054’11.6”N; Long: 750 12’.21.8’’E), in Calicut 
district of Kerala. The shell-on samples of P. viridis were thoroughly washed 
in running distilled water, and the meat (3.0 kg) was manually removed 
without applying heat. The samples were thereafter homogenized by a 
grinding machine, kept overnight under -80ºC for freezing, and were freeze-
dried in a laboratory freeze dryer (Alpha 1-4 LD plus, Germany) for 36 h to 
get the freeze-dried green mussel extract (FDPE, 213.6 g; yield 7.1 g/100g). 
This was then powdered and stored in vacuum packed polyethylene biohazard 
autoclave bags (Fisherbrand TM, Fischer Scientific) at -80 ºC until further 
processing. 
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The ground and freeze dried mussel samples (FDPE) (150 g) were 
extracted with MeOH (650 mL x3) at an elevated temperature (80 ºC) for 2h in 
a water bath. The samples were then filtered through Whatman filter paper to 
obtain the clarified filtrates (710 mL) and dried over Na2SO4 (50 g), before 
being concentrated (50 ºC) in vacuo to yield a dark brown viscous mass 
(MME, 28.08 g). A portion of the methanol extract (MME, 20g) was mixed 
with distilled water (50 mL) and partitioned with CHCl3 (2 x 100 mL) and 
EtOAc (2 x 100 mL) to separate the components with their polarity. The 
extracts were dried over anhydrous Na2SO4 (25-30 g), concentrated in vacuo 
to yield corresponding solvent fractions MCH (8.48 g) and MEA (3.01 g). 
The mussel polysaccharide was isolated from P. viridis by hot-water 
extraction followed by precipitation with ice cold (-20 ºC) ethanol. The ground 
fresh mussel meat (100 g) was extracted thrice with hot water (1:1 ratio at 
60ºC for 2 h) and the aqueous extracts were combined, pooled and centrifuged 
(model superspin R-V/Fm, Plastocrafts) at 9500 rpm for 20 min to separate the 
water insoluble impurities from the extracts. The supernatant was concentrated 
(50°C) in vacuo to one-third volume before being precipitated with ice-cold 
ethanol under stirring. The polysaccharide pellets were obtained by 
centrifugation, re-dissolved in water (5 mL) and precipitated with ice cold 
ethanol. Finally, the precipitate was lyophilized in vacuum freeze dryer (model 
ALPHA 1–4 LD plus) to obtain crude polysaccharide (MPS) (3.01 g, yield 
based on raw mussel = 3.01 %).The supernatant solution left after the 
precipitation of polysaccharide, was concentrated to dryness under vacuum to 
yield a yellow mass (MPP, 3.56 g).  
4A.2 Results and discussion 
Marine organisms are considered as vast untapped resources of 
bioactive molecules having enormous therapeutic potential, which led to the 
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growing interest in investigation of natural products with antioxidative and 
anti-inflammatory compounds lead molecules.  Perna viridis, commonly 
known as the Indian green mussel, is a widely distributed edible mytilid 
bivalve seen all along both east and west coast of India. 
4A.2.1 In vitro anti-oxidative activity of aqueous and solvent fractions of P. viridis 
The in vitro antioxidant activity of P. viridis was recorded under Table 
4.1. FDPE showed a dose dependent pattern in DPPH radical scavenging 
activities at 0.5–1 mg/mL. The observed total antioxidant radical scavenging 
activity (TARSA) of the freeze dried mussel powder (at a concentration of 1 
mg/mL) was 13%. Previous studies demonstrated the presence of antioxidative 
molecules, especially in mussels (Lemaire and Livingstone, 1993). The present 
results can also be compared with other reports of some other species, such as, 
Mytilus edulis (Cheung et al., 2002; Gaspic et al., 2002; Riveroset al., 2002; 
Sukhotin et al., 2002). The results obtained in the present study were in 
accordance with those recorded earlier. The ABTS scavenging effects shown by 
FDPE at a concentration of 0.5 mg/mL was found to be 0.2%. The results 
obtained in this study were in fair agreement with the previous investigations on 
Mytilus galloprovincialis,  
The MEA fraction was found to be more effective in stabilizing the 
ABTS.+ (23.59%, 0.5 µg/mL), and DPPH radicals (60.43%, 1 mg/mL) than 
MCH fraction (37.35% and 15.31%, respectively). The MEA fraction recorded 
significantly greater ABTS and DPPH radical scavenging capacities than 
MCH fraction (P<0.05). The extract was able to reduce stable radical DPPH to 
the yellow coloured diphenylpicrylhydrazine, which was noticeable by the 
discolouration of test samples from purple to yellow. The decrease in 
absorbance caused by the antioxidants in the extracts might be due to the 
hydrogen donating ability that resulted in the scavenging of the free radical. 
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Recent study on the methanolic extract of P. viridis showed significant radical 
scavenging property against DPPH radical (Jena et al., 2010). The antioxidant 
activity of P. viridis reassure the presence of secondary metabolites with 
antioxidant properties (Sreejamole et al., 2013). 
MPP (60.43% and 23.59%) recorded significantly greater DPPH and 
ABTS scavenging activities than MPS fractions (37.4% and 15.3%) 
respectively. The higher DPPH and ABTS activity of MPP fraction revealed 
the presence of antioxidative lead molecules in these fractions. Earlier studies 
reported that the polysaccharides from mollusks had potential pharmaceutical 
properties, such as, anti-tumor, immunity-enhancement (Vetvicka et al., 
2004), anti-inflammation (Mikheiskaya et al., 1988) and anti-aging effects. 
The ABTS assay was based on the generation of a blue/green ABTS+ which is 
applicable to both hydrophilic and lipophilic antioxidant systems. The 
antioxidant activities of polysaccharides were not a function of a single factor 
but a combination of several factors, such as, content of sulfuric radicals, 
molecular weight, protein content and type of sugar (Donghong et al., 2013).  
Table 4.1. In vitro anti-oxidative activity of aqueous and solvent fractions of P. viridis. 
 Concentration 
(mg/mL) FDPE MCH MEA MPS MPP 
DPPH 
scavenging 
activity (% 
TARSA) 
0.5 8.24±0.14a 33.14±0.24b 49.62±0.32c 26.56±0.21d 35.71±0.24b 
0.75 10.54±0.08a 41.72±0.36b 56.85±0.41c 32.83±0.26d 42.75±0.35b 
1 13.41±0.13a 46.62±0.29b 60.43±0.26c 37.35±0.13d 48.62±0.28b 
ABTS radical 
scavenging 
activity (% 
TEAC) 
0.1 0.15±0.01a 8.43±0.02b 14.51±0.08c 8.27±0.02b 11.78±0.02d 
0.3 0.19±0.01a 12.76±0.09b 19.27±0.11c 13.44±0.11bd 14.13±0.12d 
0.5 0.21±0.01a 16.24±0.15b 23.59±0.17c 15.31±0.04b 18.94±0.08d 
DPPH radical scavenging activity at 0.1 mg/mL was expressed in percent; ABTS radical 
scavenging activity at 0.1 mg/mL is expressed in percent; FDPE – Freeze dried P. viridis 
extract; MCH-Mussel chloroform fraction; MEA-Mussel ethyl acetate fraction; MPS-Mussel 
polysaccharide; MPP-Mussel polyphenol fraction. 
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4A.2.2  In vitro anti-inflammatory activity of aqueous and solvent fractions of P. 
viridis 
Freeze dried mussel powder (5 mg/mL) showed inhibitive property 
against the pro-inflammatory COX-2 and 5-LOX enzymes, and the activities 
were found to be comparable (P<0.05) with the standard NSAIDs, aspirin and 
indomethacin. The COX-1 and COX-2 inhibition properties of the freeze dried 
mussel powder were found to be comparable with the activities reported for the 
total lipid extracts of P. canaliculus, Mytilus edulis and fish oil (McPhee et al., 
2007). FDPE (5mg/mL) showed a comparable inhibition (48.5 and 51.9%, 
respectively) with aspirin and indomethacin, against pro-inflammatory COX-2 
and 5-LOX enzymes. The earlier reports (McPhee et al., 2007) indicated that the 
total lipid extracts of P. canaliculus and M. edulis realized a moderate inhibition 
of COX-1 and COX-2 (12 and 25%; 18 and 24%, respectively, in that order at 1 
μg/mL) than those reported in the present study.  
MEA fraction registered significantly greater (P<0.05) COX-1, COX-2 
and 5- LOX inhibition than MCH fraction. MEA fraction recorded greater 
COX-2 (51.4%) and 5-LOX (56.1%) inhibition than MCH fraction at 5 
mg/mL (49.8% and 52.4%, respectively). The MEA fraction exhibited positive 
correlation with COX-2 and DPPH radical scavenging activity, whereas MCH 
fraction showed negative (r2=0.87) correlation with DPPH radical scavenging 
activity. The IC50 value of COX-2 in MEA extract was found to be 4.54 
mg/mL whereas it was 5.01 mg/mL for the MCH fraction. The presence of 
diverse groups of secondary metabolites, such as alkaloids, polyphenols, 
terpenes and sterols in the ethyl acetate extract of P. viridis was reported in an 
earlier literature (Sreejamole et al., 2013).The extract from P. viridis was 
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reported to be active against inflammatory joint diseases, influenza, herpes, 
HIV, and hepatitis viral strains (Mitra and Chatterji, 2004).  
 
Fig 4.1 In vitro anti-inflammatory activity of aqueous and solvent fractions of P. viridis 
The MPS fraction appeared as white powder, and had no absorption at 280 
nm or 260 nm in the UV spectrum, indicating the absence of protein and nucleic 
acid. The supernatant solution left after the precipitation of polysaccharide, was 
evaporated to dryness under vacuum (MPP). MPS registered significantly greater 
COX-2 inhibition (74.8%) than synthetic drugs aspirin and indomethacin (58.6% 
and 59%, respectively, 5mg/mL). Also no significant differences were apparent 
between MPS (32.5%) and indomethacin (34.6%) at lower concentration (0.5 
mg/mL). MPS registered significantly greater 5-LOX inhibition (71.6%, 5 
mg/mL) than aspirin and indomethacin (54.8 and 66.3%, respectively, 5 mg/mL). 
A water soluble glucan was reported to possess significant anti-inflammatory and 
antioxidant activities (Zhang et al., 2010). 
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4A.2.3  In vivo anti-inflammatory activity of aqueous and solvent fractions of P. 
viridis 
Carrageenan induced paw edema is a standard and most commonly used 
technique to screen anti-inflammatory activity (Winter, 1962). Carrageenan is a 
sulfated polysaccharide that promotes acute inflammation by activating pro-
inflammatory cells. Inflammation induced by carrageenan, is acute, non-immune, 
well-researched, and highly reproducible. It is expected that after tissue injury, an 
animal will display spontaneous pain behaviour. This peripheral hypersensitivity 
or pain perception can be explained on the basis of local release of various 
inflammatory mediators i.e., bradykinin, prostaglandins or cytokines, which can 
activate and sensitize the peripheral nerve endings (Baccaglini, 1983). The 
inflammation is characterized by increased tissue water and plasma metabolism of 
arachidonic acid by both COX and LOX enzyme pathway (Gamache et al., 
1986). Different extracts demonstrated a time dependent anti-inflammatory 
effects in mice with carrageenan induced footpad edema. Comparison of purified 
compounds with reference drug (aspirin) on carrageenan-induced hind paw 
edema in mice were recorded in Fig 4.2. The FDPE have potent anti-
inflammatory activity, which significantly decreased paw edema (P<0.05) with a 
maximum inhibition at 6th h. Whitehouse et al. investigated the anti-inflammatory 
activity of the oil extracted from the freeze-dried powder of the New Zealand 
green-lipped mussel (Lyprinol™) in adjuvant-induced polyarthritis or collagen-
induced arthritis in rats (Whitehouse et al., 1997). Maximum inhibition of edema 
by MEA fraction (68.3%) was achieved on 5thh. However MCH fraction recorded 
maximum inhibition of edema during 6thh. The anti-inflammatory activities of 
aqueous/ethanol and methanol extracts of Perna viridis was reported in an earlier 
literature (Sreejamole et al., 2011). 
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Maximum inhibition of edema by MPS was achieved during the 4th h 
(74.2%) whereas MPP polyphenols recorded maximum activity (68.8%) in 3rd h. 
The study showed that MPS effectively suppressed the edema produced by the 
histamine, which indicated that the polysaccharide exhibited its anti-inflammatory 
activities by means of either inhibiting the synthesis, release or action of 
inflammatory mediators viz., histamine, serotonin and prostaglandin’s involved in 
the inflammatory response. The polysaccharides may be the potential therapeutic 
agent involved in the inflammatory disorders, controlling the initial phase of 
inflammation and provoking an inhibition of edema formation similar to the 
reference drugs (aspirin, 68. 7% in 2nd h) compounds. MPS and aspirin exhibited 
highest activity in 4th h (74.2% and 79.8 %, respectively) and started losing 
activity around 5th h (67.35% and 77.32%, respectively), which might be related 
to the lower level of these compounds in the blood circulation. The results 
obtained in the present study were in accordance with the previous reports that 
several glucan-type polysaccharides had potential anti-inflammatory activities 
(Czarnecki and Grzybek, 1995). 
 
Fig 4.2 Inhibition of rat paw edema (%) after the administration of solvent and aqueous 
fractions of P. viridis 
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4B. Anti-oxidative and anti-inflammatory potential of the solvent and 
aqueous fractions of Crassostrea madrasensis  
4B.1  Description of study area and preparation of Crassostrea madrasensis 
extract 
The C. madrasensis samples were collected from the intertidal rocky 
shore of Sattar island at Cochin, south west coast of India (UST: 1141160E, 
221200N) (Lat: 9058’N; Long: 76016’E), which is predominantly influenced 
by oceanic water from the Arabian sea. The tissues of edible oysters were 
combined, minced, and freeze dried to furnish freeze dried oyster powder 
(FDCP).  
The ground and freeze dried octopus samples (150 g) were extracted 
with MeOH and the extracts were filtered with Whatman filter paper No.1 to 
obtain the clarified filtrates, before being concentrated (50 ºC) in vacuo to 
yield  a dark brown  viscous mass (CME, 16.98 g). The methanolic extract 
(CME, 50g) was partitioned with CHCl3 (2 x 200 mL), and the aqueous 
portion was again partitioned with EtOAc (2 x 150 mL) to separate the 
components with varying polarity. The solvent extracts were dried over 
anhydrous Na2SO4 (45-60 g), before being concentrated in vacuo using a 
rotary vacuum evaporator (Superfit, India) to yield the corresponding solvent 
fractions CRCH (25.32 g) and CREA (6.01 g). 
The ground fresh oyster meat (100 g) was extracted with hot water (1:1 
ratio) at 60 ºC for 2 h with occasional stirring. The water extract collected by 
centrifugation were pooled together and concentrated in vacuo to one third of 
the original volume. The concentrated aqueous extract was precipitated with 
threefold volumes of ice-cold ethanol. The polysaccharide pellets were 
obtained by centrifugation and then re-dissolved in water (5 mL) before being 
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precipitated with ice-cold ethanol (10 mL). Finally, the precipitate was 
lyophilized in vacuum freeze dryer (model ALPHA 1–4 LD plus) to obtain 
crude polysaccharides (CPS) (2.85 g, yield based on raw oyster 2.85%).  CPS 
appeared as yellow powder, and no absorption was recorded at 280 nm or 260 
nm in the UV spectrum, indicating the absence of protein and nucleic acid. 
The supernatant solution left after the precipitation of polysaccharide, was 
concentrated in vacuo to dryness to yield a yellow mass (CRPP, 1.73 g).  
4.B.2 Results and discussion 
4B.2.1 In vitro antioxidative activity of aqueous and solvent fractions of C. 
madrasensis 
Antioxidant activity of the crude ethyl acetate extract derived from the 
edible muscle of C. madrasensis was evaluated through various antioxidant 
assays. The radical scavenging capacities of different solvent and aqueous 
extracts against different test radicals can be explained by different mechanisms 
involved in the radical–antioxidant reactions. DPPH is a compound that 
possesses a nitrogen free radical, and is readily neutralised by a free radical 
scavenger. This assay was used to test the ability of the antioxidative 
compounds functioning as proton radical scavengers or hydrogen donors. The 
decrease in absorbance of the DPPH radical caused by antioxidants was due to 
the scavenging of the radical by hydrogen donation.   
The DPPH radical scavenging abilities of the extracts derived from 
edible oyster were found to be comparable with that of ascorbic acid. The 
CREA fraction exhibited 55.7% DPPH radical scavenging ability and 20.83% 
ABTS radical scavenging ability at a concentration of 1 mg/mL. The CREA 
fraction exhibited significantly greater DPPH and ABTS radical scavenging 
abilities than CRCH fraction (Table 4.2, P<0.5). The method involving DPPH 
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radical scavenging activity is based on the reduction of methanolic DPPH- 
solution in the presence of hydrogen donating antioxidant, and the formation of 
the non-radical form DPPH. The CREA extract was able to reduce the stable 
radical DPPH to the yellow-colored diphenylpicrylhydrazine (Li et al., 2007). 
The methanolic extract of gastropod Pleuroploca trapezium was likewise found 
to exhibit good scavenging activity towards the DPPH radical with an IC50 value 
of 4021 μg/mL. The present study demonstrated that the CPS registered 35.9% 
DPPH and 12.2% ABTS activities whereas CRPP showed having 45.7% DPPH 
and 17.2% ABTS activities. The differences in DPPH scavenging activities 
might be due to scavenging different types of antioxidant principles extracted at 
varying solvent polarities. Previous studies on the radical scavenging abilities of 
C. madrasensis showed 23.5 % DPPH radical scavenging activity of the crude 
methanolic extract (Li et al., 2007). 
Table 4.2. In vitro antioxidative activity of aqueous and solvent fractions of C. madrasensis. 
 Concentration 
(mg/mL) FDCP CRCH CREA CPS CRPP 
DPPH 
scavenging 
activity (% 
TARSA) 
0.5 6.49±0.02a 22.62±0.13b 34.24±0.23c 22.94±0.12b 28.32±0.13d 
0.75 8.16±0.01a 34.73±0.16b 46.71±0.16c 29.52±0.24d 36.65±0.18e 
1 10.62±0.08a 40.65±0.21b 55.75±0.32c 35.85±0.17d 45.73±0.14e 
ABTS radical 
scavenging 
activity (% 
TEAC) 
0.1 0.11±0.01a 8.42±0.05b 12.52±0.05c 7.21±0.07d 8.57±0.06b 
0.3 0.14±0.01a 11.71±0.09b 16.37±0.14c 10.86±0.05b 14.55±0.09d 
0.5 0.16±0.01a 15.14±0.12b 20.83±0.27c 12.24±0.06d 17.23±0.11e 
DPPH and ABTS radical scavenging activity at 0.1 mg/mL were expressed in percent; FDPE – 
Freeze dried C. madrasensis extract; CRCH- C. madrasensis chloform fraction; CREA- C. 
madrasensis ethyl acetate fraction; CPS- C. madrasensis polysaccharide; CRPP- C. madrasensis 
polyphenol fraction. 
4B.2.2  In vitro anti-inflammatory activity of aqueous and solvent fractions of C. 
madrasensis 
The COX inhibition assay used in this study is based on the oxidation 
of 1-dichlorofluorescein (1-DCF) by the hydroperoxide formed in the 
cyclooxygenase reaction. The method determines the second peroxidase 
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reaction of the enzyme, which has a higher turnover than the initial oxygenase 
reaction (Larsen et al., 1996). The fractions CREA realized greater COX-2 
(44.8%) and 5- LOX activities (51.3%) than CRCH fractions (42.5% and 
50.1%, respectively in that order). Aspirin and indomethacin recorded 
significantly greater COX-1 activity than CREA and CRCH fractions 
(P<0.05). CPS recorded higher COX-2 (69.7%) and 5-LOX inhibitions 
(64.2%, 5 mg/mL) than CRPP (33.5% and 37.5%, respectively, at 5 mg/mL). 
CPS fraction recorded significantly greater anti-COX-2 and anti-5-LOX 
inhibition than aspirin and indomethacin (P<0.05). 
 
Fig 4.3 In vitro anti-inflammatory activity of aqueous and solvent fractions of C. madrasensis 
4B.2.3  In vivo anti-inflammatory activity of aqueous and solvent fractions of C. 
madrasensis 
Carrageenan-induced edema has been commonly used as an experimental 
animal model for acute inflammation, and is believed to be biphasic. 
Inflammation was induced by carrageenan injection for 1 h and thereafter treated 
with the crude fractions. The effect of CREA in reducing the carrageenan-induced 
acute inflammation was found to the similar to a comparable dose of aspirin. 
Inflammation was reduced by 50% compared with the untreated group within 
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three hours after the treatment with CREA. Maximum inhibition of edema by 
CREA fraction (64.9%) was achieved on 4thh whereas CRCH fraction recorded 
maximum inhibition (56.3 %) of edema in 5th h. These indicated that CREA was 
quickly absorbed and biologically available. After 5th h the inflammed pawsizes 
continued to shrink, showing that the treatment was pharmacologically active for 
a prolonged time. The in-vivo anti-inflammatory activity indicated higher activity 
of CRPP fraction (58.5%) in 3th h, and the activity was decreased to 42.3 in 6th h. 
It has been suggested that the early hyperemia of carrageenan induced edema 
result from the release of histamine and serotonin (Kulkarni et al., 1986), and the 
CRPP fraction were efficient in reducing the edema resulted from the release of 
histamine and serotonin. However maximum inhibition of edema by CPS was 
achieved during 5th h (63.3%) and CPS fractions were able to reduce the delayed 
phase of carrageenan induced paw edema resulted mainly from the potentiating 
effect of prostaglandins on mediator release, especially bradykinin.   
 
Fig 4.4 Inhibition of rat paw edema (%) after the administration of solvent and aqueous 
fractions of C. madrasensis  
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4.C Antioxidative and anti-inflammatory potential of the solvent and 
aqueous fractions of Octopus dolffusi  
4.C.1 Describtion of study area and preparation of O. dolffusi extract 
Octopus dolffusi samples were collected from the Fort Kochi harbor 
along the South-west coast of Kerala. The samples thus collected were 
immediately placed in ice for transportation and the samples were processed, 
cleaned, minced, before being stored in low temperature (-20oC) until further 
use. The samples collected were minced and freeze dried to obtain Octopus 
dolffusi powder (FROP). 
The ground and freeze dried octopus samples (100 g) were extracted with 
EtOAc: MeOH (1:1 v/v) at room temperature (500 mL x 2, 30ºC) and then at an 
elevated temperature (500 mL x 2, 50ºC) for 2 h on a water bath. The extracts 
were thereafter filtered and concentrated (50 ºC) in vacuo to yield a dark brown 
viscous mass (OEM, 16.98 g). The residue was further extracted with CHCl3: 
MeOH (1:1 v/v, 200 mL x 3) for 2 h on a water bath. The extracts were filtered 
and concentrated in vacuo (Heidolph, Germany) to afford the crude solvent 
extract (OCM, 3.01 g).  
The octopus polysaccharide was isolated from O. dolffusi by hot-water 
extraction and ethanol precipitation. The ground fresh octopus meat (100 g) 
was extracted thrice with hot water (1:1 ratio) at 60 ºC for 2 h.  The water 
extracts were collected before being centrifuged (SuperspinR-V/Fm, 
Plastocrafts) to separate the water insoluble impurities from the extracts.  The 
clarified supernatant (275 mL) was concentrated to one third of the original 
volume, and precipitated with ice-cold ethanol (95%) before being and kept at 
4ºC for overnight. The precipitated polysaccharide pellets were obtained by 
centrifugation and redissolved in water (5 mL) before being precipitated with 
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ice cold ethanol (10 mL). Finally, the precipitate was lyophilized in a vacuum 
freeze dryer (model ALPHA 1–4 LD plus) to obtain the crude polysaccharides 
(OPS) (2.55 g, yield based on raw mussel 2.55 %).The  OPS appeared as light 
pink powder, and had no absorption at 280 nm or 260 nm in the UV spectrum, 
indicating the absence of protein and nucleic acid. The supernatant solution 
left after the precipitation of polysaccharide, was concentrated in vacuo to 
obtain a highly hygroscopic light yellow powder (OPP, 1.6g).  
4.C.2 Results and discussion 
4C.2.1 In vitro antioxidative activity of aqueous and solvent fractions of O. dolffusi 
In vitro antioxidative activities of aqueous and solvent fractions of O. 
dolffusi were recorded in Table 4.3. The methanol fraction (OEM) of O. 
dolffusi exhibited 31.9% DPPH radical scavenging activity. Earlier studies 
showed that methanolic extract of B. spinosa exhibited 39.4% DPPH radical 
scavenging activity at 10 mg/mL whereas the BHT and ascorbic acid showed 
63.7 and 59.8% respectively (Premanand et al., 2010). The DPPH and ABTS 
activities of the OCM fraction was 35.2 % and13.8%, respectively, (1 mg/mL) 
and that of OEM fraction was 56.9% and 20.8%, respectively, at that 
concentration. OEM fraction recorded significantly greater DPPH and ABTS 
radical scavenging activities than OCM fraction (P<0.05). These results could 
be compared with the ethyl acetate extract of other mollusks L. duvauceli. The 
DPPH and ABTS radical scavenging activities of OPS at a concentration of 1 
mg/mL were recorded as 39.3 % and 13%, respectively. Likewise, OPS 
recorded significantly greater DPPH and ABTS radical scavenging activities 
than OPP fraction (P<0.05). The total antioxidant radical scavenging activity 
and ABTS scavenging effects of polyphenol fraction OPP (as determined by 
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DPPH radical scavenging activity) at 1mg/mL  were 45.7% and 16.2% 
respectively.Likewise, the methanolic extract of mollusk Pleuroploca 
trapezium was found to exhibit a good scavenger of DPPH radical with an IC50 
value of 4021 μg/mL (Premanand et al., 2010). 
 
Table 4.3. In vitro antioxidative activity of aqueous and solvent fractions of O. dolffusi 
 Concentration (mg/mL) FDOP OCM OEM OPS OPP 
DPPH radical 
scavenging 
activity (% 
TARSA) 
0.5 5.72±0.02a 21.26±0.16b 40.34±0.34c 20.74±0.19b 34.27±0.12d 
0.75 8.93±0.04a 31.84±0.23b 47.27±0.26c 32.62±0.24b 41.72±0.24d 
1 11.91±0.09a 35.16±0.27b 56.93±0.15c 39.25±0.28d 45.65±0.28e 
ABTS radical 
scavenging 
activity (% TEAC) 
0.1 0.11±0.01a 8.35±0.01b 11.77±0.03c 7.24±0.05b 8.51±0.01b 
0.3 0.15±0.01a 12.44±0.11b 16.36±0.13c 9.76±0.03d 13.83±0.05b 
0.5 0.19±0.01a 13.76±0.09b 20.75±0.16c 13.01±0.06b 16.24±0.09d 
DPPH and ABTS radical scavenging activities at 0.1 mg/mL were expressed in percent;; 
FDOP– Freeze dried O. dolffusi extract; OCM- O. dolffusi chloform fraction; OEM- O. 
dolffusi ethyl acetate fraction; OPS- O. dolffusi polysaccharide; OPP- O. dolffusi polyphenol 
fraction. 
 
4C.2.2  In vitro anti-inflammatory activity of aqueous and solvent fractions of O. 
dolffusi 
The OEM fraction registered significantly greater COX-1 and 5-LOX 
inhibition (54.8% and 54.6%) than OCM fraction (51.6% and 51.8%, 5 
mg/mL, P<0.05). No significant difference in anti-COX-2 activity was 
apparent between OEM fraction and OCM fraction in higher concentration 
whereas significant difference was observed in lower concentrations (Fig 4.5).  
Also no significant differences in the 5-LOX activity were apparent between 
OEM (54.6%) and indomethacin (54.8%) in higher concentration (0.5 
mg/mL). The OEM fraction registered significantly higher 5-LOX inhibition 
than aspirin at lower concentrations (0.5 and 1 mg/mL), whereas no significant 
difference was observed at higher concentration between aspirin (54.8%) and 
OEM fraction (54.6%). OPS registered significantly greater COX-2 inhibition 
(70.7%) than aspirin and indomethacin (58.6% and 59%, respectively, at 5 
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mg/mL). Also no significant differences were apparent between OPS (53.1%) 
and aspirin (52.2%) at lower concentration (1 mg/mL). OPS registered 
significantly higher 5-LOX inhibition (66.8%, 5 mg/mL) than OPP fraction at 
higher concentration, and no significant differences were observed at lower 
concentrations. OPS fraction recorded significantly higher 5-LOX inhibition 
(66.8%) than aspirin and indomethacin (54.9 and 66.3%, respectively, 5 
mg/mL). However the OPP fraction recorded significantly lower COX-2 
inhibition (25.9%) and 5-LOX inhibition (28.4%, 5 mg/mL) than aspirin and 
indomethacin. 
 
Fig 4.5 In vitro anti-inflammatory activity of aqueous and solvent fractions of  O. dolffusi 
4C.2.3  In vivo anti-inflammatory activity of aqueous and solvent fractions of O. 
dolffusi 
The carrageenanan induced paw edema method has been used to 
evaluate the effect of NSAIDs and anti-inflammatory extracts (Phadke and 
Anderson, 1988). The in-vivo anti-inflammatory activity of carrageenan 
induced paw edema recorded greater activity of OPP fraction (62.1%) in 3rd 
hour, and the activity was found to be decreased to 43.4% during 6th h (Fig 
0
10
20
30
40
50
60
70
80
0.5 mg/mL 1 mg/mL 5 mg/mL 0.5 mg/mL 1 mg/mL 5 mg/mL 0.5 mg/mL 1 mg/mL 5 mg/mL
COX-1 inhibition activity (%) COX-2 inhibition activity (%) 5-LOX inhibition activity (%)
Aspirin
Indomethacin
FDOP
OPS
OPP
OCM
OEM
Bioactive potentials with respect to anti-oxidative and anti-inflammatory properties of Perna …………. 
141 
4.6). OEM and aspirin showed highest activity in 4th h (65.65% and 79.84%, 
respectively) and started losing activity at 5th h (67.4% and 59.1%, 
respectively. Maximum inhibition of edema by OCH fraction was achieved in 
6th h (60.07%). OPS fraction recorded significantly greater anti-inflammatory 
activity (P<0.05) than OPP fraction. Maximum inhibition of paw edema for 
OPS fraction was observed in 4th hour and decreased to 49.9 during 6th h. 
Kumar (Kumar, 2003) reported anti-inflammatory effect of the methanolic 
extracts of Cypraea errones and Cypraea Arabica, against carrageenan-
induced inflammation. Novel anti-inflammatory drugs were isolated from 
corals and sponges. It was observed that the increase in the paw thickness was 
inhibited to about 73.6% by 100% acetone column-purified fraction of T. 
tentorium at a concentration of 50 mg/kg, whereas standard anti-inflammatory 
drug, diclofenac sodium (50 mg/kg) inhibited the paw thickness to 65% ( 
Chellaram et al., 2012). 
 
 
Fig 4.6 Inhibition of rat paw edema (%) after the administration of solvent and aqueous 
fractions of  O. dolffusi (%) 
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4.2 Conclusions 
The present study demonstrated the importance of P. viridis, C. 
madrasensis and O. dolffusi, in terms of their potential radical scavenging and 
anti-inflammatory properties. The antioxidant and anti-inflammatory assay 
measured the biological resistance of the organisms to the reactive oxygen 
species and oxyradical-medicated adverse disorders. The present findings 
implied that the methanolic extracts derived from these candidate bivalve 
species could be used to isolate potentially valuable antioxidative and anti-
inflammatory compounds. This forms a first comprehensive report on the 
antioxidative and anti-inflammatory properties of these seafood species as a 
novel source of antioxidants and anti-inflammatory leads. The following 
chapter focussed towards bioactivity-guided isolation and characterization of 
bioactive lead molecules with anti-oxidative and anti-inflammatory properties. 
…………??………… 
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Background of the study 
Marine environment encompasses of complex ecosystems and many of 
its inhabitants are living under constant stress from free radicals, reactive 
oxygen species, and prooxidants generated both exogenously (heat and light) 
and endogenously (H2O2 and transition metals).These inhabitants developed 
bioactive compounds as part of highly toxic defense mechanisms which is a 
reflection of the highly competitive environment in which the organisms 
reside (Grabley and Thierjcke, 1999). These antioxidant compounds include 
flavonoids, phenolic acids, carotenoids, and tocopherols that can inhibit 
Fe
3+
/arachidonate induced oxidation, scavenge free radicals, and act as 
reductants. Many bioactive compounds have been extracted, characterized and 
purified from various marine animals,such as, bacteria, algae, dino-flagellates, 
tunicates, sponges, soft corals, bryozoans, cephalopods, and echinoderms. 
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Mollusks in the oceans are a common sight and are virtually untapped 
resources for the discovery of novel bioactive compounds. Chemical 
compounds with antioxidant and anti-inflammatory properties are present in 
mollusks as a protective mechanism against various stress factors in oceanic 
ecosystem. Even though many bioactive compounds has been extracted, 
characterized and purified from various marine animals, much of the potential 
compounds from mollusks still remain unharnessed especially the organisms 
belonging to class bivalves and cephalopods. The absence of oxidative damage 
in the stress-induced biochemical parameters of mollusks from coastal 
ecosystem suggested that their cells are equipped with powerful anti-stress 
secondary metabolites with antioxidative and anti-inflammatory activities, 
which provide competitive advantages against various oxidative stress factors 
leading to the development of harmful reactive oxygen species. These sessile 
species are the richest natural sources of bioactive compounds, many of which 
belong to novel chemical classes not found in terrestrial sources.  
Mollusks are considered as one of the important sources to obtain 
bioactive compounds that exhibit anti-inflammatory and antioxidant activities 
(Sreejamole, 2011). Bioactive components, such as, peptides, enzyme and 
enzyme inhibitors have been identified from Meretrixmeretrix having useful 
effects including antihypertensive, hypolipidemic and antioxidant properties 
(Blunt et al., 2012). Mollusks were reported to contain heparin and heparin-like 
polysaccharide, such as,glycosaminoglycans. Anti-inflammatory compounds, 
such as,manoalide, pseudopterosins, topsentins, and debromohymenialdisine 
were isolated from mollusks (Blunt et al., 2013). Cyclotides represent the small 
molecular weight circular peptides with an extremely stable structural 
framework due to the knotted arrangement of disulfide bonds, and were reported 
to be endowed with antioxidative activities in mollusks. Antiproliferative and 
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antioxidant properties of mollusks, Tambjaceutae, and Bugula dentate were 
reported to possess tambjamines (Blunt et al., 2012). Dolastatins are a group of 
cyclic and linear peptides with free radical scavenging and anticarcinogenic 
activities isolated from the marine shell-less molluskDolabellaauricularia. 
Mytilin and molluskdefensins were isolated from the molluskMytilisedulis 
(Gestalet al., 2007). Polysaccharides and polysaccharide–protein complexes 
have been found as common polymers in shellfish and received considerable 
attention in recent years because of their anti-inflammatory, antioxidant, 
antitumor and immunoregulatory activities (Blunt et al., 2013). Polysaccharides 
have been used to stimulate the immune system and to fight against cancer, and 
researches shown polysaccharides to possess antioxidant activity. A glycogen 
complex extracted from Pernacanaliculus, had an anti-inflammatory activity 
(Blunt et al., 2014). Bioactive lipids, and specifically phospholipids are 
important part of the intestinal mucus, and an important regulator of epithelial 
function during inflammation by inhibiting cytokine tumor necrosis factor 
(TNF-α). Green Lipped Mussel from New Zealand has been shown to contain 
unique n-3 fatty acids, which appear to act as dual inhibitor of arachidonic acid 
oxygenation by both COX and LOX pathways (Tiffany et al., 2002), thus 
decreasing prostaglandin and leukotriene syntheses, and downregulating the 
inflammatory sequence. 
This chapter envisages the isolation and characterization of secondary 
metabolites with antioxidant and anti-inflammatory activities from 
Pernaviridis, Crassostreamadrasensisand Octopus dolffusi. Hence, the 
purification of these crude extracts was carried out by repeated purifications 
with the aid of various chromatographic techniques. A systematic search for 
the development of new sources of bioactive pharmacophores from these 
molluskswill be helpful for the development of bioactive supplements. 
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5.1. Materials and methods 
5.1.1. Chemicals and instrumentation 
All compounds, reagents and solvents were of analytical, spectroscopic or 
chromatographic reagent grade and were obtained from Merck (Darmstadt, 
Germany).  
5.1.1.1. Chromatographic analyses 
5.1.1.1A. Preparative thin layer chromatography (TLC) 
TLC was performed on pre-coated TLC plates with silica gel 60 F254 
(layer thickness 0.2 mm; 20 x 20 cm; Merck KGaA, Darmstadt, Germany) 
using different solvent systems as needed. The band separation on TLC was 
detected under UV lamp at the wavelength of 254 and 366 nm 
5.1.1.1B. Vacuum column chromatography (CC) 
Normally, the columns were dry silica gel GF254 pre-packed, of 18 cm 
height and inner diameter of 12 cm, vertically clamped. The column was filled 
and saturated with the desired non-polar solvent in the mobile phase (eg.,n-
hexane) just prior to sample loading. Samples were dissolved in a small 
volume of the same solvent used, and the resulting mixture was then packed 
onto the top of the column using special syringe. Using step gradient elution 
with non-polar solvent (n-hexane or CHCl3) and increasing amounts of polar 
solvents (e.g. EtOAc or MeOH) the successive fractions were collected. The 
mobile phase (gradient elution) was pumped through the column with the help 
of air pressure resulting in sample separation. 
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5.1.1.2. Spectroscopic analyses 
5.1.1.2A.Fourier transform infra-red spectrometer (FTIR) 
Fourier transform infra-red spectrometer (FTIR) spectra of the 
compounds under KBr pellets were recorded in a Thermo Nicolet, Avatar 370. 
The scanning was conducted in to mid IR range, i.e., between 4000-400cm
-1
. 
UV spectra were obtained on a Varian Cary 50 UV-VIS spectrophotometer 
(Varian Cary, USA). 
5.1.1.2B. Mass spectrometry (MS) and elemental analysis 
Elemental analysis of the compounds was carried out using a Euro 
Vector elemental analyzer (model no. EA3011). Liquid chromatography–mass 
spectrometry experiments were performed on an Applied BiosystemsQTrap 
2000 (Applied Biosystems, Darmstadt, Germany) coupled to an Agilent 1100 
HPLC system (Agilent, Waldbronn, Germany) using a Luna 5 μ C18 column 
(100 A, 100 × 4.6 mm, Phenomenex, Aschaffenburg, Germany) or a Luna 3 μ 
C18 column (100 A, 50 × 1.0 mm, Phenomenex, Aschaffenburg, Germany) 
and a gradient of solvents A (0.1% HCOOH) and B (CH3CN + 0.1% HCOOH; 
gradient 0% B to 100% B in 10 min) with a flow rate of 1.5 mL/min or 60 
μL/min, respectively. ESI-MS spectra were acquired in the positive and 
negative modes with a turboion spray voltage, curtain gas, turbo temperature, 
and nebulizer gas of -4500 V, 30 psi, 500 °C, and 50 psi (positive mode, flow 
rate at 1.5 mL/min. The exact molecular ion weights of the pure compounds 
have been acquired by direct injection in a high resolution mass spectrometer, 
and were compared with the MarinLit database (Royal Society of Chemistry, 
London, Burlington House, London W1J 0BA), dedicated to marine natural 
products. 
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5.1.1.2C. Nuclear magnetic resonance spectroscopy (NMR) 
The 
1
H and 
13
C NMR spectra were recorded on a Bruker AVANCE III 
500 MHz (AV 500) DRX 500 NMR spectrometer (Bruker, Karlsruhe, Germany) 
in CDCl3 as aprotic solvent at ambient temperature with TMS as the internal 
standard (δ 0 ppm) equipped with 5 mm probes. The number of attached protons 
for the 
13
C NMR signals was determined from DEPT experiments. Standard pulse 
sequences were used for Distortionless Enhancement by Polarization Transfer 
(DEPT), 
1
H–1H Correlation spectroscopy (1H–1H COSY for determining basic 
connectivity via J couplings throughbond), Nuclear Overhauser Effect 
Spectroscopy (NOESY for see through-space and conformation and for 
determining proximity of adjacent spin systems), Heteronuclear Single Quantum 
Correlation (HSQC for determining the narrower resonances for 
1
H- 
13
C 
correlations), and Heteronuclear Multiple Bond Correlation (HMBC to correlate 
Xnucleus shifts that are typically 2-4 bonds away from a proton) experiments 
5.1.2. Isolation and purification of secondary metabolites of Pernaviridis, 
Crassostreamadrasensis and Octopus dolffusi 
5.1.2.1. Isolation of secondary metabolites from Pernaviridis 
The dried mussel powder (1 kg) was extracted three times with MeOH 
(3 h) and filtered through theWhatman No. 1 filter paper. The filtrate was 
concentrated (50 °C) in vacuo, and successively partitioned with CHCl3 and 
EtOAc before being concentrated to furnish the solvent fractions designated as 
MCH (9.8 g) and MEA (8.5 g), respectively. The CHCl3 andEtOAc fractions 
were pooled together to afford the composite solvent fraction designated as 
MCT. The latter was subjected to further chromatographic fractionation. The 
schematic diagram showing the purification of P. viridisextract has been 
shown in Fig  5.1. 
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Fig 5.1 Schematic diagram showing the purification of the CHCl3 fraction derived from P. viridis 
5.1.2.1A Chromatographic purification of secondary metabolites from Pernaviridis 
The compositefraction(MCT, 8.5 g) of P. viridiswas subjected to 
vaccum liquid chromatography and eluted using a stepwise gradient system 
from n-hexane, EtOAc and MeOH to obtain a total of 12 column fractions (F1 
- F12). The fraction F4 obtained by eluting with n-hexane: EtOAc (4:1, v/v), on 
further purification using EtOAc/n-hexane(0-5% EtOAc) afforded 6 fractions 
(F13 – F18).The fraction F15 on subsequent preparative TLC purification using 
10% EtOAc:n-hexane afforded compound 1 (243 mg). The fraction F5 on 
vaccum chromatographic purification yielded seven subfractions (F19 – F25). 
The subfractionF20 on further purificationwith preparative TLC using 30 % 
EtOAc: n-hexane afforded compound 2 (46 mg). The subfraction F24 
onsubsequent column chromatographic purification using EtOAc:n-hexane(0-
70% EtOAc) afforded two compounds,3, (34 mg) and 4 (31 mg). The fraction 
F10 was flash chromatographed using a stepwise gradient using n-hexane, 
EtOAc and methanol to afford a total of 12 fractions (F26 – F35). The column 
subfractionF26 on purification with preparative TLC (10% 
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MeOH/CHCl3)afforded compound 5 (61 mg). The compound 6 (73 mg) was 
obtained after purification by preparative TLC of the column subfraction F27 
by using 15% MeOH/CHCl3. 
5.1.2.1B Physicochemical data of compound (1): 3-Hydroxy-13-vinyl-dodecahydro-11-
phenanthrenone  
Light yellow crystalline solid; m.p. 135
oC; UV (MeOH) λmax (log ε): 242 nm 
(1.74); TLC (Si gel GF254 15 mm; CHCl3/MeOH 40:60, v/v) Rf: 0.55; Rt: 7.51; 
IR (KBr,cm
-1) 1740.12 (C=O ν), 3250.90 br (O-H ν), 2942.02 (C-H ν), 1536 
(C=C ν), 724.28 (C-H ρ), 1377.22 (C-H δ); 1H NMR (500 MHz, CDCl3) δ 5.91 
– 5.68 (m, 1H), 5.36 – 5.30 (m, 1H), 5.06 – 4.84 (m, 2H), 3.62 – 3.45 (m, 1H), 
2.41 – 2.24 (m, 3H), 2.02 (dt, 2H), 1.90 – 1.80 (m, 3H), 1.50-1.01 (m, 6H), 0.94 
– 0.76 (m, 3H).HRESIMS m/z found 247.1698 (M+H), calcd 247.1709. 
5.1.2.1CPhysicochemical data ofcompound (2): 4,4,9-Trimethyl-13-vinyl-dodecahydro-
2-phenanthrenone  
White crystalline solid; m.p. 122
o
C; UV (MeOH) λmax (log ε ): 258 nm (3.41); 
TLC (Si gel GF254 15 mm; CHCl3/MeOH 80:20, v/v) Rf: 0.45; Rt: 4.70; IR 
(KBr, cm
-1
) νmax1736.96 (C=O ν), 2924.18 (C-Hν),1526.00 (C=C ν), 724.28 
(C-H ρ), 1377.22 (C-H δ ); 1H NMR (500 MHz, CDCl3) δ 6.60 (s, 1H), 6.03 – 
5.72 (m, 1H), 5.02 – 4.90 (m, 2H), 4.33 – 4.04 (m, 2H), 2.95 – 2.62 (m, 1H), 
2.41 – 2.25 (m, 4H), 2.18 (s, 3H), 2.10 – 1.99 (m, 3H), 1.86 – 1.74 (m, 1H), 
1.42 (s, 1H), 1.38 – 1.29 (m, 4H), 1.02 (m, 3H), 0.98  (s, 3H). HRESIMS m/z 
(C19H28O) found 273.2219(M+H) calcd 273.2401. 
5.1.2.1D Physicochemical data of compound (3): 11,20-Dihydroxy-6,6-dimethyl-
decahydro-5H-benzo[h]naphtho[1,2-c]chromene-16-carbaldehyde  
Yellowish crystalline solid; m.p. 165
o
C; UV (MeOH) λmax (log ε): 252 nm 
(1.61); TLC (Si gel GF254 15 mm; CHCl3/MeOH 40:60, v/ v) Rf: 0.35; Rt: 
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3.20; IR (KBr, cm
-1
) νmax 1738.56(C-O ν), 3219.90 br(O-H ν), 2924.18 (C-H 
ν), 1680 (aromatic C=C ν), 1545 (C=C ν), 724.28 (C-H ρ); 1377.22 (C-H); 1H 
NMR (500 MHz, CDCl3) δ 9.69(s,1H), 7.65 (dd, J = 5.7Hz, 2H), 7.46 (dt, J = 
5.7 Hz, 2H), 6.44 (s, 1H), 5.33 – 5.25 (dd,1H), 4.31 – 4.19 (m, 2H), 4.10 (p, 
1H), 3.60 (s, 1H), 2.37 – 2.17 (m, 4H), 1.94 (t, 2H), 1.62 – 1.47 (m, 9H), 0.91 
(dd, 1H), 0.89 – 0.64 (m, 2H); HRESIMS m/z: (C24H28O4) found 381.2067( 
M+H)
+
calcd 381.2188. 
5.1.2.1E Physicochemical data ofcompound (4): 16-Acetyl-20-hydroxy-6,6-dimethyl-
dodecahydro-5H-benzo[h]naphtho[1,2-c]chromen-12-one 
Pale yellow powder; m.p. 129
o
C; UV (MeOH) λmax (log ε): 252 nm 
(2.02); TLC (Si gel GF254 15 mm; CHCl3/MeOH 40:60, v/ v) Rf: 0.50; Rt: 
5.53; IR (KBr, cm
-1
) νmax 1731.12 (C=O ν), 3219.05br (O-H ν), 2921.46 (C-H 
ν), 1556(C=C ν), 1377.22 (C-H δ), 724.28 (C-H ρ). 1H NMR  (500 MHz, 
CDCl3) δ 7.72 (dd, 2H), 7.53 (dd, 2H), 5.58 – 5.33 (m, 1H), 5.27 (s, 1H), 4.28 
(m, 3H), 4.14 – 4.08 (m, 1H), 3.81 – 3.57 (m, 1H), 2.35-2.31  (d, 5H),  2.02 (s, 
2H), 1.79 (s, 6H), 1.29 – 0.94 (m, 6H); HRESIMS m/z C25H30O4 found 
395.2223 (M+H) calcd 394.2422  .  
5.1.2.1F  Physicochemical data of compound (5): Cholest-5-en-3β-3-yl-(30-hydroxy-3-
methyl-36-methyleneundeca-30E,34E-dienoate)  
Light yellow crystalline solid; m.p. 186
o
C; UV (MeOH) λmax (log ε  ): 266 nm 
(2.61); TLC (Si gel GF254 15 mm; MeOH/CHCl3 40:60, v/ v) Rf: 0.80; Rt: 
13.40;  IR (KBr, cm
-1
) νmax1736.96 (C=O ν), 3419.90 br (O-H ν), 2924.18 (C-
H ν), 1545(C=C ν), 724.28 (C-H ρ), 1377.22 (C-H δ); 1H NMR (500 MHz, 
CDCl3) δ 5.81 (ddt, J = 16.9 Hz, 1H), 5.37 – 5.34 (m, 1H), 5.04 – 4.87 (m, 
2H), 3.52 (tt, J = 11.0, 4.5 Hz, 1H), 2.34 – 2.20 (m, 4H), 2.17 (s, 3H), 2.07 – 
1.92 (m, 6H), 1.83 (tq, J = 15.6, 6.2, 4.5 Hz, 10H), 1.57 (s, 1H), 1.55 – 1.43 
(m, 4H), 1.33 (s, 3H), 1.28 (s, 2H), 1.18 – 1.04 (m, 10H), 1.01 (s, 3H), 0.91 (d, 
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J = 6.5 Hz, 2H), 0.88 – 0.85 (m, 9H), 0.68 (s, 3H). HRESIMS m/z: C40H64O3 
found 593.4935 (M+H) calcd 592.5146. 
5.1.2.1G  Physicochemical data ofcompound (6) Cholest-5-en-3β-3-yl-((E)-33-oxooct-
31-enoate)  
Yellow solid; m.p. 164
o
C; UV (MeOH) λmax (log ε  ): 248nm (3.21); TLC (Si 
gel GF254 15 mm; CHCl3/MeOH 40:60, v/ v) Rf: 0.85; Rt: 18.20; IR - 1736.96 
(C=O ν), 2924.18 (C-H ν), 1542 (C=C ν) , 1369.25 (C-H δ), 724.28 (C-H 
ρ);1H NMR (500 MHz, CDCl3) δ 5.90 – 5.74 (m, 1H), 5.35 (d, 1H), 5.04 – 
4.88 (m, 1H), 3.58 – 3.47 (m, 1H), 2.38 – 2.19 (m, 6H), 2.07 – 1.92 (m, 4H), 
1.99 – 1.77 (m, 7H), 1.60 – 1.40 (m, 5H), 1.42 – 1.31 (m, 5H), 1.21 – 0.89 (m, 
8H), 0.86 – 0.75 (m, 6H), 0.73 – 0.59 (m, 6H); HRESIMS m/z: C35H56O3 
found 525.4309( M+H ) calcd 524.4542. 
5.1.2.2. Isolation of secondary metabolites from Crassostreamadrasensis 
The freeze dried sample of Crassostreamadrasensis (100 g) was 
extracted with EtOAc: MeOH (500 mL X 2, 1:1, v/v) at an elevated 
temperature (50 ºC) under reflux for 2 h. The extracts were then filtered and 
concentrated (50 ºC) in vacuo to obtain the crude extract of C. madrasensis 
(CRCT, 12.56 g). The schematic diagram showing the purification of C. 
madrasensishas been illustrated under Fig  5.2. 
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Fig  5.2Schematic diagram showing the purification of EtOAc: MeOH fraction ofC. madrasensis 
5.1.2.2.AChromatographic purification of secondary metabolites fromC. madrasensis 
An aliquot of the crude C. madrasensis extract (CRCT,9.2 g) was 
slurried in silica gel (5 g, 60–120 mesh), and loaded into a glass column (90 
cm x 4 cm) packed with silica gel (60–120 mesh, 90 g) as adsorbent before 
being subjected to vacuum liquid chromatography. The column was initially 
eluted with n-hexane and the eluent polarity was gradually increased by 
addition of EtOAc (n-hexane: EtOAc, 99:1 to 30:70, v/v) to furnish a total of 
28 fractions of 35 mL each, which were reduced to 16 groups (CF1 - CF16) 
after TLC analysis (n-hexane: EtOAc, 9:1, v/v).The fraction CF6 obtained by 
eluting with n-hexane: EtOAc (6:1, v/v) was found to be a mixture, which was 
flash chromatographed (Biotage AB SP1-B1A, 230–400 mesh, 12 g; Biotage 
AB, Uppsala, Sweden) on a silica gel column (Biotage, 230–400 mesh, 12 g; 
Sweden, Biotage No. 25+M 0489-1) at a collection UV wavelength of 236 nm 
using a step gradient of EtOAc/n-hexane (0-5% EtOAc) to afford 140 fractions 
(9 mL each). Based on analytical TLC, the fractions with similar patterns were 
pooled together to afford four pooled sub-fractions (CF17 – CF20). The sub-
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fraction CF18 on subsequent preparative TLC purification using 10% EtOAc/n-
hexane yielded 12-hydroxy-2,9,9-trimethyl-10-[(2-phenylacetyl)oxy]- 
1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,14a,14b-icosahydro-2-
picenecarboxylate (7, 88 mg, Table 5.9). The fraction CF9 on flash 
chromatographic purification on a silica gel column (Biotage, 230–400 mesh, 
12 g; Sweden, Biotage No. 25+M 0489-1)at a collection UV wavelength of 
256 nm using a step gradient of EtOAc/n-hexane (0-10% EtOAc) afforded 120 
fractions (9 mL each). Based on analytical TLC, the fractions with similar 
patterns were pooled together to obtain six pooled fractions (CF21 – CF26). The 
fraction CF22 on further purificationwith preparative TLC using 40 % 
EtOAc/n-hexane yielded methyl 1,12-dihydroxy-2,9,9-trimethyl-10-[(2-
phenylacetyl)oxy]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,14a,14b-
icosahydro-2-picenecarboxylate(8, 52 mg, Table 5.9).  
5.1.2.2.B  Physicochemical data of methyl-3-(26-phenylacetyloxy)-icosahydro-19-
hydroxy-4,4,20-trimethylpicene-23-carboxylate (7) 
Yellow solid; m.p. 82 
oC; UV (MeOH) λmax (log ε): 256 nm (2.71); 
TLC (Si gel GF254 15 mm; CHCl3/MeOH 50:50, v/ v) Rf: 0.70; Rt: 12.20; IR 
(KBr, cm
-1
) νmax 1734.96 (C=O ν), 3419.90 br peak (O-H ν), 2924.18 (C-H ν), 
1545 (C=C ν), 725.28 (C-H ρ), 1580(C=C aromatic ν) 1715 (6-membered C-C 
ring ν); 1H NMR (500 MHz, CDCl3) δ 7.75 – 7.66 (m, 2H), 7.53 (dd, 3H), 
5.86 – 5.78 (m, 2H), 5.03 – 4.89 (m, 2H), 4.34 – 4.08 (m, 2H), 3.69 – 3.61 (m, 
3H), 2.30 (dq, 5H), 2.17 (s, 2H), 2.03 (dd, 8H), 1.72 (s, 2H), 1.43 (d, 5H), 1.33 
(d, 9H), 1.08 – 0.93 (m, 13H), 0.87 (d, 11H), 0.87 – 0.79 (m, 8H), 0.68 (s, 
2H); HRESIMS m/z: C35H64O5 found 549.3581( M+H ) calcd 549.3685. 
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5.1.2.2.C Physicochemical data of methyl-3-(26-phenylacetyloxy)-icosahydro-1,19-
dihydroxy-4,4,20-trimethylpicene-23-carboxylate (8) 
White powder; m.p. 87 
o
C; UV (MeOH) λmax (log ε ): 267nm (2.89); TLC 
(Si gel GF254 15 mm; CHCl3/MeOH 40:60, v/ v) Rf: 0.20; Rt: 13.8; IR (KBr, cm
-1
) 
νmax724.28(C-H ρ), 1377.22(C-H δ), 1715 (6-membered cyclic ring ν), 
1736.96(C=O ν),  2924.18(C-H ν),1642(C=C ν), 3010(C-H ν of C=C);1H NMR 
(500 MHz, CDCl3) δ 7.65 – 7.75 (m, 1H), 7.56 – 7.51 (m, 1H), 7.56 – 7.51 (m, 
1H), 5.80(m,1H),(OH-5.32), 4.96(m,1H), 4.29(t,1H), 4.12(m,1H),4.08(dd,1H), 
3.65(s,3H) 2.17(s,3H), 2.04 (m,1H),  2.02(m,2H), 1.96(m,1H), 1.85(m,2H)  
1.71(m,2H), 1.62(q,1H), 1.62(m,2H), 1.61(m,1H), 1.31(m,2H), 1.15(m,2H), 
1.28(t,1H), 1.36 (m,1H), , 1.12(m,1H),1.33(m,2H), 1.06(m,1H),  0.97(s,3H), 
0.87(s,3H), 0.84(s,3H); HRESIMS m/z: (C35H48O6) found 565.3530 (M+H) 
calcd565.3732. 
5.1.2.3 Isolation of secondary metabolites from Octopus dolffusi 
The freeze dried sample of Octopus dolffusi (100 g) was extracted with 
EtOAc: MeOH (500 mL X 2, 1:1, v/v) at an elevated temperature (50 ºC) 
under reflux for 2 h on a water bath. The extracts were filtered and 
concentrated (50 ºC) in vacuo to obtain the crude extract of O. dolffusii (OCT, 
16.98 g).The schematic diagram showing the purification of O. dolffusi extract 
has been shown in Fig 5.3. 
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Fig 5.3 Schematic diagram showing the purification of O. dolffusi extract 
5.1.2.3.AChromatographic purification of secondary metabolites from Octopus 
dolffusi 
An aliquot of the O.dolffusiextract (9.0 g) was slurried in silica gel (5 g, 
60–120 mesh), and loaded into a glass column (90 cm x 4 cm) packed with 
silica gel (60–120 mesh, 90 g) as adsorbent before being subjected to vacuum 
liquid chromatography. The column was initially eluted with n-hexane and the 
eluent polarity was gradually increased by addition of EtOAc (n-hexane: 
EtOAc 99:1 to 30:70, v/v) to furnish 14 fractions of 25 mL each, which were 
reduced to 10 groups (OF1 - OF10) after TLC analysis (n-hexane: EtOAc, 9:1, 
v/v). OF5 obtained by eluting with n-hexane:EtOAc (4:1, v/v) was found to be 
a mixture, which was flash chromatographed (Biotage AB SP1-B1A, 230–400 
mesh, 12 g; Biotage AB, Uppsala, Sweden) on a silica gel column (Biotage, 
230–400 mesh, 12 g; Sweden, Biotage No. 25+M 0489-1) at a collection UV 
wavelength of 236 nm using a step gradient of EtOAc/n-hexane (0-5% EtOAc) 
to afford 110 fractions (9 mL each). Based on analytical TLC, the fractions 
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with similar patterns were pooled together to afford five pooled fractions 
(OF11 – OF16). The fraction OF13 on subsequent preparative TLC purification 
using 10% EtOAc/n-hexane afforded 1-[17-(1,5-dimethylhexyl)-10,13-
dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-
cyclopenta[a]phenanthren-3-yl] 5-methyl 3-[(E)-1-amino-3-ethyl-6-oxo-3-
heptenyl]pentanedioate(7, 55 mg, Table 5.12). The fraction OF8 was flash 
chromatographed on a silica gel column (Biotage, 230–400 mesh, 12 g; 
Sweden, Biotage No. 25+M 0489-1) at a collection UV wavelength of 280 nm 
using a step gradient of EtOAc/n-hexane (0-70% EtOAc) to afford 180 
fractions (9 mL each). Based on analytical TLC, the fractions with similar 
patterns were pooled together to afford ten pooled fractions (OF17 – OF26). The 
sub-fraction OF21 on purification by preparative TLC in 10% MeOH/CHCl3 
afforded 4-ethyl-6-vinyl-2,3,6,7,7a,8,9,9a-octahydroazuleno[1,8-bc]pyran-2,9-
dione(8, 35 mg, Table 5.12). 
5.1.2.3.B Physicochemical data of cholesta-5-en-3β-yl-(32-methyl-(30-((E)-34-amino-36-
ethyl-39-oxohept-36-enyl)-pentanedioate (9) 
Light yellow solid; m.p. 118 
oC; UV (MeOH) λmax (log ε): 252nm 
(3.61); TLC (Si gel GF254 15 mm; CHCl3/MeOH 40:60, v/ v) Rf: 0.70; Rt: 
4.20; IR (KBr, cm
-1
) νmax 724.28(C-H ρ), 1068.21(C-O-C ν) 1377.22(C-H δ), 
1715 (6-membered cyclic ν), 1736.96(C=O ν),  2924.18(C-H νof alkanes), 
1642(C=C ν), 3010(C-H ν of C=C); 1H NMR (500 MHz, Chloroform-d) δ 
5.34 – 5.24 (m, 2H), 4.61 – 4.48 (m, 1H), 4.29 – 3.90 (m, 1H), 3.59 (s, 3H), 
2.80 – 2.66 (m, 2H), 2.29 – 2.22 (m, 4H), 2.22 – 2.15 (m, 2H), 2.01 – 1.85 (m, 
4H), 1.76 (tdd, 3H), 1.64 – 1.46 (m, 1H), 1.38 – 1.14 (m, 15H), 1.06 (ddd, 
5H), 1.01 – 0.90 (m, 5H), 0.88 – 0.73 (m, 18H), 0.61 (s, 3H); HRESIMS m/z: 
C42H69NO5 found 668.5255 (M+H) calcd668.5285 
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5.1.2.3.C Physicochemical data of 7-ethyl-9-vinyl-octahydroazuleno[1,8-bc]pyran-3,12-
dione (10) 
Yellow powder; m.p. 185 
oC; UV (MeOH) λmax (log ε): 227 nm (3.28); 
TLC (Si gel GF254 15 mm; CHCl3/MeOH 10:90, v/ v) Rf: 0.35; Rt: 6.20 min; IR 
(KBr, cm
-1
) νmax 721.29(C-H ρ), 1070(C-O-C ν), 1541(C=C ν), 1690.21 (C-CO-
C ν) 1736.96(C=O ν), 2854.74(C-H ν of alkanes); 1H NMR (500 MHz, 
Chloroform-d) δ 5.82 (ddt, 1H), 5.37 (d,1H), 5.04 – 4.89 (m, 2H), 
3.69(s,1H),2.46 – 2.11 (m, 1H), 2.07 – 1.99 (m, 3H), 1.62 (d, 2H), 1.44 (d, 1H), 
1.40 – 1.32 (m, 3H), 0.96 – 0.75 (m, 3H); 13C-NMR, 1H-1H-COSY and HMBC 
data; HRESIMS m/z:C16H18O3 found 259.1335(M+H) calcd258.1384). 
5.1.3 Antioxidant and anti-inflammatory activities of the purified 
compounds 
5.1.3.1Determination of antioxidant activities 
1, 1-Diphenyl-2-picryl- hydrazil (DPPH•) radical scavenging activity of 
the samples was measured using the DPPH stable radical as described in a 
previous section 4.1.2.1.2 2,2′-Azino-bis-3 ethylbenzothiozoline-6-sulfonic 
acid diammonium salt (ABTS) radical scavenging activity was determined by 
ABTS radical cationdecolorization assay as described earlier (4.1.2.1.1).  
5.1.3.2Determination of in vitro anti-inflammatory activities 
The in vitro anti-inflammatory activities have been carried out in this study 
by cyclooxygenase (COX-2) inhibition assays as described by 2,7-
dichloroluorescein method (Larsen et al., 1996) and 5-lipoxygenase (5-
LOX)inhibition assay (Baylac and Racine, 2003). 
 
 
Isolation and characterization of secondary metabolites fromPernaviridis………. 
159 
5.1.4Statistical analysis 
Statistical evaluation was carried out with the Statistical Program for 
Social Sciences 13.0 (SPSS Inc, Chicago, USA, ver. 13.0). Analyses were 
carried out in triplicate, and the means of all parameters were examined for 
significance by analysis of variance (ANOVA). The level of significance for all 
analyses was P<0.05. 
5.2 Results and discussion 
5.2.1. Secondary metabolites from Pernaviridis 
The CHCl3 fraction (9.2 g) of P. viridiswas subjected to vaccum liquid 
chromatography, and eluted using a stepwise gradient system from n-hexane, 
EtOAc and MeOH to obtain total of 12 column fractions (MF1 - MF12). The 
fraction MF4 obtained by eluting with n-hexane: EtOAc (4:1, v/v) was further 
purified using EtOAc /n-hexane(0-10% EtOActo afford 6 sub-fractions (MF13 – 
MF18).The fraction MF15 on subsequent preparative TLC purification using 10% 
EtOAc/n-hexane afforded compound 1 (243 mg). The fraction MF5 on vaccum 
chromatographic purification yielded seven sub-fractions (MF19 – MF25). The 
sub-fraction MF20 on further purificationwith preparative TLC using 30 % 
EtOAc/n-hexane afforded compound 2 (46 mg). The sub-fractionMF24 
oncolumn chromatographic purification using EtOAc/n-hexane(0-70% EA) 
yielded two compounds3, (34 mg) and 4 (31 mg). The fraction MF10 was flash 
chromatographed using a stepwise gradient using n-hexane, ethyl acetate and 
methanol to afford 12 fractions (MF26 – MF37). The fraction MF26 on subsequent 
purification by preparative TLC in 10% MeOH/CHCl3 yielded compound 5 (61 
mg). The fraction MF27 on preparative TLC purification using 15% 
MeOH/CHCl3 resulted compound 6 (73 mg). The yield, Rf, antioxidant and anti-
inflammatory activities of each column/P-TLC fractions and compoundswere 
given in Table 5.1. 
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Table 5.1.  Yield, Rf, antioxidant and anti-inflammatory activities of each column/P-TLC fractions 
of P. viridis 
  
Yield 
(mg) 
Rf 
DPPH 
radical  
ABTS 
radical  
COX-2  LOX-5  
scavenging  scavenging  inhibitory  inhibitory  
activity (%) activity (%) activity (%) activity (%) 
MCT CC (EtOAc/HX) 
MF-1   (2% EtOAc/HX) 54 0.12 48.95±0.00 31.81±0.15 35.16±0.03 44.49±0.08 
MF-2   (5% EtOAc/HX) 31 0.23 52.51±0.02 30.67±0.29 33.46±0.02 19.11±0.02 
MF-3   (7% EtOAc/HX) 42 0.32 49.56±0.01 29.17±0.32 26.12±0.61 17.64±0.03 
MF-4  (10% EtOAc/HX) 657 0.37 65.32±0.01 20.04±0.27 42.53±0.01 33.21±0.01 
MF-5  (20% EtOAc/HX) 987 0.45 69.25±0.01 18.79±0.25 43.15±0.24 36.38±0.01 
MF-6  (30% EtOAc/HX) 121 0.62 45.41±0.00 17.11±0.23 21.23±0.09 28.26±0.01 
MF-7  (50% EtOAc/HX) 78 0.69 42.75±0.00 15.81±0.21 26.47±0.01 25.61±0.05 
MF-8  (100% EtOAc) 44 0.72 32.49±0.00 14.81±0.20 23.58±0.01 18.42±0.06 
MF-9   (2% MeOH/EtOAc) 65 0.79 49.16±0.00 9.841±0.13 19.76±1.02 13.73±0.03 
MF-10 (5% MeOH/EtOAc) 1087 0.83 55.66±0.01 20.57±0.11 41.61±0.23 35.43±0.07 
MF-11 (15% MeOH/EtOAc) 50 0.94 43.29±0.02 14.11±0.19 32.51±0.08 11.84±1.12 
MF-12  (100% MeOH) 46 0.99 48.15±0.01 7.445±0.10 36.12±0.02 19.46±0.42 
MF-4 (CC 0-10% HX/EtOAc) 
MF-13 (1% EtOAc/HX) 121 0.25 61.41±0.01 28.40±0.76 NA NA 
MF-14 (2% EtOAc/HX) 107 0.39 45.39±0.00 22.55±0.57 NA NA 
MF-15 (4% EtOAc/HX) 169 0.48 56.29±0.01 17.30±0.23 43.33±0.06 44.28±0.29 
MF-16 (6% EtOAc/HX) 107 0.56 58.14±0.01 24.21±0.46 NA NA 
MF-17 (8% EtOAc/HX) 55 0.67 35.42±0.00 11.58±0.15 NA NA 
MF-18 (10% EtOAc/HX) 61 0.88 39.42±0.00 11.04±0.14 NA NA 
MF-5  (CC 0-15% HX/EtOAc) 
MF-19  (1% EtOAc/HX) 21 0.21 35.29±0.05 20.03±0.25 NA NA 
MF-20  (2% EtOAc/HX) 217 0.29 70.48±0.00 32.20±0.43 44.57±0.02 48.21±0.01 
MF-21  (5% EtOAc/HX) 49 0.35 55.81±0.03 21.93±0.08 NA NA 
MF-22  (7% EtOAc/HX) 389 0.54 58.29±0.01 29.05±0.39 NA NA 
MF-23  (10% EtOAc/HX) 35 0.69 60.18±0.00 22.17±0.65 NA NA 
MF-24  (12% EtOAc/HX) 164 0.74 68.46±0.00 32.92±0.44 41.53±0.05 47.82±0.01 
MF-25  (15% EtOAc/HX) 51 0.84 48.29±0.01 27.05±0.39 NA NA 
MF-10 (CC HX/MeOH/EtOAc) 
MF-26  (2% HX/EtOAc) 225 0.15 69.24±0.00 30.20±0.84 44.25±0.03 48.67±0.02 
MF-27  (10% HX/EtOAc) 256 0.23 66.65±0.00 31.40±0.35 43.28±0.01 47.43±0.16 
MF-28  (15% HX/EtOAc) 19 0.28 63.12±0.00 20.09±0.27 NA NA 
MF-29  (25% HX/EtOAc) 44 0.34 65.58±0.00 24.67±0.47 NA NA 
MF-30  (50% HX/EtOAc) 49 0.48 58.41±0.00 28.37±0.76 NA NA 
MF-31  (100% EtOAc) 55 0.51 60.66±0.00 27.57±0.73 NA NA 
MF-32  (2% MeOH/EtOAc) 66 0.67 35.42±0.00 11.58±0.15 NA NA 
MF-33  (5% MeOH/EtOAc) 84 0.78 39.42±0.00 11.04±0.14 NA NA 
MF-34  (10% MeOH/EtOAc) 28 0.84 35.42±0.00 11.58±0.15 NA NA 
MF-35  (25% MeOH) 66 0.88 39.42±0.00 11.04±0.14 NA NA 
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MF-15 (PTLC 10% EA/HX) 
MF-36 31 0.32     
MF-37 24 0.59 70.18±0.00 21.53±0.56 NA NA 
MF-38 39 0.65 75.24±0.36 29.48±0.23 47.26±0.87 50.64±0.23 
MF-39 55 0.89 79.46±0.00 35.21±0.27 47.15±0.07 47.86±0.01 
MF-20 (PTLC 20% EA/HX) 
MF-40 27 0.25 33.35±0.01 15.08±0.20 NA NA 
MF-41 35 0.38 38.16±0.00 6.977±0.09 NA NA 
MF-42 24 0.46 65.24±0.01 24.65±0.19 NA NA 
MF-43 46 0.58 72.56±0.14 21.75±0.56 49.76±0.33 50.34±0.23 
MF-44 49 0.75 68.19±0.01 29.19±0.12 48.29±0.02 51.67±0.02 
MF-24(PTLC 20% EA/HX) 
MF-45 94 0.24 55.19±0.01 22.36±0.30 NA NA 
MF-46 34 0.57 78.65±0.25 31.4±0.89 45.28±0.55 47.43±0.45 
MF-47 31 0.69 78.46±0.16 32.92±0.49 46.53±0.14 47.82±0.56 
MF-26(PTLC 5% MeOH/CHCl3) 
MF-48 32 0.24 51.44±0.00 24.44±0.30 NA NA 
MF-49 47 0.37 59.18±0.00 21.25±0.29 NA NA 
MF-50 61 0.54 71.47±0.14 33.29±0.23 47.25±0.54 48.67±0.8 
MF-51 54 0.72 61.32±0.00 14.69±0.19 NA NA 
MF-27(PTLC 10% MeOH/CHCl3) 
MF-52 34 0.23 55.34±0.02 24.13±0.19 NA NA 
MF-53 27 0.46 59.26±0.01 24.05±0.10 NA NA 
MF-54 73 0.55 68.21±0.18 28.67±0.14 49.28±0.23 48.57±0.49 
MF-55 46 0.64 56.64±0.00 22.85±0.30 NA NA 
MF-56 55 0.76 59.82±0.00 21.43±0.29 NA NA 
DPPH radical scavenging activity at 0.1 mg/mL was expressed in percent;ABTS radical 
scavenging activity at 0.1 mg/mL is expressed in percent; COX-2 inhibitory activity at 0.1 
mg/mL was expressed in percent; LOX-5 inhibitory activity at 0.05 mg/mL was expressed in 
percent; NA – not assayed, ie. the fractions with lesser yield were evaluated only for DPPH 
and ABTS radical scavenging activity. CC – Column chromatography; PTLC -Preparative 
thin layer chromatography; MeOH - Methanol; EA - Ethyl acetate; HX - n-hexane; CHCl3 - 
Chloroform; MCT - Compositefraction of  P. viridis 
 
5.2.1.1Antioxidant and anti-inflammatory activities of the purified compounds 
The order of DPPH radical-scavenging abilities of the test compounds 
were as follows: 3>4>1>2>5>6 (Table 5.2). The ABTS
.+
radical scavenging 
activity was found to be in the order: 5>4>3>1>6>2. The COX-2 inhibition 
activity was found to be in the order, 2 >6>1>5 and 5-LOX inhibition activity 
was in the order, 1 >2>5>6.The anti-inflammatory activities of compounds 3 
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and 4 were found to be lesser than other compounds purified from the CHCl3 
fraction of P. viridis. 
Table 5.2. Radical scavenging and in vitro anti-inflammatory activities of the compounds 
isolated from the CHCl3 fraction of Pernaviridis 
Compounds 
DPPH radical 
scavenging 
activity 
ABTS radical 
scavenging 
activity 
COX-2 inhibition 
activity 
5-LOX inhibition 
activity 
Compound 1 75.24±0.36pq 29.48±0.23p 47.26±0.87p 50.64±0.23p 
Compound 2 72.56±0.14pq 21.75±0.56p 49.76±0.33p 50.34±0.23p 
Compound 3 78.65±0.25p 31.4±0.89p 45.28±0.55p 47.43±0.45p 
Compound 4 78.46±0.16p 32.92±0.49p 46.53±0.14p 47.82±0.56p 
Compound 5 71.47±0.14q 33.29±0.23p 47.25±0.54p 48.67±0.8p 
Compound 6 68.21±0.18q 28.67±0.14p 49.28±0.23p 48.57±0.49p 
DPPH
.
and ABTS
.+
 radical scavenging activities (at 0.1 mg/mL) were expressed as percent. 
COX-2 and 5-LOX inhibition activities(at 0.05 mg/mL) were expressed as percent. p, q - 
Column wise values with different superscripts indicates significant difference (P<0.05). 
Results were expressed as mean ± SD (n = 3). 
5.2.1.2 Chromatographic purification and spectral analyses of secondary 
metabolites fromPernaviridis 
Chromatographic separation led to the isolation of six new secondary 
metabolites. The novelty of these compounds has been verified with the 
MarinLit and SciFinder databases. The molecular structures of the purified 
compounds were proposed on the basis of comprehensive analysis of the 
1
H 
NMR, 
13
C NMR, including 2D-NMR experiments (
1
H–1H COSY, HMQC, 
HMBC, and NOESY) and mass spectra. 
5.2.1.2A  Chromatographic purification and spectral analyses of 3-hydroxy-13-vinyl-
dodecahydro-11-phenanthrenone (1) 
 The compound 3-hydroxy-13-vinyl-dodecahydro-11-phenanthrenone 
(1), a new phenanthrenone derivative was isolated as light yellow crystalline 
solid upon repeated chromatography over silica columns/TLC. The UV 
absorbance at λmax (log ε) 242 nm (1.74) has been assigned to be a 
chromophore with olefinic system. Its mass spectrum exhibited a molecular 
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ion peak at m/z247 (HRESIMS m/z 247.1698amu, [M+1]
+
), which in 
combination with its 
1
H and 
13
C NMR data (Table 5.3) indicated the elemental 
composition as 3-hydroxy-13-vinyl-dodecahydro-11-phenanthrenone (1) with 
six degrees of unsaturation. Three degrees of unsaturation from the double 
bond equivalent and the other three degrees of unsaturation were due to a 
cyclic ring system, which was not of aromatic type. This was based on the 
absence of the aromatic proton signal in the 
1
H NMR spectrum.  
Table 5.3.  NMR spectroscopic data of 3-hydroxy-13-vinyl-dodecahydro-11-phenanthrenone (1) 
isolated from Pernaviridis 
  Compound 1  
  
Position  
No. 
13C NMR 
δ1H NMR (int., mult., J 
in Hz)b 
1H-1H COSY HMBC(1H-13C) 
1 22.69 1.28(m,2 H) 2-H C-2,3 
2 29.1 1.47(m,2H) - - 
3 76.75 3.51 (m,1H) 4-H, 2-H C-4,5 
4 32.74 2.31(m,2H) 3-H C-3 
5 100 - - - 
6 140.45 5.35 (m,1H) 7-H C-7,4 
7 29.15 1.99(m,2H) 8-H C-6,8 
8 31.92 1.30(m,1H) - C-7 
9 29.69 1.08(t,1H) 10-H C-11,10 
10 29.15 1.85(m,1H) - - 
11 187.35 - - - 
12 29.1 2.02(m,2H) 13-H C-13 
13 50.36 2.21(m,1H)  C-12,15,16 
14 14.11 0.88 (m,2H) 8-H C-13 
15 132.18 5.81 (m,1H) 16-H C-12 
16 116.46 4.97 (dd,2H) 15-H C-15 
 
a
 NMR spectra recorded using Bruker AVANCE III 500 MHz (AV 500) spectrometers. 
b 
Values in ppm, multiplicity and coupling constants (J¼ Hz) are indicated in parentheses. The 
assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY 
experiments. 
OH
O
1
5
8
10
13
15
16
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The olefinic (C=C) and carbonyl (C=O) groups have been symbolized 
by the absorption bands at 1536 and 1740 cm
-1
,respectively. The characteristic 
IR absorption spectra at 3250 cm
-1
 (O-H stretching vibration), 2942.02 cm
-1
 
(C-H stretching), 724.28  cm
-1
 (C-H rocking) and 1377.22 cm
-1
 (C-H bending) 
also support the structure of tricyclic moiety. 
The 
1
H, 
13
C along with 
135
DEPT NMR experiments confirmed the 
occurrences of seven each of methylenes and methines along with two 
quaternary carbons. The olefinic peaks were apparent at δ 132.18(C-15) and 
116.46(C-16) attributing the presence of double bonds, which were correlated 
to the protons by HSQC with δ 5.81 and 4.97, respectively thereby ascribing 
the occurrence of vinyl (>CH=CH2) moiety attached to the tricylic system. Its 
position was further corroborated by the HMBCs from δ 2.21(H-13) to δ 
132.18(C-15) and 116.46(C-16). The deshielded peak at δ 3.51(H-3) exhibited 
HSQC correlation with the carbon at δ 76.75, which appropriately indicated 
the presence of possible oxygenation {could be a hydroxyl group directly 
linked to methine proton (>CH-OH)} in its vicinity. The relatively greater 
chemical shift of quaternary carbon at δ 187.35(C-11) referred to carbonyl 
directly bonded to ring system. The HMBCs from δ 1.08(H-9) to δ 187.35(C-
11) validated the above assignments. The signals at δ 5.35(H-6) with δC 
140.45 attributed the presence of an olefinic framework, which was bonded to 
the quaternary alkenic signal at δ 100.00(C-5). The correlations, such as δ 
2.31(H-4)/3.51(H-3)/1.47(H-2)/1.28(H-1)/1.85(H-10)/1.08(H-9)/1.30(H-
8)/1.99(H-7)/5.35(H-6) and δ 1.30(H-8)/0.88(H-14)/2.21(H-13)/2.02(H-12) 
supported the tricyclic framework along with δ 2.21(H-13)/5.81(H-
15)/4.97(H-16), which established the exocyclic vinylic moiety in the 
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compound. Other long-range relations from δ 1.28(H-1) to δ 76.75(C-3); δ 
3.51(H-3) to δ 100.00(C-5) and δ 5.81(H-15) to δ 29.12(C-12) further 
supported the presence of 3-hydroxydodecahydro-11-phenanthrenone 
framework. Hence, the double bond equivalence of six was accounted for 
three double bonds and three ring systems. The geometric isomerism of 
olefinic protons has been established by greater coupling constants (J) of 
9.2(H-15) and 7.9(H-16) Hz, which appropriately validated the trans(E) 
configuration of the vinyl group. The NOE correlations were recorded 
between δ 3.51(H-3)/5.81(H-15)/1.08(H-9), which depicted that these were in 
identical plane of symmetry and α-orientated. The hydroxyl at C-3 was β-
oriented being opposite to the α-disposed proton at δ 3.51(C-3). The NOESY 
cross-peaks between δ 1.85(H-10)/2.21(H-13)/1.30(H-8) indicated that these 
were disposed in identical plane of reference, and β-oriented.  
The LCMS spectrum of 3-hydroxy-13-vinyl-dodecahydro-11-phenanthrenone 
(1) showed an adduct (2M+1) peak at m/z 492.3 (C32H44O4
 •
+), which 
appeared to undergo elimination of hydroxyl groups (-OH) to  form the 
daughter ion peaks at m/z 476.3 (C32H44O3) and m/z 460.3 (C32H44O2). The 
molecular ion was found to be at m/z 246.1 (C16H22O2). 
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Fig 5.4.A. 
1
H NMR spectrum of 3-hydroxy-13-vinyl-dodecahydro-11-phenanthrenone (1) isolated from 
Pernaviridis. 
 
 
Fig 5.4. B.
13
C NMR spectrum of 3-hydroxy-13-vinyl-dodecahydro-11-phenanthrenone (1)isolated from 
Pernaviridis. 
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Fig 5.4.C. 
1
H–1H COSY  spectrum of 3-hydroxy-13-vinyl-dodecahydro-11-phenanthrenone 
(1)isolated from Pernaviridis. 
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Fig 5.4.D. NOE spectrum of 3-Hydroxy-13-vinyl-dodecahydro-11-phenanthrenone (1) isolated 
from Pernaviridis 
 
Fig 5.4.E  Mass spectrum of 3-hydroxy-13-vinyl-dodecahydro-11-phenanthrenone (1 )isolated 
from Pernaviridis 
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5.2.1.2B Chromatographic purification and spectral analyses of 4,4,9-trimethyl-13-
vinyl-dodecahydro-2-phenanthrenone (2) 
The compound 4,4,9-trimethyl-13-vinyl-dodecahydro-2-phenanthrenone 
(2) isolated as white crystalline solid which showed characteristic peaks as 
compound (1) although some differences were observed in the first ring. The 
peak position at H-3(δ3.51) was absent in compound (2) and extra methyl 
peaks at H-17 (δ 1.02), H-18(δ 0.98) and α, β unsaturatedolefinic proton at 
highly downfield shift δ6.59 were apparent. The UV absorbance at λmax (log ε) 
258nm (3.41) was assigned to be positioned at a chromophore with α, β 
unsaturated olefinic system. Its mass spectrum exhibited a molecular ion peak 
at m/z273 (M+1)
+
(HRESIMS m/z273.2219amu, which in combination with its 
1
H and 
13
C NMR data (Table 5.4) indicated the elemental composition as 
4,4,9-trimethyl-13-vinyl-dodecahydro-2-phenanthrenone (2) with six degree of 
unsaturation. 
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Table 5.4. NMR spectroscopic data of 4,4,9-trimethyl-13-vinyl-dodecahydro-2-phenanthrenone (2) 
isolated from the CHCL3 extract of Pernaviridis 
 Compound 2 
 
O
1
3
17
6
19 16
8
 
Position  
No. 
13CNMR 
δ1H NMR (int., 
mult., J in Hz)b 
1H-1H COSY HMBC(1H-13C) 
1 129.55 6.59(S) - C-2,10 
2 184.16 - - - 
3 50.1 4.25(S) - C-2,1,10 
4 33.86 - - - 
5 46.87 2.79(dd) 6-H C-4,10,6 
6 33.55 2.33(m) 7-H C-8,9 
7 29.15 1.99(m)  C-8,5 
8 31.92 1.88(t) 7-H C-13,11,14 
9 31.98 - - - 
10 169 - - - 
11 29.5 1.28(m) 12-H C-19,12 
12 28.96 1.35(m) 13-H, 15-H C-13 
13 33.51 2.01(m) 14-H C-12,15 
14 29.15 1.30(m) 8-H - 
15 139.5 5.82(m) 13-H - 
16 113.97 4.99(dd) 15-H - 
17 16.81 1.02(s) - C-4,5,2 
18 14.1 0.98(s)  C-5 
19 19.01 2.21(s)  C-10,11 
a
 NMR spectra recorded using Bruker AVANCE III 500 MHz (AV 500) spectrometers. 
b 
Values in ppm, multiplicity and coupling constants (J¼ Hz) were indicated in parentheses. 
The assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY 
experiments. 
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The structure of 2 was similar to that of 1, except for three additional 
methyl groups at C-4 and C-9 in 2. Also, the carbonyl carbon (C=O) at C-11 in 
1 was shifted to the C-2 position in 2. The 
1
H, 
13
C along with 
135
DEPT data 
established the occurrences of seven methylenes, four quaternary carbons, five 
methines and three methyl singlets. Olefinic signals were evident at δ 
139.50(C-15) and 113.97(C-16), which indicated the presence of methine and 
methylene groups that were correlated to the protons at δ 5.82 and 4.99, 
respectively by HSQC. Thus, the presence of terminal vinyl (>CH=CH2) 
moiety attached to the main tricylic system was appropriately validated, and 
its position was identified by HMBCs from δ 2.01(H-13) to δ 139.50(C-15). 
Higher chemical shift signals at δ 6.59(H-1) was found to be a singlet methine 
attached to δ 129.55(C-1), which apparently indicated the presence of olefinic 
framework in the ring. It was positioned between the highly deshielded 
quaternary alkenic carbon at δ 169.00(C-10) and carbonyl carbon (C=O) at δ 
184.16(C-2). Therefore, the methine at C-1 was found to be singlet proton. 
The HMBCs from δ 6.59(H-1) to δ 184.16(C-2), 169.00(C-10) and δ 4.25(H-
3) to δ 184.16(C-2), 169.00(C-10), 129.55(C-1) corroborated the dispositions 
of the protons at C-10, C-3, C-1 and C-2. The COSY correlations, such as δ 
2.79(H-5)/2.33(H-6)/1.99(H-7)/1.88(H-8)/1.30(H-14)/2.01(H-13)/1.35(H-
12)/1.28(H-11) supported the tricyclic framework along with δ 2.01(H-
13)/5.82(H-15)/4.99(H-16) to assign that the exocyclic vinyl moiety was 
attached at C-13. Long range HMBCs from δ 2.79(H-5) to δ 169.00(C-10); δ 
1.88(H-8) to δ 29.50(C-11), 29.16(C-14); δ 1.28(H-11) to δ 19.01(C-19); δ 
1.02(H-17) to δ 46.87(C-5), 184.16(C-2); δ 0.98(H-18) to δ 46.87(C-5) and δ 
2.21(H-19) to δ 169.00(C-10) supported the occurrence of 4,4,9-trimethyl-13-
vinyl-dodecahydro-2-phenanthrenone part. Therefore, the double bond 
equivalences of six were deduced for three double bonds and three ring 
systems. The geometric isomerism of olefinic protons was established by the 
greater coupling constants (J) of 9.4(H-15) and 11.6(H-16) Hz that validated 
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the trans(E) configuration of vinyl group at C-13. The NOE correlations were 
apparent between δ 6.59(H-1)/2.21(H-19)/2.79(H-5), which depicted that these 
were in the identical plane and α-orientated. Other NOESY cross-peaks among 
δ 2.01(H-13)/5.82(H-15)/1.88(H-8)/1.02(H-17) indicated that these groups 
were located in an identical plane of reference and β-oriented. 
The LCMS spectrum of the compound (2) formed a sodium adduct 
(M+Na) peak at m/z 295.2 (C19H28ONa •+) The molecular ion peak appeared to 
be at m/z272.2(C19H28O•+) that undergoes elimination of methyl group and 
doublebond to form octahydro trimethyl phenanthrenone which appeared at 
m/z246.2 (C17H26O). 
 
Fig 5.5.A. 
1
H NMR spectrum of 4,4,9-trimethyl-13-vinyl-dodecahydro-2-phenanthrenone (2). 
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Fig 5.5.B. 
13
C NMR spectrum of 4,4,9-trimethyl-13-vinyl-dodecahydro-2-phenanthrenone (2). 
 
Fig 5.5.C. 
1
H–1H COSY NMR spectrum of 4,4,9-trimethyl-13-vinyl-dodecahydro-2-
phenanthrenone (2). 
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Fig 5.5.D. NOE spectrum of 4,4,9-trimethyl-13-vinyl-dodecahydro-2-phenanthrenone (2). 
 
 
Fig 5.5.E. Mass spectrum of 4,4,9-trimethyl-13-vinyl-dodecahydro-2-phenanthrenone (2). 
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5.2.1.2C Chromatographic purification and spectral analyses of 11,20-dihydroxy-6,6-
dimethyl-decahydro-5H-benzo[h]naphtho[1,2-c]chromene-16-carbaldehyde (3) 
The compound 11,20-dihydroxy-6,6-dimethyl-decahydro-5H-benzo[h] 
naphtho[1,2-c]chromene-16-carbaldehyde (3) was isolated as yellowish 
crystalline solid upon repeated chromatography over silica columns/TLC. The 
ultraviolet absorbance at λmax (log ε) 252 nm (1.61) and its mass spectrum 
exhibited a molecular ion peak at  380 (HRESIMS m/z 381.4684amu [M+1]), 
which in combination with its 
1
H and 
13
C NMR data (Table 5.5) indicated the 
molecular formula as C24H28O4 (11,20-dihydroxy-6,6-dimethyl-decahydro-5H-
benzo[h]naphtho[1,2-c]chromene-16-carbaldehyde) with 11 degrees of 
unsaturation.  Four degrees of unsaturation were due to the aromatic cyclic 
ring system and three degrees of unsaturation were from double bonds, and the 
remaining four degrees of unsaturation were due to the cyclic ring systems. 
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Table 5.5 NMR spectroscopic data of 11,20-dihydroxy-6,6-dimethyl-decahydro-5H-
benzo[h]naphtho[1,2-c]chromene-16-carbaldehyde (3) isolated from Perna viridis 
  Compound 3  
 
Position 
No 
13C NMR 
δ1H NMR (int., mult., J in 
Hz)b 
1H 1H COSY HMBC(1H-13C) 
1 130.9 7.46 (dt, J = 6.1,1H), 2-H C-2,3 
2 130.02 7.46 (dt, J = 6.1,1H), - - 
3 129.94 7.65 (dd, J = 5.7,1H) 4-H C-1,4 
4 128.84 7.65 (dd, J = 5.7,1H) - - 
5 153.13 - - - 
6 33.94 - - - 
7 31.93 2.29(m,2H) 8-H C-6,8 
8 34.12 4.10(m,1H) 13-H, 9-H C-10,13 
9 99.99 - - - 
10 144.42 - - - 
11 160.88 - - - 
12 69.9 4.24(dd,1H) 13-H C-13 
13 29.7 3.66(m,1H) 14-H C-7,14 
14 14.11 0.88(m,2H) 15-H C-15 
15 22.69 1.54(m,2H) - C-13,16,22 
16 59.68 - - - 
17 107.09 - - - 
18 129.73 5.26(dd,1H) 19-Ha C-19 
19 24.7 1.94(t,1H)2.01(m,1H) - C-18,22 
20 65.04 4.08(m,1H) 20-H C-19 
21 27.23 2.24(m,2H) - C-22,19 
22 179.25 - 20-H - 
23 29.36 1.23(m,3H) - C-7,8 
24 29.07 1.25(m,3H) - C-4 
a 
NMR spectra recorded using Bruker AVANCE III 500 MHz (AV 500) spectrometers. 
b 
Values in ppm, multiplicity and coupling constants (J¼ Hz) were indicated in parentheses. 
Assignments were made with the aid of the 
1
H-
1
H COSY, HSQC, HMBC and NOESY 
experiments. 
OOH
H
O
OH
1
5
24
8
11
13
20
22
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Aromatic proton signals were recorded at δ 7.46 and 7.65 with total 
proton integral of four, which validated the presence of di-substituted aromatic 
ring. Aromatic carbon signals were registered at δ 130.90(C-1), 130.02(C-2), 
129.94(C-3) and 128.84(C-4), which were corresponded to methine carbons, 
whereas the resonances at δ 153.13(C-5) and 144.42(C-10) were attributed to 
the aromatic quaternary carbons as deduced from the combined 
13
C and 
135
DEPT spectral data. The combined 
1
H, 
13
C and DEPT NMR experiments 
recorded the occurrences of twenty-four carbon atoms with five each of 
methylenes and methines, along with two methanes (singlets) and seven 
quaternary carbons. The olefinic signals were apparent at δ 99.99(C-9), 
160.88(C-11), 107.09(C-17) and δC 129.73(C-18)/δH 5.26. The highly 
deshielded carbon at δ 160.88(C-11) represented a directly linked 
electronegative group in its vicinity. Hence, the four valences of carbon at C-
11 were satisfied with the highly electronegative oxygen, hydroxyl and alkenic 
bonds {>C-9=C-11(-O-)-OH}. The hydroxymethyl at C-20 was attributed to δ 
4.08, which displayed HSQC correlation with δC 65.04, and this greater 
chemical shift was because of the presence of adjacent alkene at C-18. The 
methine at δ 4.10(H-8) and 3.66(H-13) were characteristic to the junction 
point of a cyclic moiety. An aldehyde group was apparent at the ring junction, 
C-16 with δ 59.68 and carbonyl carbon of aldehyde part {-C(=O)H} was 
recorded at δ 179.25(C-22), which was supported by HMBCs from δ 1.54(H-
15) to δ 179.25(C-22); δ 1.94(H-19) to δ 179.25(C-22) and δ 2.24(H-21) to δ 
179.25(C-22). The two singlet methyl groups were recorded at δH 1.23/δC 
29.36 and δH 1.25/δC 29.07, which were linked at δ 33.94(C-6). It exhibited 
four significant spin systems, such as δ 7.46(H-1)/7.65(H-2) and δ 7.65(H-
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3)/7.46(H-4) for aromatic ring, δ 2.29(H-7)/4.10(H-8)/3.66(H-13)/4.24(H-12) 
along with δ 3.66(H-13)/0.88(H-14)/1.54(H-15) and δ 5.26(H-18)/1.94(H-
19)/4.08(H-20)/2.24(H-21), appropriately supported the presence of tetracyclic 
ring system. The HMBC resonances from δ 4.10(H-8) to δ 144.42(C-10), 
29.70(C-13); δ 3.66(H-13) to δ 31.93(C-7); δ 1.54(H-15) to δ 29.70(C-13); δ 
2.24(H-21) to δ 24.70(C-19); δ 1.23(H-23) to δ 31.93(C-7) and δ 1.25(H-24) to 
δ 29.07(C-4) further supported the structural. Hence, the eleven degrees of 
hydrogen deficiencies were deduced for one aromatic ring, threedouble bonds 
and four cyclic rings. The NOE couplings among δ 0.88(H-14)/4.08(H-20) 
depicted that these were in indistinguishable plane of orientation, and 
therefore, were designated to be α-orientated. The hydroxyl at C-20 was 
located at β-position being opposite to α-proton at C-20. Other NOESY 
correlations among δ 4.10(H-8)/5.26(H-18)/4.24(H-12) indicated that these 
were aligned in same plane of reference, and therefore, these protons were β-
oriented. 
The  LCMS spectrum of the compound 11,20-dihydroxy-6,6-dimethyl-
decahydro-5H-benzo[h]naphtho[1,2-c]chromene-16-carbaldehyde (3) formed 
an sodium  adduct (M+Na) peak at m/z 403.8 (C24H28O4Na). The molecular 
ion peak appeared to be at m/z380.5(C24H28O4 •+), undergo elimination of 
hydroxyl groups and aldehyde to form daughter ion at m/z364.5 (C24H28O3) and 
m/z320.5 (C23H28O).The base peak was found to be at m/z 292.4 (C21H24O) 
indicates the presence of be as benzo naphtho chromene fragment.  
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Fig 5.6.A. 
1
H NMR spectrum of 11,20-dihydroxy-6,6-dimethyl-decahydro-5H-benzo[h] 
naphtho[1,2-c]chromene-16-carbaldehyde (3) 
 
Fig 5.6.B. 
13
C NMR spectrum of 11,20-dihydroxy-6,6-dimethyl-decahydro-5H-benzo[h]naphtha  
[1,2-c]chromene-16-carbaldehyde (3). 
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Fig 5.6.C.  NOE spectrum of 11,20-dihydroxy-6,6-dimethyl-decahydro-5H-benzo[h]naphtho[1,2-c] 
chromene-16-carbaldehyde (3). 
 
Fig 5.6.D. 
1
H–1H COSY spectrum of 11,20-dihydroxy-6,6-dimethyl-decahydro-5H-benzo 
[h]naphtho[1,2-c]chromene-16-carbaldehyde (3).  
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Fig 5.6.E.  DEPT NMR spectrum of 11,20-dihydroxy-6,6-dimethyl-decahydro-5H-benzo[h] 
naphtho[1,2-c]chromene-16-carbaldehyde (3). 
 
Fig 5.6.F.  HMBC NMR spectrum of 11,20-dihydroxy-6,6-dimethyl-decahydro-5H-benzo[h] 
naphtho[1,2-c]chromene-16-carbaldehyde (3). 
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Fig 5.6.G.  HSQC NMR spectrum of 11,20-dihydroxy-6,6-dimethyl-decahydro-5H-benzo[h] 
naphtho[1,2-c]chromene-16-carbaldehyde (3). 
 
Fig 5.6.H. Mass spectrum of 11,20-dihydroxy-6,6-dimethyl-decahydro-5H-benzo[h]naphtho [1,2-c] 
chromene-16-carbaldehyde (3). 
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5.2.1.2D Chromatographic purification and spectral analyses of 16-acetyl-20-
hydroxy-6,6-dimethyl-dodecahydro-5H-benzo[h]naphtho[1,2-c]chromen-12-
one (4) 
The compound 16-acetyl-20-hydroxy-6,6-dimethyl-dodecahydro-5H-
benzo[h]naphtho[1,2-c]chromen-12-one (4) isolated aspale yellow powder and 
showed close structural similarity with 11,20-dihydroxy-6,6-dimethyl-decahydro-
5H-benzo[h]naphtho[1,2-c]chromene-16-carbaldehyde (3) except the additional 
carbonyl group in third ring in compound 4 and the extra peak at H-23(2.35) 
signifying the methyl singlet attached to the carbonyl group. Mass spectrum 
displayed the molecular ion peak at  394.3 (HRESIMS m/z 394.5682 amuwhich 
in combination with its 
1
H and 
13
C NMR data (Table 5.6) indicated the molecular 
formula as C25H30O4with 11 degree of unsaturation.  
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Table 5.6. NMR spectroscopic data of 16-acetyl-20-hydroxy-6,6-dimethyl-dodecahydro-5H-
benzo[h]naphtho[1,2-c]chromen-12-one 
  Compound 4  
 
Position No 13CNMR 
δ1H NMR (int., mult., J in 
Hz)b 
1H-1H COSY HMBC(1H-13C) 
1 128.84 7.71(m) 2-H C-2,3 
2 130.94 7.53(m) - - 
3 130.9 7.53(m) - C-1,4 
4 128.03 7.71(m) 4-H - 
5 120.98 - - - 
6 48.78 - - - 
7 33.15 2.32(dt) 8-H C-6,8,10 
8 62.13 4.14(m) 13-H, 9-H C-11,9,12 
9 68.79 5.26(s) 8-H C-11,7,13 
10 120 - - - 
11 173.31 - - - 
12 52.7 4.30(m) 13-H C-11,18,14 
13 62.12 3.66(d) 14-H C-7,14 
14 34.73 1.73(m) 15-H C-13,12,17 
15 31.9 1.32(t) - C-16,22 
16 37.8 - - - 
17 114 - - - 
18 129.9 5.34(t) 19-Ha C-19,20,16 
19 
27.21 
2.01(dd) 
20-H C-18,22,20  1.92(m) 
20 61.2 4.09(m) - C-19 
21 24 1.56(s) 20-H C-22 
22 179.81 - - - 
23 34.24 2.35(s) - - 
24 22.71 1.23(s) - C-7,5,8 
25 21.1 1.25(s) - C-7 
a
 NMR spectra recorded using Bruker AVANCE III 500 MHz (AV 500) spectrometers. 
b 
Values in ppm, multiplicity and coupling constants (J¼ Hz) were indicated in parentheses. 
The assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY 
experiments. 
 
OO
O
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The structure of the studied compound was found to be similar with 3 
except the acetyl side chain at C-16 in 4,whereas, the carbaldehyde moiety 
was positioned at C-16 in 3. The aromatic proton signals were displayed at δ 
7.71 and 7.53 with total proton integral of four, which appropriately validated 
the occurrence of di-substituted aromatic ring. Aromatic methines were 
registered at δ 128.84(C-1), 130.94(C-2), 130.90(C-3) and 128.03(C-4), 
whereas the aromatic quaternary carbons were recorded at δ 120.98(C-5) and 
120.01(C-10). The 
13
C and 
135
DEPT experiments recorded 24 carbons with 
five methylenes, ten methines, three methanes (singlets) and seven quaternary 
carbons. The proton at δ 4.09 (HSQC with δC 61.20) was due to the presence 
ofhydroxylatedmethine (-CH-OH) at C-20 and this higher chemical shift was 
attributed to the adjacent alkene at C-18 (δH 5.34/δC 129.90). The acetyl {-
C(=O)-CH3} group was recorded at C-16(δ 37.80) and carbonyl carbon of 
ketone was found at δ 179.81(C-22). This was supported by the HMBCs from 
δ 2.01(H-19) to δ 179.81(C-22); δ 1.56(H-21) to δ 179.81(C-22) and 1.32(H-
15) to δ 179.81(C-22). The singlet methyl at δ 2.35 correlated to δ 34.24(C-
23), was ascribed to be a part of acetyl moiety and its attachment at C-16 was 
corroborated by the HMBCs from δ 2.35(H-23) to δ 179.81(C-22) and δ 
1.56(H-21) to δ 34.24(C-23). The singlet methyls at δH 1.23/δC 22.71 and δH 
1.25/δC 21.10 were linked at the quaternary carbon of δ 48.78 at C-6. The 
assignments were made according to long-range coupling values at δ 1.23(H-
24) to δ 33.15(C-7), 120.98(C-5), 62.13(C-8) and δ 1.25(H-25) to δ 33.15(C-
7). Four significant spin systems were validated by COSYs at δ 7.71(H-
1)/7.53(H-2) and δ 7.53(H-3)/7.71(H-4) for aromatic ring, δ 2.32(H-7)/4.14(H-
8)/5.26(H-9), 3.66(H-13) along with δ 4.30(H-12)/3.66(H-13)/1.73(H-
14)/1.32(H-15) and δ 5.34(H-18)/2.01, 1.92(H-19)/4.09(H-20)/1.56(H-21) for 
the tetracyclic moiety in 4 (Fig. 2C). The HMBCs from δ 2.32(H-7) to δ 
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48.78(C-6), 120.01(C-10); δ 4.14(H-8) to δ 173.31(C-11), 52.70(C-13); δ 
5.26(H-9) to δ 33.15(C-7), 173.31(C-11), 62.12(C-12); δ 4.30(H-12) to δ 
34.73(C-14), 129.90(C-18); δ 1.73(H-14) to δ 114.00(C-17); δ 5.34(H-18) to δ 
61.20(C-20), 37.80(C-16) and δ 1.56(H-21) to δ 179.81(C-22) further 
supported the structural attributions. Hence, the double bond equivalences of 
eleven were deduced for one aromatic ring, threedouble bonds and four rings. 
The NOE couplings were displayed between the protons at δ 1.73(H-
14)/4.09(H-20)/5.26(H-9), which represented that these protons were in same 
plane of orientation, and considered as α-orientated. The hydroxyl group at C-
20 was β-disposedbeing opposite to α-proton at C-20. Other NOESYs among 
δ 4.14(H-8)/5.34(H-18)/4.30(H-12) indicated that these groups were located in 
the identical plane of reference, and opposite to α-orientated protons, thus, 
considered as β-aligned. 
The  LCMS spectrum of the compound 4, 16-acetyl-20-hydroxy-6,6-
dimethyl-dodecahydro-5H-benzo[h]naphtho[1,2-c]chromen-12-one (4) spectra 
are presented in Fig 5.7.Its molecular ion peak was appeared at 
m/z394.2(C25H30O4 •+). 
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Fig 5.7. A. 
13
C NMR spectrum of 16-acetyl-20-hydroxy-6,6-dimethyl-dodecahydro-5H-benzo[h] 
naphtho[1,2-c]chromen-12-one (4). 
 
Fig 5.7.B. 
1
H NMR spectrum of 16-acetyl-20-hydroxy-6,6-dimethyl-dodecahydro-5H-benzo[h] 
naphtho[1,2-c]chromen-12-one (4). 
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Fig 5.7.C.  
1
H–1H COSY  spectrum of 16-acetyl-20-hydroxy-6,6-dimethyl-dodecahydro-5H-
benzo[h]naphtho[1,2-c]chromen-12-one (4).The key 
1
H-
1
H COSY couplings have been 
represented by the bold face bonds. 
 
 
Fig 5.7.D.  NOE NMR spectrum of 16-acetyl-20-hydroxy-6,6-dimethyl-dodecahydro-5H-
benzo[h]naphtho[1,2-c]chromen-12-one (4). 
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Fig 5.7.E.  HMBC NMR spectrum of 16-acetyl-20-hydroxy-6,6-dimethyl-dodecahydro-5H-benzo[h] 
naphtho[1,2-c]chromen-12-one (4). 
 
 
Fig 5.7.F HSQC NMR spectrum of 16-acetyl-20-hydroxy-6,6-dimethyl-dodecahydro-5H-benzo[h] 
naphtho[1,2-c]chromen-12-one (4). 
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Fig 5.7.G. Mass spectrum of 16-acetyl-20-hydroxy-6,6-dimethyl-dodecahydro-5H-benzo[h] 
naphtho[1,2-c]chromen-12-one.  
 
5.2.1.2E Chromatographic purification and spectral analyses of cholest-5-en-3-3-yl-
(30-hydroxy-3-methyl-36-methyleneundeca-30E,34E-dienoate) (5) 
The compound cholest-5-en-3β-3-yl-(30-hydroxy-3-methyl-36-
methyleneundeca-30E,34E-dienoate) (5)was isolated as a light yellow 
crystalline solid upon repeated chromatography over silica columns. The mass 
spectrum of the compound exhibited the molecular ion peak at m/z 592 
(HRESIMS at m/z 592.9562 [M]
+
) that alongwith the detailed NMR 
spectroscopic experiments established the molecular formula as C40H64O3.  
The number of carbon atoms was established as 40 through the 
combined 
1
H, 
13
C and 
135
DEPT analyses, which included seven methyls, 
twelve methines, fifteen methylenes and six quaternary carbons. The alkenic 
resonances appeared at δ 140.75(C-5) and 121.70(C-6) in the carbon spectrum 
attributed the presence of a double bond. Significantly higher downfield shift 
at δC 140.75 suggested that it belonged to a quaternary carbon subsequent to 
the alkenic bond in a ring system. One highly deshielded signal was found at δ 
5.35(H-6) (HSQC with δ 121.70), which was deduced to be a triplet due to the 
Isolation and characterization of secondary metabolites fromPernaviridis………. 
191 
nearby proton at δ 2.28(C-7) (HSQC with δC 31.92; >C=CH-CH2-). The 
deshielded proton at δ 3.52(δC 71.80) was due to the presence of methine, 
which was directly linked to an oxygenated side chain. Two spin systems were 
recorded in the studied cholestane, wherein two spin systems were accounted 
for the side chain, which were tabulated by the COSYs, δ 1.28(H-1)/1.97(H-
2)/3.52(H-3)/2.30(H-4); δ 5.35(H-6)/2.28(H-7)/1.98(H-8)/0.95(H-9)/1.49(H-
11)/1.46(H-12); δ 1.98(H-8)/1.11(H-14)/1.58(H-15)/1.86(H-16)/1.13(H-
17)/1.33(H-20)/1.82(H-22), 0.98(H-21) and δ 1.85(H-24)/1.99(H-25)/0.89(H-
26), 0.87(H-27) to support the presence of cholestene framework. The three 
characteristic shielded methyl protons of the sterol framework were appeared 
at δ 0.68 (s), 1.01 (s) and 0.98 (d), which were due to the carbons at C-18, C-
19 and C-21 positions, respectively. The HMBCs from δ 2.30(H-4) to δ 
31.66(C-2), 140.75(C-5), 121.70(C-6); δ 5.35(H-6) to δ 42.30(C-4), 31.00(C-
8); δ 1.98(H-8) to δ 24.30(C-15); δ 0.95(H-9) to δ 37.27(C-1), 21.10(C-11) 
and δ 1.01(H-19) to δ 50.15(C-9), 21.10(C-11), 36.51(C-10), 71.80(C-3) 
further supported the occurrence of C-27 sterol moiety. The 30-hydroxy-3-
methyl-36-methyleneundeca-30,34-dienoate chain was attached at C-3 
position of the sterol skeleton, and was confirmed by HMBCs from δ 2.38(H-
29) to δ 71.80(C-3). The side chain enclosing three spin systems were 
validated by COSYs from H-31 to H-35 {δ 5.80(H-31)/4.16(H-32)/1.57, 
1.03(H-33)/5.17(H-34)/4.32(H-35)} and H-37 to H-38 {δ 1.84(H-37)/0.80(H-
38)}. A carbonyl carbon was positioned at δ 173.92(C-28) and hydroxyl 
attached methine was recorded at δ 65.09, which exhibited C-H correlation 
with δ 4.16(H-32). The long-range C-H couplings from δ 5.17(H-34) to δ 
37.15(C-37); δ 4.32(H-35) to δ 114.06(C-39); δ 4.94(H-39) to δ 37.15(C-37), 
14.11(C-38) and δ 2.17(H-40) to δ 138.10(C-30) deduced the presence of side 
chain. The greater coupling constants at H-34(J=8.3 Hz) and H-35(10.9 Hz) 
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supported the trans (E) orientation of double bond at -CH(34)=CH(35)- 
position. Hence, the double bond equivalences of nine were deduced for five 
double bonds and four ring skeletons. The NOESY correlations, δ 3.50(H-
3)/5.35(H-6)/1.11(H-14)/4.16(H-32) suggested that they were located in same 
plane, and were considered as α protons. This, in turn, indicated the β-position 
of hydroxyl at C-3 and C-32. The methyls at H-18 and H-19 of the cholestane 
were correlated with δ 1.98(H-8) and 1.13(H-17) that apparently attributed 
their β-orientation. 
Table 5.7. NMR spectroscopic data of cholest-5-en-3β-3-yl-(30-hydroxy-3-methyl-36-
methyleneundeca-30E,34E-dienoate) (5) isolated from Pernaviridis 
 
 Compound 5 
 
Position 
No 
13C NMR δ1H NMR (int., mult., J in Hz)b 1H-1H COSY HMBC(1H-13C) 
1 37.27 1.28( m ) 2-H - 
2 31.66 1.98(m) - C-1,C-3 
3 71.8 3.52 (p, J = 11.0, 4.5 Hz, 1H) 1-H,2-H,4-H - 
4 42.3 2.30(m) - C-2,1,3,5,6 
5 140.75 - - - 
6 121.7 5.35 (td, J = 5.2, 2.3 Hz) 7-H C-4,7,8 
7 31.92 2.28(m) 8-H C-5,C-6 
8 31 1.98(m) 14-H C-9, C-15 
9 50.15 0.95(m) 11-H C-1,C-11 
10 36.51 - - - 
O
OCH
3
OHCH
2
3
6
10
12
16
19
18
23
26
27
31
36
37
39
40
28
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11 21.1 1.49(m) 12-H C-5,6,9,12 
12 39.8 1. 46(m) 11-H C-9,C-13 
13 42.33 - - - 
14 56.78 1.11 8-H C-26 
15 24.3 1.58(m) 16-H C-13 
16 28.24 1.86(m) 17-H,15-H C-15,C-18,C-20 
17 56.16 1.13 18-H C-13 
18 35.79 1.33 19-H C-22,C-16 
19 18.73 0.98(d) 20-H C-20 
20 36.2 1.82(tq) - - 
21 23.84 1.80 (tq) 22-H C-24,20,23 
22 39.53 1.85(tq) 23-H C-24 
23 28.02 1.99 25-H,24-H C-25,24 
24 22.56 0.89 23-H C-25 
25 22.69 0.87(m) 23-H C-24 
26 11.87 0.68(s) - C-17,13,12 
27 19.4 1.01(s) - C-9,11,10,3 
28 173.92 - - - 
29 34.19 2.38(d) 2.27(m) - C-28 
30 138.1 - - - 
31 126.73 5.80(dd) 32-H C-32 
32 65.09 4.16(m) 33-H  
33 24.2 1.57(m) , 1.03(m) 34-H C-34 
34 131.82 5.17(q) 35-H C-38 
35 106 4.32(d) - C-37 
36 156 - - - 
37 114.06 4.94(ddd) - C-39,38 
38 37.15 1.84(m) 39-H  
39 14.11 0.80(t) 38-H C-40 
40 31.07 2.17(s) - C-30 
a 
NMR spectra were recorded using Bruker AVANCE III 500 MHz (AV 500) spectrometers. 
b
Values in ppm, multiplicity and coupling constants (J¼ Hz) were indicated in parentheses. 
Assignments were made with the aid of the 
1
H-
1
H COSY, HSQC, HMBC and NOESY 
experiments. 
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The ultraviolet absorbance at λmax (log ε) 266 nm (2.61) has been 
assigned to be a chromophore with multiple olefinic system. The H–H and C–
H connectivities apparent in the 
1
H–1H COSY and HMBC spectra indicated 
nine degrees of unsaturation in 5. Five degrees of unsaturation from the double 
bond equivalency and the other was due to a cyclic ring system. The olefinic 
(C=C), carbonyl (C=O) and ether (C-O-C) groups have been symbolized by 
the absorption bands at 1642, 1736.96 and 1068 cm
-1
,respectively. The 
characteristic IR absorption spectra atνmax1736.96 cm
-1
 (C=O stretching), 
3419.90cm
-1 
(O-H stretching vibration), 2924.18 cm
-1
 (C-H stretching of 
alkanes), 1545cm
-1 
(C=C stretching), 724.28 cm
-1
 (C-H rocking), 1377.22 cm
-1
 
(C-H bending) supported the structure of steroid framework. The 
1
H, 
13
C, 
1
H–
1
H COSY, HMBC, and NOE spectra were presented in Fig 5.8.  
 
 
Fig 5.8.A. 
13
C NMR spectrum of cholest-5-en-3β-3-yl-(30-hydroxy-3-methyl-36-methyleneundeca-
30E,34E-dienoate (5). 
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Fig 5.8.B. 
1
H NMR spectrum of cholest-5-en-3β-3-yl-(30-hydroxy-3-methyl-36-methyleneundeca-
30E,34E-dienoate (5). 
 
 
Fig 5.8.C.
 1
H–1H COSY spectrum of cholest-5-en-3β-3-yl-(30-hydroxy-3-methyl-36-methyleneundeca-
30E,34E-dienoate (5). 
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Fig 5.8.D. HSQC Spectrum of cholest-5-en-3β-3-yl-(30-hydroxy-3-methyl-36-methyleneundeca-
30E,34E-dienoate (5). 
 
 
Fig 5.8.E. HMBC spectrum of cholest-5-en-3β-3-yl-(30-hydroxy-3-methyl-36-methyleneundeca-
30E,34E-dienoate (5). 
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5.2.1.2F. Chromatographic purification and spectral analyses of cholest-5-en-3β-3-yl-((E)-
33-oxooct-31-enoate (6) 
The compound cholest-5-en-3β-3-yl-((E)-33-oxooct-31-enoate (6) isolated 
as yellow solid upon repeated chromatography over silica columns/TLC.Its mass 
spectrum exhibited a molecular ion peak at m/z 524(HRESIMS m/z  524.8364 
which in combination with its 
1
H and 
13
C NMR data (Table 5.8) indicated the 
molecular formula as (C35H56O3) as cholest-5-en-3β-3-yl-((E)-33-oxooct-31-
enoate with eight degree of unsaturation. Four degree of unsaturation from double 
bonds and the remaining four degree of unsaturation were due to a cyclic ring 
system. 
The number of carbons was established as 35 through combined 
1
H, 
13
C and 
135
DEPT experiments, which included six methyls, fourteen 
methylenes, ten methines and five quaternary carbons. Considerably 
deshielded shift at δC 140.76 was belonged to the quaternary carbon adjacent 
to an alkenic bond in a cyclic ring. Highly deshielded signal at δ 5.35(H-6) 
exhibited HSQC correlation with δ 121.72, and was found to be a triplet due to 
the nearby proton at δ 2.29(C-7) bonded to δC 31.92 (>C=CH-CH2-). The 
deshielded proton at δ 3.52 was belonged to the methine with δC 71.81, which 
confirmed that it was directly linked to an oxygenated end. The presence of 
two spin systems in sterol skeleton was established by COSY correlations, δ 
1.32(H-1)/1.97(H-2)/3.52(H-3)/2.28(H-4); δ 5.35(H-6)/2.29(H-7)/1.98(H-
8)/1.34(H-9)/1.49(H-11)/1.15(H-12); δ 1.98(H-8)/1.53(H-14)/1.58(H-15)/ 
1.86(H-16)/0.99(H-17)/1.33(H-20)/0.91(H-21), 1.33(H-22) and δ 1.26(H-
24)/1.92(H-25)/0.89(H-26)/0.91(H-27). The shielded protons of sterol 
framework were found to appear at δ 0.69 (s), 1.01 (s) and 0.91 (d), which 
exhibited HSQC correlations with the carbons at δ 18.69(C-18), δ 19.38(C-19) 
and δ 18.73(C-21), respectively. The HMBCs from δ 2.28(H-4) to δ 31.62(C-
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2), 140.76(C-5), 121.72(C-6); δ 2.29(H-7) to δ 140.76(C-5); δ 1.34(H-9) to δ 
24.30(C-15); δ 1.15(H-12) to δ 42.30(C-13) and δ 1.01(H-19) to δ 37.26(C-1) 
supported the occurrence of C-27 sterol moiety. The 33-oxooct-31-enoate side 
chain placed at C-3 of sterol skeleton was confirmed from HMBC correlation 
from δ 2.33(H-29) to δ 71.81(C-3). The presence of side chain was 
corroborated by COSYs from δ 2.33(H-29)/2.04(H-30); δ 5.80(H-31)/4.88(H-
32) and δ 2.00, 1.86(H-34)/0.88(H-35). The chemical shifts due to the carbons 
associated with ester and ketone groups (δ 174.00 and 194.01, respectively) 
were assigned to C-28 and C-33, respectively based upon the HMBC 
experiment. The long-range C-H correlations from δ 2.04(H-30) to δ 
174.00(C-28); δ 5.80(H-31) to δ 29.70(C-29); δ 4.88(H-32) to δ 29.37(C-30), 
194.01(C-33) and δ 0.88(H-35) to δ 136.00(C-31), 194.01(C-33) further 
validated the presence of side chain assignments. Therefore, the eight degrees 
of unsaturation were assigned to each of four double bonds and ring moieties. 
The greater coupling constants at H-31(J = 9.1 Hz) and H-32(10.4 Hz) 
attributed the trans (E) configuration of the olefinic bond at -CH-(34)=CH-
(35)-The NOESYs at δ 3.52(H-3)/5.35(H-6)/1.53(H-14) appropriately 
suggested that they were aligned towards the identical plane of reference, and 
considered as α-protons. This, in turn, indicated the β-disposition of hydroxyl 
at C-3. The methyls at δ 0.69(H-18) and 1.01(H-19) of cholestane were related 
with the protons at δ 1.98(H-8) and 0.99(H-17), which did not exhibit any 
cross-peaks with the α-assigned protons, and considered as β-protons. 
The  LCMS spectrum of the compound 5, cholest-5-en-3β-3-yl-((E)-33-
oxooct-31-enoate is given in Fig 5.9. The molecular ion peak appeared to be at 
m/z524.4 (C35H56O3 •+), undergo elimination of methyl groups to form daughter 
ions at m/z496.4 (C33H52O3).These daughter ion undergo further elimination of series 
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of methyl groups to form daughter ions at m/z482.4(C32H50O3), m/z468.4 (C31H48O3) 
and m/z454.3 (C30H46O3) respectively.  
Table 5.8. NMR spectroscopic data of cholest-5-en-3β-3-yl-((E)-33-oxooct-31-enoate (6) 
  Compound 6 
 
Position 
No 
13CNMR 
δ1H NMR (int., 
mult., J in Hz)b 
1H-1H COSY HMBC(1H-13C) 
1 37.26 1.32(m) 2-H - 
2 31.62 1.98(m) - C-1,C-3 
3 71.81 3.52(td) 1-H,2-H,4-H - 
4 42.31 2.28 3-H C-3,5,6,2 
5 140.76 - - - 
6 121.72 5.35 7-H C-7 
7 31.92 2.28(m) 8-H C-5,C-6 
8 31.92 1.98(t) 14-H,9-H C-9, 
9 50.14 1.34(m) 8-H C-15 
10 36.52 - - C-11,19,12 
11 21.1 1.49(m) 12-H - 
12 39.79 1.15(t) 11-H C-13,C-12 
13 42.3 - - C-18,C-13 
14 56.78 1.53(m) 8-H - 
15 24.3 1.58(m) 16-H C-13 
16 28.24 1.86(m) 17-H,15-H - 
17 56.16 0.99(m) 20-H C-15,C-22,C-20 
18 18.69 0.69(s) - C-14,C-13 
19 19.38 1.01(s) - C-13,C-17,C-11 
20 35.79 1.33 21-H - 
21 18.73 0.91(d) 20-H C-22,C-16 
22 36.21 1.33(m) 23-H C-20 
23 23.83 1.15 22-H C-20,C-16 
24 39.53 1.26 25-H C-25,C-24 
25 28.02 1.92 26-H C-22 
O
O
O
1
5
9
12
14
17
19
20
23
25
26
27
28
35
18
21
22
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26 22.82 0.89(d) 25-H - 
27 22.83 0.91(d) - C-25 
28 174 - - - 
29 29.7 2.33(m) 30-H - 
30 29.37 2.04(m) - C-28 
31 136 5.80(m) 35-H C-29 
32 111 4.88(d),4.95(d) 37-H C-30,C-32 
33 194 - - - 
34 29.67 2.00(m), 1.86(m) 38-H - 
35 14.12 0.88(t) 37-Ha C-31,C-35 
a NMR spectra were recorded using Bruker AVANCE III 500 MHz (AV 500) spectrometers.bValues in 
ppm, multiplicity and coupling constants (J¼ Hz) are indicated in parentheses. Assignments were made with 
the aid of the 1H-1H COSY, HSQC, HMBC and NOESY experiments. 
 
 
 
Fig 5.9.A. 
13
C NMR spectrum of cholest-5-en-3β-3-yl-((E)-33-oxooct-31-enoate (6). 
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Fig 5.9. B. 
1
H NMR spectrum cholest-5-en-3β-3-yl-((E)-33-oxooct-31-enoate (6). 
 
Fig  5.9.C.  
1
H–1H COSY spectrum of cholest-5-en-3β-3-yl-((E)-33-oxooct-31-enoate (6). The key 1H-1H 
COSY couplings have been represented by the bold face bonds. 
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Fig  5.9.D. HMBC spectrum of cholest-5-en-3β-3-yl-((E)-33-oxooct-31-enoate (6). 
 
Fig  5.9.E.  HSQC spectrum of cholest-5-en-3β-3-yl-((E)-33-oxooct-31-enoate (6). 
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Fig 5.9.F. NOEspectrum of cholest-5-en-3β-3-yl-((E)-33-oxooct-31-enoate (6). 
 
Fig 5.9.G. Mass spectrum of cholest-5-en-3β-3-yl-((E)-33-oxooct-31-enoate (6). 
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5.2.1.3Conclusion 
Currently, the reactive oxygen species and lipid oxidation in food industry 
are being controlled or minimized by the addition of synthetic antioxidants. The 
chloroform partitioned methanolic extract of Pernaviridis was 
chromatographically fractionated over silica columns to yield  3-hydroxy-13-
vinyl-dodecahydro-11-phenanthrenone (1), 4,4,9-trimethyl-13-vinyl-dodecahydro 
-2-phenanthrenone (2), 11,20-dihydroxy-6,6-dimethyl-decahydro-5H-benzo[h] 
naphtho[1,2-c]chromene-16-carbaldehyde (3), 16-acetyl-20-hydroxy-6,6-
dimethyl-dodecahydro-5H-benzo[h]naphtho[1,2-c]chromen-12-one (4), cholest-
5-en-3β-3-yl-(30-hydroxy-3-methyl-36-methyleneundeca-30E,34E-dienoate (5) 
and cholest-5-en-3β-3-yl-((E)-33-oxooct-31-enoate (6).The structures of the 
compounds, as well as their relative stereochemistries, were established by means 
of spectral data analyses, including 2D-NMR experiments. The scavenging effect 
of the purified compounds decreased with the order: 3>4>1>2>5>6.These 
compounds could effectively inhibit COX-2 as well as LOX-5 enzymes.This 
study established the potential of marine derived compounds as potential natural 
lead antioxidative and anti-inflammatory molecules for use in pharmaceutical and 
food industries.The knowledge on the structural features responsible for 
antioxidative and anti-inflammatory activities will guide us to synthesize the 
molecules in commercial scale for use as new generation antioxidant and anti-
inflammatory leads. 
5.2.2. Secondary metabolites from Crassostrea madrasensis 
An aliquot of the C. madrasensis extract (CRCT,9.2 g) was slurried in 
the silica gel (5 g, 60–120 mesh), and loaded into a glass column (90 cm X 4 
cm) packed with silica gel (60–120 mesh, 90 g) as adsorbent before being 
subjected to vacuum liquid chromatography. The column was initially eluted 
with n-hexane and the eluent polarity was gradually increased by addition of 
EtOAc (n-hexane:EtOAc 99:1 to 30:70, v/v) to furnish a total of 28 fractions 
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of 35 mL each, which were reduced to 16 groups (CF1 - CF16) after TLC 
analysis (n-hexane: EtOAc, 9:1, v/v).CF6 obtained by eluting with n-
hexane:EtOAc (4:1, v/v) was found to be a mixture, which was flash 
chromatographed (Biotage AB SP1-B1A, 230–400 mesh, 12 g; Biotage AB, 
Uppsala, Sweden) on a silica gel column (Biotage, 230–400 mesh, 12 g; 
Sweden, Biotage No. 25+M 0489-1) at a collection UV wavelength of 236 nm 
using a step gradient of ethyl acetate/n-hexane (0-5% ethyl acetate) to afford 
140 fractions (9 mL each). Based on analytical TLC, the fractions with similar 
patterns were pooled together to afford four pooled fractions (CF17 – CF20). 
The fraction F14 on subsequent preparative TLC purification using 10% 
EtOAc /n-hexane afforded methyl-3-(26-phenylacetyloxy)-icosahydro-19-
hydroxy-4,4,20-trimethylpicene-23-carboxylate0020(7, 88 mg). The fraction 
CF9 on flash chromatographic purification on a silica gel column (Biotage, 
230–400 mesh, 12 g; Sweden, Biotage No. 25+M 0489-1)at a collection UV 
wavelength of 256 nm using a step gradient of EtOAc/n-hexane (0-10 % 
EtOAc) to afford 120 fractions (9 mL each). Based on analytical TLC, the 
fractions with similar patterns were pooled together to afford six pooled 
fractions (CF21 – CF26). CF22 on further purificationwith P-TLC using 40% 
EtOAc/n-hexane afforded the compound, methyl-3-(26-phenylacetyloxy)-
icosahydro-1,19-dihydroxy-4,4,20-trimethylpicene-23-carboxylate (8, 52 mg). 
The yield and antioxidant activities of each column/P-TLC fractions and anti-
inflammatory activities of the selected fractions were presented in Table 5.8. 
The Rf of all the P-TLC fractions were also shown in Table 5.9. 
  
Chapter 5  
206 
Table 5.9.  Yield, Rf, antioxidant and anti-inflammatory activities of each column/P-TLC 
fractions of C. madrasensis. 
 
Yield 
(mg) 
Rf 
DPPH radical ABTS radical COX-2 LOX-5 
scavenging scavenging inhibitory inhibitory 
activity (%) activity (%) activity (%) activity (%) 
CRCT (HX/EA) 
CF-1     (1% EA/HX) 102 0.13 50.14±0.32 20.60±0.42 NA NA 
CF-2    (2% EA/HX) 245 0.18 49.67±0.11 19.27±0.39 NA NA 
CF-3    (3% EA/HX) 83 0.21 35.89±0.24 14.33±0.26 NA NA 
CF-4    (4% EA/HX) 158 0.28 40.02±0.16 15.85±0.30 NA NA 
CF-5    (5% EA/HX) 67 0.31 33.98±0.18 15.43±0.29 NA NA 
CF-6    (6% EA/HX) 530 0.34 48.34±0.12 19.250.29 29.49±0.14 30.46±0.08 
CF-7     (7% EA/HX) 102 0.38 47.81±0.12 25.81±0.12 NA NA 
CF-8   (10% EA/HX) 42 0.42 32.22±0.15 12.79±0.25 NA NA 
CF-9   (12% EA/HX) 34 0.45 47.38±0.22 18.46±0.14 28.46±0.05 32.17±0.21 
CF-10 (14% EA/HX) 51 0.49 48.59±0.01 22.79±0.44 NA NA 
CF-11 (16% EA/HX) 49 0.56 44.28±0.00 23.32±0.18 NA NA 
CF-12 (18% EA/HX) 65 0.63 59.38±0.00 25.31±0.09 NA NA 
CF-13 (20% EA/HX) 72 0.84 49.32±0.00 24.67±0.22 NA NA 
CF-14 (22% EA/HX) 805 0.89 53.59±0.00 21.90±0.16 NA NA 
CF-15 (25% EA/HX) 43 0.92 63.96±0.01 18.31±0.11 NA NA 
CF-16 (30% EA/HX) 22 0.95 56.32±0.09 20.89±0.09 NA NA 
CF-6 (P-TLC 10% EA/HX) 
CF-17 51 0.32 31.24±0.11 24.65±0.11 NA NA 
CF-18 356 0.56 56.57±0.25 20.64±0.25 40.56±0.33 38.29±0.02 
CF-19 84 0.73 57.77±0.08 21.87±0.08 NA NA 
CF-20 39 0.85 50.65±0.07 181.34±0.07 NA NA 
CF-14 (P-TLC 10% EA/HX) 
CF-21 21 0.25 59.44±0.17 26.65±0.17 NA NA 
CF-22 304 0.32 60.73±0.01 27.98±0.01 46.73±0.11 44.28±0.25 
CF-23 168 0.44 54.61±0.08 23.51±0.08 NA NA 
CF-24 89 0.67 49.64±0.14 24.84±0.14 NA NA 
CF-25 37 0.72 47.76±0.06 20.69±0.06 NA NA 
CF-26 66 0.92 53.13±0.07 23.56±0.07 NA NA 
CF-18 (P-TLC 5% EA/HX) 
CF-27 88 0.24 72.47±0.23 31.47±0.23 49.56±0.11 48.16±0.01 
CF-28 52 0.35 61.64±0.25 28.64±0.25 NA NA 
CF-29 34 0.46 63.46±0.09 29.41±0.09 NA NA 
CF-30 18 0.57 70.85±0.16 29.96±0.16 NA NA 
CF-31 54 0.68 64.45±0.46 28.49±0.46 NA NA 
CF-22 (P-TLC 40% EA/HX) 
CF-32       68 0.27 57.1±0.04 20.1±0.04 NA NA 
CF-33 52 0.46 68.76±0.04 32.76±0.04 48.22±0.0 48.38±0.26 
CF-34 52 0.59 55.8±0.33 22.42±0.33 NA NA 
CF-35 72 0.63 49.35±0.18 20.54±0.18 NA NA 
CF-36 43 0.75 48.47±0.08 18.65±0.08 NA NA 
DPPH radical scavenging activities at 0.1 mg/mL were expressed in percent; COX-2 
inhibitory activity at 0.1 mg/mL was expressed in percent; LOX-5 inhibitory activity at 0.05 
mg/mL was expressed in percent; NA -not assayed, ie, the fractions with low yield were 
evaluated only for DPPH and ABTS radical scavenging activity. CC -column 
chromatography; P-TLC -preparative thin layer chromatography; EA - ethyl acetate; HX- n-
hexane; CRCT -EtOAc- methanol fraction of C.madrasensis 
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5.2.2.1 Chromatographic purification and spectral analyses of secondary 
metabolites fromCrassostreamadrasensis 
Chromatographic separation led to the isolation of two new derivatives. 
The molecular structures of the purified compounds was proposed on the basis of 
comprehensive analysis of the 
1
H NMR, 
13
C NMR, including 2D-NMR 
experiments (
1
H–1H–COSY, HMQC, HMBC, and NOESY), and mass spectra. 
5.2.2.1.A Chromatographic purification and spectral analyses of methyl-3-(26-
phenylacetyloxy)-icosahydro-19-hydroxy-4,4,20-trimethylpicene-23-
carboxylate (7) 
The compound methyl-3-(26-phenylacetyloxy)-icosahydro-19-
hydroxy-4,4,20-trimethylpicene-23-carboxylate(7), a new picene derivative 
was isolated as  yellow solid upon repeated chromatography over silica 
columns/TLC. The olefinic (C=C), carbonyl (C=O), alcoholic (O-H) and 
aromatic (C=C) groups were assigned by the absorption bands at 1545, 1734, 
3419 and 1580 cm
-1
respectively. The UV absorbances at λmax (log ε) 256 nm 
(2.71) were assigned to be a chromophore with carbonyl groups and olefinic 
system.  
Table 5.10. NMR spectroscopic data of methyl-3-(26-phenylacetyloxy)-icosahydro-19-hydroxy-
4,4,20-trimethylpicene-23-carboxylate (7) isolated from Crassostrea madrasensis 
  Compound 7  
 
Position 
No. 
13CNMR 
δ1H NMR (int., 
mult., J in Hz)b 
1H-1H COSY 
HMBC 
(1H-13C) 
1 19.19 1-H 1.44(m,2H) 2-H 
2 30.58 2-H 1.71(m,2H) 3-H 
O
O
O
O
OH
1
4
9
13 17
20
24
2527
29
33
34
35
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3 65.56 3-H 4.29(t,1H) - 
4 34.06 - - - 
5 30.2 5-H 1.62(q,1H) 6-H 
6 28.96 6-H 1.31(m,2H) 7-H 
7 24.87 7-H 1.15(m,2H) 8-H 
8 29.7 8-H 1.28(t,1H) 14-H,9-H 
9 33.82 9-H 1.36 (m,1H) 11-H 
10 32.71 10-H 2.04 (m,1H) 1-H 
11 128.84 11-H 5.80(m,1H) 12-H 
12 114.05 12-H 4.96(m,1H) 13-H 
13 31.44 13-H 1.96(m,1H) 14-H 
14 38.88 14-H 1.06(m,1H) 15-H 
15 25.93 15-H 1.85(m,2H) - 
16 33.75 16-H 2.02(m,2H) 17-H,15-H 
17 38.88 17-H 1.12(m,1H) - 
18 43.39 18-H 1.61(m,1H) 13-H 
19 64.8 19-H 4.12(m,1H) 18-H 
 - - (OH-5.32) - 
20 56.14 - - - 
21 30.56 21-H 1.62(m,2H) 22-H 
22 29.51 22-H 1.33(m,2H) 17-H 
23 172.97 - - - 
24 51.44 24-H 3.65(s,3H)  
25 167.7 - - - 
26 49.57 26-H 2.17(s,3H) - 
27 139.27 - - - 
28 132.52 28-H 7.56 – 7.51 (m, 1H) 29-H 
29 130.89 29-H 7.65 – 7.75 (m, 1H) - 
30 124.05 30-H 7.65 – 7.75 (m, 1H) - 
31 130.29 31-H 7.65 – 7.75 (m, 1H) 32-H 
32 132.53 32-H 7.56 – 7.51 (m, 1H) 31-H 
33 14.11 33-H 0.97(s,3H) - 
34 13.72 34-H 0.87(s,3H) - 
35 22.69 35-H 0.84(s,3H) - 
a NMR spectra were recorded using Bruker AVANCE III 500 MHz (AV 500) spectrometers. 
b Values in ppm, multiplicity and coupling constants (J¼ Hz) were indicated as parentheses. The 
assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY experiments. 
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The mass spectrum exhibited a molecular ion peak at m/z548 
(HRESIMS m/z 549.7785(M+H) amu), which in combination with 
1
H and 
13
C 
NMR data (Table 5.10) assigned the molecular formula as C35H64O5with 12 
degrees of unsaturation. Six degrees of unsaturation were from double bonds 
and the remaining six degrees of unsaturation were due to a cyclic ring system, 
from which one was of aromatic type.  
The 1D (
13
C and DEPT) NMR data demonstrated the presence of nine 
methylenes, seventeen methines and five quaternary carbons. Highly deshielded 
olefinic signals were apparent at δ 128.8 (C-11) and 114.0 (C-12), which were 
correlated to δ 5.80 (H-11) and 4.96 (H-12), respectively indicating the presence 
of isolated double bond in the compound. The position of the double bond was 
confirmed by the long-range C-H correlation from δ 5.80 (H-11) to δ 31.4 (C-13) 
and 114.0 (C-12) along with δ 4.96 (H-12) to δ 31.4 (C-13) and 43.3 (C-18). The 
relatively downfield shift of methine proton at δ 4.29 (H-3) exhibited HSQC 
correlations with δ 65.5 (C-3), which referred to a possible electronegative atom 
in its locality and was the characteristic junction point of the cyclic moiety with 
the ester linked side chain. The occurrence of three singlets at δ 0.97, 0.87 and 
0.84 corresponded to the 
13C signals at δ 14.1, 13.7 and 22.6, respectively 
indicating that the methyl groups were positioned at C-33, C-34 and C-35, 
respectively. The presence of hydroxyl at C-19 {-CH(OH)} and the long range C-
H correlation between δH 4.12/δC 64.8 was deduced from the HMBCs between δ 
4.12 (H-19) to δ 172.9 (C-23). The 1H-1H COSY correlations established the 
occurrence of four spin systems, which were due to the signals at δ 1.44 (assigned 
to H-1)/1.71 (H-2)/4.29 (H-3) in ring A, δ 1.62 (H-5)/1.31 (H-6)/1.15 (H-7)/1.28 
(H-8)/1.36 (H-9)/2.04 (H-10) along with δ 1.36 (H-9)/5.80 (H-11)/4.96 (H-
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12)/1.96 (H-13)/1.06 (H-14)/1.85 (H-15)/2.02 (H-16)/1.12 (H-17)/1.33 (H-
22)/1.62 (H-21) and δ 1.28 (H-8)/1.06 (H-14), which were found to correspond to 
the B/C/D/E rings (tetracyclic moiety), whereas that at δ 7.55 (H-28)/7.70 (H-29) 
were assigned to the aromatic ring system. The HMBC correlations deduced an 
acetate group {-C(O)O-(CH3)} at C-20 from the cross-peaks between δ 3.65 (H-
24) to δ 172.9 (C-23) and δ 1.62 (H-21) to δ 172.9 (C-23). The HMBC 
correlations from δ 4.29 (H-3) to δ 34.0 (C-4); δ 2.02 (H-16) to δ 29.5 (C-22); δ 
1.36 (H-9) to δ 128.8 (C-11) and δ 1.28 (H-8) to δ 38.8 (C-14) further 
corroborated the presence of the picene-23-carboxylate framework in 7. The 
aromatic signals in the region δH 7.56-7.75 with an integral value of five 
demonstrated the presence of mono-substituted aromatic ring and the deshielded 
quaternary carbon at δ 139.2 suggested the side chain remained attached to the 
picene framework. The 
13
C NMR peaks at δ 139.2 (C-27), 132.5 (C-28), 130.8 
(C-29), 124.0 (C-30), 130.2 (C-31), 132.5 (C-32) along with the HSQC and 
HMBC spectroscopic data deduced the 2-phenylacetate group attached to the C-3 
carbon of icosahydropicenecarboxylate moiety. The attachment of 2-phenyl 
acetate with C-3 was confirmed by the HMBC correlation of δ 4.29 (H-3) with δ 
167.7 (C-25). The relative stereochemistry of the chiral centres, particularly those 
of δ 4.29 (C-3) and δ 4.12 (C-19) was deduced by the NOESY correlation 
indicating that these two were oriented towards the same plane and was arbitrarily 
considered as α-disposed. The protons at H-5, H-9, H-14 and H-18 exhibited 
NOESY correlations with each other and considered to be aligned towards the β-
side of the molecule, being opposite to the α-protons. 
The compound 7 formed an sodium  adduct peak at m/z 571.3 
(C35H48O5Na•
+
) which appeared to undergo elimination of C9H10O2(m/z:150.07) 
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to yield a peak at m/z 414.3 (C27H42O3•
+
).The latter appeared to undego molecular 
fragmentatation to afford the fragments with m/z 74.04 (C3H6O2•+)assigned to 
be as methylacetate, and icosahydro-trimethylpicenol with the m/zof 356.3. 
 
Fig 5.10.A.
1
HNMR spectrum of methyl-3-(26-phenylacetyloxy)-icosahydro-19-hydroxy-4,4,20-
trimethylpicene-23-carboxylate (7) 
 
Fig 5.10.B. 
13
C NMR spectrum of methyl-3-(26-phenylacetyloxy)-icosahydro-19-hydroxy-4,4,20-
trimethylpicene-23-carboxylate (7) 
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Fig 5.10.C. HMBC spectrum of methyl-3-(26-phenylacetyloxy)-icosahydro-19-hydroxy-4,4,20-
trimethylpicene-23-carboxylate (7) 
 
Fig 5.10.D. HSQC spectrum of methyl-3-(26-phenylacetyloxy)-icosahydro-19-hydroxy-4,4,20-
trimethylpicene-23-carboxylate (7) 
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Fig 5.10.E. 
1
H–1H COSY spectrum of methyl-3-(26-phenylacetyloxy)-icosahydro-19-hydroxy-4,4,20-
trimethylpicene-23-carboxylate (7) 
 
Fig 5.10.F.  Mass spectra of methyl-3-(26-phenylacetyloxy)-icosahydro-19-hydroxy-4,4,20-
trimethylpicene-23-carboxylate (7). 
5.2.2.1.B Chromatographic purification and spectral analyses of methyl-3-(26-
phenylacetyloxy)-icosahydro-1,19-dihydroxy-4,4,20-trimethylpicene-23-
carboxylate( 8) 
Methyl-3-(26-phenylacetyloxy)-icosahydro-1,19-dihydroxy-4,4,20-
trimethylpicene-23-carboxylate,  a new picene derivative was isolated as white 
powder upon repeated chromatography over silica columns/TLC. The olefinic 
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(C=C) and (C=O stretch) groups were depicted by the absorption bands at 1642 
and 1736.96 cm
-1 
respectively. The UV absorbances at λmax (log ε) 252nm (3.61) 
was assigned to be a chromophore with carbonyl groups and olefinic system. Its 
mass spectrum exhibited a molecular ion peak at m/z580.7732(HRESIMS m/z 
580.7732 [M+1] amu), which in combination with its 
1
H and 
13
C NMR data 
(Table 5.11) indicated the molecular formula as C36H52O6 with twelve degrees of 
unsaturation. Three degree of unsaturation was from the double bonds, five 
degrees of unsaturation were due to a cyclic ring system, which was not of 
aromatic type and the remaining four degrees of unsaturation was due to aromatic 
ring system.  
Table5.11. NMR spectroscopic data of methyl-3-(26-phenylacetyloxy)-icosahydro-1,19-
dihydroxy-4,4,20-trimethylpicene-23-carboxylate (8) isolated from 
Crassostreamadrasensis 
 
 Compound 8 
 
Position 
No. 
13CNMR 
δ1H NMR (int., 
mult., J in Hz)b 
1H-1H COSY 
HMBC 
(1H-13C) 
1 71.8 1-H 4.08(dd,1H) 10-H 
2 30.58 2-H 1.71(m,2H) 3-H 
3 65.57 3-H 4.29(t,1H) - 
4 34.06 - - - 
5 30.2 5-H 1.62(q,1H) 6-H 
6 28.96 6-H 1.31(m,2H) 7-H 
7 24.87 7-H 1.15(m,2H) 8-H 
8 29.7 8-H 1.28(t,1H) 14-H,9-H 
9 33.83 9-H 1.36 (m,1H) 11-H 
10 32.71 10-H 2.04 (m,1H) 1-H 
11 128.84 11-H 5.80(m,1H) 12-H 
12 114.06 12-H 4.96(m,1H) 13-H 
13 31.44 13-H 1.96(m,1H) 14-H 
14 38.88 14-H 1.06(m,1H) 15-H 
15 25.93 15-H 1.85(m,2H) - 
16 33.75 16-H 2.02(m,2H) 17-H,15-H 
17 38.88 17-H 1.12(m,1H) - 
18 43.39 18-H 1.61(m,1H) 13-H 
O
O
O
O
OH
OH
1
4
9
13 17
20
24
2527
29
33
35
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19 64.8 19-H 4.12(m,1H) (OH-5.32) 18-H 
 56.14 - - - 
20 30.56 21-H 1.62(m,2H) 22-H 
21 29.51 22-H 1.33(m,2H) 17-H 
22 173.2 - - - 
23 51.44 24-H 3.65(s,3H) - 
24 167.67 - - - 
25 49.57 26-H 2.17(s,3H) - 
26 139.28 - - - 
27 132.38 28-H 7.56 – 7.51 (m, 1H) 29-H 
28 130.9 29-H 7.65 – 7.75 (m, 1H) - 
29 124.05 30-H 7.65 – 7.75 (m, 1H) - 
30 130.29 31-H 7.65 – 7.75 (m, 1H) 32-H 
31 132.53 32-H 7.56 – 7.51 (m, 1H) 31-H 
32 14.11 33-H 0.97(s,3H) - 
33 13.72 34-H 0.87(s,3H) - 
34 22.69 35-H 0.84(s,3H) - 
a
 NMR spectra were recorded using Bruker AVANCE III 500 MHz (AV 500) spectrometers. 
b 
Values in ppm, multiplicity and coupling constants (J¼ Hz) were indicated in parentheses. 
The assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY 
experiments. 
Compound 8 showed close structural similarity with 7 except the 
appearance of additional hydroxyl group at C-1 position in 8. The new 
dihydroxypicene derivative, methyl-3-(26-phenylacetyloxy)-icosahydro-1,19-
dihydroxy-4,4,20-trimethylpicene-23-carboxylate (2)was isolated as white 
solid on repetitive chromatographic purification. The olefinic and carbonyl 
groups were symbolized by the IR bonds at 1642 and 1737 cm
-1
,respectively. 
The relatively downfield shift of the methine proton at δ 4.30 (H-3) and 4.14 
(H-19) referred to the possible oxygenation in its vicinity. An extra proton 
peak at δ 4.08 was found to be attached with δ 71.8 (C-1), and these 
attributions were supported by 
1
H-
1
H COSY and HMBC correlations, such as 
δ4.08 (H-1)/2.06 (H-10) and δ 4.08 (H-1) to δ 32.7 (C-10), respectively. The 
1
H-
1
H COSY correlations between δ4.08 (H-1)/1.72 (H-2)/4.30 (H-3); δ1.63 
(H-5)/1.30 (H-6)/1.17 (H-7)/1.29 (H-8)/1.37 (H-9); δ 1.37 (H-9)/5.82 (H-
11)/4.98 (H-12)/1.99 (H-13)/1.04 (H-14)/1.89 (H-15)/2.05 (H-16)/1.11 (H-
17)/1.34 (H-22)/1.63 (H-21)and δ 1.63 (H-18)/4.14 (H-19) supported the 
presence of the pentacyclic ring in 2. As discussed in the previously described 
compound 1, the appearance of aromatic peaks along with a singlet methylene 
(-CH2) at δH 2.18/δC 49.57 (C-26position) in the 
1
H and 
13
C NMR spectra 
confirmed the occurrence of 2-phenylacetate moiety. This attributions were 
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validated by the HMBCs from δ 2.18 (H-26) to δ 139.2 (C-27) and 132.3 (C-
28). The methine proton at δ 4.30 (H-3) were showed NOE cross-peak with δ 
4.14 (H-19), which indicated that these were in same plane of symmetry 
(arbitrarily defined as α-disposed). The methine proton at H-3 did not exhibit 
NOE interactions with δ 4.08 (H-1), thereby indicating that these groups were 
disposed at the opposite direction of the plane and considered as β-oriented. 
The molecular ion peak at m/z 564.2 (C35H48O5 •+) appeared to undergo 
elimination of C2H2O2 yielded trimethylpicene-2-carboxylate derivative at m/z 
506.3 (C33H46O4•+).The daughter ion again undergo elimination of phenylacetate 
(C8H7O2, m/z: 135.04) to yield another daughter ion at m/z 430.3 (C27H44O4•+). 
 
Fig 5.11.A.  
1
HNMR spectrum of methyl-3-(26-phenylacetyloxy)-icosahydro-1,19-dihydroxy-4,4,20-
trimethylpicene-23-carboxylate (8). 
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Fig 5.11.B. 
13
C NMR spectrum of methyl-3-(26-phenylacetyloxy)-icosahydro-1,19-dihydroxy-4,4,20-
trimethylpicene-23-carboxylate (8). 
 
 
Fig 5.11.C. 
1
H–1H COSYspectrum of methyl-3-(26-phenylacetyloxy)-icosahydro-1,19-dihydroxy-
4,4,20-trimethylpicene-23-carboxylate (8). 
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Fig 5.11.D.  HMBC spectrum of methyl-3-(26-phenylacetyloxy)-icosahydro-1,19-dihydroxy-
4,4,20-trimethylpicene-23-carboxylate (8). 
 
Fig 5.11.E.  HSQC spectrum of methyl-3-(26-phenylacetyloxy)-icosahydro-1,19-dihydroxy-4,4,20-
trimethylpicene-23-carboxylate (8). 
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Fig 5.11.F.  DEPT spectrum of methyl-3-(26-phenylacetyloxy)-icosahydro-1,19-dihydroxy-4,4,20-
trimethylpicene-23-carboxylate (8). 
 
Fig 5.11.G.  Mass spectrum of methyl-3-(26-phenylacetyloxy)-icosahydro-1,19-dihydroxy-4,4,20-
trimethylpicene-23-carboxylate 8). 
5.2.2.2 Conclusion  
Currently, reactive oxygen species and lipid oxidation in food industry are 
being controlled or minimized by the addition of synthetic antioxidants. The 
ethylacetate:methanol extract of Crassostrea madrasensis was fractionated 
chromatographically to yield methyl-3-(26-phenylacetyloxy)-icosahydro-19-hydroxy-
4,4,20-trimethylpicene-23-carboxylate (7) and methyl-3-(26-phenylacetyloxy)-icosahydro-
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1,19-dihydroxy-4,4,20-trimethylpicene-23-carboxylate (8). The structures of the 
compounds, as well as their relative stereo chemistries, were established by means 
of spectral data analyses, including 2D-NMR experiments. Among the 
compounds isolated from Crassostrea madrasensis, compound 7 showed 
maximum DPPH radical-scavenging ability (72.5 percent) than 8. No significant 
differences in the ABTS
.+
 radical-scavenging activity, COX-2 and 5-LOX 
inhibition activities were observed for 7 and 8.The effective antioxidant property 
of these compounds indicated that they have potential as natural antioxidant lead 
molecules in the food industry. The knowledge on the structural features 
responsible for antioxidative bioactivities will guide us to synthesize the 
molecules in commercial scale for use as new generation antioxidant leads 
5.2.3. Secondary metabolites from O. dolffusi 
The yield, Rf and antioxidant activities of each column/P-TLC fractions and 
anti-inflammatory activities of the selected fractions were given in Table 5.12. 
Table 5.12. Yield, Rf and antioxidant activities of each column/P-TLC fractions and anti-
inflammatory activities of the selected fractions of O.dolffusi 
 Yield (mg) Rf 
DPPH radical ABTS radical COX-2 LOX-5 
scavenging scavenging inhibition inhibition 
activity (%) activity (%) activity (%) activity (%) 
OCT EXT 5000      
OCT CC (EA/HX) 
OF-1   (2% EtOAc/HX) 101 0.23 35.43±0.22 21.36±0.31 48.41±0.01 46.40±0.76 
OF-2   (5% EtOAc/HX) 97 0.36 54.88±0.14 20.28±0.28 47.39±0.00 46.55±0.57 
OF-3  (10% EtOAc/HX) 92 0.45 44.39±0.36 14.73±0.17 36.29±0.01 35.30±0.23 
OF-4  (15% EtOAc/HX) 456 0.56 39.42±0.18 15.79±0.25 38.14±0.01 29.21±0.46 
OF-5  (20% EtOAc/HX) 922 0.61 53.68±0.08 22.34±0.13 46.29±0.01 45.05±0.39 
OF-6  (25% EtOAc/HX) 84 0.67 52.13±0.22 23.42±0.01 47.18±0.00 45.17±0.65 
OF-7  (35% EtOAc/HX) 176 0.73 44.84±0.14 17.63±0.20 23.12±0.00 20.09±0.27 
OF-8  (50% EtOAc/HX) 906 0.81 56.66±0.32 25.81±0.13 45.58±0.00 44.67±0.47 
OF-9  (75% EtOAc/HX) 337 0.85 25.72±0.62 8.577±0.18 40.66±0.00 37.57±0.73 
OF-10         (100 %HX) 56 0.91 43.11±0.12 12.11±0.25 36.38±0.01 38.20±0.54 
OF-5 (EA/HX) 
OF-11 (0.5%EtOAc/HX) 71 0.25 35.56±0.14 11.68±0.23 NA NA 
OF-12    (1%EtOAc/HX) 55 0.37 55.34±0.19 25.54±0.17 NA NA 
OF-13 (1.5%EtOAc/HX) 289 0.54 64.52±0.32 26.75±0.28 48.16±0.00 46.56±0.09 
OF-14    (2%EtOAc/HX) 92 0.68 39.42±0.15 11.04±0.14 NA NA 
OF-15    (3%EtOAc/HX) 26 0.72 41.46±0.09 17.90±0.24 NA NA 
OF-16    (4%EtOAc/HX) 49 0.86 46.88±0.21 22.73±0.36 NA NA 
OF-16    (5%EtOAc/HX) 250 1.86 46.88±0.22 22.73±0.37 NA NA 
OF-8 (EA/HX) 
OF-17   (2 %EtOAc/HX) 48 0.24 56.66±0.05 30.81±0.27 NA NA 
OF-18   (5 %EtOAc/HX) 35 0.35 53.84±0.01 31.67±0.18 NA NA 
OF-19 (10 %EtOAc/HX) 49 0.39 52.19±0.10 26.17±0.16 NA NA 
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OF-20 (12 %EtOAc/HX) 27 0.48 64.48±0.09 25.11±0.22 NA NA 
OF-21 (15 %EtOAc/HX) 244 0.55 58.58±0.02 27.81±0.26 48.24±0.05 47.56±0.01 
OF-22 (20 %EtOAc/HX) 44 0.67 35.24±0.13 11.54±0.14 NA NA 
OF-23 (25 %EtOAc/HX) 168 0.73 56.42±0.42 26.45±0.11 NA NA 
OF-24 (30 %EtOAc/HX) 45 0.84 54.54±0.22 27.46±0.19 NA NA 
OF-25 (50 %EtOAc/HX) 38 0.92 35.24±0.15 14.25±0.57 NA NA 
OF-26 (70 %EtOAc/HX) 54 0.24 58.34±0.01 28.71±0.11 NA NA 
OF-13 (P TLC 10% EA/HX) 
OF-27 36 0.24 61.85±0.25 25.67±0.28 NA NA 
OF-28 61 0.37 65.32±0.41 26.48±0.35 NA NA 
OF-29 55 0.42 70.95±0.13 31.33±0.28 52.32±0.03 50.45±0.26 
OF-30 32 0.55 60.15±0.16 22.24±0.27 NA NA 
OF-31 47 0.68 58.55±0.21 21.09±0.15 NA NA 
OF-32 25 0.79 67.49±0.09 27.22±0.23 NA NA 
OF-21 (P TLC 10% MeOH/CHCl3) 
OF-31 54 0.24 68.34±0.01 28.71±0.11 NA NA 
OF-32 45 0.35 69.13±0.29 31.43±0.39 NA NA 
OF-33 61 0.47 58.29±0.00 24.92±0.10 NA NA 
OF-34 35 0.54 71.05±0.10 33.81±0.05 54.26±0.05 52.64±0.06 
OF-35 29 0.69 72.21±0.01 30.54±0.22 NA NA 
DPPH and ABTS radical scavenging activities at 0.1 mg/mL was 
expressed in percent;COX-2 inhibitory activity at 0.1 mg/mL was expressed in 
percent; LOX-5 inhibitory activity at 0.05 mg/mL was expressed in percent; 
NA – not assayed,ie, the fractions with low yield were evaluated only for 
DPPH and ABTS radical scavenging activity. CC – column chromatography; 
P TLC -preparative thin layer chromatography; MeOH - methanol; EtOAc - 
ethyl acetate; HX - n-hexane; CHCl3- chloroform; OCT- EtOAc-MeOH 
fraction of O.dolffusi. 
5.2.3.1 Chromatographic purification and spectral analyses of secondary 
metabolites from O.dolffusi 
Chromatographic separation led to the isolation of two new derivatives. 
The molecular structures of the purified compounds were proposed on the 
basis of comprehensive analysis of the 
1
H NMR, 
13
C NMR, including 2D-
NMR experiments (
1
H–1H–COSY, HMQC, HMBC, and NOESY), and mass 
spectra. 
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5.2.3.1.A Chromatographic purification and spectral analyses of cholesta-5-en-3-yl-
(32-methyl-(30-((E)-34-amino-36-ethyl-39-oxohept-36-enyl)-
pentanedioate (9). 
The compound 9 is cholesta-5-en-3β-yl-(32-methyl-(30-((E)-34-amino-
36-ethyl-39-oxohept-36-enyl)-pentanedioate, new phenanthere derivative was 
isolated as light yellow solid upon repeated chromatography over silica 
columns/TLC. The olefinic (C=C) and ether (C-O-C) groups were assigned by 
the absorption bands at 1642 and 1068 cm
-1 
respectively. The UV absorbances 
at λmax (log ε) 252nm (3.61) were assigned to be a chromophore with carbonyl 
groups and olefinic system. The mass spectrum exhibited a molecular ion peak 
at m/z667 (HRESIMS m/z 668.0425 [M+1] amu), which in combination with 
1
H and 
13
C NMR data (Table 5.11) assigned the molecular formula as 
C42H69NO5with 9 degrees of unsaturation. Five degrees of unsaturation were 
from the double bonds and the remaining four degrees of unsaturation were 
due to cyclic ring systems, which was not of aromatic type.  
Table 5.13  NMR spectroscopic data of cholesta-5-en-3β-yl-(32-methyl-(30-((E)-34-amino-36-ethyl-
39-oxohept-36-enyl)-pentanedioate (9) isolated from Octopus dollffusi. 
  Compound 9 
 
Position 13CNMR δ1H NMR (int., mult., J in Hz)b 1H-1H COSY HMBC(1H-13C) 
1 37.01 1-H 1.30(m,2H) 2-H 
2 31.87 2-H 1.98(m,2H) - 
3 73.69 3-H 4.52(m,1H) 1-H,2-H,4-H 
4 42.31 4-H 2.30(m,2H) - 
O
OO
O
O
NH
2
3
9
11
14
17
18
23
26
27
28
31
34
40
39
41
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5 139.7 - - - 
6 122.57 6-H 5.35(dd,1H) 7-H 
7 31.92 7-H 2.28(m,2H) 8-H 
8 31.79 8-H 1.98(t,1H) 14-H 
9 50.03 9-H 0.95(m,1H) 11-H 
10 36.19 - - - 
11 21.03 11-H 1.49(m,2H) 12-H 
12 39.74 12-H 1.26 (t,2H) 11-H 
13 42.31 - - - 
14 56.14 14-H 1.03(m,1H) 8-H 
15 24.28 15-H 1.58(m,2H) 16-H 
16 28.23 16-H 1.86(m,2H) 17-H,15-H 
17 56.14 17-H 0.99(m,1H) 18-H 
18 35.79 18-H 1.27(m,1H) 19-H 
19 18.73 19-H 0.98 20-H 
20 36.19 20-H 1.83(m,2H) - 
21 23.83 21-H 1.80(m,2H 22-H 
22 39.52 22-H 1.85(m,2H 23-H 
23 28.01 23-H 0.90 (m,1H) 25-H,24-H 
24 22.82 24-H 1.99(m,3H) 23-H 
25 22.69 25-H 1.92(m,3H) 23-H 
26 11.85 26-H 0.70(s,3H) - 
27 19.32 27-H 1.02(s,3H) - 
28 173.35 - - - 
29 34.59 29-H 2.34(d,2H) 33-H 
30 29.36 30-H 2.04(m,1H) 29-H 
31 34.73 31-H 2.23(dd,2H) - 
32 174.36 - - - 
33 51.42 33-H 3.59(s,3H)  
34 24.96 34-H 1.06(m,1H) 35-Hb 
35 39.76 35-Ha, 1.78(dd,1H) - 
  35-Hb 1.93(dd,1H) - 
36 155.38 - - - 
37 129.91 37-H 5.27(td,1H) 38-H 
38 29.65 38-H 2.73(d,2H) 37-H 
39 195.37 - -  
40 34.59 40-H 2.23(s,3H)  
41 38.09 41-H 2.21(m,2H) 42-H 
42 14.11 42-H 1.54(t,3H) - 
a 
NMR spectra were recorded using Bruker AVANCE III 500 MHz (AV 500) spectrometers. 
b 
Values in ppm, multiplicity and coupling constants (J¼ Hz) were indicated in parentheses. The 
assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY experiments. 
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The molecular ion peak appeared at m/z667.5, which undergoes 
elimination of the methyl groups  to afford a daughter ion  with m/z 625.5 
(C39H63NO5
+
).The latter appeared to undergo molecular fragmentation to 
afford the fragment with m/z583.4(C36H57NO5).The multiple electronegative 
centres of the compound and electron delocalization served as the potential 
electronegative centres of the compound resulting in higher antioxidative and 
anti-inflammatory potential. 
 The olefinic and ether groups were assigned due to the FTIR absorption 
bands at 1642 and 1068 cm
-1
, respectively. The mass spectral data displayed 
the molecular ion peak at m/z 667 (HRESIMS m/z: found 
forC42H69NO5667.5180 [(M)
+
], cal. 667.5176), with 9 degree of unsaturations. 
Five degrees of unsaturations were attributed to the double bonds and the 
remaining four were due to the tetracyclic rings.  
 The 
13
C along with DEPT NMR data revealed the occurrence of sixteen 
methylenes, eleven methines, eight methanes and seven quaternary positions 
in the molecule. The characteristic olefinic signals were observed at δ 
139.7/122.5 in the sterol framework (C5=C6) and δ 155.3/129.9 in the side 
chain (C36=C37) at C-3. Highly deshielded proton signals at δ 5.35 (H-3) and 
5.27 (H-33) were found to correspond to alkenes, whereas δ 4.52 and 3.59 
were represented by the carboxylate end of methylene and methyl groups 
positioned at C-3 and C-33, respectively.  
 The 
1H NMR spectrum displayed five methyls at δ 0.70 (s), 1.02 (s), 
0.98 (m), 0.81 (d) and 0.83 (d), which were connected to the carbons at δ 11.8 
(C-18), 19.3 (C-19), 18.7 (C-21), 22.8 (C-26) and 22.6 (C-27), respectively 
based on the HSQC experiments. These groups were characteristic groups of 
the sterol framework. The chemical shift value at δ 4.52 (H-3) exhibiting 
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HSQC correlation with δ 73.6 (C-3) was found to be higher than the usual 
>CH-OH shift of δ 3.50. This validated that C-3 was directly attached to the 
oxygen atom of highly electronegative group like carboxylate.  
 The 
1
H-
1
H COSY experiment exhibited five spin systems in the sterol 
moiety, and were δ 1.30 (assigned to H-1)/1.98 (H-2)/4.52 (H-3)/2.30 (H-4); δ 
5.35 (H-6)/2.28 (H-7)/1.98 (H-8)/0.95 (H-9)/1.49 (H-11)/1.26 (H-12) along 
with δ 1.98 (H-8)/1.03 (H-14); δ 1.58 (H-15)/1.86 (H-16)/0.99 (H-17)/1.27 (H-
20)/0.98 (H-21); δ 1.83 (H-22)/1.80 (H-23)/1.85 (H-24) and δ 1.99 (H-
25)/0.81 (H-26)/0.83 (H-27), which established the basic C-27 sterol skeleton. 
The HMBC correlations between δ 1.98 (H-2) to δ 37.8 (C-1), 73.6 (C-3); δ 
2.30 (H-4) to δ 37.0 (C-1), 31.8 (C-2), 73.6 (C-3), 139.7 (C-5), 122.5 (C-6); δ 
1.49 (H-11) to δ 139.7 (C-5), 50.0 (C-9), 39.7 (C-12) and δ 1.26 (H-12) to δ 
50.0 (C-9), 42.3 (C-13) further corroborated the occurrence of sterol skeleton. 
The deshielded peak at δ 4.52 (H-3) was found to be the junction point of the 
side chain, 30-(34-amino-36-ethyl-39-oxohept-36-enyl)-pentanedioate.  
 Three spin system were found in the side chain, δ 1.78, 1.93 (H-35)/1.06 
(H-34)/2.04 (H-30)/2.23 (H-31), 2.34 (H-29); δ 5.27 (H-37)/2.73 (H-38) and δ 
2.21 (H-41)/1.54 (H-42) .The 
13C peaks at δ 173.3 (C-28) and 174.3 (C-32) 
represented ester carbonyl and the peak at δ 195.3 (C-39) was related to 
carbonyl moiety in the side chain. The long range C-H couplings from δ 2.34 
(H-29) to δ 34.7 (C-31), 51.4 (C-33); δ 2.04 (H-30) to δ 174.3 (C-32); δ 2.23 
(H-31) to δ 155.3 (C-6), 39.7 (C-35); δ 5.27 (H-34) to δ 195.3 (C-39) and δ 
2.21 (H-41) to δ 155.3 (C-36), 39.7 (C-35), 24.9 (C-34) attributed to the side 
chain fragment. The proton at δ 4.52 (H-3) displaying J1,3=4.1 indicated that 
the proton was situated in the axial position thereby indicating that the C-3 
attached carbonyl was at the equatorial position.  
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 The spatial correlations at the chiral centers, δ 4.52 (H-3) and δ 2.04 (H-
30) were showed NOE correlation, which implied that they were in the same 
plane and considered as α-protons. The methine proton at C-3 group did not 
show NOE signal with H-18 and H-19, which indicated that these were 
situated at the opposite plane and β-oriented. There was no NOESY 
correlation was found between δ 5.27 (H-37) and δ 2.73 (H-38), 2.21 (H-41). 
However, NOESY relation was apparent among δ 2.73 (H-38) and δ 2.73 (H-
38) which suggested the trans (E) orientation of trisubstituted alkene 
>C(36)=C(37) in the side chain of 3. 
 
Fig 5.12.A.
1
H NMR spectrum of cholesta-5-en-3β-yl-(32-methyl-(30-((E)-34-amino-36-ethyl-39-
oxohept-36-enyl)-pentanedioate (9). 
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Fig 5.12.B. 
13
C NMR spectrum of cholesta-5-en-3β-yl-(32-methyl-(30-((E)-34-amino-36-ethyl-39-
oxohept-36-enyl)-pentanedioate (9). 
 
Fig 5.12.C.  DEPT NMR spectrum of cholesta-5-en-3β-yl-(32-methyl-(30-((E)-34-amino-36-ethyl-
39-oxohept-36-enyl)-pentanedioate (9). 
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Fig  5.12.D.  
1
H–1H COSYspectrum of cholesta-5-en-3β-yl-(32-methyl-(30-((E)-34-amino-36-
ethyl-39-oxohept-36-enyl)-pentanedioate (9). 
 
 
Fig 5.12.E. HSQC spectrum cholesta-5-en-3β-yl-(32-methyl-(30-((E)-34-amino-36-ethyl-39-
oxohept-36-enyl)-pentanedioate (9). 
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Fig 5.12.F. HMBC spectrum cholesta-5-en-3β-yl-(32-methyl-(30-((E)-34-amino-36-ethyl-39-
oxohept-36-enyl)-pentanedioate (9). 
 
Fig 5.12.G  Mass spectrum of cholesta-5-en-3β-yl-(32-methyl-(30-((E)-34-amino-36-ethyl-39-
oxohept-36-enyl)-pentanedioate (9). 
5.2.3.1.B Chromatographic purification and spectral analyses of 7-ethyl-9-vinyl-
octahydroazuleno[1,8-bc]pyran-3,12-dione (10) 
The compound 7-ethyl-9-vinyl-octahydroazuleno[1,8-bc]pyran-3,12-
dione (9), a new pyranderivative, was isolated as white solid upon 
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repeatedchromatography over silica columns/TLC. The presence of 4-ethyl-6-
vinyl-2,3,6,7,7a,8,9,9a-octahydroazulene and pyran-2,9-dione, groups were 
confirmed by detailed NMR and mass spectroscopic experiments.  
The compound 7-ethyl-9-vinyl-octahydroazuleno[1,8-bc]pyran-3,12-dione 
(10), a new derivative of substituted pyran was isolated as a yellow solid. It 
exhibited 8 degrees of unsaturation which includes five double bonds and three 
cyclic ring system. The 1D (
13
C and DEPT) NMR data demonstrated the presence 
of five each of methylenes, methines and quaternary carbons (Table S2). The 
alkenic signals at δ 5.81 (H-13) and 4.97 (H-14) appeared significantly deshielded 
due to its position at the terminal (-CH=CH2) part of the alkenic side chain, which 
was directly attached to the ring system at C-9. The quaternary carbon appeared at 
δ 148.0 (C-5) was established as the junction point between the pyran ring system 
and octahydroazulene ring. The peaks at δ 148.0 (C-5), 131.3 (C-6), 139.2 (C-7) 
and 122.2 (C-8) indicated the presence of olefinic groups, which deduced the 
presence of tricyclic skeleton by the HMBC experiments. The 
13C signals at δ 
196.4 (C-3) and 173.0 (C-12) were found to correspond to ketone group in the 
cyclopentanone ring and ester carbon of pyranone ring, respectively. The proton δ 
1.46 (H-1) showed HMBC correlations with δ 28.9 (C-2) and 22.6 (C-10). 
Likewise, the proton δ 3.69 (H-4) afforded HMBC relation with δ 148.0 (C-5) and 
196.4 (C-3), which indicated that the pyran ring was attached to the substituted 
azulene ring in the compound. The 
1
H-
1
H COSY exhibited two spin systems, 
which were due to δ 2.01 (assigned to H-2)/1.46 (H-1)/1.38 (H-10)/2.04 (H-
9)/5.37 (H-8) along with δ 2.04 (H-9)/5.81 (H-13)/4.97 (H-14) corresponding to 
the octahydro azuleno ring attached to vinyl moiety at C-9 and δ 1.29 (H-15)/0.87 
(H-16) for terminal ethyl side chain at C-7. The structure and its side chain 
attachments were further corroborated by HMBC correlations. The long range 
couplings from δ 3.69 (H-4) to δ 148.0 (C-5), 196.4 (C-3); δ 5.37 (H-8) to δ 139.2 
(C-7); δ 2.04 (H-9) to δ 137.0 (C-13), 114.0 (C-14); δ 2.33 (H-11) to δ 173.0 (C-
12), 131.3 (C-6); δ 4.94 (H-14) to δ 33.8 (C-9) and δ 1.29 (H-15) to δ 139.2 (C-7) 
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validated the structural attributions of the compound 10. The relative 
sterochemistries at the chiral centres, δ 1.46 (H-1) were exhibited NOESY cross-
peaks with δ 2.04 (H-9), which implied that these were in the same plane and 
denoted as β-protons. Therefore, the vinyl group at C-9 was placed at the opposite 
face of α-protons. The proton at δ 3.69 (H-4) did not show NOE correlation with 
H-1, thereby indicating its α-disposition with reference to the molecular plane of 
symmetry. The olefinic, carbonyl and ether groups were symbolized by the 
absorption bands at 1541, 1736 and 1070 cm
-1
,respectively. The characteristic IR 
absorption spectra at 721 (C-H rocking), 1736 (C-CO-C stretching) and 2923 cm
-1
 
(C-H stretching of alkane) supported the structural attributions of 7-ethyl-9-vinyl-
octahydroazuleno[1,8-bc]pyran-3,12-dione (10). 
The  LCMS spectrum of the compound 10, showed an sodium adduct 
(2M+1) peak at m/z 281.1 (C16H18O3Na •+).The mass spectrum exhibited a 
molecular ion peak at m/z 258.1, which in combination with its 
1
H and 
13
C 
NMR data (Table 5.14) indicated the elemental composition of C16H18O3.The 
molecular ion peak at m/z 258.1 appeared to undergo elimination of C2H2 (m/z 
26) to yield m/z 232.1(C14H16O3.The mass spectrum  of 7-ethyl-9-vinyl-
octahydroazuleno[1,8-bc]pyran-3,12-dione were presented in Fig 5.10. 
Table 5.14. NMR spectroscopic data of and 7-ethyl-9-vinyl-octahydroazuleno[1,8-bc]pyran-3,12-
dione (10) isolated from Octopus dollffusi. 
 Compound 10 
 
Position No. 13C NMR 
δ1H NMR (int., 
mult., J in Hz)b 
1H-1H COSY HMBC(1H-13C) 
1 1 29.62 1-H 1.46(m,1H) 
2 2 28.96 2-H 2.01(d,2H) 
O
O
O
1
3
6
9
11
12
13
14
15
16
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3 3 196.4 - - 
4 4 55.9 4-H 3.69(s,1H) 
5 5 148.08 - - 
6 6 131.3 - - 
7 7 139.28 - - 
8 8 122.28 8-H 5.37(d,1H) 
9 9 33.82 9-H 2.04(m,1H) 
10 10 22.69 10-H 1.38(t,2H) 
11 11 51.23 11-H 2.33(s,2H) 
12 12 173.09 - - 
13 13 137.01 13-H 5.81(m,1H) 
14 14 114.05 14-H 4.97(m,2H) 
15 15 31.93 15-H 1.29(m,2H) 
16 16 14.11 16-H 0.87(t,3H) 
a NMR spectra were recorded using Bruker AVANCE III 500 MHz (AV 500) spectrometers. 
b Values in ppm, multiplicity and coupling constants (J¼ Hz) were indicated in parentheses. 
Assignments were made with the aid of the 1H-1H COSY, HSQC, HMBC and NOESY experiments. 
 
 
Fig 5.13. A. 
1
H NMR spectrum of 7-ethyl-9-vinyl-octahydroazuleno[1,8-bc]pyran-3,12-dione (10). 
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Fig 5.13.B. 
13
C  NMR spectrum of 7-ethyl-9-vinyl-octahydroazuleno[1,8-bc]pyran-3,12-dione (10). 
 
 
 
Fig 5.13.C. DEPT NMR spectrum of 7-ethyl-9-vinyl-octahydroazuleno[1,8-bc]pyran-3,12-dione (10). 
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Fig 5.13.D.  NOE spectrum 7-ethyl-9-vinyl-octahydroazuleno[1,8-bc]pyran-3,12-dione (10). 
 
 
 
Fig 5.13.E. HMBC spectrum of 7-ethyl-9-vinyl-octahydroazuleno[1,8-bc]pyran-3,12-dione (10). 
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Fig 5.13.F.  
1
H–1H COSYof 7-ethyl-9-vinyl-octahydroazuleno[1,8-bc]pyran-3,12-dione (10). 
 
Fig 5.13.G. Mass spectrum of 7-ethyl-9-vinyl-octahydroazuleno[1,8-bc]pyran-3,12-dione (10). 
5.2.3.2 Conclusions 
The  ethyl acetate-methanol extract of Octopus dolffusiyielded two pure 
compounds, namely, cholesta-5-en-3β-yl-(32-methyl-(30-((E)-34-amino-36-
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ethyl-39-oxohept-36-enyl)-pentanedioate (9) and 7-ethyl-9-vinyl-
octahydroazuleno[1,8-bc]pyran-3,12-dione (10). The structures of the 
compounds, as well as their relative stereo chemistries, were established by 
means of spectral data analyses, including 2D-NMR experiments. Both 
compounds (9 and 10) isolated from Octopus dolffusishowed similar effect in 
inhibiting the DPPH and ABTS
.+
radicals. The in vitro anti-inflammatory 
properties with respect to COX-2 and 5-LOX inhibitory activities were also 
found to be similar for 9 and 10. This study established the potential of marine 
derived natural alternatives as potential lead antioxidative molecules to the 
synthetic antioxidants for use in pharmaceutical and food industries. The 
knowledge on the structural features responsible for antioxidative bioactivities 
will guide us to synthesize the molecules in commercial scale for use as new 
generation antioxidant leads. 
The compounds belonging to phenanthrenone and chromene 
derivatives, isolated from the extract of P. viridis, demonstrated higher anti-
inflammatory and antioxidative properties compared to the compounds 
isolated from C. madrasensis and O. dolffusi.The effective antioxidant and 
anti-inflammatory property of these compounds indicated that they have 
potential as natural lead molecules in the food industry. The anti-inflammatory 
potential of these compounds are proved to be comparable to the synthetic 
anti-inflammatory agents, aspirin and indomethacin. It is therefore, the P. 
viridis having anti-inflammatory potential is used for the preparation of an 
anti-inflammatory concentrate, for use as nutraceuticals and/or functional 
foods, and candidates in combating carcinogenesis, oxidative stress-induced 
and inflammatory diseases which can offer solutions to the drawbacks of the 
adverse effects of synthetic painkillers. 
………………… 
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The increasing knowledge regarding the impact of diet on human 
health along with state-of-the-art technologies has led to significant nutritional 
discoveries and product innovations on an unprecedented scale. In particular, 
the naturally occurring bioactive extracts or single compounds thereof, that are 
believed to benefit human health, have spawned an important and dynamic 
new area of research resulting in substantial advances in nutritional 
knowledge. There is also growing awareness that dietary source and form of 
food may affect overall health. Suitably, the role of food as an agent for 
improving health has been recognized, initiating the development of new 
classes of food, known as functional foods. However, proving that these 
naturally occurring bioactive substances have a defined health benefit poses a 
dilemma in nutritional research as investigating preventive activity can be 
difficult when effect is only moderate. This means that the effect of the 
compounds on the human body may be very small over relatively short 
periods, but could contribute significantly to health when they are consumed 
throughout life as part of the daily diet.  
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The marine environment is an untapped source of functional 
ingredients that can be applied to various aspects of food processing, storage, 
and fortification. The marine world, due to its phenomenal biodiversity, is a 
rich natural resource of many biologically active compounds, such as, 
polyunsaturated fatty acids (PUFAs), sterols, proteins, polysaccharides, 
antioxidants and pigments. Marine-derived nutrients and other marine 
bioactive components have great potential as functional food ingredients as 
they possess advantageous physiological effects, with medicinal 
characteristics and added health benefits, such as, anticancer or anti-
inflammatory activities. As reactive oxygen species (ROS) are important 
mediators that initiate and propagate inflammatory responses by stimulating 
release of pro-inflammatory mediators the mechanisms for nutritional defense 
and disease prevention includes ROS scavenging, reduction of peroxides and 
repair of peroxidized biological membranes. Marine-derived bioactive food 
ingredients can be derived from a vast array of sources, and several marine 
invertebrates based bioactive compounds interfere with the pathogenesis of 
diseases. Among the marine invertebrates, the mollusks are  potential sources 
of bioactive substances. Therefore, to facilitate the nutritional defense and 
disease prevention the chapter describes suitability of marine-derived 
bioactive compounds as functional food ingredients for the prevention and 
treatment of chronic diseases. The chapter is divided into four sections. 
6A) Preparation of potential anti-inflammatory combination stabilized 
with natural anti-oxidants from P. viridis. 
6B) Enrichment of the potential anti-inflammatory combination by anti-
inflammatory principles isolated from P. viridis 
6C) Response of pro-inflammatory prostaglandin contents in anti-
inflammatory supplements from green mussel P. viridis 
6D) Toxicity profile of the nutraceutical formulation derived from green 
mussel P. viridis  
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6A) Preparation of potential anti-inflammatory combination 
stabilized with natural antioxidants from P. viridis 
Background of the study 
There has been a growing interest in functional foods in recent years 
and the functional foods, enriched with natural ingredients are able to provide 
or promote a beneficial action for human health. The bioactive compounds in 
functional foods exist as natural constituents or as fortificants in food having 
the potential to provide health benefits beyond the basic nutritional value of 
the product. Marine-derived nutrients and other marine bioactive components 
have excellent potential as functional food ingredients as they possess 
advantageous physiological effects, with medicinal characteristics and added 
health benefits, such as, anticancer or anti-inflammatory activity. 
Inflammation is a process involved in the pathogenesis of several 
disorders viz., arthritis and cardiovascular diseases (Calder, 2006). 
Cycloxygenase (COX) and lipoxygenase (LOX) are the two major enzyme 
families that catalyze the rate-limiting step in the formation of prostanoids, 
prostaglandins, and thromboxane A2 by the COX pathway, and leukotrienes 
by the LOX pathway, whose products are significant mediators of pain, fever 
and inflammation (Coy et al., 2009). COX-1 is constitutive, and biosynthesize 
prostaglandins (PGs) that protect the stomach and kidney from damage. COX-
2 is induced by inflammatory stimuli, such as cytokines, and produces 
prostaglandins (PGs) that contribute to the pain and inflammatory disorders. 
The systemic inhibition of the COX-1 leads to a subsequent reduction in 
cytoprotective PGs required for an effective mucosal defense. 
Current symptomatic treatment of inflammation is mainly by non-
steroidal anti-inflammatory drugs (NSAIDs), which exert anti-inflammatory 
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actions by inhibiting cycloxygenase enzymes (Jaggi et al., 2004). NSAIDs 
produce intestinal tract ulcers (with potential internal bleeding) in 10-30 
percent of long-term users, and erosions of the stomach lining and intestinal 
tract in 30-50 percent of cases (McPhee et al., 2007). Selective COX-2 
inhibitors (Coxibs) have come to attention in recent years, although they too 
exhibit side effects, most notably in relation to cardiovascular disturbances. It 
is of note that the simultaneous inhibition of COX-2/5-LOX is important to 
allow synthesis of lipoxins to resolve inflammation and attenuate any 
remaining leukotriene effect. As a result, medical researchers are looking for 
safer, more efficacious alternatives to both the traditional NSAIDs and the 
Coxibs. It is therefore, necessary to find suitable medications that can inhibit 
5-LOX and COX-2 simultaneously while maintaining COX-1/COX-2 ratio 
below the threshold limit (preferably lesser than 1.0) for targeted and selective 
activities against the inflammatory response. 
Traditionally, indigenous people, notably in Western Mexico and 
throughout the South Pacific use shellfish supplements as a remedy for arthritis 
(Whitehouse et al., 1997). The commercially available products, such as, freeze-
dried extract (Seatone) and CO2 extracted oil (Lyprinol), obtained from Perna 
canaliculus were reported to inhibit experimentally induced inflammation in the 
treatment of rheumatoid arthritis and osteoarthritis (McPhee et al., 2007). 
Okinawan mollusk Pinna muricata contains a pinnatoxin A, which is reported to 
have Ca2+ channel activating and anti-inflammatory properties (Uemura et al., 
1995). The green lipped mussel, P. canaliculus is restricted to the temperate 
waters around New Zealand, whereas Perna viridis occurs widely in tropical 
waters throughout the Indo-Pacific region (Spencer, 2002).  
Mussels constitute about 14% of total bivalve landing in India (CMFRI, 
2003), and are distributed all along the east and west coast. Marine mussels are 
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abundant in the low tide level to a depth of 10 meters, and being used as food 
for thousands of years. P. viridis considered to be an economically important 
bivalve mollusk, and is abundantly available in the coastal and estuarine 
waters of the Indo-Pacific region. P. viridis was reported to grow and 
reproduce at a temperature range between 11-32°C, and a wide-ranging 
salinity of about 18-33% at about 2m below water surface, rich in 
phytoplankton. P. viridis is harvested in the Indo-Pacific region as a food 
source due to its exceptionally fast growth and high nutritional properties. P. 
viridis supports a traditional fishery in the Peninsular India, particularly at 
Malabar and Konkan areas, accounting for the bulk of the mussel production 
(Kripa and Mohammed, 2008). In recent years, the n-3 PUFAs from bivalve 
mollusks provide an unlimited variety of long chain PUFAs with reported 
beneficial roles in human health, such as, alleviating symptoms of thrombosis, 
inflammatory conditions (James et al., 2000), and asthma (Emelyanov et al., 
2002). The extract from P. viridis was reported to be active against 
inflammatory joint diseases, influenza, herpes, HIV, and hepatitis viral strains 
(Mitra and Chatterji, 2004). Although the coastline of South Indian 
subcontinent is bestowed with large assemblage of P. viridis, they have not 
been explored in detail regarding their potential to be used as nutritional 
supplement. 
Considering the importance and easy availability of P. viridis, 
compared with other species, an anti-inflammatory concentrate from P. viridis, 
for use as nutraceuticals or functional foods, in combating oxidative stress-
induced and inflammatory diseases, has been formulated. Specifically a 
nutraceutical formulation that can simultaneously inhibit 5-LOX and COX-2 
with COX-1/COX-2 ratio below the safety threshold limit leading to selective 
activity against inflammatory mediators has been prepared. 
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However it is to be noted that the active ingredients of P. viridis extract 
are lipidic in nature, and therefore, are susceptible to peroxidation (or 
oxidation) due to the presence of olefinic bonds in their structure, resulting in 
low molecular weight aldehydes, ketones, and deleterious free radical species 
under shelf, and are major risk factors for cardiovascular and inflammatory 
diseases. The product, which is not of sufficient stability, can result in changes 
in physical (like color, flavor, odor etc.) as well as chemical characteristics 
(formation of high risk decomposition substances, such as, free radicals, small 
molecular weight aldehydes, and ketones. The harmful reactive oxygen 
species (ROS), which attack the biological macromolecules, leading to the 
formation of lipid hydroperoxides produced either through non-enzymatic 
ways, or through the action of ROS on polyunsaturated fatty acids, or as 
specific products of LOX and COX activities. It is therefore, necessary to 
arrest the oxidation of the mussel active principles by antioxidants, and to 
retain its anti-inflammatory qualities for a longer period on shelf. 
The ROS in food industry is being controlled or minimized by the 
addition of commercial synthetic antioxidants like BHA (butylated 
hydroxyanisol), BHT (butylated hydroxytoluene) and TBHQ (tert-butyl 
hydroquinone). Recently, there has been an increasing interest in the use of 
natural antioxidants, such as, tocopherols and flavonoids for the preservation 
of food materials because these natural antioxidants avoid the toxicity 
problems, which arise due to the synthetic antioxidants. These compounds can 
trap the free radicals directly or scavenge them through a series of coupled 
reactions with antioxidant enzymes thereby having antioxidant, anti-
inflammatory and anticancer activities. 
In recent years, the use of antioxidants of natural origin is considerably 
enhanced, by the concern about the adverse side effects of these popularly 
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used synthetic antioxidants and other analogues. The present study, therefore, 
explored natural alternatives to arrest the degradation of vital nutrients with 
respect to the LC-PUFAs of the P. viridis concentrate. The different 
compositions of oleoresins (Rosmarinusofficinalis (ROO) and Curcuma longa 
(CLO) and other natural antioxidant additives in different proportions were 
blended with the extract (FDPE) in different combinations (GME1, GME2, 
GME3 and GME4). These experimental combinations were subjected to 
accelerated shelf life study for a period of 90 days (d90) to find their individual 
and synergistic effects, which were able to reduce the free radicals causing 
oxidation reactions thereby deteriorating the nutritional compositions of the 
mussel extract. 
6A.1 Materials and methods 
6A.1.1 Reagents and instrumentation 
All solvents (E-Merck, Darmstadt, Germany) were of analytical or high 
performance liquid chromatography (HPLC) grade as required. All glasswares 
were rinsed with CHCl3/CH3OH (2:l v/v), and dried under N2. All other 
reagents were of analytical grade, and purchased from E-Merck. DPPH (1, 1-
diphenyl-2-picrylhydrazyl), Folin–Ciocalteau reagent, bovine serum albumin, 
trichloroacetic acid and gallic acid are obtained from HiMedia. Standards of 
fatty acid methyl esters (SupelcoTM 37 Component FAME Mix, Catalog No. 
47885-U), tert-butyl hydroxyquinone (TBHQ), and boron trifluoride/methanol 
(14% BF3/CH3OH, w/v) were procured from Sigma-Aldrich Chemical Co. 
Inc. (St. Louis, MO). Unless otherwise stated, starting material, reactants and 
solvents were used as such, or purified and dried by standard means.  
GLC data were recorded on a Perkin-Elmer AutoSystem XL gas 
chromatograph (HP 5890 Series II, Perkin Elmer, and USA). Carnosic acid, 
Chapter 6 
244 
carnosol, curcuminoids and vitamin content were quantified using reverse-
phase isocratic HPLC system (Shimadzu LC-20AD) fitted with a C18 column 
(Phenomenex, 250 mm length, 4.6 mm i.d, 5µ particle size) and photo diode 
array detector (PDA). HPLC data of amino acids were analyzed using Waters 
(Waters Corp., Milford, Massachusetts, USA) equipped with a column oven, 
on-line degasser, and detector (Waters 2487 dual absorbance detector). The 
spectrophotometric measurements were performed using Varian Cary 50 conc 
UV-visible spectrophotometer. A benchtop refrigerated centrifuge (Heraeus 
Biofuge Stratos benchtop centrifuge, Thermo Scientific, Waltham, MA 02454 
USA) was used for centrifugation. The distillation under reduced pressure was 
performed using rotary vacuum evaporator (Heidolph, Germany; Hei-VAP 
series). The samples for shelf life studies were kept in an incubator (Labline, 
India). A laboratory Freeze Dryer (Alpha 1-4 LD plus, Germany) was used for 
freeze-drying the samples. 
6A.1.2. Collection of samples  
Green mussel P. viridis (10 kg) were collected from their natural habitat 
at Elathur (Lat: 11054’11.6”N; Long: 750 12’.21.8’’E), in Kozhikode district in 
Kerala. The shell-on samples of P. viridis were thoroughly washed in running 
distilled water, and the meat (3.0 kg) was manually removed without applying 
heat. The samples were thereafter homogenized by a grinding machine, kept 
overnight under -80ºC for freezing, and were freeze-dried in a laboratory freeze 
dryer (Alpha 1-4 LD plus, Germany) for 36 h to get the freeze-dried green 
mussel extract (FDPE, 213.6 g; yield 7.1 g/100g). This was then powdered and 
stored in vacuum packed polyethylene biohazard autoclave bags 
(FisherbrandTM, Fischer Scientific) at -80 ºC until further processing. 
Standards of curcumin (from Curcuma longa ≥ 80%), carnosic acid and 
carnosol (from Rosmarinus officinalis ≥ 91%) were procured from Sigma-
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Aldrich Chemical Co. Inc. (St. Louis, MO). The leaves of rosemary were 
purchased from a local company (BOS Natural Flavors Pvt. Ltd, Cochin, 
Kerala). Rhizomes of turmeric (Curcuma longa) and ginger (Zingiber 
officinale; Zingiberaceae); fruits of tamarind (Tamarindus indica; 
Leguminosae), Indian gooseberry (Emblica officinalis; Phyllanthaceae), lemon 
(Citrus limon; Rutaceae) and pineapple (Ananascomosus; Bromeliaceae) were 
collected freshly from the local farms (Cochin, Kerala). The brown seaweeds, 
Turbinaria conoides and Sargassam myriocystum (Sargassaceae) were 
collected from the Gulf of Mannar of Mandapam region on the south east 
coast of India. 
6A.1.3 Preparation and analysis of rosemary and turmeric oleoresins  
The air dried (50°C) leaves of R. officinalis (50 g) were subjected to 
soxhlet extraction (70°C ) in EtOAc (250 mL), and evaporated to dryness in 
vacuo (50°C; Heidolph, Germany, 5.6 g). The EtOAc extract thus obtained 
was stirred with n-hexane (16 mL) for 1 h. The n-hexane solubles were 
centrifuged (Superspin Plasto Crafts, Mumbai, India) and the centrifugate was 
concentrated in vacuo to obtain semi-purified oleoresin of R. officinalis (2.2 
g). This was further emulsified with polysorbate 80 (Tween 80; 1:1 w/w) and 
designated as ROO. Likewise, air-dried (50°C), powdered rhizomes of C. 
longa (100 g) was extracted with EtOAc (800 mL x 3) and concentrated to 50 
mL, and to this concentrate, n-hexane (100 mL) was added. The mixture was 
kept at room temperature for 8 h and centrifuged. The residue obtained was 
dried in vacuo to furnish the semi-purified oleoresin of C. longa (9 g). This 
was further emulsified with polysorbate 80 (Tween 80; 1:1 w/w) and 
designated as CLO. 
The quantification of carnosic acid, carnosol in ROO, and 
curcuminoids in CLO were performed using reverse-phase binary gradient 
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HPLC system (Shimadzu LC -20AD) fitted with a C18 column (phenomenex, 
250 mm length, 4.6 mm i.d, 5µ particle size) and photo diode array detector 
(PDA). Carnosic acid and carnosol were detected at 230 nm by using 
acetonitrile: 1% acetic acid in HPLC water (55:45, v/v) as mobile phase. The 
curcuminoids were detected at 420 nm using acetonitrile: 0.1% citric acid in 
HPLC water (60:40, v/v) as mobile phase.  
6A.1.4 Preparation of aqueous extracts of natural additives 
The air dried (50°C), pulverized samples of Z. officinale, T. indica, E. 
officinalis, C. limon, and A. comosus (100 g each) were separately refluxed 
(100°C, 2h) with distilled water (100 mL x 2), filtered, freeze-dried in a 
laboratory freeze drier (Alpha 1-4 LD plus, Germany) to obtain aqueous 
extracts of Z. officinale (ZOE, 3.5 g), T. indica (TIE, 14.1 g), E. officinalis 
(PEE, 3.8 g), C. limon (CLE, 3.9 g), and  A. comosus (ACE, 5.5 g). The shade 
dried, powdered brown seaweeds, T. conoides and S. myriocystum 
(Sargassaceae) (100 g) were refluxed (100°C, 2 h) with distilled water (400 
mL x 3)  centrifuged, freeze-dried to furnish the aqueous extract of T. conoides 
(TCE, 15 g) and S. myriocystum (SME, 13.2 g).  
6A.1.5. Preparation of P. viridis extract, experimental combinations and 
designing of stability studies. 
The P. viridis meat (3.0 kg) acquired manually from the shell-on 
samples was freeze dried to furnish P. viridis extract (FDPE; 213.6 g; yield - 
7.1%). By assigning FDPE as the base material, four different combinations of 
GME with antioxidative oleoresins (ROO an CLO) and aqueous extracts of the 
additives were prepared according to Table 6A.1 
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Table 6A.1 Compositions (in g/100g) of different treatments (GME1-4) along with control GME0 (FDPE) 
Treatments 
Composition (in g/100g) 
CLO ROO ZOE PEE CLE TIE TCE SME ACE 
GME0 0 0 0 0 0 0 0 0 0 
GME1 0.4 0.8 0.05 0.05 0.05 0.05 0.025 0.025 - 
GME2 0.8 0.4 0.05 0.05 0.05 0.05 0.025 0.025 - 
GME3 0.8 0.8 0.05 0.05 0.05 0.05 0.025 0.025 - 
GME4 0.8 0.4 0.05 0.05 0.05 0.05 0.025 0.025 0.05 
CLO: C. longa oleoresin (water-dispersible); ROO: R. officinalis oleoresin (water-dispersible); ZOE: Z. 
officinale lyophilized aqueous extract; PEE: E. officinale  lyophilized aqueous extract; CLE: C. limon 
lyophilized aqueous extract; TIE: T. indica lyophilized aqueous extract; TCE: T. conoides lyophilized aqueous 
extract; SME: S. myriocystum lyophilized aqueous extract; ACE: A. comosus lyophilized aqueous extract. The 
additives were dissolved in 100 mL double distilled water. Mussel extract, FDPE (GME0) was added to this 
antioxidant solution, stirred and then lyophilized to get different treatments, GME1-4. 
In order to find the most effective antioxidant combination, the stability 
of different biochemical characteristics of these four treatments compared with 
GME0 were tested by time dependent accelerated shelf life study in a 
thermostatically controlled incubator at an elevated temperature of 50°C. The 
samples (10 g each; GME1-4 and GME0) were kept in screw capped flat bottom 
culture tubes (Vensil; 30 mL capacity, 20 mL relative volume; 10 mL head 
space), and were evaluated for the changes in anti-inflammatory and anti-
oxidative status (at day 0, 15, 30, 60 and 90), and nutritional assays in relation 
to the various nutritional indicators namely fatty acids (at day 0, 1, 2, 4, 5, 8, 
15, 30, 60 and 90); amino acids and total protein (at day 0 and 90); vitamins 
and carotenoids (at day 0, 15, 60 and 90).  
6A.1.6  Evaluation of antioxidative status of the green mussel extract spiked 
with various combinations of additives  
The capability of the samples to scavenge hydrogen peroxide (H2O2) 
was determined according to the established method (Ruch et al., 1989). A 
solution of H2O2 (10mM) was prepared in phosphate buffer (pH 7.4). Reaction 
mixtures contained 10mM of H2O2 and 5 mg/mL of test samples, and 
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absorbance values were measured at 0 min after 10 min using wavelength of 
240nm. Ascorbic acid was used as the standard and H2O2 scavenging activity 
was expressed as % [H2O2] scavenged = {(A0 - A1)/A0} 100, where A0 was the 
absorbance of the control, and A1 was the absorbance in the presence of the 
sample. The amount of total phenolics, 2, 2-diphenyl -1- picrylhydrazyl 
(DPPH) radical scavenging activity and degree of lipid peroxidation were 
determined as described earlier (Tai et al., 2011). Total phenolic contents of 
GME0-4 (5mg) were estimated using Folin-Ciocalteu reagent and gallic acid 
standard. The absorbance was measured at 760 nm and the result was 
expressed as gallic acid equivalent in mg (mg GAE)/g sample. The lipid 
peroxidation ability was determined through thiobarbituric acid reactive 
substances (TBARS) formation inhibitory activity assay. The samples (10 mg) 
were incubated with AcOH (2 mL, 1.03 g/mL) and an aqueous solution of 
thiobarbituric acid (TBA, 2 mL, 0.78 g/100 mL) at 95 °C for 45 min. The 
resultant mixture (5 mL) was cooled to room temperature and clarified by 
centrifugation (8 000 r/min, 10 min) to get the supernatant. The absorbance of 
the supernatant was recorded at 532 nm and the antioxidant capacity was 
expressed as equivalent mmol of malonaldehyde (MDA)/kg of sample. 
TBARS concentration was calculated using a standard curve based on MDA 
and expressed as mM malondialdehyde equivalents (mM MDAEQ)/kg of the 
sample. For ABTS (2, 2′-azino-bis-3-ethylbenzothiozoline-6-sulfonic acid 
diammonium salt) assay, the procedure followed the method of Arnao et al. 
(Arnao et al., 2001) with suitable modifications.  
6A.1.7 Nutritional parameters and time series stability studies  
Lipid compositions of the samples (0.1g each) were determined using 
established methods (Bligh and Dyer, 1959) and the fatty acid composition of 
the total lipids was determined as described elsewhere (Chakraborty and 
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Paulraj, 2009).Results were expressed as percent of total fatty acids (% TFA). 
The total digestible protein contents in the samples (0.1g each) were estimated 
by the established method (Lowry et al., 1951) using a UV-Visible 
spectrophotometer (Varian Cary, USA) and expressed as mg/100g sample. 
Estimation of amino acid in samples (0.1g each) was carried out using the 
Pico-Tag method (Heinrikson and Meredith, 1984) using reversed-phase 
binary gradient HPLC (Waters reversed-phase PICO.TAG amino acid analysis 
system), fitted with a packed column (dimethylocatadecylsilyl- bonded 
amorphous silica; Nova-Pak C18, 3.9 X 150 mm) maintained at 38 ± 1°C in a 
column oven to be detected by their UV absorbance (λmax 254 NM; Waters 
2487 dual absorbance detector), and the results were expressed in mg/100g 
sample. Estimation of fat soluble vitamins (A, D3, E and K) was carried out by 
the method of Salo-Vaananen et al. (Salo-Vaananen et al.,2000) using HPLC 
equipped with a C18 column (Phenomenex, 250 mm length, 4.6 mm I.D., 5µm) 
in column oven (32 °C) and photo diode array (PDA) detector. Vitamin C was 
determined based upon the quantitative discoloration of 2, 6-dichlorophenol 
indophenol titrimetric method as described (AOAC, 2005). The vitamins A, 
D3, E, K1 and C were expressed as µg/100g sample. The total carotenoid 
content was determined using the method described by Jensen (Jensen, 1978) 
at 414 nm against 95% EtOH as blank. 
6A.1.8. In vitro and in vivo anti-inflammatory assays 
Cyclooxygenase (COX) inhibition assay was performed using 
established 2, 7-dichlorofluorescein method (Larsen et al., 1996) as described 
in the section 4.1.2.2.1. The 5-lipoxygenase (5-LOX) inhibition assay was 
carried out using the principle of 1-4 diene (linoleic acid) oxidation to 1- 3-
diene (Baylac and Racine, 2003) with modification as illustrated in the section 
4.1.2.2.2. The in vivo carrageenan-induced mice paw edema experiment was 
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carried out as previously described (Winter et al., 1962) as explained in the 
section 4.1.2.3. 
6A.1.9. Spectroscopic analyses  
Fourier Transform Infra Red spectrometer (FTIR) spectra of the 
compounds under KBr pellets were recorded in a Thermo Nicolet, Avatar 370 
explained in 5.1.1.2A. 
6A.1.10 Statistical analyses 
One-way analysis of variance (ANOVA) was carried out with the 
Statistical Program for Social Sciences 13.0 (SPSS, USA, ver. 13.0) to assess 
for any significant differences between the means. Differences between means 
at the 5% (P<0.05) level were considered as significant. 
6A.2 Results and discussion 
6A.2.1 Antioxidant and lipoperoxidation inhibitory activities of the natural 
additives to the green mussel extract  
The antioxidative activities of different compositions of turmeric and 
rosemary oleoresins when blended with freeze-dried mussel extract (GME0) 
were studied in order to find their individual and synergistic effects (Table 
6A.2). The HPLC chromatograms of carnosic acid, carnosol in ROO, and 
curcuminoids in CLO were represented in Fig.6A.1.The maximum DPPH 
radical scavenging activity was observed for the ratios in the order: CLO (0.8 
g/100g): ROO (0.4 g/100g) > CLO (0.8 g/100g): ROO (0.8 g/100g) > CLO (0.4 
g/100g): ROO (0.8 g/100g) (Table 6A.2). The TBARS formation inhibitory 
activity maxima were observed for CLO (0.8 g/100g): ROO (0.4 g/100g) 
followed by CLO (0.4 g/100g): ROO (0.8 g/100g) (Table 6A.2). It is evident 
that CLO and ROO added individually (1g/100g each) to GME0 showed 
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significantly low (P<0.05) TBARS formation inhibitory activity (2.55 & 2.38 
mM MDAEQ/kg, respectively). The high antioxidant activity obvious for the 
mixed combinations compared to individual combinations inferred to be due to 
the synergistic effects of the individual components (Koduru et al., 2007). This 
study showed that the effective oleoresin combinations imparting anti-oxidative 
stability to GME0 are CLO (0.8 g/100g): ROO (0.4 g/100g); CLO (0.8 g/100g): 
ROO (0.8 g/100g) and CLO (0.4 g/100g): ROO (0.8 g/100g), and therefore, 
these ratios of oleoresins were selected for making the four experimental 
combinations. The antioxidant activity of rosemary extract can be attributed to 
two major phenolic components, carnosic acid and carnosol (Cheung and Tai, 
2007). Curcuminoids from C. longa rhizomes had been reported to inhibit the 
activity of the free radicals, and are inhibitors of lipid peroxidation. An equal 
concentration of water extracted freeze-dried powder samples from different 
natural sources (ZOE, TIE, PEE, CLE, TCE, SME) were added with the base 
green mussel extract formulation containing antioxidant oleoresins of ROO and 
CLO (GME1 through GME4), and the respective composition of each, as their 
individual activity did not influence the results of this study, with each sample 
treated the same. The study on the DPPH free radical scavenging activities of 
the trace amounts of natural additives determined individually were in the order: 
SME ~ TCE ~ PEE  (IC50 <0.15 mg/mL) >  ZOE ~ TIE ~ ACE ~ CLE (IC50 0.3-
1.1 mg/mL). The addition of these natural compounds has been demonstrated to 
enhance the antioxidative stability of the control mussel extract blended with 
antioxidant oleoresins. Since these natural additives have been added with equal 
proportion to the base formulation, their individual activities don’t have any 
influence on the results in the comparison of the differing ratios of ROO and 
CLO. ZOE was reported to contain gingerols, which inhibit the formation of 
free radicals. CLE contains ascorbic acid as a primary antioxidant component in 
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addition to citric acid, which make up about 5-6% of the fluid (Gironés-
Vilaplana et al., 2012). TIE and PEE extracts primarily contain tartaric acid and 
ascorbate, respectively, the reported antioxidants in addition to the tannins, 
viz.,emblicanin A, emblicanin B (or β-glucogallin), and mucic acid (1,4-lactone 
5-O-gallate) (Scartezzini et al, 2006). A. comosus contains anti-inflammatory 
enzyme, bromelain that was proved to alleviate various inflammatory conditions 
(Taussig and Batkin, 1998). 
Table 6A.2  Free radical scavenging (DPPH. scavenging activity) and lipid peroxidation inhibitory 
activities (TBARS formation inhibition activity) with different ratios of oleoresins 
spiked to the control (GME0). 
Spiked antioxidant (g/100g) DPPH. scavenging activity* TBARS formation inhibitory activity ** 
GME0 (100g) 13.00±0.24a 3.94±0.04a 
GME0 (99.9)+ CLO (0.1) 15.60±0.16be 2.85±0.03b 
GME0 (99.6)+ CLO(0.4) 18.84±3.13ce 2.99±0.05c 
GME0 (99.2)+ CLO(0.8) 22.23±0.47df 2.75±0.02d 
GME0 (99)+ CLO(1) 22.26±0.23d 2.72±0.05e 
GME0 (99.9)+ ROO(0.1) 16.93±1.81e 2.95±0.13c 
GME0 (99.6)+ ROO(0.4) 18.35±0.64ce 2.79±0.09d 
GME0 (99.2)+ ROO(0.8) 19.02±0.39ce 2.58±0.02e 
GME0 (99)+ ROO(1) 19.03±1.16ce 2.58±0.04e 
GME0(99.7)+ CLO(0.2) + ROO(0.1) 23.12±0.46d 2.31±0.07g 
GME0(98.8)+ CLO(0.8) + ROO (0.4) 26.35±0.44g 2.18±0.07h 
GME0(99.7)+ CLO(0.1) + ROO (0.2) 19.56±0.45c 2.43±0.07i 
GME0(98.8)+ CLO(0.4) + ROO(0.8) 23.61±0.59d 2.19±0.02hj 
GME0(98.4)+ CLO(0.8) + ROO (0.8) 26.18±0.05g 2.23±0.05j 
GME0(98)+ CLO(1) + ROO(1) 26.18±0.15g 2.21±0.07hj 
GME0: freeze-dried mussel extract without additives (control). a-j: Column wise values with 
different superscripts of this type indicate significant differences (P<0.05) within different 
ratios. *DPPH activities were expressed as percentage of total antioxidant radical scavenging 
activity (% TARSA). **TBARS inhibition activity expressed as the equivalence of millimolar 
malondialdehyde formed per kilogram (mM MDAEQ/kg) of the sample. The oleoresins were 
added to GME0 in different concentrations (g/100g) which are given in the parentheses. 
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Fig 6A.1  Active antioxidant principles of the additives used to supplement the mussel extract and 
their structural features responsible for anti-oxidative activities. (A) Rosemary phenolic 
antioxidants bearing o-hydroxyphenolic functionalities that produce stable o-quinone 
material, which play a key role as a radical scavenger; (B) Curcumin-I bearing ortho-
methoxyphenolic functionalities as representative antioxidant principles of turmeric. 
HPLCchromatograms of (A1) standard carnosic acid and (A2) rosemary oleoresin. Mobile 
phase: Acetonitrile: 1% acetic acid (55:45, v/v). HPLC chromatograms of (B1) standard 
curcuminoids and (B2) turmeric oleoresin. Mobile phase: Acetonitrile: 0.1% citric acid 
(60:40, v/v). 
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6A.2.2 Time series studies of antioxidative activities of various treatments of 
green mussel extract (GME0 in relation to GME1-4) 
The accelerated stability study has been designed using a time and 
temperature matrix, which can result in robust models to quickly and reliably 
predict the shelf life period. In this study, accelerated testing is performed at 
elevated temperatures in an attempt to obtain information on the shelf life of 
the product in a relatively short time. The accelerated shelf life study of 90 
days was carried out in this experiment by following the International 
Conference on Harmonization (ICH) guidelines (ICH, 2003). The duration of 
the shelf life period under the accelerated stability conditions (50°C) with 
acceptable stability for 60-120 days is equivalent to that of two years stability 
at room temperature. The shelf-life of the product rich in lipidic ingredients (as 
in green mussel extract) is primarily determined by the oxidative status at 
various time intervals during the storage period as described below.  
6A.2.2.1 Hydrogen peroxide scavenging ability 
H2O2 formed can release H., O., HO., or HOO.  free radicals,  which can 
start a sequel of oxidative chain reaction. Initially the treatments GME2 and 
GME4 registered higher H2O2 scavenging abilities than other treatments. A 
marginal reduction (with respect to d=0, 0th day) in the H2O2 scavenging 
ability of GME2 and GME4 were more apparent after 90 days (d=90) of 
accelerated stability study than in GME3, GME1, and GME0, which exhibited a 
significant (P<0.05) reduction in activity during the same time period. The 
high H2O2 scavenging activity of these treatments is attributed to the 
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polyphenolic compounds present in the extracts of R. officinalis, Z. officinalis, 
and P. emblicato scavenge HOO., superanions and HO. radical Table 6A.3.  
6A.2.2.2 Total polyphenolic content   
The total phenolic content was observed to be significantly higher in the 
treatments GME1 - GME4 than GME0 (P<0.05) (Table 6A.3), and this is due to 
the presence of phenolic compounds present in the natural additives. GME0 
exhibited accelerated degradation in its total polyphenolic content due to the 
absence of antioxidant additives leading to photodegradation of phenolic groups 
into aromatic radicals. The accelerated storage conditions (50°C) resulted in 
incremental degradation of polyphenolics in GME0 at various time intervals 
during the storage period by auto-oxidation and epimerization evidently due to the 
absence of antioxidant additives (Table 6A.3). The addition of natural extracts 
with phenolic moieties (as in GME1-4) as additives apparently shielded the mussel 
active principles against thermally induced autoxidation at elevated temperatures 
as evident by decelerated degradation rate of GME1 through GME4.  
6A.2.2.3 DPPH and ABTS radical scavenging activities  
GME2 and GME4 showed a significantly higher DPPH scavenging activity 
as compared to other treatments and GME0 (P<0.05) (Table 6A.3). The ability of 
GME0 to stabilize the free radical was significantly reduced (P<0.05) after d=90 
of accelerated shelf life study with respect to its initial activity (d=0). The 
significant reduction of total polyphenolic content in storage might be one of the 
primary factors causing the reduction in radical scavenging activity of GME0. The 
DPPH scavenging activity of GME2 and GME4 showed decelerated reduction of 
its initial activity than those shown by GME1 and GME3 at d=90. The reduction in 
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ABTS radical scavenging activity was significant for GME0 compared with 
GME2 and GME4 (P<0.05) after accelerated oxidation of 90 days. GME1 and 
GME3 showed significant reduction of its initial activity than GME2 and GME4 
after d=90. It is interesting to note that GME3 has higher concentrations of 
phenolics (ROO and CLO = 0.8 g/100g each) than in GME4, GME2 (CLO and 
ROO of 0.8 and 0.4 g/100g, respectively) and GME1 (CLO and ROO of 0.4 and 
0.8 g/100g, respectively). However, the presence of higher phenolic content in 
GME3 has no direct impact on antioxidant activities of that particular treatment. 
This may be explained by the fact that a threshold level of CLO: ROO of 0.8 
g/100g: 0.4 g/100g is sufficient for optimum antioxidant activity, and further 
addition of endogenous antioxidants (ROO to 0.8 g/100g as in GME3) does have a 
negative impact on the stability of the active principle (GME0). A possible 
explanation for this synergistic effect would be that a heterogeneous activation of 
a hydroxyl group on the antioxidant principles of other antioxidants to enhance 
the formation of H radical, which rapidly reacts with exogenous free radical 
(DPPH.) to quench it (Vaya and Michael,  2001). A phenolic antioxidant bearing 
ortho-dihydroxyl groups as in carnosic acid (with 1-(1, 1-dimethylperhydro-4-
naphthalenyl)-1-ethanone) and carnosol (with perhydro-1-isochromenone and 3-
isopropyl-1, 2-benzenediol) in rosemary was investigated as efficient 
antioxidants, and the produced stable o-quinone material plays a key role in its 
antioxidant activity (Wei and Ho, 2006) (Fig. 6A.2). 
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Fig. 6A.2 Schematic diagram illustrating lipid peroxidation inhibitory and antioxidant mechanism of 
rosemary active principles carnosic acid with 1-(1, 1-dimethylperhydro-4-naphthalenyl) -1-
ethanone) and carnosol with perhydro-1-isochromenone and 3-isopropyl-1, 2-benzenediol, which 
together are responsible for ~90% of antioxidant activity. HAT (H-donation) and chain breaking 
mechanism, as in phenolic  antioxidants, is the mode of action of CA and carnosol. Another 
mechanism by that these polyphenolic compounds exhibit lipid peroxidation is of metal (Fe2+) ion 
chelation by phenoxyl radical and free hydrogen on -OH group. The polyphenols with o-dihydroxy 
groups provide improved stability to polyphenol radical by electron delocalization through the 
system accompanying radical formation. 
 
 Curcumin-I and II, the major curcuminoids of C. longa were reported 
to possess phenolic 2-methoxy-1-methyl-4-[(E)-1-propenyl]benzene and 1-
methyl-4-[(E)-1-propenyl] benzene moieties with an additional 2,4-
pentanedione system, which are efficient to scavenge free radicals. Ortho-
methoxyl group as in curcumin-I can form intramolecular hydrogen bonds 
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with the phenolic hydrogen, making the H-atom abstraction from the ortho-
methoxyphenols easy (de Heer et al., 2000). The antioxidant action of 
curcuminoids was also found to be associated with the β-dicarbonylic system 
in the heptadienone link of curcumin-I, which has conjugated double bonds 
(dienes) (Fig.6A.3). H-atom abstraction from the CH2 group in the 
heptadienone link of curcumin-I also may be involved in antioxidant activity. 
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Fig.6A.3.  Schematic diagram illustrating lipid peroxidation inhibitory and antioxidant mechanism of 
curcumin-I. Ortho-methoxyl group of curcumin-I can form intramolecular hydrogen bonds 
with the phenolic hydrogen, making the H-atom abstraction from the o-methoxyphenols 
easy. The antioxidant efficiency of phenolics is enhanced by the introduction of a second OH 
group and is increased by one or two methoxy substitutions in positions ortho to the OH 
group as in curcuminoids. The antioxidant action of curcuminoids was also found to be 
associated with the β-dicarbonylic system in the heptadienone link of curcumin-I, which has 
conjugated double bonds (Dienes). H-atom abstraction from the -CH2 group in the 
heptadienone link of curcumin-I also may be involved in antioxidant activity  
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6A.2.2.4 Lipid peroxidation assay  
Lipid peroxidation is a free radical (peroxides and hydroperoxides) 
mediated process in biological systems due to the oxidation of unsaturated fatty 
acids. Anti-oxidative substances are able to trap free radicals, and terminate the 
chain reaction leading to lipid oxidation. As evident from Table 6A.3, the 
TBARS content of GME0 increased significantly during the 90 days of 
accelerated oxidation study as compared to those in GME2 and GME4 (P<0.05). 
The effective inhibition of lipid peroxidation in the treatments GME2 and GME4 
may be attributed to the presence of phenolic antioxidants in the additives that 
were reported to disrupt free-radical chain reaction by donating a proton to fatty 
acid radicals to terminate chain reactions, and have roles to inhibit lipid 
peroxidation. Though carnosic acid is the primary antioxidant in rosemary, and it 
metabolized to other compounds like carnosol, rosamanol and rosamariqionone, 
which too were reported to possess antioxidant and lipid peroxidation inhibitory 
properties. Rosmarinic acid possesses 1, 2-dihydroxybenzene (catechol) ring 
system, contributing to its antioxidant activity. Furthermore, the presence of four 
phenolic hydrogens in 4-[(E) -1-propenyl] -1, 2-benzenediol moiety in rosmarinic 
acid significantly increased the polarity of the catechol ring system. These 
phenolic hydrogens undergo intramolecular H-bonding thereby improving its 
radical stability, and ease of H-atom abstraction from catechol forming phenoxyl 
radical. Another mechanism by that these polyphenolic compounds exhibit lipid 
peroxidation is of metal (Fe2+) ion chelation by phenoxyl radical and free 
hydrogen on -OH group (Wei and Ho, 2006; Seeram and Nair, 2002). The 
polyphenols with ortho-dihydroxy groups provide improved stability to 
polyphenol radical by electron delocalization through the system accompanying 
radical formation (de Heer et al., 2000). Curcuminoids, besides harboring two 
aromatic groups (two 2-methoxy-1-methyl-4-[(E) -1-propenyl] benzene in 
curcumin-I and one each of 2-methoxy-1-methyl-4-[(E) -1-propenyl] benzene and 
1-methyl-4-[(E) -1-propenyl] benzene in curcumin-II, also possess a diketone 
group (2,4-pentanedione moiety) that can react with and H2O2 and OH radicals 
(Fig.6A.3). 
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Table 6A.3  In vitro antioxidative activity of different treatments compared withGME0 during 
accelerated shelf life study 
Days GME0 GME 1 GME 2 GME 3 GME 4 
H2O2 radical scavenging capacity (%) 
0 48.64±0.25ap 51.24±0.56abp 55.17±0.05cp 52.15±1.92bp 58.42±0.53dp 
15 46.61±0.61ar 51.04±0.18abp 51.71±1.15abq 51.16±1.51br 53.27±0.09br 
60 34.33±0.33as 49.21±0.65bq 49.84±0.81bq 50.65±0.08cs 51.63±0.04cs 
90 31.79±1.23at 44.32±1.09bcr 49.32±1.38bdq 45.73±0.52cdt 52.73±1.24et 
x 34.6 13.5 10.6 12.3 9.7 
Total phenolic content (mg GAE/g) 
0 2.70±0.03ap 4.02±0.01bp 4.84±0.07cp 5.11±0.01dp 4.92±0pe 
15 1.77±0.02as 3.52±0.03br 4.25±0.13cs 4.25±0.22cs 4.41±0.14dr 
60 1.60±0.02au 2.94±0.03bu 3.98±0.14cu 4.16±0.01cu 4.15±0.05cs 
90 0.80±0.02av 2.72±0.02bv 3.82±0.02cv 3.18±0.02cv 3.93±0.02ct 
x 70.4 32.3 21.1 37.8 20.1 
DPPH scavenging activity (% TARSA) 
0 13.0±0.03ap 25.6±0.02bp 29.2±0.23cp 23.1±0.03dp 29.5±0.14ep 
15 9.04±0.02ar 20.9±0.07br 26.3±0.24cr 21.4±0.02dr 26.6±0.44eq 
60 2.07±0.02au 17.1±0.09bt 21.9±0.06cu 17.9±0.02du 22.4±0.01es 
90 1.03±0.01av 16.8±0.04bu 21.6±0.15cu 16.3±0.15du 21.8±0.03et 
x 92.1 34.4 26 29.4 26.1 
ABTS  radical scavenging activity (% TEAC) 
0 0.21±0.01ap 0.42±0bp 0.66±0.02cp 0.45±0.01bp 0.67±0cp 
15 0.19±0apq 0.4±0.02bp 0.62±0.04cp 0.41±0.01bp 0.63±0.03cpq 
60 0.15±0.01aq 0.38±0.01bp 0.61±0cp 0.4±0.02bp 0.61±0.01cq 
90 0.14±0aq 0.37±0.02bp 0.61±0.06cp 0.38±0.01bp 0.61±0.01cq 
x 35 11.2 7.9 14.9 9 
TBARS formation inhibitory activity (mM MDAEQ/kg) 
0 3.94±0.01ap 2.00±0.05bp 2.01±0.02bp 2.08±0.04bp 2.06±0.05bp 
15 4.62±0.06aqr 2.69±0.15bq 2.52±0.02cr 2.33±0.03cpq 2.35 ±0.04cpq 
60 8.2±0.09at 4.0±0.09bs 3.39±0.02bct 4.43±0.02bs 3.23±0.01cr 
90 10.4±0.22au 4.14±0.07bs 3.42±0.17ct 4.85±0.04dt 3.32 ±0.09cr 
x 164 107 70.1 133.2 61.2 
a-e: Row wise values with different superscripts of this type indicate significant differences (p< 0.05) 
within different samples. p-w: Column wise values with different superscripts of this type indicate 
significant differences (P< 0.05) within different days. The values are expressed as mean standard 
deviation, n=3. H2O2 radical scavenging capacity is in %. The total phenolic content was expressed as 
gallic acid equivalent in mg (mg GAE/g sample). DPPH radical scavenging activity was expressed as 
Total antioxidant radical scavenging activity (% TARSA). ABTS+ radical scavenging activity was 
expressed relative to trolox in terms of % TEAC (Trolox equivalent antioxidant capacity). Lipid 
peroxidation inhibitory activity expressed as mMmalondialdehyde (MDA) equivalents/ kg (mM 
MDAEQ/kg) of the sample. ‘x’ represents the percent reduction in activity on 90th day (d=90) with 
respect to 0th day (d=0). 
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6A.2.3 Effect of various combinations of natural additives on nutritional 
parameters in different treatments of green mussel Extract  
6A.2.3.1 Fatty acids  
This study used different treatments supplemented with anti-oxidative 
ingredients (GME1-4) to arrest the oxidation of these fatty acids under 
accelerated shelf storage for a period of 90 days (d=90). The addition of 
natural extracts of additives with polyphenolic moieties (in GME1-4) 
apparently shielded the mussel PUFAs against oxidation as evident by higher 
PUFAs in GME1-4 as compared to GME0 after 90 days (d=90) of accelerated 
shelf life study. PUFAs in GME0 experienced a significant reduction in their 
total content from the initial composition after d=90 as compared to the 
treatments (GME1-4), which point towards the beneficial effect of natural 
additives added to it. The total n-3 PUFA content in GME0 (19.5%) was found 
to be lesser than recorded in GME0 supplemented with additives at d = 0, 
thereby indicating the added n-3 fatty acid pool to GME0 by the additives. The 
content of the n-3 fatty acid 22:6n-3 in GME2 and GME4 (8.7 and 7.4%) were 
found to be higher than in GME1 (8%) and GME3 (7.6%) at d=0. This fatty 
acid registered a significant reduction (>35%, P<0.05) in GME0, after d=90. 
The treatments GME2 and GME4 were able to effectively protect this 
important fatty acid from oxidative degradation after d=90 than did GME1 and 
GME3. The comparatively poor shelf-life of GME3 than GME2 in degradation 
of DHA to a minimum in spite of higher concentration of antioxidant 
principles can be explained by the fact that a threshold level of CLO: ROO of 
0.8:0.4 g/100g is sufficient for optimum antioxidant activity, and further 
addition of antioxidants (as 0.8 g/100g ROO in GME3) does have negative 
impact on stability of the fatty acid.  
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The antioxidant additives serve as oxidation “chain breakers” for the 
treatments (GME1-4) by intercepting the free radicals generated from 
unsaturated fatty acids during accelerated storage. The treatments GME2 and 
GME4 were found to exhibit maximum n-3/n-6 ratio than recorded in GME3, 
GME1, and GME0 n-3/n-6 ratio was increased within the treatments GME2-4 
over a period of 90 days of accelerated shelf-life study than in GME0. Phenolic 
compounds present in the additives have been demonstrated to exhibit a 
scavenging effect of free radicals present in the system. It is apparent that 
ROO and CLO contain polyphenolic compounds with multiple –OH 
groups/centers of unsaturation that are capable of deactivating free radical to 
initiate a chain breaking peroxidation of olefinic bonds in n-3 PUFAs. The 
addition of natural extracts of additives with polyphenolic moieties (as in 
GME1-4) apparently shielded the mussel active ingredient against oxidation as 
evident by higher n-3/n-6 ratio as compared to GME0 after d=90 (Table 6A.4).  
6A.2.3.2 Protein and amino acid contents  
The total digestible protein contents during shelf life study were 
determined and are presented in Table 6A.5.It is of note that the degradation 
of the total digestible proteins after 90 days of accelerated shelf life study 
(d=90) were significantly higher (P<0.05) in GME0 (16.4%) with respect to 
d=0 than in treatments with antioxidant additives GME2 and GME4, which 
showed a decelerated degradation of total digestible protein (6.6, and 6.7% 
decrease at d=90 with respect to those at d=0) throughout the period during 
shelf life study. It is, therefore, apparent that the treatments GME2 and GME4 
were efficient to reasonably arrest the degradation of total digestible protein 
throughout the period under the shelf (d=90) with respect to that recorded at 
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d=0. The total essential amino acid (EAA) was found to be significantly higher 
in the treatments supplemented with additives (GME3> GME1> GME2> 
GME4) than in GME0. The most abundant essential amino acids of GME1-4 
were found to be arginine (average - 400 mg/100 g) followed by lysine 
(average - 264 mg/100 g), and leucine (average - 242 mg/100 g) at d=0. 
Among the non-essential amino acids, negatively charged amino acid 
glutamate and aspartate were observed to be the predominant amino acids in 
the treatments (GME1-4). The ratio of essential amino acid (EAA/NEAA) was 
recorded to be 0.9in the treatments (GME1-4). It is interesting to note that the 
treatments GME2 and GME4 recorded an increase of this ratio after d=90 than 
in GME0. These differences also appeared to be due to proteolysis of amino 
acids that might have occurred to a higher extent in the samples without any 
added additives. In the present study, the essential and non-essential amino 
acids in GME0 experienced a maximum reduction in terms of their total 
content from the baseline composition (d=0) during the accelerated shelf life 
study for 90 days (d=90) than did the treatments (GME1-4), which point 
towards the beneficial effect of natural additives. It is, therefore, evident that 
the preparations GME2,GME3 and GME4 were found to be more effective to 
prevent the essential amino acids from degradation after 90 days (d=90) of 
accelerated storage than GME1 seemingly due to comparatively less titre of 
curcuminoids in GME1 (CLO 0.4 g/100g) than in GME2 and GME4 (CLO 0.8 
g/100g).  
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6A.2.3.3 Vitamins and carotenoids  
The variation in the stability of vitamins and carotenoids during the 
accelerated shelf life study is shown in Table 6A.6.The total vitamin C 
content in GME0 was found to be lesser than recorded in the treatments at d = 
0, thereby indicating the added vitamin C pool to GME0 by C. limon, P. 
emblica, and T. indica aqueous extract (0.05 g/100g each). Vitamin C, 
associated with antioxidant activity by scavenging free radicals, registered a 
significant reduction (91.4%) in GME0, after d = 90 with respect to d=0 
(P<0.05) than in treatments with antioxidant additives GME1-4, which showed 
a decelerated reduction of the same (Table 6A.6). This is due to the presence 
of polyphenolic compounds present in the natural additives that prevent 
degradation of ascorbic acid in shelf. Vitamin E which reacts with peroxyl 
radicals produced from PUFAs thereby reducing harmful lipid free radicals 
was found to be higher in the treatments GME2-4 than in GME0 at d=0. A 
significant decrease of vitamin E (46% with respect to the initial value, P 
<0.05) was observed in GME0 after d=90 than in GME1 through GME1, which 
experienced an insignificant reduction with respect to the baseline value (d=0) 
(P >0.05). Likewise the treatments GME2 and GME4 were able to arrest the 
degradation of vitamin D3 after d = 90 than did GME1, GME3 and GME0. The 
treatments GME2 and GME4 effectively arrested the degradation of vitamin 
K1, which have been supported by a moderate reduction than GME0 (>94%) 
without added additives. A 67% reduction in vitamin K1 during 90th day as 
compared to d=0 was observed within GME1, apparently due to comparatively 
less titre of curcuminoids which were reported to possess potential to arrest 
oxidation of the vitamins. GME0 is susceptible towards oxidation by free 
radicals, thereby reducing the content of these vitamins, if stored for a longer 
time period under shelf.  
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Table 6A.6  Variation in fat soluble vitamins A, D3, E, K1 and total carotenoid content of different 
treatments compared with GME0 during the accelerated shelf life study of 90 days 
(d=90). 
Nutrients 0 15 60 90 X 
Retinol (Vit A IU/100g) 
GME0 479.28±0.34ap 99.25±0.40aq 70.57±0.63ar 41.4±0.86as 91.36 
GME 1 495.49±3.73bp 479.52±1.00bq 443.82±1.33br 384.48±1.23bs 22.40 
GME 2 770.20±1.85cp 722.15±1.09cq 656.31±0.31cr 615.22±0.72cs 20.12 
GME 3 856.25±3.04dp 798.46±0.09dq 711.21±1.34dr 613.32±0.81ds 28.37 
GME 4 771.56±2.63ep 762.36±4.15ed 674.90±0.59er 602.94±0.59es 21.85 
Cholecalciferol (Vit D3 IU/100g) 
GME0 21553.5±1.5ap 15925.5±0.5aq 20692±1.1ar 12411.5±1.0as 42.42 
GME 1 32093.12±4bp 27543±3.0bq 21949±7.0br 20151±1.2bs 37.21 
GME 2 28325.5±0.5cp 27741.5±4.5cq 23363±7.3cr 21400±2.2cs 24.45 
GME 3 33594.5±4.5dp 29098.5±0.5dq 26701±1.02dr 21088±0.5ds 37.23 
GME 4 28356.2±2ep 27562±1.01dq 23212±5.5eq 21411.0±0.5es 24.49 
α-Tocopherol (Vit E IU/100g) 
GME0 1.94±0.02ap 1.70±0.14aq 1.89±0.07ar 1.67±0.98as 13.92 
GME 1 1.77±0.01bp 1.54±0.02bq 1.045±0.85br 0.95±0.21bs 46.33 
GME 2 2.56±0.07cp 2.12±0.02cq 1.81±2.71cr 1.71±0.11cs 33.20 
GME 3 3.345±0.21dp 2.805±0.17dq 2.505±0.14dr 2.36±0.19dr 29.34 
GME 4 2.73±0.15er 2.5±0.04eq 2.64±0.34er 2.12±0.05es 22.34 
Phylloquinone (Vit K1 µg/100g) 
GME0 57.03±0.03ap 27.73±0.76aq 7.35±0.09ar 3.27±0.28as 42.47 
GME 1 67.535±2.31bp 45.545±1.00bq 27.433±1.11br 22.48±0.05bs 94.27 
GME 2 69.24±0.09cp 67.45±0.82cq 52.8±0.74cr 43.92±0.61cs 36.57 
GME 3 69.83±0.06dp 58.79±0.50dq 50.61±0.11dr 40.17±0.12ds 66.71 
GME 4 71.81±0.50ep 69.2±0.63cq 55.47±0.08er 47.29±0.25es 34.15 
Total carotenoids (µg/g) 
GME0 459.51ap±0.48 387.74aq ±0.14 265.92ar ±0.39 201.10as±0.12 56.22 
GME 1 784.40bp±0.15 691.58bq±0.02 530.69br ±0.24 510.49bs ±0.24 34.88 
GME 2 1426.3cp±0.03 1389.1cq ±0.12 1093.5cr ±0.32 955.36cs ±0.41 33.04 
GME 3 1385.6dp±0.13 1282.5dq ±0.12 887.48dr ±0.32 735.45ds ±0.21 46.94 
GME 4 1451.2ep±0.03 1233.6eq ±0.12 922.41er ±0.32 960.8es±0.01 33.80 
Ra-e: Row wise values with different superscripts of this type indicate significant differences 
(P<0.05) within different samples; p, q, r: Column wise values with different superscripts of 
this type indicate significant differences (P<0.05) within different days of shelf life study. 
Results are expressed as mean ± SD (n = 3). X represents the percent change of vitamins and 
carotenoids at the end of the experiment (d=90) with respect to baseline (d=0) 
In the present study, the total carotenoid content in GME0 (460 µg/g) 
was found to be significantly lower than recorded in GME0 supplemented with 
additives (GME2-4 ~1400 µg/g, d=0) thereby indicating the added carotene 
pool to GME0 by the additives (P<0.05). The carotenoid content in GME0 
registered a significant reduction (P<0.05) at d=90 (Table 6A.6) than in the 
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treatments (GME1-4), which point towards the beneficial effect of natural 
additives. Interestingly enough, though an inverse correlation was observed 
between higher ROO and CLO concentrations and efficacy to contain 
carotenoid degradation in GME2 and GME4 at d=0 and at the end of the study 
(d=90), this does not hold true for GME3, which showed an accelerated 
degradation of carotenoids. As obvious, the treatments GME2 and GME4 
recorded a decelerated degradation of carotenoids (~33%) after 90 days (d=90) 
of accelerated storage than did GME3 (46.9%). 
6A.2.4 Time series studies of in vitro anti-inflammatory activities of various 
combinations of green mussel extract (GME1 - GME4) 
6A.2.4.1 Inhibition of cycloxygenase-2 (COX-2) 
The COX-2 inhibition assay used in this study is based on the oxidation 
of (1-DCF) by the hydroperoxide formed in the COX reaction. Time series 
studies of in vitro anti-inflammatory activities of various combinations of green 
mussel extract are given Table 6A.7. The treatment GME4 was significantly 
(P<0.05) effective in inhibiting COX-2 than other treatments. The COX-2 
inhibition rate of GME0 was significantly reduced (P<0.05) on d=30, and a 
significant reduction in activity was apparent after 90 days (d=90, P<0.05) with 
respect to the baseline activity (d=0). In general, the reduction in the 
inflammatory response is directly proportional to the active ingredients in GME0 
as apparent from the potential of the same to inhibit COX-2. Apparently, among 
the treatments, GME4 and GME2 showed a marginal reduction with respect to 
initial activity as compared to GME1 and GME3. GME2 and GME4 exhibited 
dose dependent inhibition of COX-1 and COX-2. At higher concentration (1 
mg/mL) the treatments GME2 and GME4 inhibited COX-2 to the tune of 49.9 
and 46.7%, respectively, than did indomethacin.  
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Table 6A.7  In vitro anti-inflammatory activities of different treatments (GME1- GME4) compared 
with control (GME0) (5mg/ml) during the accelerated shelf life study. 
Inhibitory activity of COX-2 (percent) 
Days GME0 GME1 GME2 GME3 GME4 
0 48.4apq ±0.03 50.02bp ±1.02 52.1cp ±0.59 51.6dp ±0.23 52.9ep ±0.56 
2 48.4aq ±1.56 50.23bq ±2.05 52.0cp ±2.0 51.4dq ±1.2 52.9eq ±0.9 
15 47.69ap ±1.25 49.89br ±1.65 51.89cp ±1.35 51.0dr ±0.59 52.01cr±0.45 
60 43.02ar ±0.25 47.06bs ±0.38 49.56cq ±1.97 49.56ct ±0.89 51.02ds±1.4 
90 37.23as ±2.36 46.56bt ±0.56 49.02cr ±0.56 47.56du ±0.74 51.0es±1.45 
x 23.1 6.9 5.9 7.8 3.6 
Inhibitory activity of 5-LOX (percent) 
0 51.9ap ±0.56 51.26bp ±0.45 58.2cp ±1.25 57.325dp ±0.32 62.3ep ±1.56 
2 51.23aq ±0.45 51.02bq ±0.89 57.89cq ±0.98 57.36dq ±1.56 61.89eq ±1.45 
15 49.56ar ±0.08 49.38br ±0.23 55.68cr ±0.14 57.022dr ±1.78 60.56er ±0.1 
60 48.65as ±0.25 47.89as ±0.36 54.0cs ±1.56 56.25cs ±0.89 58.36ds ±0.45 
90 42.25at ±0.02 45.25bt ±0.25 53.56ct ± 0.89 52.01dt ±0.45 57.56et ±1.5 
x 18.6 11.7 8.0 9.3 7.6 
Results are expressed as percent activity with respect to the samples, and as mean ± SD (n = 3). ‘x’ 
represents percent reduction in activity on 90th day (d=90) with respect to 0th day (d=0).a, b, c, d: 
Row wise values with different superscripts of this type indicate significant differences (P<0.05) 
within different samples; p, q, r, s: column wise values with different superscripts of this type 
indicate significant differences (P<0.05) within different days of shelf life study.  
 
It is known that COX-2 catalyzes the two-step conversion of ARA to 
PGH2, and other inflammatory PGs. The CA and RA in rosemary share a 
closer physicochemical status with ARA, and appeared to mimic the latter as a 
competitive COX-2 inhibitor. ARA was found to have tPSA and Pl as 37.3 
and 38.25 among electronic variables, and are closely matched with those 
calculated for CA (Table 6A.8) thereby indicating that CA may competitively 
inhibit with ARA for COX-2 by efficient complexation (salt bond) with the 
guanidinium group of charged amino acid residue Arg120 in the COX active 
site (Kurubail, 1998).  
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Table 6A.8 Physicochemical descriptor variables of natural vis a vis synthetic antioxidants and some 
commercially available anti-inflammatory compounds 
Compounds Physicochemical descriptor variables 
 Electronic Hydrophobic Steric 
 tPSA Pl Log P Clog P MV P MR CMR 
Arachidonic acid 37.3 38.25 6.16 7.392 327.7 798.4 100.35 9.5406 
Rosemary (Rosmarinus officinalis) 
 
Carnosic acid 
 
Rosmarinic acid 
 
Ursolic acid 
 
Carnosol 
Carnosic acid  77.76 39.12 5.14 3.132 316.2 789.2 98.70 9.3220 
Rosmarinic acid 144.52 36.21 2.07 1.0996 232.8 705.6 90.45 9.2512 
Ursolic acid - 53.50 9.69 13.269 440.5 1077.5 135.43 13.6428 
Carnosol 66.76 32.12 3.78 2.125 228.8 638.5 83.54 8.217 
Turmeric (Curcuma longa) 
Curcumin-I Curcumin-II 
 
Aryl turmerone 
 
Curlone 
Curcumin-I 52.6 43.58 4.31 4.7222 323.5 826.8 113.6 11.2364 
Curcumin-II 43.37 40.93 4.44 4.8032 299.5 770.1 106.71 10.6195 
Aryl turmerone 17.07 25.26 3.52 3.511 211.5 508.8 66.46 6.4853 
Curlone 17.07 27.21 3.26 3.1422 237.2 559.3 72.19 7.0685 
Indian gooseberry (Emblica officinalis Gaertn.)  
 
β-glucogallin 
 
Mucic acid 1,4-lactone 5-O-gallate 
β-glucogallin 177.14 28.27 -1.42 -1.1735 179.5 603.9 71.48 7.1714 
Mucic acid 1,4-lactone 5-O-gallate 191.05 28.20 -1.53 -4.0155 178.0 599.3 70.25 7.0897 
Zingiber officinale Roscoe L. 
  
             Zingiberene                 [6] Shogaol                                                                                      Gingerol [6]  
Gingerol [6] 66.76 32.88 3.59 2.943 271.7 693.0 83.32 8.2854 
(6) Shogaol 46.53 32.31 4.01 3.9112 267.4 666.1 83.79 8.1829 
[6] Paradol 46.53 32.29 4.69 4.2452 273.8 678.8 81.86 8.1323 
Zingiberene - 27.16 4.8 5.02 241.0 554.2 73.25 6.8808 
Zingerone 46.53 21.27 1.95 1.0712 174.8 440.1 54.12 5.3495 
Commercially available antioxidants 
BHT: butylated hydroxyl toluene 20.23 27.64 5.54 5.426 237.5 556.0 72.34 7.0159 
BHA: butylated hydroxyl anisole 29.46 21.09 3.22 3.3002 178.5 426.9 54.01 5.3138 
TBHQ 40.46 19.18 2.96 2.534 152.9 385.3 48.58 4.85 
Gallic acid 97.99 15.39 0.47 0.4255 97.2 314.4 37.53 3.8005 
Commercially available NSAIDs 
Salicylates (aspirin) 63.6 17.65 1.21 1.0235 139.5 370.9 43.29 4.4576 
Propionic acid derivatives (ibuprofen) 37.3 24.09 3.75 3.679 200.3 497.6 61.2 6.124 
Acetic acid derivatives (indomethacin) 66.84 37.49 3.58 4.18 269.5 707.6 93.56 9.5053 
Pl: Polarisability (cm3/mol), P: Parachor (cm3); tPSA: Calculation of polar surface area based on 
fragment contributions; CLogP to calculate n-octanol/water partition coefficient (log Pow); MR: molar 
refractivity (cm3/mol); CMR to calculate Molar Refractivity; MV: molar volume (cm3).  
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CH3CH3
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CH3 CH3
CH3
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The hydrophobic and steric parameters of CA too enjoy a close 
relationship with the substrate fit, eliminating ARA to occupy the desired 
active site to synthesize inflammatory PGs. The active principles (Curcumin-I, 
II) in CLO were found to have higher charges (electronic) and π-electron 
interactions with the amino acyl residues at the COX-2 active site (e.g., 
guanidinium group of Arg120 and aromatic ring of Phe/Tyr355 residues, 
respectively) than others due to higher electronic values (tPSAcurcumin-I 
52.6, curcumin-II 43.37; Pl 43.58 and 40.93, respectively) (Fig.6A.4). No 
significant differences (P>0.05) in hydrophobic and steric/bulk parameters 
indicate the similarities in molecular properties of curcuminoids and substrate 
(ARA) thereby indicating the potential of the former to mimic the enzyme 
(COX-2) inhibiting the biosyntheses of inflammatory PGs (Fig.6A.4 and 
Fig.6A.5). It is interesting to note that the molecular descriptor variables of the 
active principles of these natural additives realized distinctly different 
properties as compared to the NSAIDs thereby indicating the different anti-
inflammatory mode of action (Table 6A.8). The ability of Z. officinale to 
reduce inflammation is due to its neutralizing action upon free radicals by 
phenolic compounds viz., gingerol, zingerone, and shogaol (with 2-methoxy-
4-propylphenol moiety). The active ingredients in Z. officinale and E. 
officinalis contributed towards efficient ion pair with the amino acid residues 
in the enzyme active site apparently due to higher electronic effects (Table 
6A.8) than hydrophobic or steric effects. These compounds reported in the 
additives appeared to ion pair with the guanidinium group of Arg120, which 
also ion pairs with the carboxylate of ARA thereby mimicking the substrate to 
competitively inhibit the production of inflammatory PGs (Fig.6A.6).  
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Fig.6A.4  Schematic representation of the COX-2 active site amino acyl residues with the 
substrate (ARA) forming the inflammatory PGH2, PGE2, PGF2α, and TxA2 
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Fig.6A.5. Schematic representation of the 5-LOX active site amino acyl residues with the 
substrate forms the inflammatory leukotrienes.  
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Fig.6A.6  Schematic representation of the COX-2 active site amino acyl residues with the competitive 
inhibitiors, Carnosic acid and curcumin-I inhibiting the formation of inflammatory 
prostanoids (PGH2, PGE2, PGF2α, and TxA2). 
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6A.2.4.2. Inhibition of lipoxygenase-V (5-LOX) 
Lipoxygenases catalyze the dioxygenation of polyunsaturated fatty 
acids (PUFAs), such as, ARA (20:4n-6), which contain one or more 1, 4-cis, 
cis-pentadiene units to yield hydroperoxide products. Though 5-LOX, 12-
LOX, and 15-LOX were known to be involved in leukotriene biosynthesis, 5-
LOX appears to be the key enzyme. . In this study, GME4 showed higher 
inhibition of 5-LOX during the initial hours (d=0) than other treatments 
(Table 6A.7). Bromelain enzyme escharase present in A. cosumus used as a 
supplement in GME4 is attributable to the significant activity that supports 
higher anti-inflammatory action than other combinations (Brien et al., 2006). 
The anti-inflammatory activities were realized for GME0 as apparent from the 
potential of the same to inhibit 5-LOX. Decelerated 5-LOX inhibition by 
GME4 (7.6%), GME1 (7.8%), GME2 (8.0%) and GME3 (9.3%) than in GME0 
(18.6%) after 90 days of accelerated storage can be explained due to the 
absence of antioxidant additives in the latter. As in COX-2, charge/π-electron 
and hydrophobic interactions in the catalytic domain of lipoxidase play a 
major role in catalyzing ARA to yield hydroperoxide products. The active 
ingredients present in the additives used in the present work shares comparable 
structural/molecular features with the substrate (ARA) as established by 
calculating the molecular descriptors (Table 6A.8). The active ingredients in 
GME0 along with the major active principles in the additives appeared to 
hinder the desired 5-LOX catalyzed formation of hydroperoxide products 
thereby combating the inflammatory response.  
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6A.2.5 IR Spectroscopic analyses of the mussel extract supplemented with 
the natural additives (GME1-GME4) in a time series accelerated shelf-
life study at various intervals of incubation 
One of the principle active ingredients responsible for anti-
inflammatory activities in green mussel P. viridis was found to be 
polysaccharides and polysaccharide complexes. These biopolymers in 
shellfish received considerable attention in recent years because of their anti-
inflammatory, antitumor and immunoregulatory activities. The IR spectrum of 
the mussel extract indicates the presence of polysaccharide units and 
glycosidic bonds along with common functional groups present in 
polysaccharides. The absorbance in the range of 1037–1239 cm−1 indicates 
pyranose ring structure. Strong and wide absorption peaks in the region of 
3196-3509 cm−1 are due to a large amount of -OH stretching vibration 
characteristic of the polysaccharides. C-H stretching vibrations were 
characterized by the strong absorption peaks at 2854-3073 cm−1. The 
absorption bands appeared at 1644-1686 cm−1 is due to water associated with 
polysaccharides (Zhang et al., 2010). About other bands, there were intense 
absorbance with a peak of around 1629-1686 cm−1(C=O asymmetric stretching 
vibrations of the carboxylic groups), and bands of about 1403 and 1456 
cm−1(C=O symmetric stretching vibrations), indicated that there were carboxyl 
groups in the active principle. The band near 1543 cm−1 was assigned to the 
amide–II band resulting from the coupling between the NH2 deformation 
mode and -CN stretching vibration. The spectrum shows absorption at around 
845-933 cm-1 representing glycosidic linkages of polysaccharides. The spectra 
(Fig 6A.7) have been reported principally as a fingerprint for any future 
identification, since the absorption bands for such complex compounds are 
usually broad and diffuse.  
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Fig 6A.7(A)  Infrared spectra of mussel crude extract at baseline (d=0) vis-à-vis  GME2 and GME4 
during (B & D) 30 (d=30) and (C & E) 90 days (d=90) of accelerated shelf-life study. 
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The FT-IR spectra of GME2 and GME4 combinations at various time 
intervals are shown in Fig 6A.7 to understand the possible 
degradation/retention of these anti-inflammatory principles (polysaccharides) 
in a time-dependent manner till the end of 90 days of accelerated shelf life 
study. In this context it is important to note that the treatments GME2 and 
GME4 showed significant stability towards the polysaccharide complexes of 
mussel extract as evident by the presence of characteristic peaks of pyranose 
ring structure (1100–1200 cm−1), OH moieties (3200-3500 cm−1), C–H 
stretching vibrations (2900-3000 cm−1), and glycosidic linkages of 
polysaccharides (825-950 cm-1). Also of note is the presence of characteristic 
bands at 1235-1400 cm−1 (symmetric CH3 bending as in polysaccharides) and 
1660-1670 cm−1 (water associated with polysaccharides) appeared at 
throughout the period in shelf after 90 days (d=90) of accelerated shelf life 
study in GME2 and GME4 with respect to those recorded at baseline (d=0) and 
at d=30 (Fig 6A.7). GME2 and GME4 exhibited the signals at 1600–1700 
cm−1, 1400 cm−1, and 1540-1554 cm−1 indicating the presence of –COOH and 
–NH groups at d=90. Hence, the present investigation demonstrated that the 
combinations GME2 and GME4 have the potential to retain the active 
principles, particularly the polysaccharide fraction. 
6A.2.6 In vitro and in vivo anti-inflammatory studies of the potential anti-
inflammatory treatments (GME2 and GME4) 
The in vitro stability studies of anti-inflammatory activity in time series 
accelerated shelf life study showed that GME2 and GME4 retained the anti-
inflammatory activity of GME0, and, therefore, these were shortlisted for 
further evaluation of in vitro and in vivo anti-inflammatory activities, and were 
compared to synthetic NSAIDs. 
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6A.2.6.1 In vitro anti-inflammatory activities  
GME2 and GME4 exhibited dose dependent inhibition of COX-1 and 
COX-2. At higher concentration (1 mg/mL) the treatments GME2 and GME4 
inhibited COX-2 to the tune of 49.9 and 46.7%, respectively, than did 
indomethacin. Particularly, GME4 showed excellent inhibitory activity against 
COX-1, COX-2, and 5-LOX, respectively, and its inhibitory activities were well 
balanced for these enzymes. It is worth mentioning that a comparable inhibition 
of these treatments (GME2 and GME4) with indomethacin (≥ 58%, 5 mg/mL) 
was found on inhibiting LOXV, and was higher than aspirin. This discovery 
preceded the observation that dual inhibitors of COX-2 and 5-LOX may have a 
better therapeutic profile and have fewer side effects than NSAIDs. 
COX-1 is termed as the housekeeper enzyme due to its presence in most 
tissues, particularly gastrointestinal tract lining. COX-2 is inducible by the 
inflammatory response, and increases in response to inflammation including 
arthritis. It is desirable to inhibit this pro-inflammatory enzyme to deter 
inflammation. COX-1 maintains normal gastric mucosa, and, therefore, it is 
undesirable to inhibit this enzyme in an exclusive manner. COX-1/COX-2 ratio 
apparently provides us with the selectivity of the anti-inflammatory agents. 
Analysis of COX-1/COX-2 ratio and side effects of the NSAIDs show that the 
higher the ratio, the lower the selectivity towards inhibiting inflammation, and 
consequently higher are a side effect. Earlier studies reported that (Engelhardt et 
al., 1995) tenoxicam, diclofenac, tenidap and piroxicam possess higher COX-
1/COX-2 ratio (15, 2.2, 122 and 33, respectively), which are undesirable 
indicators of an ideal anti-inflammatory agent. In the recent context, selective 
COX-2 inhibitors are gaining importance as potential new generation selective 
anti-inflammatory agents. In the present study, the treatments GME2 and GME4 
realized the COX-1/COX-2 ratios less than 1.0, as compared to the NSAIDs 
(COX-1/COX-2 > 1.0). A lower COX-1/COX-2 ratio of GME2 and GME4 relates 
to less gastrointestinal side-effect profiles, and effectively manages the 
manifestations of pain and arthritis. 
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In recent times, interest has been focused towards LOX inhibitors, which 
were reported to block the synthesis of leukotriene metabolites. Though 5-LOX, 
12-LOX, and 15-LOX were known to be involved in leukotriene biosynthesis, 5-
LOX appears to be the key enzyme. Accordingly, a lower COX-1/5-LOX (<1.0) 
indicates higher selectivity and lower side-effect profiles of the anti-inflammatory 
agents GME2 and GME4. Ideally, the simultaneous inhibition of COX-2and 5-
LOX maximize the anti-inflammatory effects, and, therefore, the pharmaceutical 
companies are in search of anti-inflammatory agents with lower COX-1/COX-2 
and COX-1/5-LOX due to their higher selectivity against inflammatory response 
and lower undesirable side effects or toxicity. 
 
Table 6A.9  Percentage inhibition of COX-1, COX-2 and 5-LOX enzymes and  ratios of pro-
inflammatory enzyme inhibition by anti-inflammatory formulations (GME2 and GME4) 
vis-à-vis standard anti-inflammatory drugs, aspirin and indomethacin at different 
concentrations (0.5 mg/mL, 1 mg/mL, 5 mg/mL).  
 
  Aspirin Indomethacin GME2 GME4 
 Inhibition (percent) of COX-1  
0.5 mg/mL 44.6±0.55p 45.6±0.80p 28.6±0.61q 28.1±0.94q 
1 mg/mL 52.0±1.83p 54.0±1.05p 41.1±0.95q 42.6±0.52q 
5 mg/mL 70.0±0.10p 72.1±0.92p 44.2±0.41q 44.5±1.41q 
COX-1/COX-2 1.16±0.94p 1.32±0.14q 0.96±0.24p 0.90±0.14p 
COX-1/5-LOX 1.42±0.04p 1.39±0.01p 0.65±0.02q 0.62±0.03q 
 Inhibition (percent) of COX-2 
0.5 mg/mL 38.5±0.09p 34.6±0.59p 29.9±0.10p 31.2±0.19p 
1 mg/mL 52.2±0.10p 46.3±0.49q 49.9±0.30pq 46.65±0.13q 
5 mg/mL 58.6±0.60p 59.0±1.0p 52.1±1.10q 52.9±0.12q 
COX-1/COX-2 1.00±0.01p 1.17±0.02p 0.82±0.04q 0.91±0.05p 
COX-1/5-LOX 1.29±0.01p 1.14±0.04p 0.87±0.07q 0.86±0.03q 
 Inhibition (percent) of 5-LOX 
0.5 mg/mL 31.3±0.55p 32.9±0.90p 43.8±0.61q 45.1±0.94q 
1 mg/mL 40.2±1.83p 47.2±1.05q 47.1±0.95q 49.6±0.52q 
5 mg/mL 54.8±0.10p 66.3±0.95q 58.2±0.41q 62.3±1.41q 
COX-1/COX-2 1.19±0.03p 1.22±0.02p 0.85±0.03q 0.84±0.04q 
COX-1/5-LOX 1.28±0.05p 1.09±0.04p 0.76±0.02q 0.71±0.02q 
 COX-1/COX-2 and COX-1/5-LOX are referred to as selectivity indicators of anti-
inflammatory properties of the anti-inflammatory formulations (GME2 and GME4) vis-à-vis 
synthetic NSAIDs. p, q: Row wise values with different superscripts of this type indicate 
significant differences (P<0.05) within different samples. 
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6A.2.6.2  In vivo anti-inflammatory activities of the shortlist combinations on 
carrageenan-induced rat paw edema 
GME2 and GME4 showed to be potent anti-inflammatory supplements; 
and, therefore, they were further evaluated for their activities in an in vivo 
system. In the carrageenan administered animals (control) severe swelling was 
observed at 5th h, and the swelling was maintained until 6th h. Though the 
aspirin treated groups decreased paw edema significantly (P<0.05) with a 
maximum inhibition (80.87%) after 4th h the edema exhibited an incremental 
trend during 6th h. The effects of aspirin, ibuprofen and stabilized freeze-dried 
P. canaliculus extract in carageenan-induced inflammation in rodents, which 
revealed that stabilized mussel extract reduced edema significantly higher 
(90%) compared with aspirin (40%) and ibuprofen (60%). Notably, the 
animals challenged with GME2 and GME4 significantly mitigated the edema 
in rats in a time-dependent manner till the end of the 6th h  as compared to the 
control animals throughout the period of study (P<0.05) (Table 6A.10). GME2 
and GME4 showed inhibition of the edema to the tune of 52.31 and 50.52%, 
respectively (250 mg/kg dose) during the 3rd h after the carrageenan injection, 
which reached to 72.96 and 73.48%, respectively after the 6th h as compared to 
~80% for standard synthetic drug (aspirin) (Fig 6A.6). However, it was 
interesting to note that the activity of GME2 and GME4 improved with time, 
indicating their potential to release the active principle throughout an extended 
period, unlike the standard, which showed a deceleration in activity after 4 h. 
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Fig 6A.8  Effect of the anti-inflammatory treatment GME2 and GME4 compared with the standard 
drug (aspirin) on carrageenan-induced hind paw edema in BALB/C mice. (A) & (B):  
Reductions in rat paw edema in treated (by GME2) rats; (C) & (D): Carrageenan-induced 
hind paw edema in BALB/C mice without any treatment; (E) Rate of change in rat paw 
edema (%) after administration of anti-inflammatory treatments GME2 and GME4 vis-à-
vis standard drug (aspirin). 
6A.3 Conclusions 
The dual inhibitory activity of the aqueous extract of Indian green 
mussel, P. viridis against pro-inflammatory COX-2 and 5-LOX enzymes 
demonstrated its better therapeutic profile and fewer side effects than synthetic 
NSAIDs. From the present study, it is revealed that different additives from 
natural origin, such as, Curcuma longa, Rosmarinus officinalis etc., added in 
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different combinations can retain the anti-inflammatory activity of P. viridis 
extract by stabilizing its active anti-inflammatory ingredients. The FT-IR 
spectra at various time intervals showed the possible degradation/retention of 
the anti-inflammatory principles of P. viridis vis a vis different combinations, 
in a time-dependent manner demonstrating that the combinations GME2 and 
GME4 have the potential to retain the active principles throughout the 
experimental period under shelf. A lesser COX-1/COX-2 and COX-1/5-LOX, 
simultaneous inhibition of COX-2 and 5-LOX enzymes and significant in vivo 
activity of GME2 and GME4 indicates higher selectivity and lower side-effect 
profiles. Hence, the anti-inflammatory formulations, GME2 and GME4 are 
effective new generation green alternatives to the synthetic NSAIDs for use 
against a cascade of mammalian inflammatory diseases. 
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6.B  Enrichment of the potential anti-inflammatory combination by 
anti-inflammatory principles isolated from P. viridis 
Background of the study 
The green mussel P. viridis is a bivalve mussel (family Mytilidae) found 
in the coastal sea beds along the south west coast of India, and considered to be 
an economically important bivalve mollusk. Green mussel, abundant in C20-C22 
n-3 PUFAs, particularly eicosapentaenoic acid (20:5n-3, EPA) and 
docosahexaenoic acid (22:6n-3, DHA), which are the precursors of anti-
inflammatory resolvins (E- and D-series). EPA is more efficient in reducing 
cellular inflammation preventing depression disorders, and in the reduction of 
serum triacylglycerols (formerly known as triglycerides).  DHA is a component 
of the phospholipid membrane of brain and retina cells; consequently, it is 
essential for human health. Phospholipids and phosphatidylcholine applied to 
either the apical or the basolateral surfaces, was integrated into the cells and 
significantly inhibited TNF-α-induced inflammatory responses. In animal 
studies the exogenous phospholipids or phospholipids contained in food have 
been shown to prevent mucosal damage induced by acids, nonsteroidal anti-
inflammatory drugs, or bile salts in the stomach, duodenum, and small intestine. 
Phosphatidylcholine (PC) and lysophosphatidylcholine (LPC) are the major 
phospholipid classes found in the mucus, the anti-inflammatory action of 
choline in guinea pigs. 
Polysaccharides and polysaccharide–protein complexes have been found 
as common polymers in shellfish and received considerable attention in recent 
years because of their anti-inflammatory, antitumor and immunoregulatory 
activities. Polysaccharides have been used for decades to stimulate the immune 
system and to fight against cancer. And several researches have shown that 
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some polysaccharide possessed an antioxidant activity. Perna viridis was 
reported to yield heparin and heparin-like glycosaminoglycans with fewer 
impurities (Arumugam and Shanmugam, 2004).  
The present work involves the extraction and isolation of different anti-
inflammatory principles from P. viridis. Specifically the anti-inflammatory 
lecithin and polysaccharides along with glycolipoprotein and n-3 
polyunsaturated fatty acids were isolated from this bivalve mollusk in an 
attempt to enrich the anti-inflammatory activity of the formulations. The 
isolation of active components from whole organisms requires several 
purification steps, with each step requiring a screening process to target the 
active components. These isolated naturally derived anti-inflammatory 
components were added in various compositions to the said anti-inflammatory 
combination GME2 (discussed in section 6A) to prepare different experimental 
combinations (Q1 to Q2). 
Another area of concern is that a product of green mussel origin is 
embedded in unsaturated lipid matrix. This can potentially result in changes in 
its physicochemical characteristics (formation of high risk decomposition 
substances viz., free radicals, small molecular weight aldehydes, and ketones) 
during storage thereby changing its anti-inflammatory properties. The present 
work explored the role of various natural additives with antiradical active 
principles to retain the anti-inflammatory potential of the anti-inflammatory 
concentrate. Naturally derived antioxidants were added to the anti-
inflammatory combination, and were subjected to accelerated shelf life study 
(50°C) for a period of 90 days (d=90) to evaluate the anti-inflammatory 
activities of different combinations, supplemented with natural additives 
during the study period.  
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6B.1  Isolation of anti-inflammatory principles from P. viridis 
The anti-inflammatory activity of P. viridis extract might be due to the 
presence of one or more constituents present in the extract. These components 
might act synergistically to reduce inflammation, limit further cartilage 
degeneration, and potentially support the regeneration of damaged joint 
cartilage and synovial fluid. The exact natures of the anti-inflammatory 
compounds can be elucidated by the purification of P. viridis sample by 
different methods. The identification of major compounds in it may be helpful 
in delineating the pharmacological activity and the underlying mechanisms. 
6B.1.1 Isolation of polysaccharides from P. viridis 
The ground fresh mussel sample (100 g) was extracted thrice with 
water (60ºC, 1:1 ratio, 2 h) and centrifuged (model superspinR-V/Fm, 
Plastocrafts) at 9500 rpm for 20 min to separate the water insoluble impurities 
from the extracts.  The combined extracts were concentrated (50°C) in vacuo 
to one-third volume and precipitated with ice-cold 95% ethanol under rigorous 
stirring. The polysaccharide pellets were obtained by centrifugation and freeze 
dried to obtain crude polysaccharides 11 (MPS) (30.01 g, yield based on raw 
mussel, 3.01%). The crude polysaccharide obtained from P. viridis was 
purified by ion exchange chromatography DEAE (Bio-Rad, USA) column (Cl− 
form, 2.5 x 9 cm) equilibrated with 0.1 M NaCl. Briefly, the solution of 
ethanol precipitate in NaCl (0.1 M) was charged to the anion exchanger, and 
the column was successively eluted with a NaCl linear gradient (0.1 to 1.5 M) 
until the disappearance in the eluent of positive reaction for carbohydrates. 
The fractions containing polysaccharide were vacuum concentrated, dialyzed 
against distilled water for 36 h, and lyophilized. The major peak was collected 
and further purified on a Sephacryl S-300 HR gel-permeation chromatography 
to afford (→4)-2, 4 di-(N-acetyl-β-D-mannosamine) -(1→4)-2-N-acetyl- β-D-
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galactosamine-(1→) - (4-N-acetyl p-phenoxyl) motifs. The purified fraction 
was monitored by HPLC on a SUPELCOSIL LC-NH2 column (Supelco, 5 μm, 
25 cm × 4.6 mm) using acetonitrile: water (75:25; % v/v, 1 mL/min) as mobile 
phase at 35ºC using a RI detector for the presence of oligosaccharide units 
(12).  
6B.1.2 Isolation of lysolecithin from P. viridis 
The FDPE was further extracted with MeOH (3 x 650 mL,70 ºC for 2-4 h 
under N2), filtered through Whatman No. 1 filter paper, and the pooled filtrate 
was concentrated (50ºC) in vacuo to one-third volume. The methanolic extract 
was partitioned with CHCl3: MeOH (100 mL x 3) and concentrated in vacuo to 
furnish a fraction termed as PME0. The PME0 was subjected to a silica gel (60–
120 mesh) column (60 g) chromatography, and eluted using a stepwise gradient 
system from CHCl3 (100%) to MeOH (100%) to obtain eleven column fractions 
(PME1-11). The purification procedure was monitored by different 
chromatographic analyses which revealed the purity of PME11 fraction, which 
was characterized as lysolecithin (12).  
6B.1.3 Extraction and purification of glycolipoprotein 
The extraction of glycogen from P. viridis samples were carried out 
following the method of Miller et al (Miller et al., 1993) with suitable 
modifications. The fresh, ground P. viridis sample (500g) was extracted with 5 
volumes (w/v, 2500mL) of aqueous phenol (w/v 15%) at 15-20ºC for 45-60 
min. The mixture was then centrifuged (8000-12000 rpm) for 5-8 min and the 
upper aqueous layer containing glycogen was aspirated. About 6 volumes 
(3000 mL) of 95% ethanol was added and centrifuged (8000-12000 rpm) for 
5-10 min to obtain the precipitate. This precipitate was washed with distilled 
water (5 x 200 mL) to remove the phenol content and lyophilized to get the 
GLP (GLP, 3.35g; yield based on raw material, 0.7%).  
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The GLP was refluxed with aqueous KOH (20%, 30mL) in a water 
bath at 100ºC for 2-4 h under N2 and left to cool at 4ºC overnight. The mixture 
containing the precipitate was centrifuged and washed with distilled water 
(3x40 mL) to make the pH neutral. The obtained glycoprotein was lyophilized 
(GP, 0.1g; yield based on raw mussel, 0.02%). The GP (50mg) was dissolved 
in phosphate buffer (0.1M, 1mL, pH 7.4) and hydrolysed by proteinase K 
enzyme (2% in distilled water; 12µL) and kept at 37ºC for 8-24 h preferably 
for 16 h. The precipitate was centrifuged (8000-12000 rpm) for 20min, washed 
with distilled water (2x40 mL) and the obtained product was lyophilized to get 
glycogen (G, 0.05g; yield based on raw mussel, 0.008%). 
6B.1.4 Enrichment of polyunsaturated fatty acids by amide complexation 
The FDPE (160g) was homogenized with ethyl alcohol (640 mL), 
sonicated for 10 min, and the homogenate was refluxed (55-60 ºC) for 30 min. 
The alcoholic solution was vacuum-filtered by using a buchner funnel through 
Whatman No. 1 filter paper, and concentrated using a rotary evaporator at 40 ºC. 
The obtained extract was saponified to furnish free fatty acids (FFAs) as follows.  
The extract (ALE, 18 g, yield,12.1%) was treated with 0.001 % butylated 
hydroxytoluene (BHT) and saponified by refluxing for 1 h under a blanket of N2 
using aqueous mixture of KOH (55.5 mL, 1.33N). To the saponified mixture, 
distilled water (50 mL) was added and the unsaponifable matter was extracted 
with n-hexane (100 mL x 2) and discarded. The aqueous layer containing 
saponifable matter was acidified (pH 1.0) with 3N HCl (19 mL). The mixture was 
transferred to a separatory funnel and the liberated fatty acids were extracted with 
of n-hexane (50 mL). The n-hexane layer, containing free fatty acids, was then 
dried over anhydrous Na2SO4 and the solvent was removed at 40 ºC to recover the 
free fatty acids. The polyunsaturated fatty acids (PUFAs) in these free fatty acids 
were concentrated by urea-fatty acid complexation. Briefly, the free fatty acids (6 
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g), to which urea (24 g) in ethyl alcohol (95% v/v, 240 mL) was added, and the 
contents were heated (60–65ºC) until a clear homogeneous solution was obtained. 
The urea complexes were allowed to crystallize overnight at 4ºC. The formed 
crystals (urea complexing fraction, UCF) were separated from the liquid (non-
urea complexing fraction, NUCF) by filtration. The NUCF was diluted with water 
(720 mL) and acidified to pH 4-5 with using 6N HCl (5 mL).The mixture was 
further extracted with n-hexane (20 mL), and the combined organic layers were 
washed with water, and dried over anhydrous Na2SO4, and the solvent was 
removed at 40ºC using a rotary evaporator. 
6B.1.5  Preparation of enriched anti-inflammatory compositions, experimental 
treatments and designing of stability studies 
The best anti-inflammatory formulation GME2 (section 6A) was enriched 
with anti-inflammatory components (MPS, glycolipoprotein, PME0, NUCF), 
isolated from P. viridis. For the identification of potent ratios of MPS, two 
different formulations with MPS were prepared by assigning GME2 as the base 
material. The enriched compositions were stabilized by adding 0.1% of E. 
officinalis extract (PEE). E. officinalis (100 g) was extracted thrice with distilled 
water (100 mL), centrifuged and lyophilized to obtain crude aqueous extract. The 
anti-inflammatory components, such as, MPS, glycolipoprotein, NUCF, PME0 
along with PEE were homogenized in distilled water and added to FDPE in 
different ratios according to Table 6B.1. In order to find the potent anti-
inflammatory combination, these combinations were studied for their different 
biochemical characteristics in order to find their individual and synergistic effects. 
The samples were kept in glass vials (10 g each) in an incubator at 50°C, were 
evaluated the 0th day, and at regular time intervals according to the experimental 
design for a period of 90 days (3 months). A time-dependent accelerated shelf life 
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studies were conducted in order to find the effects of different compositions of 
additives in the enriched anti-inflammatory composition. 
Table 6B.1: Composition (in percent) of different formulations: 
Components added Q1 Q2 
GME2 97.7 97.7 
MPS 1.2 0.8 
GLP 0.4 0.4 
PME0 0.4 0.8 
NUCF 0.2 0.2 
PEE  0.1 0.1 
FDPE: freeze dried mussel extract without additives (control). MPS (crude polysaccharides 
isolated P. viridis), PME0 (methanol extract of P. viridis), GLP (Glycolipoprotein), NUCF 
(non-urea complexing fraction), PEE (lyophilized aqueous extracts of E. officinalis) 
6B.1.6 Antioxidant and anti-inflammatory assays 
The capability of the samples to scavenge hydrogen peroxide (H2O2) 
was determined according to the established method (Ruch et al., 1989). Lipid 
compositions of the samples (0.1g each) were determined using established 
methods (Bligh and Dyer, 1959) and the fatty acid composition of the total 
lipids was determined as described elsewhere (Chakraborty and Paulraj, 2009). 
The amount of total phenolics, 2, 2-diphenyl -1- picrylhydrazyl (DPPH) 
radical scavenging activity and degree of lipid peroxidation were determined 
as described earlier (Tai et al., 2011). Cyclooxygenase (COX-1  and COX-2) 
inhibition assays were performed using 2, 7-dichlorofluorescein method 
(Cheung et al., 2007). The 5-lipoxygenase (5-LOX) inhibition assay was 
carried out using the principle of 1-4 diene (linoleic acid) oxidation to 1- 3-
diene (Baylac et al., 2003). The in vivo carrageenan-induced mice paw edema 
experiment was carried out as previously described (Winter et al., 1962).  
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6B.1.7 Spectroscopic analyses  
Fourier Transform Infra Red spectrometer (FTIR) spectra of the 
compounds under KBr pellets were recorded in a Thermo Nicolet, Avatar 370 
explained in 5.1.1.2A. The Gas Chromatography-Mass Spectrometry (GC-
MS) analyses were performed in electronic impact (EI) ionization mode in a 
Varian GC (CP-3800) interfaced with a Varian 1200L single quadruple Mass 
Spectrometer and the 1H and 13CNMR spectra were recorded on a Bruker 
AVANCE III 500 MHz (AV 500) DRX 500 NMR spectrometer (Bruker, 
Karlsruhe, Germany) detailed in  5.1.1.2B and 5.1.1.2C respectively. 
6B.1.8 Statistical analyses 
One-way analysis of variance (ANOVA) was carried out with the 
Statistical Program for Social Sciences 13.0 (SPSS, USA, ver. 13.0) to assess 
for any significant differences between the means. Differences between means 
at the 5% (P<0.05) level were considered significant. 
6B.2 Result and discussion 
6B.2.1 Enrichment of polyunsaturated fatty acids by amide complexation 
The fatty acid compositions of the two fractions were determined using 
GC and recorded in Table 6B.2. FDPE showed a total PUFA content of 
28.4%. The monounsaturated fatty acids (MUFAs) accounted for 
approximately 20.9%, of which the dominant was found to be 22:1n-9. Gordan 
et al reported the fatty acid profiles of mollusks, usually dominated by 
saturated fatty acids (SFAs), apparently our study reported 42.3% SFA in P. 
viridis (Gordan et al., 1982). The most dominant SFA was 16:0 (25.9%). The 
major long chain PUFAs was found to be 22:6n-3 (7.9%) and 20:5n-3 (7.0%). 
The total SFAs (72.2%) in ALE comprised of 8.8, 43.6, 4.5, and 1.8% of 
C14:0, C16:0, C17:0, C18:0 and C20:0 SFAs, respectively. The MUFA was 
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recorded to be higher (11.4%) compared to total PUFA (10.9%). PUFA was 
mainly contributed by the fatty acids 20:5n-3 (2.4%) and 22:6n-3 (3.1%). The 
FFA (6 g, yield-3.7%), obtained after  saponification were purified by 
complexation with urea, to obtain non-urea complexed fraction (NUCF, 3 g;  
yield-1.9%) and urea crystallized fraction (UCF,16g). The interfering SFAs 
and most of the MUFAs (long-and straight-chain molecules) were removed in 
the form of urea inclusion complex, while the PUFAs remained in solution. 
Urea fractionation resulted in significant reduction in SFAs (72.2% to 
39.2%TFA). The total PUFA after urea fractionation was recorded to be 
34.6%, mainly comprising by EPA (9.8% of TFA), 18:3n-3 (2.6% of TFA), 
and 22:6n-3 (10.1% of TFA). The complete removal of SFAs by urea 
complexation is impossible since some of saturated fatty acids do not form 
complex with urea during crystallization (Ratnayake et al., 2006). A small 
proportion of PUFAs appeared to be complexed with urea, and was detected in 
UCF (9.1%). 
Table 6B.2:   Fatty acid composition of ethanolic extract (AEE), urea complexed fraction (UCF) 
and non-urea complexed fraction (NUCF). 
Fatty acid (as weight %) 
 FDPE AEE NUCF UCF 
Saturated fatty acids 
12:0 0.14a 0.15a 0.13a 0.25a 
13:0 0.07a 0.08a 0.05a 0.13a 
14:0 6.09a 8.79b 6.15a 7.63c 
15:0 0.13a 1.96b 0.72a 1.85b 
iso 15:0 0.06a 0.19a 0.12a 0.19a 
16:0 25.9a 43.6b 21.2a 46.8b 
iso 16:0 0.99a 0.9a 0.45a 0.95a 
17:0 0.33a 4.52b 1.52c 4.85b 
18:0 6.09a 9.64b 8.13c 10.1b 
20:0 2.14a 1.85a 0.3b 2.39a 
22:0 0.16a 0.31a 0.26a 0.45a 
24:0 0.21a 0.25a 0.15a 0.3a 
∑ SFA 42.3a 72.2b 39.2a 76b 
Functional Food Enriched with Natural Ingredients from Green Mussel P. viridis 
293 
Monounsaturated fatty acids 
14:1n7 1.21a 1.23a 1.81a 1.06a 
16:1n7 trans 0.27a 0.07a 0.05a 0.05a 
16:1n7 cis 8.8a 4.39b 8.86a 3.14c 
16:1n9 cis 1.42a 1.53a 2.41b 1.65a 
17:01 0.22a 0.16a 0.35a 0.27a 
18:1n7 cis 2.56a 0.58b 1.41b 0.64b 
18:1n9 trans 0.08a 0.05a 0.03a 0.04a 
18:1n9 cis 2.63a 1.51b 3.55a 1.62b 
20:1n11 0.03a 1.05b 1.11b 1.02b 
22:1n9 2.76a 0.52b 1.69c 0.87b 
24:01:00 0.93a 0.3a 0.45a 0.26a 
∑ MUFA 20.9a 11.3b 21.7a 10.6b 
Polyunsaturated fatty acids 
16:2n4 0.21a 0.27a 1.51b 0.18 a 
16:3n4 0.14a 0.18a 0.26a 0.21a 
18:2n6 trans 0.11a 0.09a 0.08a 0.11a 
18:2n6 cis 2.39a 0.55b 3.28a 0.62b 
18:3n6 2.46a 1.53a 2.03a 1.85a 
18:4n6 2.28a 0.28b 0.45b 0.15 b 
18:3n3 1.61a 0.42b 2.61c 1.34a 
18:4n3 1.1a 0.12b 0.35b 0.15b 
20:2n6 0.31a 0.4a 0.49a 0.39a 
20:3n6 0.47a 0.21a 0.41a 0.11a 
20:4n6 0.58a 0.45a 0.6a 0.08a 
20:3n3 0.28a 0.28a 0.68a 0.3a 
20:5n3 6.98a 2.37b 9.78c 1.28b 
22:5n3 1.56a 0.69b 1.92a 0.15b 
22:6n3 7.92a 3.11b 10.1c 2.21b 
∑ PUFA 28.4a 10.9b 34.6c 9.13b 
∑ n3 8.49 6.99 25.5 5.43 
∑ n6 9.84 3.51 7.34 3.31 
∑ C18PUFA 8.62 2.99 8.8 4.22 
∑ C20PUFA 2.29 3.71 11.9 2.16 
n3/n6 0.67 1.99 3.47 1.64 
∑PUFA/∑SFA 12 0.15 0.88 0.12 
EPA/AA 1.13 5.26 16.3 16 
DHA/EPA 0.46 1.31 1.03 1.72 
Data are expressed as mean ± standard deviation of three replicates. ΣSFA Total saturated fatty 
acids, ΣMUFA   Total   monounsaturated fatty acids, ΣPUFA Total polyunsaturated fatty acids. 
Means with different superscripts (a, b, c, d) in the same row indicates a statistical difference 
(P<0.05).  
6B.2.2: Anti-inflammatory compounds isolated from P.viridis 
The biopolymers in shellfish received considerable attention in recent 
years because of their anti-inflammatory, antitumor and immunoregulatory 
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activities (Dai et al., 2009). The oligosaccharide (compound 11) was 
characterized as di-(N-acetyl-β-D-mannosamine) -(1→4)-2-N-acetyl-β-D-
galactosamine-(1→) - (4-N-acetyl p-phenoxyl) motifs. IR spectrum of (→4)-2, 4 
di-(N-acetyl-β-D-mannosamine) -(1→4)-2-N-acetyl- β -D-galactosamine-(1→) - 
(4-N-acetyl p-phenoxyl) unit revealed the broad and  intense stretching at 3400 
cm−1 is characteristic of hydroxyl groups and the weak stretching at 2930 cm−1 is 
attributed to the C–H bond. The fraction also exhibited an obvious characteristic 
absorption at 925 and 800 cm−1 corresponding to the existence of mannose. The 
characteristic absorptions at 850 cm−1 in the IR spectra indicated the presence of 
α-glycosidic linkages. The 1H NMR spectrum (500 MHz) (Fig 6B.1A) showed 
anomeric proton signals at δ 5.28-5.35  and δ 4.5 in a molar ratio of about 2:1, 
which were assigned to the two types of sugar units. The structure characteristics 
of oligosaccharide, especially the chain linkage and conformation of the sugar 
units, were completed and confirmed by 1D and 2D NMR. The signals around δ 
3.5–4.5 were assigned to be as the cross ring protons Fig 6B.1.    
 
Fig 6B.1 (A) 1H NMR, and (B) 13C NMR spectra of polysaccharide isolated from P.viridis. 
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Similarly, the 13C spectrum (Fig 6B.1B) showed four signals δ 102.2, 
100.8, 98.2 and δ 94.6 in a molar ratio of nearly 6:1:1:3, which were assigned to 
be the anomeric carbon of sugar units. The other signals around δ 60–85 were also 
assigned to be as carbon signals for C2–C5. The complete assignment of the 
chemicals-shifts of the sugar units were obtained from 2D NMR (Table 6B.3), 
including 1H-1H COSY (Supplementary Figure S1), NOESY (Supplementary 
Figure S2b), 1H-13C HMBC and HMQC (Figure 4) were acquired, according to 
the published methodology (Shankaracharya, 1998).  
Table 6B.3  NMR spectroscopic data of(→4)-2, 4 di-(N-acetyl-β-D-mannosamine) -(1→4)-2-N-
acetyl- β-D-galactosamine-(1→) - (4-N-acetyl p-phenoxyl) unit (11) 
 Carbon Position 
13C NMR δ
1H NMR 
(int., mult., J in Hz)b 
1H-1H COSY 
(4-N-acetyl-p-
phenoxyl) unit- A 
A-1 132   
A-2 130 7.42-7.52 (J=9.09 Hz) A-3 
A-3 126 7.59-7.67 (J=9.01 Hz)  
A-4 136   
A-5 125 7.59-7.67 (J=9.01Hz) A-6 
A-6 128 7.42-7.52 (J=9.09 Hz)  
A-7 N 3.47-3.50  
A-8 174   
A-9 33 1.98-2.30  
2-N-acetyl-β-D-
galactosamine unit -B 
B-1 106.93 5.28-5.35 B-2 
B-2 99.00 3.20-3.30  
B-3 87.29 3.75-3.85 B-4 
B-4 100.25 4.20-4.25  
B-5 93.24 3.60-3.75 B-6 
B-6 68.54 3.80-3.90  
B-7 N 3.85-3.90  
B-8 174   
B-9 33.97 1.98-2.30  
Di-(N-acetyl-β-D-
mannosamine)-C 
C-1 106.93 5.28-5.35 C-2 
C-2 101.70 3.20-3.30  
C-3 82.73 4.10-4.20 C-4 
C-4 93.81 3.50-3.70  
C-5 82.73 3.20-3.30  
C-6 74.70 3.60-3.75 C-5 
C-7,7’ N 3.29  
C-8,8’ 164   
C-9,9’ 31.93 2.05-2.30  
aNMR spectra recorded using Bruker AV III 500 MHz spectrometer. bValues in ppm, multiplicity and 
coupling constants (J¼ Hz) are indicated in parentheses. Assignments were made with the aid of the 1H–
1H COSY, HMQC, and HMBC experiments. 
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The down field-shifts in carbon signals of the sugar units compared to the 
native glucan might suggest the possible linkage information, e.g., the downfield-
shift in the C-3 position of the W indicated it might be 3-linked mannose. 
Similarly, units U, V and X were deduced to be as 6-linked glucose, terminal 
glucose and 3,6-linked mannose, respectively. The linkage information of the 
sugar units were further confirmed by NOESY and HMBC experiments. In the 
HMBC spectrum, the intra- and inter-residual connectivities of both anomeric 
protons and carbons of each of the glycosyl residues were summarized in Table 
6B.3. The cross peaks indicated the correlation signals which were found between 
C-1 of the residue U (δ 102.2) with H-6 of residue X (U C-1, X H-6), H-1 of 
residue U (δ 5.33) with C-6 of residue X (U H-1, X C-6), indicating that  U was 
linked to the 6-position of X. Similarly, the correlation signals W H-1–X C-3 
indicated the unit W linked to the 3-position of X. Thus, both 3 and 6 positions of 
X were substituted. The correlation signals V H-1–W C-3 and V C-1–W H-3 
indicated unit V linked to the 3-position of the unit W; an intraresidual coupling 
between H-1 of residue U with its own C-6 (U H-1, U C-6) indicated that the 6-
linkage was among different U repeats. In the NOESY spectrum (Supplementary 
Figure S2b), similar correlations of the protons were observed: U1–X6, V1–W3, 
W1–X3 and X1–U6, which confirmed the above results from HMBC. Based on 
all these results from methylation analysis and 2D NMR, the main repeating unit 
structure of BEPS-IB was deduced and was shown in Fig 6B.2.  
 
 
 
 
Functional Food Enriched with Natural Ingredients from Green Mussel P. viridis 
297 
 
 
Fig 6B.2A 1H-1H COSY spectra of (→4)-2, 4 di-(N-acetyl- β -D-mannosamine) -(1→4)-2-N-acetyl- 
β-D-galactosamine-(1→) - (4-N-acetyl p-phenoxyl) unit isolated from P. viridis. 
 
 
Fig 6B.2B HSQC spectra of (→4)-2, 4 di-(N-acetyl-β-D-mannosamine) -(1→4)-2-N-acetyl- β-D-
galactosamine-(1→) - (4-N-acetyl p-phenoxyl) unit isolated from P. viridis. 
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 Fig 6B.2C  HMBC spectra of (→4)-2, 4 di-(N-acetyl- β -D-mannosamine) -(1→4)-2-N-acetyl- β-
D-galactosamine-(1→) - (4-N-acetyl p-phenoxyl) unit isolated from P. viridis. 
 
Fig 6B.2D NOE spectra  of (→4)-2, 4 di-(N-acetyl- β -D-mannosamine) -(1→4)-2-N-acetyl- β-D-
galactosamine-(1→) - (4-N-acetyl p-phenoxyl) unit isolated from P. viridis. 
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The compound 12 contain C-28 carbon lysolecithin isolated from the 
green mussel, whereas the ultraviolet absorbance at λmax (log ε) 244 (3.11) nm 
(in MeOH) has been assigned to the choline and glycerol systems. Its mass 
spectrum exhibited a molecular ion peak at m/z 550 (C28H57NO7P). 1H NMR 
in conjugation with 13C NMR recorded the signature peaks of choline, glycerol 
and fatty acid portion of the lysolecithin. 13C NMR spectra displayed three 
close peaks at δ 54.31(C-1), δ 54.21(C-2) and δ 53.56(C-3) that were attached 
to the nitrogen represented singlet at δ 3.19 (s) with an integral value of 9 
(Table 6B.4).  
Table 6B.4 NMR spectroscopic data 2-[(2-(Acetyloxy)-3-[(E)-9-octadecenyloxy] propoxy 
hydroxyphosphoryl) oxy] ethyl (trimethyl)ammonium (12) 
 
 Carbon Position 
13C NMR 
ppm 
 
H -type 
δ1H NMR(int., mult., 
J in Hz)b 
1H-1H 
COSY 
HMBC 
1H →13C 
Choline 
1 54.31 1-H 3.19(s)   
2 54.21 2-H 3.19(s)  C-4 
3 53.56 3-H 3.19(s)   
4 66.17 4-H 3.62(dd,2H) 5-H C-5 
5 59.49 5-H 4.22(t,2H)   
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6 63.30 6-H 3.69(d,2H) 7-H C-7,9 
Glycerol 
7 69.48 7-H 3.83(m,1H) 8-H  
8 59.61 8-H 4.03(d,2H)   
9 176.48     
10 34.12 10-H 2.26(m,3H)   
Ether/Fatty 
Acid part 
11 71.79 11-H 3.32(m,2H) 12-H C-12 
12 31.96 12-H 1.46 13-H  
13-17 29.90-25.63  2.01-1.21(m)   
18 27.08 18-H 1.99(m,2H) 19-H  
19 129.87 19-H 
5.27(dd,1H 
J=9.4Hz) 
18-H C-18 
20 129.54 20-H 
5.30(dd,1H 
J=9.2Hz) 
21-H  
21 25.62 21-H 2.78(m,2H)   
21-28 29.61-14.12  1.48-0.81(m)   
a NMR spectra recorded using Bruker AV III 500 MHz spectrometer.bValues in ppm, 
multiplicity and coupling constants (J¼ Hz) are indicated in parentheses. Assignments were 
made with the aid of the 1H–1H COSY, HMQC, and HMBC experiments 
The carbon atoms at δ 66.17 (C-4) and δ 59.49 (C-5) as shown HSQC 
correlated with δ 3.62 (H-4) and δ 4.22 (H-5), respectively, supports the 
presence of the choline moiety.  The downfield shift of δ 3.69 (H-6), δ 3.83 (H-
7) and δ 4.03 (H-8) attached to δ 63.60 (C-6), δ 69.48 (C-7) and δ 59.61 (C-8), 
respectively revealed the presence of glycerol moiety with acetyl group attached 
to the C-7 position. The proton integral values and 13C NMR peaks appeared at 
upfield region in combination with COSY and HMBC spectra revealed the 
presence of 18 carbon fatty acid chain with double bond at C-19. The proton and 
carbon connectivities deduced from the HSQC and HMBC experiments 
confirmed the side chain framework, and was presented in Fig 6B.3.  
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Fig 6B.3A  1H NMR spectra of 2-[(2-(acetyloxy)-3-[(E)-9-octadecenyloxy] propoxy hydroxyphosphoryl) 
oxy] ethyl (trimethyl)ammonium (12) 
 
 
Fig 6B.3B 1H-1H COSY spectra of 2-[(2-(acetyloxy)-3-[(E)-9-octadecenyloxy] propoxy 
hydroxyphosphoryl) oxy] ethyl (trimethyl)ammonium (12) 
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Fig 6B.3C  13C NMR spectra of 2-[(2-(acetyloxy)-3-[(E)-9-octadecenyloxy] propoxy hydroxyphosphoryl) 
oxy] ethyl (trimethyl)ammonium (12) 
 
 
Fig 6B.3D HSQC spectra of 2-[(2-(acetyloxy)-3-[(E)-9-octadecenyloxy] propoxy hydroxyphosphoryl) 
oxy] ethyl (trimethyl) ammonium (12) 
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6B.2.3:  In vitro anti-inflammatory activities of the isolated components from 
P. viridis. 
The in vitro anti-inflammatory activities were studied by using 
indomethacin and aspirin as positive controls (Table 6B.5). MPS registered 
significantly greater COX-2 inhibition (74.8%) than aspirin and indomethacin 
(58.6% and 59%, respectively, 5mg/mL). No significant differences were 
apparent between MPS (32.5%) and indomethacin (34.6 %) at lower 
concentration (0.5 mg/mL). MPS showed significantly lesser (56.4%) 
inhibition of COX-1 than aspirin (70.0 %) and indomethacin (72.1%). Earlier 
studies indicated the anti-inflammatory properties of several glucan-type 
polysaccharides (Czarnecki and Grzybek, 1995). PME11 (68.9 %) and PME0 
(64.5%) exhibited strong, concentration dependent inhibition of COX-2, and 
was more inhibitory than the traditional NSAID COX inhibitor, indomethacin, 
at comparable concentrations. PME11 (68.9%, 54.6%) showed significantly 
greater inhibition towards COX-2 than that of PME0 (64.5%, 44.6%) (at 5 
mg/mL and 1 mg/mL, respectively). PME11 (55.68%) and PME0 (51.7%) 
showed significantly lesser inhibition of COX-1, when compared with aspirin 
(78.8%) and indomethacin (72.1%). PME0 (27.4%) exhibited significantly 
lesser inhibition of COX-1 than FDPE (33.2%) at lower concentration (0.5 
mg/mL). GP showed significantly greater inhibition of COX-1 and COX-2, 
and did not appear to exhibit selectivity in their inhibition pattern towards 
these inflammatory enzymes. Glycogen (59.7% and 69.6%) recorded 
significantly greater COX-1 and COX-2 inhibition than that of glycoprotein 
and glycolipoprotein (54.5% and 64.5%, & 57.2% and 67.8 %, respectively, 5 
mg/mL). Glycolipoprotein and glycogen exhibited a similar level of inhibition 
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at the same concentration, suggesting that they contain related bioactive 
compounds. NUCF (68.2%) recorded significantly greater COX-2 inhibition 
than aspirin and indomethacin, in higher concentration (5 mg/mL). NUCF 
(68.2%) was found to be more efficient than aspirin (58.6 %) to inhibit COX-
2.  It is likely that the PUFA is biologically active component explained by the 
greater bioactivity NUCF fraction. Studies have shown that the phospholipids 
(polar lipid) fraction of Lyprinol® exhibited moderate inhibition towards 
COX-2, whilst COX-1 inhibition was not significant (McPhee et al., 2007). 
Upon examination of the IC50 inhibitory concentration values, it was found 
that NUCF exhibited approximately 2 times more inhibitory activity against 
COX-2 than that of FDPE. Among different isolated compounds, MPS (1.21 
mg/mL) was found to have the lowest IC50 value to inhibit COX-2 than NUCF 
(1.90 mg/mL), PME11 (1.89 mg/mL) and glycolipoprotein (1.83 mg/mL).in 
other words, the polysaccharide fraction (MPS) was found to be significantly 
active against COX-2 followed by glycolipoprotein, lysolecithin (PME11), and 
polyunsaturated fatty acid complex (NUCF) in descending order.  
LOXs are sensitive to antioxidants, and the most common way of their 
action is inhibition of lipid hydroperoxide formation appeared to be due to the 
scavenging of lipidoxy- or 9-lipidperoxy-radicals formed during course of 
enzymic peroxidation. This can limit the availability of lipid hydroperoxide 
substrate necessary for the catalytic cycle of LOX. Since COX isozymes and 
5-LOX share the same substrate arachidonic acid, inhibition of COX pathways 
could lead to a shift towards the production of cysteinyl-LT and LTB4 by 5-
LOX due to increased substrate availability, thereby leading to development of 
gastrointestinal ulcers (Hudson et al., 1993). MPS showed significantly greater 
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inhibition towards 5-LOX (IC50 0.88 mg/mL) than aspirin (IC50 3.88 mg/mL) 
and indomethacin (IC50 2.35 mg/mL). However lysolecithin derivative showed 
comparable inhibition towards 5-LOX (IC50 2.63 mg/mL) as recorded with 
aspirin (IC50 2.67 mg/mL) and indomethacin (IC50 2.07 mg/mL). Glycoprotein 
(5 mg/mL) showed significantly greater 5-LOX inhibition than 
glycolipoprotein (70.2%) and glycogen (70.20%). At lower concentration (1 
mg/mL & 0.5 mg/mL) the  inhibition of glycoprotein towards 5-LOX was 
significantly higher (53.20% and 32.50%, respectively) than glycogen (48.7%, 
33.1%, respectively) and glycolipoprotein (50.5%, 31.40%, respectively). The 
studies implicated that oxygen free radicals in the process of inflammation and 
phenolic compounds that might block the cascade process of arachidonic acid 
metabolism by inhibiting lipoxygenase activity, and might serve as a 
scavenger of reactive free radicals, which are produced during the arachidonic 
acid metabolism. The NUCF (56.30%) showed significantly greater 5-LOX 
inhibition than aspirin (at 5 mg/mL) but lower than indomethacin. Since COX 
isozymes and 5-LOX share the similar substrate (arachidonic acid), inhibition 
of COX pathways could lead to a shift towards the production of cysteinyl-LT 
and LTB4 by 5-LOX due to the increased substrate availability, thereby 
leading to development of gastrointestinal ulcers (Hudson et al., 1993).  
  
Chapter 6 
306 
  
Ta
bl
e.
6B
.5
 C
om
pa
ris
on
 of
 in
 vi
tro
 an
ti-
inf
lam
ma
to
ry
 ac
tiv
ity
 of
 is
ola
ted
 co
mp
ou
nd
s, 
wi
th
 FD
PE
 an
d s
ta
nd
ar
d a
nt
i-i
nf
lam
ma
to
ry
 dr
ug
s 
FD
PE
: f
re
ez
e 
dr
ie
d 
m
us
se
l e
xt
ra
ct
 w
ith
ou
t a
dd
iti
ve
s 
(c
on
tro
l).
 M
PS
 (c
ru
de
 p
ol
ys
ac
ch
ar
id
es
 is
ol
at
ed
 P
. v
ir
id
is
) P
M
E 0
 (m
et
ha
no
l e
xt
ra
ct
 o
f 
P.
 v
iri
di
s)
, P
M
E 1
1 
(P
ur
ifi
ed
 fr
ac
tio
n 
of
 P
M
E 0
), 
G
LP
 (
G
ly
co
lip
op
ro
te
in
), 
G
P 
(G
ly
co
pr
ot
ei
n)
, G
 (
G
ly
co
ge
n)
, N
U
C
F 
(n
on
-u
re
a 
co
m
pl
ex
in
g 
fr
ac
tio
n)
 
Functional Food Enriched with Natural Ingredients from Green Mussel P. viridis 
307 
6B.2.4 In vivo anti-inflammatory activity of the isolated compounds. 
Carrageenan induced paw edema is a standard and most commonly 
used technique to screen the anti-inflammatory activity (Winter, 1962). 
Carrageenan is a sulfated polysaccharide that promotes acute inflammation by 
activating the proinflammatory cells. Inflammation induced by carrageenan, is 
acute, nonimmune, well-researched, and highly reproducible. It is expected 
that after tissue injury, an animal will display spontaneous pain behavior. This 
peripheral hypersensitivity or pain perception can be explained on the basis of 
local release of various inflammatory mediators i.e. bradykinin, prostaglandins 
or cytokines, which can activate and sensitize the peripheral nerve endings 
(Baccaglini, 1983). Inflammation is characterized by increased tissue water 
and plasma metabolism of arachidonic acid by COX and LOX enzyme 
pathway (Gamache et al., 1986). There are biphasic effects in carrageenan 
induced edema. The first phase begins immediately after injection and 
diminishes in 1 hour and the second phase begins after 1 hour. It has been 
suggested that the early hyperemia of carrageenan induced edema results from 
the release of histamine and serotonin. On the other hand, the delayed phase of 
carrageenan induced edema results mainly from the potentiating effect of 
prostaglandins on mediator release, especially of bradykinin. Different extracts 
demonstrated a time dependent anti-inflammatory effect in rats with 
carrageenan induced footpad edema. Comparison of purified compounds with 
the reference drug (aspirin) on carrageenan-induced hind paw edema in mice 
were recorded in Table.6B.6. MPS registered significantly greater edema 
inhibition (64.4%,  h) than FDPE (34.3%, 2 h). Maximum inhibition of edema 
by MPS was achieved in 4 h (77.2%). The study showed that MPS effectively 
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suppressed the edema produced by the histamine, which indicated that the 
polysaccharide exhibited its anti-inflammatory action by means of either 
inhibiting the synthesis, release or action of inflammatory mediators, such as, 
histamine, serotonin  and prostaglandin’s. Polysaccharide might be the 
potential therapeutic agent involved in inflammatory disorders, controlling the 
initial phase of inflammation and provoking an inhibition of edema formation 
similar to the reference drug (aspirin, 68.67% in 2h) compounds. MPS and 
aspirin exhibited highest activity in 4 h (77.2% and 82.1%, respectively) and 
started losing activity around 5 h (72.2% and 65.7%, respectively) which 
mightbe related to a lower level of these compounds in the blood circulation. 
The result was in accordance with the previous reports that several glucan-type 
polysaccharides were shown to possess anti-inflammatory activities 
(Czarnecki & Grzybek, 1995). The administration of glycolipoprotein limited 
the edema to 51.1% which was 34.3% for FDPE after 2h. Glycolipoprotein 
registered significantly greater inhibition (61.2 %, 3 h) than glycogen and 
glycoprotein (57.1% and 58.7%, 3 h respectively). Glycoprotein (65.7 %, 5 h) 
recorded significantly lesser inhibition than glycolipoprotein (71.9%, 5 h). 
These results indicated that the activity of glycoprotein was lost following the 
KOH formulation of glycolipoprotein. Essentially, the same result pattern as 
that GLP (65.8 %, 4h) was obtained when proteinase-K-treated glycogen 
(64.1%, 4 h) was administered to the subjects challenged with carrageenan. 
The glycolipoprotein (78.7%, 6 h) showed significantly greater inhibition than 
glycogen (74.1%, 6 h).The results revealed that the active component of 
mussel resided within a protein moiety associated with glycogen (Miller et al., 
1993). Maximum suppression of inflammation by glycogen and 
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glycolipoprotein administration was achieved during 6th h (78.4% and 75.4%, 
respectively). These results demonstrated that the glycogen and 
glycolipoprotein, exerts an anti-edematous effect during the second phase of 
paw edema due to the reduction of prostaglandins, which are second phase 
inflammatory mediators. Therefore, the present results suggest that the 
mechanism of the anti-inflammatory effect of glycogen might involve the 
inhibition of the COX pathway. NUCF showed a gradual increase in inhibition 
from 2nd to 6th h (49.23 to 70.33%). The PME0 extract (6 h) exhibited 
significant anti-inflammatory activity (72.4%) at 100 mg/kg whilst aspirin 
showed 80.56% inhibition of edema (200 mg/kg, 6 h). It was observed that the 
increase in the paw thickness was inhibited to about 82.06% (3 h) by aspirin, 
whereas the fraction PME11 inhibited the paw thickness to 65.36%. At the end 
of 6 h, PME11 fraction (lysolecithin) (79.45%, 50 mg/kg) was found to show 
greater activity towards the inhibition of paw edema than aspirin (80.27%, 200 
mg/kg). In the present study, the edema inhibition by PME11 was more 
pronounced at the second phase, which suggests that the inhibition of 
prostaglandin production could be one of the ways by which PME11 exerted 
the anti-inflammatory effect. 
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6B.2.5  Identification of potent formulations by in vitro anti-inflammatory and 
antioxidant assays. 
The in vitro anti-inflammatory and antioxidant activities of the various 
treatments have been compared with control mussel (FDPE) and were 
recorded in Table 6B.7. Various inflammatory parameters have been 
determined in order to understand whether prolonged storage had any negative 
effect on the target bioactivity. FDPE recorded 48.9% inhibition towards 
COX-1 in 0thday (baseline) whereas Q1 and Q2 showed 51.2 and 49.5% 
inhibition, respectively. During the 60 days of shelf life study, Q1 and Q2 
recorded 49.6 and 47. 6% inhibition, respectively, while the FDPE showed 
only 44.9%. The formulations Q1 and Q2 showed 62.2 and 61.5% inhibition 
respectively in 0th day while the FDPE showed only 48.6% inhibition for 
COX-2 enzyme. During 60 days shelf life study Q1 and Q2 showed 59.2% and 
59% inhibition, respectively, while FDPE showed only 43.02%.  The 5-LOX 
inhibition study of Q1 showed 56. 9 % inhibition at the 0thday, while FDPE 
showed only 51.9% inhibition for 5-LOX. The LOX inhibition of Q1 during 30 
days shelf-life study was 42.2% although for Q2 and FDPE the inhibition was 
found to be as 41.6 and 32. 9%, respectively. During the 60 days shelf-life 
study, the decrease in LOX inhibition of Q1 (40.7%) was lower, compared 
with Q2 (39.64 %) and FDPE (29.54%).  
The DPPH inhibition assay measured the ability of compounds to transfer 
the labile hydrogen atoms to radical. The DPPH activity of FDPE was 13% at 
baseline (t=0) and  decreased to 2.07% at 60th day during storage at 50°C, 
whereas Q1 showed a lower reduction in DPPH radical scavenging capacity 
(34.5%-26.8%) than that of FDPE. During 60 days of accelerated shelf life study, 
the reduction in total antioxidant capacity (TARSC) of Q1 (34.5%-26.8%) was 
lower than Q2 (33.895-24.11%) and FDPE (13.0%-2.07%). The malondialdehyde 
formation in FDPE was increased from 3.94 – 8.20 mM MDAequivalent/kg 
sample during the 60 days of accelerated shelf life study. The TBARS value of Q1 
and Q2 was increased from 2.02-4.37 and 2.11 - 4.7 mM MDA equivalent /kg 
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sample, respectively. The rate of increase of TBARS in Q1 lower when compared 
to Q2, which meant that lipid peroxidation was more for Q2 than in Q1. The anti-
inflammatory composition containing greater concentration of MPS in (1.2%) 
(ie.Q1) showed greater antioxidant activity and lesser lipid peroxidation, which are 
the preferred indices to assess the stability of the anti-inflammatory neutraceutical.  
Table.6B.7  Anti-inflammatory and antioxidant activities of FDPE and different formulations (5 
mg/mL) during accelerated shelf life study. 
H2O2 inhibition activity (%) 
 0 day 30 day 60 day 90 day 
FDPE 48.64±1.07a 45.96±1.68a 33.86±1.56b 26.21±0.53c 
Q1 55.08±1.03a 51.83±0.73a 50.65±1.26a 46.35±0.60b 
Q2 53.11±1.12a 51.07±1.83a 48.14±1.98a 45.48±1.04a 
COX-1 inhibition activity (%) 
FDPE 48.9±0.13a 46.11±0.41a 44.85±0.43b 43.15±0.43c 
Q1 51.2±0.22a 50.36±0.16a 49.61±0.26b 47.88±0.11b 
Q2 49.5±0.76a 48.77±0.29a 47.56±0.32b 46.91±0.24b 
COX-2 inhibition activity (%) 
FDPE 48.4±0.19a 45.01±0.05a 43.02±0.70a 35.21±1.61b 
Q1 62.23±0.43a 61.05±0.06a 59.21±0.26a 55.24±1.47a 
Q2 61.49±0.50a 59.87±0.27a 58.96±0.42a 55.01±1.42a 
5-LOX inhibition activity (%) 
FDPE 51.9 ±0.50a 49.3 ±0.01a 48.65 ±0.41a 42.25 ±0.63b 
Q1 56.89 ±0.79a 55.23 ±0.08a 53.76 ±0.25a 51.11 ±0.82a 
Q2 53.42 +0.33a 51.97 ±0.03a 50.35 ±0.03a 50.99 ±0.81a 
DPPH scavenging activity (%) 
FDPE 13.01+0.33a 6.6+0.21b 2.07+0.37c 1.03±0.46d 
Q1 34.53+0.29a 30.78+0.44a 26.80+0.47b 20.15±0.44c 
Q2 33.89+0.07a 29.80+0.52b 24.11+0.85c 19.84±0.5d 
TBARS (mM MDA/kg) 
FDPE 3.94+0.04a 5.18+0.03b 8.20+0.06c 10.4±0.46d 
Q1 2.02+0.03a 3.98+0.05a 4.37+0.09a 5.69±0.6b 
Q2 2.11+0.06a 4.02+0.13b 4.7+0.07b 6.02±0.65c 
Data are expressed as mean ± standard deviation of three replicates. FDPE: freeze dried 
mussel extract without additives (control). Q1 and Q2 were the enriched formulations 
prepared from the extract of P. viridis) 
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6B.2.6 Identification of potent formulation with high nutritional value 
viz. fatty acid compositions 
The essential characteristic of the nutritional and functional quality of 
marine food product is its fatty acid composition. Depending on the time, 
temperature and other conditions of storage, highly lipidic material like P. 
viridis can undergo various changes in its fatty acid profile owing to the 
activity of various enzymes. Fatty acids are very important biochemical 
indicators contributing to the nutritional quality of the samples. Unfavourable 
composition of nutritional fatty acids is a major risk factor for cardiovascular 
and inflammatory diseases. The total SFAs in Q1 andQ2 were found to be 
higher than in FDPE. In particular, Q1 effectively arrested the increase of the 
SFA at various scheduled intervals of accelerated shelf-life study than did Q2 
and FDPE, which realized a significant increase from 0th day to 90th day 
(Table 6B.8). Q1 and Q2 realized a decelerated increase of palmitic acid 
(C16:0), the predominant among the SFAs than in FDPE. 
The PUFAs viz., arachidonic acid (20:4n-6), 20:5n-3 and 22:6n-3 in P. 
viridis concentrate is important biochemical indicators contributing to the 
nutritional quality in addition to the reported anti-inflammatory properties 
(Calder, 2009). The addition of natural additives with polyphenolic moieties in 
Q1 and Q2 apparently shielded the mussel PUFAs against oxidation as evident 
by higher PUFA content in Q1 and Q2 as compared to FDPE during 90 days of 
accelerated shelf life study. The FDPE showed a total PUFA content of 29.03 
% in 0th day while Q1 and Q2 showed 32.48% and 32.58% respectively. The 
total n-3 PUFA content of FDPE was found to be lesser than Q1 and Q2 at 0th 
day, thereby indicating the added n-3 fatty acid pool to FDPE by the natural 
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additives. The n-3 fatty acid, 22:6n-3 registered a significant reduction in 
FDPE, at 90th day. The combinations Q1 and Q2 effectively prevented 22:6n-3 
from oxidative degradation at 90th day than did FDPE. The fatty acid 20:5n-3, 
which competes with AA for COX-2 and 5-LOX active sites to synthesize 
anti-inflammatory PG metabolites (Calder, 2009) were found to be higher in 
Q1 and Q2 than in FDPE. It is interesting to note that a major reduction of EPA 
content were apparent in Q1 at 90th day as compared to that in FDPE and Q2, 
which realized a significant reduction in EPA content at 90th day. Earlier 
studies (Whitehouse et al., 1997) reported that the anti-inflammatory activity 
in a lipid extract from green lipped mussel is associated with PUFAs with 
multiple (4-6) double bonds. In the present study, the PUFAs with 4-6 double 
bonds in FDPE were found to be significantly reduced at 90th day. However, 
no significant reduction of this group of fatty acids was noticeable for Q1 and 
Q2. Apparently, the antioxidant additives serve as oxidation “chain breakers” 
for Q1 and Q2 by intercepting the free radicals generated from PUFAs during 
accelerated storage  
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Fig.6B.4:  Fatty acid content of control (FDPE) and different formulations (Q1 and Q2) during 90 
days shelf life study. 
FDPE was found to be susceptible towards peroxidation by free 
radicals, and therefore, could not retain the n-3/n-6 ratio for a longer time 
period under shelf, and the additives (as in Q1 and Q2) were used to shield the 
oxidation of FDPE. Initially, the total content of deleterious trans fatty acids 
were found to be 0.35%, 0.27%, and 0.33%, respectively for FDPE, Q1 and Q2 
in that order. The combinations Q1 and Q2 effectively arrested the isomeric 
conversion of monoenoic and dienoic cis-fatty acid isomers (7 cis 18:1n-9 and 
9 cis, 12 cis 18:2n-6) to their trans isomers (7 trans18:1n-9 and 9 trans, 12 
trans 18:2n-6) at different time intervals of incubation during accelerated 
shelf-life study for 90 days (Fig 6B.5). Trans 16:1n-7 exhibited a significant 
increase in FDPE, than in Q1 and Q2 that realized a moderate increase (upto a 
maximum of 0.05%) throughout the period on shelf. This increase of trans 
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isomers of fatty acids is related to the initiation of lipid peroxidation, which is 
initiated by a homogeneous split of a C-H bonds adjacent to cis double bonds 
in the unsaturated fatty acids.  
 
Fig.6B.5  Trans-fatty acid (%) of control (CM) and different formulations (Q1 and Q2) during 90 
days shelf life study. 
6B.2.7 In vivo anti-inflammatory studies of potential formulation  
Carrageenan-induced paw edema is a standard and most commonly 
used technique to screen the anti-inflammatory activity (Winter 1962). It is the 
most commonly used method in experimental pharmacology causing 
inflammation by producing inflammatory histamines, and prostaglandins. 
Therefore, in the present study, time dependent anti-inflammatory properties 
in mice with carrageenan–induced foot paw edema were investigated and the 
effect of Q1 was compared with standard drug, aspirin. The arrows in Fig 6B.7 
indicated the swelling of dorsal surface of the paw. The control group animals 
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showed maximum swelling at the fifth hour, which increased further until the 
sixth hour (Table 6B.9). The anti-inflammatory formulation Q1 showed 
significant inhibition of the edema (> 50%) during the third hour after the 
carrageenan injection, which reached ≥ 72.0% after the sixth hour as compared 
to ~80% noted for the standard (aspirin). It was interesting to note that the 
activity of Q1 improved with time, indicating their potential to release the 
active principle throughout an extended period, unlike the standard, which 
showed a deceleration in activity after the fourth hour.  Comparison of Q1 with 
reference drug (aspirin) on carrageenan-induced hind paw edema in mice were 
given in Table 6B.9. The aspirin treated groups significantly decreased the 
paw edema with maximum inhibition of 82.07% at 4th h. Q1 (34.34%, 2 h) 
recorded significantly higher edema inhibition than FDPE (55.98%, 2h).Q1 
showed considerable inhibition on swelling as compared to aspirin (80.27 and 
78.37%, respectively) in the 6thh, illustrating that Q1 is potent but relatively 
slow-acting anti-inflammatory agent. The development of carrageenan induced 
edema is biphasic; the first phase is attributed to the release of histamine and 
kinins, while the second phase is related to the release of prostaglandins (Vane 
and Booting, 1987). Hence, the present investigation demonstrated that Q1 
showed significant reduction in the biphasic response of carrageenan induced 
edema.   
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Fig.6B.6 Inhibition of paw edema (%) on Q1 treated mice 
 
Fig.6B.7 In vivo anti-inflammatory activities of anti-inflammatory formulation Q1 on 
carrageenan-induced mice paw edema. (A) Carrageenan-induced hind paw edema in 
BALB/C mice. The arrow indicates the swelling of dorsal surface of the paw; (B) 
Reductions in mice paw edema in treated (by Q1) mice. The reduction in paw swelling 
is indicated by an arrow. 
 
6B.2.8 Conclusion 
Two combinations (Q1 and Q2) of the freeze dried P. viridis extract 
(FDPE) supplemented with the antioxidative oleoresins and aqueous extracts 
of natural additives were prepared based on their antiradical properties. 
Among the different treatments of enriched green mussel extracts Q1 exhibited 
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significant inhibition of pro-inflammatory COX-1, COX-2 and 5-LOX 
enzymes, indicating their potential for use as effective green alternatives to the 
synthetic drugs with multiple several adverse effects on human health. 
Significant in vivo activities also indicated better therapeutic profile and fewer 
side effects of the anti-inflammatory formulation Q1 as compared to the 
synthetic non-steroidal anti-inflammatory drugs. The different anti-
inflammatory combinations, demonstrated that the combinations Q1 have the 
potential to retain the active principles throughout the experimental period 
under shelf. Therefore, Q1 proved to be the effective new generation green 
alternatives to the synthetic non-steroidal anti-inflammatory drugs for use 
against a cascade of mammalian inflammatory diseases. 
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6.C Response of pro-inflammatory prostaglandin contents in anti-
inflammatory supplements from green mussel Perna viridis L.  
Background of the study 
Bioactive lipids like prostaglandins (PGs) are potent lipid signaling 
mediators of inflammation, and are derived from arachidonic acid (AA; 
C20:4n-6) and related 20 carbon polyunsaturated fatty acids (PUFAs) by 
cyclooxygenase (COX) enzymes. COX is a bi-functional enzyme containing a 
site that converts AA to prostaglandin G2 (PGG2) and another site that reduces 
PGG2 to prostaglandin H2 (PGH2), which is metabolized to prostaglandin E2 
(PGE2) and prostaglandin F2α (PGF2α) (Fernandes et al., 2004). Production of 
inflammatory PGE2 is mediated by three enzymatic reactions involving 
phospholipase A2 (PLA2), COX, and PGE2 synthase (PGES). In this 
biosynthetic pathway, AA releases from membrane phospholipids by cytosolic 
or secretory PLA2 and is converted to PGH2 by COX. PGH2 is then isomerized 
to PGE2 by terminal PGES enzymes. Studies have shown elevated COX 
activity and resulting increased levels of PGE2 in various tissues, including 
human colon and prostate tumor (Hidalgo et al., 2002). PGE2 and PGF2α have 
been found to stimulate the proliferation of various cancer cells and promote 
tumor development (Koehne et al., 2004).  
Considerable attention has been devoted to study the role of PGE2 in 
inflammation and tumor progression, the role of which is supported by high 
concentrations of the major urinary metabolite of PGE2, tetranor PGE-M 
(Fig.6C.1), through a series of reaction intermediates in patients suffering from 
inflammatory responses (Neale  and  Dean, 2008). The enzyme COX-2 is 
expressed and up-regulated in the rheumatoid synovium (Claria and Romano, 
2005), and inhibition of this enzyme is proposed as a safe and effective treatment 
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modality in rheumatoid arthritis (Charlier and Michaux, 2003). Current 
symptomatic treatment of inflammation is mainly by non steroidal anti-
inflammatory drugs (NSAIDs) that exert anti-inflammatory actions by inhibiting 
COX, which exits as two isoforms: COX-1, constitutively expressed in most cells 
under physiological conditions and COX-2, which induced by pro-inflammatory 
agents such as TNF-α, LPS and tumor-promoting factors (Jaggi et al., 2004). 
However, NSAIDs inhibit not only COX-2, which produces PGs associated with 
pain induction, but also COX-1, which produces PGs involved in maintaining the 
integrity of gastrointestinal mucosa, and, therefore, are noted for undesirable 
gastrointestinal side effects related to their use (Parente and Perretti, 2003). For 
this reason, selective COX-2 inhibitors have come to attention in recent years 
(Chen et al., 2005). It is desirable to develop more potent and selective inhibitors 
of COX-2 for development of the next-generation therapeutics. 
O
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Fig.6C.1  Metabolic conversion of pro-inflammatory PGE2 to tetranor PGE-M, which is a major 
causative agent in inducing a series of reactions in inflammation and tumor progression. 
Earlier studies reported that commercially prepared freeze-dried extract 
of New Zealand green-lipped mussel P. canaliculus shows a capacity to 
inhibit experimentally induced inflammation and can act as dual inhibitor of 
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membrane arachidonic acid oxygenation by both COX and lipoxygenase 
(LOX) pathways, thus decreasing PG and leukotriene synthesis and down 
regulating the inflammatory sequence (Miller et al.,1993; Tiffany and Bui, 
2002). Nutritional supplements Seatone® and Lyprinol containing freeze-dried 
tissues and mussel oil, respectively, from P. canaliculus, are used as anti-
inflammatory medication (Cobb and Ernst, 2006).  
Marine bivalves are virtually untapped resource for the discovery of 
novel bioactivities and were reported to contain abundance of bioactive 
principles, and many of these can influence human health (Chellaram et al., 
2004). Marine originated bioactive lipids have been reported to be linked in 
alleviating the symptoms of inflammatory conditions (Calder, 2004). Green 
mussel, like Perna viridis, is abundant in C20-C22 n-3 PUFAs, particularly 
eicosapentaenoic acid (C20:5n-3, EPA) and docosahexaenoic acid (C22:6n-3, 
DHA), which are the precursors of anti-inflammatory resolvins (E- and D-
series) (King et al., 1990). The coastline of South Indian subcontinent is 
bestowed with large assemblage of P. viridis; and they have been found to 
possess anti-inflammatory principles. According to recent studies, reactive 
oxygen species (ROS) are important mediators that initiate and propagate 
inflammatory responses by stimulating release of pro-inflammatory cytokines 
such as interleukin-1b (IL-1b) and tumor necrosis factor (TNF-a) (Geronikaki 
and Gavalas, 2006). This indicates that free radical scavengers might be a 
useful means of attenuating inflammatory effects. Accordingly, anti-
inflammatory and antioxidative agents interfering with eicosanoid synthesis 
require a well-balanced pharmacological profile to minimize these on-target 
side effects. In this context, it needs to be mentioned that the harmful ROS 
attack the multiple olefinic bonds in the lipids, which are abundantly present in 
any marine fauna like green mussel, leading to the formation of lipid 
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hydroperoxides, small molecular weight aldehyde and ketones, among various 
degradation products. P. viridis are also rich in long chain PUFAs with 20 
carbon atoms, mainly AA, which are precursors of inflammatory PGs. It has 
been demonstrated that marine organisms are capable of metabolizing C20 n-6 
PUFA to oxidized fatty acid derivatives, PGs, via oxidative pathways. There is 
tendency of these multiple inflammatory PGs particularly PGE2 and PGF2α 
metabolized from C20 n-6 PUFA to increase in mussel meat or extract unless 
otherwise any attempt is made to arrest the oxidative pathways towards this 
direction by addition of antioxidative principles (Droge, 2002). It is, therefore, 
necessary to arrest the formation of inflammatory PGs in the mussel extract 
from C20 n-6 PUFAs (like AA) by different antioxidants, and to retain its anti-
inflammatory property for a longer time period in shelf. 
The present study explored various natural additives, which are able to 
reduce the free radicals that cause oxidation reactions, and simultaneously 
hinder the formation of inflammatory PGs. Antioxidant principles play an 
important role to deter the formation of PGE2 and PGF2α, and, therefore, have 
added advantage other than maintaining high shelf-life of the active ingredient. 
These led us to incorporate natural antioxidants in ‘green’ and ‘environmentally 
safe’ preparations of mussel in different combinations to arrest the formation of 
inflammatory PGE2 and PGF2α from C20 n-6 PUFAs. The different compositions 
of oleoresins (Rosmarinus officinalis and Curcuma longa) and other natural 
antioxidant additives in different proportions were blended with freeze dried 
green mussel extract (GME0) to find their individual and synergistic effects to 
arrest the formation of inflammatory PGE2 and PGF2α. The purpose of the 
stability study is to determine the levels of PGE2 and PGF2α in GME0 and that 
supplemented with natural antioxidant additives (GME1, GME2, GME3 and 
GME4) during the course of an accelerated shelf-life study of 90 days to 
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understand the differential pattern of PGE2 and PGF2α in different combinations 
thereby establishing its shelf life, the time period of its storage. 
Because of broad involvement of PGs in normal and pathophysiological 
processes, their quantification is critical in understanding their role in anti-
inflammatory activities. Common methods used to quantify PGE2, PGF2α and 
their metabolites include immunological assays, gas chromatography, high 
performance liquid chromatography (HPLC), and mass spectrometry. Although 
immunoassays are sensitive and can accommodate high-throughput 
applications, specificity of the antibody is a concern regarding selectivity for the 
desired antigen, which can lead to variable results and an overestimation of 
analyte levels. As compared to other methods, HPLC and HPLC with tandem 
mass spectrometer detection (LC/MS/MS) has several advantages because of its 
high selectivity, its high sensitivity, and its potential for simultaneous 
quantification for several PGs and isoprostanes without any derivatization with 
relatively low cost of analysis (Yue et al., 2007). 1H NMR has been used to 
further validate the results obtained by HPLC to understand and compare the 
signal pattern and intensity of GME0 vis-à-vis GME1-4 after 90 days of 
accelerated shelf-life study. Simultaneous 1H NMR and mass spectroscopic 
monitoring of the PG formation in GME0 and GME1-4 gives a fair description of 
anti-inflammatory status. The present study therefore also focusses to 
understand the differential indicative information regarding the presence of 
characteristic signature peaks of PGE2 and PGF2α. 
6C.1 Materials and methods 
6C.1.1  Preparation of P. viridis extract, experimental combinations and 
designing of stability studies. 
The P. viridis meat (3.0 kg) acquired manually from the shellon samples 
was freeze dried to furnish P. viridis extract (GME; 213.6 g; yield - 7.1%). By 
assigning FDPE as the base material, four different combinations GME1, GME2, 
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GME3 and GME4 with anti-oxidative oleoresins (ROO and CLO) and aqueous 
extracts of the additives were prepared as discussed in chapter 6A.The samples 
(GME0, GME1, GME2, GME3, and GME4) were kept in glass vials (10 g each) 
and were evaluated at 0th day and after a period of 90 days (3 months) for the 
changes in inflammatory PGE2 and PGF2α and the fatty acid C20:n-6 and C22:n-
3. All the samples were withdrawn in triplicate at same intervals. Cyclooxygenase 
(COX) inhibition assay was performed using established 2, 7-dichlorofluorescein 
method (Larsen et al., 1996) as described in the section 4.1.2.2.1.  
6C.1.2 C20 and C22 polyunstaurated fatty acid compositions during an 
accelerated shelf life study of 90 days  
Lipids of GME1, GME2, GME3 and GME4 vis-à-vis GME0 collected for 
baseline (d =0) and at the end of the study (d=90) were extracted according to 
Bligh and dyer (Bligh and Dyer, 1959). The fatty acid composition of the total 
lipids was determined as described elsewhere with suitable modification 
(Metcalf et al., 1966; Chakraborty and Paulraj, 2007). Identification of 
FAMEs was confirmed by chromatographic comparison of retention times 
with known FAME standards. Results were expressed as percent weight of 
total fatty acids. The fatty acid methyl esters (FAMEs) were also resolved by 
TLC (5 cm X 20 cm), pre-coated with silica gel and impregnated with AgNO3 
following reported method (Chakraborty and Paulraj, 2007).  
6C.1.3 Isolation and identification of prostaglandins PGE2 and PGF2α in the 
mussel extract (FDPE) and different treatments during an accelerated 
shelf life study for a period of 90 days 
GME0 (5g) was extracted thrice with EtOAc (3 X 20mL) following the 
modified method of Jurenka et al. (Jurenka et al., 1999), and filtered under 
vacuum to yield 55 mL of total PG extract. The combined EtOAc extracts 
were evaporated under N2 to dryness (150 mg), which was redissolved in 
EtOAc (2 mL), before being charged to a small silicic acid column (2 mm i.d.  
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90 mm long, 60-120 mesh silicic acid). The PGs were eluted with the 
sequential addition of 30 mL of increasingly polar solvents starting with 100% 
n-hexane, followed by n-hexane:EtOAc (1:1, v/v) EtOAc: acetonitrile (1:1, 
v/v), 100% acetonitrile, acetonitrile: MeOH (1:1, v/v), and 100% MeOH. PGs 
were eluted in the acetonitrile: MeOH fraction. For the quantitative analysis of 
PGE2 and PGF2α analytical HPLC was performed on a Phenomenex ODS 
column (C18 25 cm X 4.6 mm i.d.) (Phenomenex, Torrance, CA) with UV 
detector (196 nm) in an isocratic mobile system of MeOH–0.1% formic acid in 
H2O (70:30) at a flow rate of 0.8 mL/min. The run time was 30 min. 
6C.1.4  Identification of prostaglandins in the mussel extract (GME0) and 
different treatments by positive mode ESI-MS and 1H NMR experiments 
The NMR spectra of PGs were recorded in CDCl3 on a Bruker DRX 
NMR spectrometer operating at 400 MHz for 1H NMR. Chemical shift (δ) 
values are expressed in parts per million (ppm) and are referenced to the 
residual solvent signals of CDCl3. The identification of the products was 
confirmed by comparing NMR spectra with earlier published data. Mass 
spectrometric detection was performed using a FT-ESI-MS with positive mode 
electrospray ionization and on a Bruker Daltonic (GmbH, Germany) micro-
TOF series with electrospray ionization (ESI-MS). Positive ion ESI (M+H+) 
was calculated. HPLC-MS has been carried out with an Agilent G1312 binary 
gradient pump with the solvent program for elution: 30% B (30% water and 
0.1% HCOOH) and A 70% A (70% MeOH and 0.1% HCOOH) upto 100% 
MeOH (and 0% water) with a total run time is 25 min with slice width of 1.0 
points/sec. The flow rate was 0.6 mL/min, and the injection volume was 5µL. 
Equilibration time between runs was 5 min. The separation was carried out 
using a Luna C18 column (3 μm, 100 Å pore diameter, 150 x 2.0 mm, 
Phenomenex, Torrance, CA, USA) with a stainless steel frit filter (0.5 μm) and 
security guard cartridge system (C18) (Phenomenex, Torrance, CA, USA). The 
HPLC system consisted of an Agilent 1100 series LC pump equipped with a 
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wellplate autosampler (Agilent Technologies, Santa Clara, CA). A 5 μL out of 
30 μL sample was injected onto a chromatographic column. Detector used in 
this study was Agilent DAD G131B and scanned through 190-600 nm 
wavelength; the spectra has been started at 190 min and completed at 1200 
min. The maximum pressure was 380 bar. The HPLC column was kept at 
column oven under 25°C. Total ion chromatogram (TIC) in MS was used to 
identify the PGs. Zero-grade air was used as the nebulizing and curtain gases 
at a temperature of 700°C. The ionization energy was set to 4000 V, and the 
declustering potential was 30.0 V. The scan rate was 4000 amu/s with a range 
from 100 to 500 amu. Complete system control, data acquisition, and 
processing were performed using Analyst 1.4.2 software.  
6C.2 Results and discussion 
6C.2.1 Time series studies of in vitro anti-inflammatory activity of mussel 
extract (GME0) and different treatments during an accelerated shelf 
life study of 90 days 
The anti-inflammatory properties of GME1, GME2, GME3 and GME4 
were evaluated in vitro during accelerated shelf life study of 90 days to determine 
their COX-2 inhibitory potencies, and were compared to GME0 (Table 6A.1). 
Table 6C.1  In vitro anti-inflammatory activities of different combinations (GME1- GME4) 
compared with control (GME0) (5 mg/mL) during accelerated shelf life study  
 COX-2  Inhibition activity (%) 
Days (d) GME0 GME1 GME2 GME3 GME4 
0 48.4apq ±0.03 50.02bp ±1.02 52.1cp ±0.59 51.6dp ±0.23 52.9ep ±0.56 
15 48.4aq ±1.56 50.23bq ±2.05 52.0cp ±2.0 51.4dq ±1.2 52.9eq ±0.9 
30 47.69ap ±1.25 49.89br ±1.65 51.89cp ±1.35 51.0dr ±0.59 52.01cr±0.45 
60 43.02ar ±0.25 47.06bs ±0.38 49.56cq ±1.97 49.56ct ±0.89 51.02ds±1.4 
90 37.23as ±2.36 46.56bt ±0.56 49.02cr ±0.56 47.56du ±0.74 51.0es±1.45 
x 23.1a 6.9b 5.9c 7.8b 3.6d 
*Results are expressed as percent activity with respect to the samples, and as mean ± SD (n = 3). ‘x’ 
represents percent reduction in activity on 90th day (d=90) with respect to 0th day (d=0). 
a-e: Row wise values with different superscripts of this type indicate significant differences (P < 0.05) 
within different samples; p-t: Column wise values with different superscripts of this type indicate 
significant differences (P < 0.05) within different days of shelf life study 
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 GME2 and GME4 were more effective in inhibiting COX-2 enzymes 
compared to GME1, GME3 and GME0. The principle anti-inflammatory 
ingredients used in GME2 and GME4 are rosemary oleoresin (with carnosic and 
rosmarinic acid), and curcuminoids, which share a close physicochemical status 
with AA, the natural COX-2 substrate, thereby indicating the potential of GME2 
and GME4 active principles to mimic the target enzyme (COX-2) (Fig.6C.2). 
Also to note that n-3 PUFAs (present in GME0) compete with AA for COX-2 
active site to synthesize anti-inflammatory lipid mediators thereby inhibiting this 
enzyme. The treatment GME4 was more effective in inhibiting COX-2 than other 
treatments at day 0. The COX-2 inhibition rate of GME0 was significantly 
reduced on d=15, and a significant percent reduction in COX-2. inhibitory activity 
was apparent after 90 days with respect to the baseline activity (d=0). In general, 
the reduction in inflammatory response is directly proportional to the active 
ingredients in GME0 as apparent from the potential of the same to inhibit COX-2. 
However, it could not retain the activity for a longer time period, and therefore, 
various additives have been tried to retain the activity of the active ingredient of 
GME0. The functional advantages of the additives are two-fold, the first to arrest 
the oxidation of GME0, and second to increase the anti-inflammatory potential. 
Apparently, among the treatments, GME4 and GME2 showed marginal percent 
reduction in COX-2 inhibition activity with respect to initial activity as compared 
to GME1 and GME3. The ability of Z. officinale to reduce inflammation is due to 
its neutralizing action upon free radicals by phenolic compounds viz., gingerol, 
zingerone, and shogaol (with 2-methoxy-4-propylphenol moiety) (Onyenekwe 
and Hashimoto, 1999). The active ingredients in Z. officinale (gingerol) and 
Indian gooseberry (E. officinalis) contributed towards mimicking the substrate 
(AA, C20n-6 PUFA) to competitively inhibit the production of pro-inflammatory 
PGE2 and PGF2α.  
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Fig.6C.2 Schematic representation of the COX-2 active site amino acyl residues with the 
substrate (AA) forming the inflammatory PGH2, PGE2, PGF2α, and TxA2. The ∆11-double 
bond of AA interacts with Tyr355/385 in an olefinic interaction with COX-2. PGE2 is 
metabolized to PGH2 by peroxidase activity intrinsic to COX-2/ COX-1 to give PGH2 that 
serve as the precursor to inflammatory prostanoids. 
6C.2.2 Effect of various combinations of natural additives on C20-22n-3 and C20n-6  
PUFAs during an accelerated shelf life study for a period of 90 days 
C20n-6 and C22n-6 fatty acid profiling of GME0 vis-à-vis different 
combinations supplemented with antioxidative ingredients (GME1-4) used in 
this study as a factor of time are detailed in Table 6A.2. PUFAs with more 
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than 20 carbon atoms were found to represent more than 17% of the total fatty 
acids for GME0 and different combinations (GME1-4). However, the C20n-6 
PUFAs in GME0 experienced an increase in terms of their total content from 
the initial composition after accelerated shelf life study of 90 days as 
compared to the treatments GME2, GME3 and GME4, which point towards the 
beneficial effect of natural additives added to it. In the present study, total 
C20-22n-3 PUFA content in GME0 was found to be lesser than recorded in 
GME1 - GME4 at d=0, thereby indicating the added n-3 fatty acid pool to 
GME0 by the additives. The content C22:6n-3 PUFA, registered a significant 
reduction in GME0, after 90 days. GME2 and GME4 were able to effectively 
protect C22:6n-3 from oxidative degradation even after 90 days of accelerated 
storage than did GME1 and GME3. The comparatively poor shelf-life of GME3 
than GME2 in terms of containing degradation of C22:6n-3 to a minimum in 
spite of higher concentration of antioxidant principles can be explained by the 
fact that a threshold level of CLO: ROO of 0.8%:0.4% is sufficient for 
optimum antioxidant activity, and further addition of endogenous antioxidants 
(ROO to 0.8% as in GME3) does have negative impact on stability of the fatty 
acid. This observation was supported in an earlier study Lampi et al. (Lampi et 
al. 1999) on fish oil, which implies that above a certain concentration, added 
antioxidants lose efficiency in stabilizing PUFA. The fatty acid C20:5n-3, 
which compete with AA for COX-2 active site to synthesize EPA-derived 
anti-inflammatory PG metabolites including series-E resolvins were found to 
be higher in GME2 and GME4 than in GME1 and GME0 (Fig.6C.2). 
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Table 6C.2 C20n-6 and C22n-3 fatty acid profile of freeze-dried green mussel extract (GME0), 
different combinations GME1-4 during accelerated shelf life study  
  Fatty acids (% total fatty acids TFA) 
Fatty acid descriptors DAY 0 (d =0) 
 GME0 GME1 GME2 GME3 GME4 
20:2n-6 0.31±0.01 0.28±0.01 0.14±0.01 0.24±0.02 0.36±2.51 
20:3n-6 0.47±0.01 0.45±0.01 0.27±0.01 0.34±0.01 0.31±2.25 
20:4n-6 0.58±0.01 1.29±0.01 1.17±0.01 1.18±0.16 1.19±0.02 
20:5n-3 6.98±0.23 6.79±0.6 7.85±0.34 7.89±0.02 7.74±0.01 
22:5n-3 1.56±0.09 1.73±0.02 1.89±0.01 1.86±0.02 1.74±0.01 
22:6n-3 7.92±0.18 7.96±0.01 8.7±0.22 7.58±0.24 7.43±0.02 
Σ C20n-6 PUFA 1.36 2.02 1.58 1.76 1.86 
Σ C20-22n-3 PUFA 16.46 16.48 18.44 17.33 16.91 
Σ C20n-6/ C22n-3 PUFA 0.08 0.12 0.09 0.1 0.11 
 DAY 90 (d =90) 
 GME0 GME1 GME2 GME3 GME4 
20:2n-6 1.13*±0.09 0.76±0.31 0.21±0.05 0.28±2.77 0.28±0.06 
20:3n-6 0.07*±0.001 0.06±0.01 0.05±0 0.05±0.02 0.07±2.31 
20:4n-6 1.96*±0.05 1.86±0.05 1.23±0.03 1.34±0.01 1.29±0.06 
20:5n-3 4.53*±0.15 5.12*±0.31 7.61±0.2 7.63±0.06 6.74±0.06 
22:5n-3 0.73*±0.01 0.86*±1.25 1.42±0.11 1.46±0.01 0.97±0.01 
22:6n-3 5.11*±0.26 5.36*±0.11 7.84±0.31 5.24*±0.02 7±0.03 
Σ C20n-6 PUFA 3.16* 2.68* 1.49 1.67 1.64 
Σ C20-22n-3 PUFA 10.37* 11.34* 16.87 14.33* 14.71 
Σ C20n-6/ C22n-3 PUFA 0.3 0.24 0.09 0.12 0.11 
All samples were analyzed in triplicate (n=3) from a pooled samples. The values are expressed 
as mean ± standard deviation. ΣPUFA: total polyunsaturated fatty acids.  
* shows significant difference (P < 0.05) at d=90 compared to d=0  
It is interesting to note that insignificant reduction of C20:5n-3 were 
apparent in GME2 and GME4 after 90 days as compared to that in GME0 and 
GME1, which realized a significant reduction in the content of this fatty acid. 
In the present study, the PUFAs with C20-22n-3 PUFAs in GME0, were found 
to be significantly reduced after 90 days (37% with respect to initial value at 
d=0) of accelerated storage. However, no significant reduction of this group of 
fatty acids was noticeable for GME2 and GME4 (% reduction = 8.5 & 13.0%, 
respectively). Apparently, the antioxidant additives serve as oxidation “chain 
breakers” for the treatments (GME1-4) by intercepting the free radicals 
generated from unsaturated fatty acids during accelerated storage (Fig.6C.3). 
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The PUFAs with C20n-6 PUFA configuration (e.g., arachidonate) may 
potentially be oxidized to pro-inflammatory PGE2 and PGF2α (Fig.6C.3). In 
recent times, considerable attention has been devoted to study the role of 
inflammatory PGs in inflammation. There is tendency of these multiple 
inflammatory PGs metabolized from C20n-6 PUFA to increase in the product 
based on green mussel meat or extract unless otherwise any attempt is made to 
arrest the oxidative pathways towards this direction by addition of antioxidative 
principles. A schematic diagram illustrating lipid peroxidation inhibitory and 
antioxidant mechanism of rosemary active principles carnosic acid with 1-(1, 1-
dimethylperhydro-4-naphthalenyl)-1-ethanone) and carnosol (with perhydro-1-
isochromenone and 3-isopropyl-1, 2-benzenediol moieties has been depicted 
under Fig.6C.3. These phenolic active principles together are responsible for 
~90% of antioxidant activity of rosemary. Hydrogen atom transfer (HAT or H-
donation) and chain breaking mechanism, as in phenolic antioxidants, is the 
mode of action of carnosic acid and carnosol. It was found to form radical 
species due to HAT, undergoing rearrangement in multiple steps to satisfy the 
vacant electron shell to exhibit its antioxidant activity. The effective inhibition 
of lipid peroxidation in GME4 and GME2 may be due to the presence of 
polyphenolic antioxidants that were reported to disrupt free-radical chain 
reaction by donating proton to fatty acid radicals to terminate chain reactions. 
Though carnosic acid is the primary antioxidant in rosemary, and it metabolized 
to other compounds like carnosol, rosamanol and rosmariquinone, which too 
were reported to possess antioxidant and lipid peroxidation inhibitory properties. 
Another mechanism by that these polyphenolic compounds exhibit lipid 
peroxidation is by metal (Fe2+) ion chelation by phenoxyl radical and free 
hydrogen on -OH group. The polyphenols with ortho-dihydroxy groups provide 
improved stability to polyphenol radical by electron delocalization through the 
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system accompanying radical formation. The lipid peroxidation inhibitory and 
antioxidant mechanism of curcumin-I has also been illustrated under Fig.6C.3, 
whereas the ortho-methoxyl group of curcumin-I can form intramolecular 
hydrogen bond with the phenolic hydrogen, making the H-atom abstraction 
from the ortho-methoxyphenols easy. The antioxidant efficiency of phenolics is 
enhanced by the introduction of a second OH group and is increased by one or 
two methoxy substitutions in positions ortho to the OH group as in 
curcuminoids. Antioxidant action of curcuminoids was also found to be 
associated with the β-dicarbonylic system in the heptadienone link of curcumin-
I, which has conjugated double bonds (dienes). H-atom abstraction from the -
CH2 group in the heptadienone link of curcumin-I also may be involved in 
antioxidant activity (Fig.6C.3).  
The C20n-6/C20-22n-3 fatty acid ratio is directly proportional to the 
anti-inflammatory activities due to the fact that C20:5n-3 is a precursor to anti-
inflammatory lipid mediators (E-series of resolvins, RvE1), whereas 
docosanoids C22:6n-3 to D-series of resolvins (RvD1) and protectins 
(neuroprotectin D1, NPD1). The combinations GME1 and GME4 were found 
to exhibit high C20n-6/C20-22n-3 ratio than recorded in GME2, GME3, and 
GME0. It is interesting to note that the combinations, GME2 and GME4 did not 
exhibit any change in this ratio after a period of 90 days accelerated shelf-life 
study whereas in GME0 an increase in this ratio was observed. It is apparent 
that ROO and CLO contain phenolic compounds with multiple centers of 
unsaturation capable of deactivating free radicals to initiate chain breaking 
peroxidation of olefinic bonds in C20-22n-3 PUFAs (Fig 6C.3). GME0 is 
susceptible towards peroxidation by free radicals, and therefore could not 
retain the C20n-6/C20-22n-3 ratio for a longer time period under shelf, and the 
additives (as in GME1-4) were used to shield the oxidation of GME0. The 
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combination GME1  realized an increase of C20n-6/C20-22n-3 as compared to 
the initial value, apparently due to comparatively less titre of curcuminoids 
(T1: CLO and ROO of 0.4 and 0.8%, respectively), which were reported to 
possess potential to arrest oxidation of long chain PUFAs.  
The long chain C20-22n-3 PUFAs have been demonstrated to modulate 
the inflammatory reaction especially by a competition mechanism at the level 
of COX-2, resulting in a reduced release of pro-inflammatory eicosanoid 
metabolites PGE2 and PGF2α. The C20-22n-3-PUFAs viz., EPA and DHA 
modulate the inflammatory reaction especially by a competition mechanism at 
the level of COX-2, resulting in a reduced release of pro-inflammatory AA 
metabolites PGE2, and PGF2α. The long chain-C20-22n-3-PUFAs have been 
demonstrated to combat chronic inflammatory diseases by inhibiting the 
formation of inflammatory PGs derived from AA by replacing the fatty acid as 
an eicosanoid substrate and inhibiting AA metabolism. 
6C.2.3  Effect of potential combinations of natural additives on pro-
inflammatory prostaglandins PGE2, PGF2α in a time course accelerated 
shelf-life study for a period of 90 days 
PGE2 is one of the major PGs produced in substantial amounts during 
inflammation by AA metabolism, and a positive correlation between PGE2 and 
PGF2α concentration during the course of inflammatory response was reported 
in earlier studies (Sanchez-Moreno et al., 2006). An isocratic reversed-phase 
HPLC separation of the PG derivatives in GME0 and GME1-4 in a time course 
accelerated shelf-life study for a period of 90 days was achieved within 30 min 
in a single run. The peaks of esters were completely resolved when a 25-cm 
column was used. With a 15-cm column, the resolution of PGE2 and PGF2α 
was poorer, but the analysis time was reduced to 16 min. As a rule, we 
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determined the sum of PGE2 and PGF2α because many tests on a 25-cm 
column showed that the amount of PGE2 related to that of PGF2α as 25:10 and 
this value were quite stable in all experiments. HPLC chromatogram of 
authentic standards, PGE2 and PGF2α along with GME0, GME2 and GME4 after 
90 days of accelerated stability study is shown in Fig.6C.4.  
 
Fig.6C.4  HPLC Chromatograms of (A1) standard prostaglandins, PGE2 and PGF2α; (A2) Control 
mussel extract (MSL) after 90 days; (A3) concentration of PGE2 and PGF2α in GMET2 after 
90 days of accelerated shelf life study; (A4) concentration of PGE2 and PGF2α in GMET4 
after 90 days of accelerated shelf life study. 
The concentrations of PGE2 and PGF2α after an accelerated shelf-life 
study of 90 days (d=90) were significantly higher (P < 0.05) in GME0 on day 
90 of the intervention than among GME2 and GME4 (Table 6A.3). An inverse 
correlation between antioxidative effects of the additives (ROO and CLO: 0.4 
and 0.8%, respectively) and PGE2 concentrations in both GME2 and GME4 at 
baseline (day 0, d=0) and at the end of the study (day 90, d=90) was apparent. 
The relative increases and time-courses of formation of AA and PGE2/ PGF2α 
were highly correlated. Of note again, however, is that the levels of PGE2 
registered an approximately 24.35 times increase in GME0 at the end of the 
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study (day 90, d=90) than at baseline (day 0, d=0) compared with GME2 and 
GME4 realizing a meager increase of 2.49 and 2.56 times (at d=90). The 
decelerated increases of inflammatory PGs of both GME2 and GME4 during 
later times of incubation were due to the presence of antoxidative components 
present in the additives. This was confirmed by demonstrating that an increase 
in levels of PGE2 and PGF2α in GME0 was mirrored by a decline in levels of 
antioxidant status (Table 6A.3) with an increase in COX-2 titre. The fold-
increase in levels of PGF2α in GME2 and GME4 treated with additives are 
significantly less (6.40 and 6.52) as compared to levels measured in GME0 
greatly exceeded (18.30 fold increase) that of GME2 and GME4. The results of 
this study highlight the greater utility of measuring PGE2 and PGF2α as an 
index of antioxidant status and lipid peroxidation. The principle anti-
inflammatory ingredients used in GME2 and GME4 are rosemary oleoresin 
(with carnosic and rosmarinic acid), and curcuminoids (curcumin-I and II), 
which share a close physicochemical status with arachidonate (as detailed 
under section 3.1), the natural COX-2 substrate, thereby indicating the 
potential of the former to mimic the enzyme (COX-2) inhibiting the 
biosyntheses of inflammatory PGE2/ PGF2α.  
Table 6C.3  Changes in inflammatory prostaglandin contents (PGE2 and PGF2α ppm) in different 
treatments of P. viridis (GME1, GME2, GME3 and GME4) compared with freeze-dried 
green mussel extract (GME0) during before (day 0, d=0) and after accelerated shelf 
life study of 90 days (d= 90). 
 PGE2 (ppm) PGF2α (ppm) PGE2 + PGF2α (ppm) 
Samples 0th day 90 th day 0th day 90 th day 0th day 90 th day 
GME0 74.82 1822.2* 44.3 810.6* 119.12 2632.8* 
GME1 75.21 241.32* 46.21 354.21* 121.42 595.53* 
GME2 76.89 189.72* 45.68 292.21* 122.57 481.93* 
GME3 76.89 206.35* 47.21 326.35* 124.1 532.7* 
GME4 75.23 192.35* 46.23 301.37* 121.46 493.72* 
All samples were analyzed in triplicate (n=3) from a pooled samples. The values are expressed as 
mean standard deviation. * shows significant difference (P < 0.05) at d=90 compared to d=0  
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A higher titre of PGF2α represents oxidative stress status in the system, 
and its role in the pathogenesis of diseases (Roberts and Morrow, 2000). 
Evidence from prospective studies suggests that an overexpression of PGE2 
associated with increased susceptibility to inflammatory response, including 
cancer, aging and cystic fibrosis (Stables and Gilroy, 2011).  
We have identified PGE2 and PGF2α, as major eicosanoids in GME0. 
The presence of these compounds was confirmed by co-chromatography with 
the authentic PG standards using TLC and HPLC. The structure of PGE2 and 
PGF2αwas unequivocally proved by analysis of their 1H NMR spectra which 
were identical to those of authentic PG and the spectra reported previously 
(Fusetani and Hashimoto, 1984). 
6C.2.4 Electrospray ionization (ESI) liquid chromatographic tandem mass 
spectrometric (LC/MS/MS) analyses of prostaglandins PGE2 and PGF2α 
Tandem LC/MS/MS methods allow a highly selective, sensitive, 
simultaneous analysis for analysis for PGs without derivatization. In the 
application of LCMS of biological samples, ESI has been proven to desolvate 
and ionize fragile chemical species (Sajiki and Kakimi, 1998). A systematic 
approach was used to evaluate the ESI mass spectral (ESI-LCMS) analysis of 
PGE2 and PGF2α. The LC/MS/MS data shows parent peak of PGE2 and PGF2α 
at 5.5 and 4.8 minutes exhibiting parent [M+H]+ ions at m/z 353.2 and 355.2, 
respectively.  
The parent ion (M+1, m/z 353.2) of PGE2 undergoes the addition of a 
Na+ ion to yield an additive peak at m/z 375.2. Ions at m/z 291.2 (2-(Z)-hex-2-
enyl)-4-hydroxy-3-((1E,3E)-octa-1,3-dienyl)cyclopentanone) would indicate 
the loss of –COOH group from ion (7-((1R,2R,3R)-3-hydroxy-2-((1E,3E)-
octa-1,3-dienyl)-5-oxocyclopentyl) hept-5-enoic acid (M+1, m/z 335.2). The 
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mass spectral pattern agreed well with that of authentic standard of PGE2. The 
daughter ions of PGE2 at m/z 291.2 and 305.2 as shown in the Fig. 6C.5A are 
due to (M+1) signals of (2R,3R,4R)-2-((Z)-hex-2-enyl)-4-hydroxy-3-((1E,3E)-
octa-1,3-dienyl) cyclopentanone and (2R,3R,4R)-2-((Z)-hept-2-enyl)-4-
hydroxy-3-((1E,3E)-octa-1,3-dienyl) cyclopentanone, respectively. Other 
PGE2 daughter ions viz.,(5Z)-7-((1R,2R,3R)-3-hydroxy-2-((1E,3E)-octa-1,3-
dienyl)-5-oxocyclopentyl)hept-5-enoic acid (M+1, m/z 335.2) and (4S,5R)-5-
((Z)-hex-2-enyl)-4-((1E,3E)-octa-1,3-dienyl)cyclopent-2-enone (M+1, m/z 
317.2) are also apparent due to the ESI cleavage of neutral loss of uncharged 
molecule of water. Likewise the daughter ions of PGF2α at m/z 337.2 and 
319.2 resulted from the loss of water molecules are due to (M+1) signals of 
(5Z)-7-((1R,2R,3R)-3,5-dihydroxy-2-((1E,3E)-octa-1,3-dienyl)cyclopentyl) 
hept-5-enoicacid and(5Z)-7-((1R,5S)-2-hydroxy-5-((1E,3E)-octa-1,3-dienyl) 
cyclopent-3-enyl)hept-5-enoic acid, respectively resulted from ESI cleavage of 
parent ion. The PGE2 daughter ion at m/z 293.3 identified as(1R,4R,5R)-4-
((Z)-hex-2-enyl)-5-((1E,3E)-octa-1,3- dienyl)cyclopentane-1,3-diol (M+1, m/z 
293.3) as shown in the Fig. 6C.5A resulted from the ESI cleavage of CO2 from 
(5Z)-7-((1R,2R,3R)-3,5-dihydroxy-2-((1E,3E)-octa-1,3-dienyl) cyclopentyl) 
hept-5-enoic acid (M+1, m/z 337.2). Further loss of a water molecule from 
(1R,4R,5R)-4-((Z)-hex-2-enyl)-5-((1E,3E)-octa-1,3-dienyl) cyclopentane-1,3-
diol (M+1, m/z 293.3) resulted in (4S,5R)-5-((Z)-hex-2-enyl)-4-((1E,3E)-octa-
1,3-dienyl)cyclopent-2-enol (M+1, m/z 275.5), which eliminates another 
molecule of water to yield (S)-1-((Z)-hex-2-enyl)-5-((1E,3E)-octa-1,3-dienyl) 
cyclopenta-1,3-diene (M+1, m/z 257.2), which is a characteristic fragment of 
PGF2α, where the proposed fragmentation is shown in Fig. 6C.5B. The data 
have been compared with authentic PG standards. 
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Fig. 6C.5  (A) Positive mode electrospray ionization mass (ESI-MS, M+H+) spectra of PGE2 and 
PGF2α parent and daughter ions as recorded on a Bruker Daltonic (GmbH, Germany) 
micro-TOF series with ESI-MS and an Agilent HPLC fitted with G1312 binary gradient 
pump. (B) Schematic representation of the signature LC-MS fragmentation pattern of 
parent and daughter ions of PGE2 and PGF2α. 
6C.2.5 NMR analyses of prostaglandins PGE2 and PGF2α 
Proton NMR (1H NMR) has been carried out for the purified PG mix to 
further validate the results obtained by understand the component intensities 
and ratios in GME0 (not fortified with antioxidant additives) and GME1-4 
(fortified with antioxidant additives) after 90 days of accelerated shelf-life 
study (Fig.6A.6). Since the spectra is a mixture of different PGs, we have 
found it difficult to analyse some multiplets due to their complexity to 
B 
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interpret (due to the strong coupling) and peak overlap as a result of natural 
line width limitation imposed by the T2 (spin-spin relaxation), which prevents 
valuable information to be detected in the multiplets. Large number of 
transitions in 1H NMR spectra in the mixture of PGs was made simplified by 
the peak analysis algorithm, Global Spectral Deconvolution (GSD), which 
applies a deconvolution of the whole spectrum thereby making us to work out 
the signature peaks in an effective manner.  1H NMR has been used to further 
validate the results obtained by HPLC to understand and compare the signal 
pattern and intensity of the control samples of P. viridis (GME0) vis-à-vis the 
samples fortified with antioxidant additives (GME2) after a 90 days of 
accelerated shelf-life study. The NMR spectrum (Fig.6C.6A) has been 
obtained from the purified PGs of GME2, whereas (Fig.6C.6B) has been 
derived from the purified PGs of GME0. The signal at δ4.6 ppm, which is the 
signature peak of –OH groups, was integrated to result number of protons as 
4.92 in the sample GME0 as compared to 1.56 proton integer in GME2. This 
result apparently indicates the lower concentration of PGs (4 times) in GME2 
than GME0. HPLC data validate the observation as PGF2α recorded to be 
present at 810 ppm in GME0 and 292 ppm in GME2 (about 4 times less than in 
control) after 90 days of accelerated shelf-life study. In particular PGF2α 
possess three –OH groups as compared to PGE2 (with two –OH groups), and a 
higher peak intensity at δ 4.6 ppm with respect to GME0  apparently indicates 
the presence of the former (PGF2α) PGs in a higher quantitities in GME0 than 
recorded in GME2. The 1H NMR data presented here give indicative 
information regarding the presence of characteristic signature peaks of PGE2 
and PGF2α. 
 
Chapter 6 
346 
 
 
 
Fig.6C.6  H NMR spectra of (A) PGE2 and (B) PGF2α as recorded in CDCl3 on a Bruker DRX NMR 
spectrometer operating at 400 MHz for 1H NMR. Chemical shift (δ) values are 
expressed in parts per million (ppm) and are referenced to the residual solvent 
signals of CDCl3. 
O
HO
2.18
2.80
O
HO OH
0.8-1.5
Signature peaks of PGF2- 
Signature peaks of PGE2
HO
HO OH
2.1-2.3
1.7
2.4, 1.7
3.6
3.6
A 
Signature peaks of 
PGF2- 
B 
Functional Food Enriched with Natural Ingredients from Green Mussel P. viridis 
347 
The methine signal (CH) at δ 2.7 ppm belongs to the cyclopentanone 
moiety of PGE2 and the downfield shift of the CH proton was found to be due 
to the proximity of 1 alpha -C=C from CH group under consideration. The 
other CH group of cyclopentanone appeared at δ 2.12 ppm. One of the protons 
of the methylene group (CH2) of the cyclopentanone moiety appeared at δ 
2.34. The downfield shift of the proton is due to the proximity of >C=O group. 
The methine signals at δ CH 3.9 ppm and 3.8 ppm appeared downfield. The 
CH signal at δ 3.8 ppm is due to propan-2-ol moiety of the side chain (non-2-
en-4-ol) of PGE2. The downfileld shift appeared to be due to 1α-O from -CH 
and 1β-C=C from -CH group. Likewise the downfield shift of the methine 
(CH, δ 3.8) proton of cyclopentanone moiety is due to 1α-C=C and 1α-O. The 
olefinic protons appeared in the range between δ 5.4-5.7 ppm and apparently 
reside at the side chains of PGE2, viz., oct-5-enoic acid and non-2-en-4-ol. The 
downfield shift of the olefinic protons was found to be due to 1-C and 1-C-O 
gem gem groups of PGE2. The methylene signals at δ 3.3 and 2.1 ppm of the 
5-octenoate moiety of PGE2 were shifted downfield due to the proximity of 
the electron withdrawing effects of the groups 1α-C=C and 1β-C (=O)-C. The 
CH2 groups of 5-octenoate moiety flanked between carboxylate and olefinic 
groups of PGE2 appeared downfield at δ 1.7-2.2 ppm. Also the signals at δ1-
1.4 ppm are due to the – CH2 and –CH3   signals of non-2-en-4-ol moiety.  
The 1H NMR spectrum of PGs showed a terminal methyl signal at δ 0.89 
ppm (t), one carbinol methine at δ 4.09 ppm (m), three sets of double bound at δ 
5.40, 5.43, 5.61, 5.70 ppm, and a methylene adjacent to a carboxyl group at δ 
2.32 ppm. The values of 5, 6, and 16 Hz coupling constants are typical of the δ 
5(Z) and δ 13(E) olefin functionalities. A set of double bound at δ 6.18, 7.50 
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ppm suggested the presence of α, β-unsaturated cyclopentenone. These features 
were quite similar to those of PGE2 ester. The spectrum also showed signals of 
four coumarin protons at δ 6.33, 6.84, 6.99, 7.42 ppm and a methoxy group at δ 
3.66 ppm (s). The 1H NMR spectra of other compounds contained the described 
signals of the methyl methoxy coumarin group and signals similar to 1H NMR 
shifts of PG esters published elsewhere (Mikolajczyk et al., 2000). 
The characteristic 1H NMR signals of PGF2α resemble to a large extent 
to that of PGE2. However, the peak intensities (integer values) of the signature 
peaks of PGE2 and PGF2α are higher than expected apparently due to the 
addition of these two PG components. The only difference of PGE2 and PGF2α 
are with an extra –OH group in the cyclopentane moiety (as cyclopentane-1, 3-
diol) of the former (PGF2α), which result in the additional signals of a –CH 
group attached with a –OH. The CH and CH2 signals of the cyclopentane-1, 3-
diol moiety in PGF2α appeared slight upfield than in PGE2 apparently due to 
the substitution of one >C=O with –OH group in PGF2α. For example, the –
CH peaks appeared at δ 1.7 and 2.3 ppm, which are not the part of isopropanol 
part of cyclopentane-1, 3-diol ring system unlike δ2.1 and 2.8 ppm with 
respect to 3-hydroxycyclopentanone ring system of PGE2. Likewise, the –CH 
groups, which are part of propan-2-ol system of 3-hydroxycyclopentanone 
ring system appeared upfield (than in PGE2) at δ 3.3 ppm due to the reason 
stated earlier. 
6C.3 Conclusion 
The present study provides the effects of various proportions of natural 
antioxidant additives viz., Rosmarinus officinalis (ROO) and Curcuma longa 
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oleoresins (CLO) in four different proportions as GME1, GME2, GME3 and 
GME4 on pro-inflammatory PGE2 and PGF2α in an accelerated shelf-life study of 
90 days. Among the four combinations, GME2 and GME4 were found to 
effectively arrest the activity of pro-inflammatory COX-2 for a longer time 
period on shelf as compared to GME1, GME3 and GME0. A threshold level of 
CLO:ROO of 0.8%:0.4% in GME3 was found to be effective for optimum 
antioxidant activity. GME2 and GME4 were able to effectively protect C20:5n-3 
and C22:6n-3 from oxidative degradation even after 90 days (d=90) of 
accelerated storage as compared to that in GME0, which realized a significant 
reduction in the content of these fatty acids. The phenolic compounds with 
multiple centers of unsaturation in the antioxidant additives used to prepare the 
formulation intercepted the free radical chain reaction on unsaturated fatty acids 
during accelerated storage resulting in the storage stability of the long chain 
C20-22n-3 PUFAs. The concentrations of pro-inflammatory PGE2 and PGF2α 
after an accelerated shelf-life study of 90 days were significantly higher (P < 
0.05) in GME0 than among GME2 and GME4 due to the presence of phenolic 
antoxidative components present in the additives. The study also highlights the 
utility of measuring PGE2 and PGF2α as an index of antioxidant status and lipid 
peroxidation. The results obtained by HPLC were further validated using 
tandem LC/MS/MS and 1H NMR analyses to understand and compare the signal 
pattern and intensity of the PG in GME0 vis-à-vis the samples fortified with 
antioxidant additives after 90 days of accelerated shelf-life study. 
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6.D Toxicity profile of a nutraceutical formulation derived from 
green mussel Perna viridis  
Background of the study 
Bivalves are considered vital, next to fish and prawns from the nutritive 
point of view. Bivalve mollusks were reported to contain bioactive lipids, 
which include fatty acids; sphingolipids, phytosterols, diacylglycerols, etc. and 
many of these can influence human health and disease linked to alleviating the 
symptoms of inflammatory conditions (Li and Sinclair, 2007). The green 
mussel Perna viridis (family: Mytilidae) is a bivalve mollusk native of the 
Indian coast and throughout the Indo-Pacific and Asia-Pacific (Benson et al., 
2001). It forms a significant fishery and contributes nearly 50% to the total 
bivalve production of the area (Laxmilatha et al., 2011)  
There are several drugs like NSAIDs (aceclophenac, diclophenac etc.), 
steroids (glucocorticoid) and DMARDs (methotrexate, cyclosporin A), coxibs 
(celecoxib, rofecoxib) for managing moderate to severe cases of arthritic pain, 
stiffness and inflammation (Quan et al., 2008). However, the side effects of 
these drugs are often deleterious, which includes gastrointestinal ulcers, 
cardiovascular diseases, and reported toxic effects on the vital organs in the 
body (Schnitzer et al., 1999). 
The in vitro and in vivo anti-inflammatory studies of the green mussel 
derived nutraceutical formulation showed that the green mussel Perna viridis 
contains anti-inflammatory ingredients, which can be useful against 
inflammatory pain. With the interesting pharmacological properties of the said 
formulation, it has become imperative that the anti-inflammatory preparation 
be evaluated for its toxicity profile. As a part of the safety evaluation of this 
nutraceutical formulation, the present study was carried out to determine the 
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changes in body weight, food and water consumption, hematological 
parameters, serum biochemistry and histopathological changes as indices of 
toxicosis with the aim to provide guidance for selecting a safe dose of its use. 
The acute oral toxicity study in 14-days were carried out at a very high dose, 
whereas the repeated dose 90-day oral toxicity study was performed to 
establish the no-observed-adverse-effect level (NOAEL) of the formulation as 
parts of a safety assessment according to the internationally accepted 
guidelines. 
6D.1. Materials and methods  
6D.1.1 Animals  
The short-term and sub-chronic toxicity studies were conducted in adult 
Wistar rats (both males and females) which purchased from Sri 
Venkateshwara Enterprises, Bangalore. They were housed in well ventilated 
polypropylene cages under controlled temperature (22-25oC), pressure, 
relative humidity (60-80%), light-dark cycle of 12 h and provided with rat feed 
(Sai Durga Feeds and Foods, Bangalore, India) and water ad libitum. The age 
of the animal was approximately 7 - 8 weeks with body weights (BW) in the 
range of 200-250 g. All animal experiments were conducted after getting prior 
permission from the Institutional Animal Ethics Committee and as per the 
instructions prescribed by the Committee for the Purpose of Control of 
Supervision of Experiments on Animal (CPCSEA), Ministry of Environment 
and Forest, Government of India.  
6D.1.2 Test article and evaluation of anti-inflammatory activities 
The test article (GME2) is a nutraceutical formulation prepared from 
the green mussels (Perna viridis) and the detailed collection of the raw 
material, processing, method(s) used to assure stability under storage 
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conditions, chemical analysis demonstrating the composition of the material 
have been described section 6A.1.  
6D.1.3 Lethal dose 50 (LD50) of green mussel formulation 
Fifteen animals were divided randomly into three groups containing 5 
numbers each. After being fasted for 16 h, the animals were administered with 
different doses of green mussel formulation suspended in distilled water (5000, 
2500 and 1500 mg/kg BW), and administered as a single dose through oral 
gavage to be monitored for 14 days for mortality, clinical and behavioral 
symptoms, and any adverse reaction. 
6D.1.4 Acute oral toxicity study of green mussel formulation  
Forty animals (20 males and 20 females) were divided into 4 groups, 
each consisting of  5 male and 5 female rats, and three doses (2.5, 1.0 & 0.5 
g/kg) of the green mussel formulation were administered orally (once daily) 
for 14 days. The control received 1 mL of water as vehicle every day. The 
animals were monitored for mortality, clinical and any adverse reaction of the 
test material. The body weight and food consumption were determined on 
every third day. After 14 days, the animals were sacrificed under mild ether 
anesthesia and the blood was collected by direct heart puncture method. 
Necropsy was performed and observations were recorded. Selected organs 
such as the liver, kidney, brain and spleen were dissected out and weights were 
recorded and histopathological analyses were performed. 
6D.1.5 Sub-chronic oral toxicity study of green mussel formulation  
Forty animals (20 males and 20 females) were divided into 4 groups, 
each consisting of 5 male and 5 female rats, and three doses (2.0, 1.0 & 0.5 
g/kg) of the green mussel formulation (1 g suspended in 6 mL double distilled 
water) were administered orally (once daily) for 90 days (Ezeja et al., 2014). 
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The control received 1 mL of water as vehicle every day. The test animals 
were monitored, during this period for any type of clinical symptoms, 
mortality, and adverse reaction. The body weight and food consumption were 
determined every seven days. On the 91st day, the animals were sacrificed 
under mild ether anesthesia. Blood was collected by direct heart puncture 
method. Necropsy was performed and observations were recorded. Selected 
organs such as the brain, kidney, liver and spleen were dissected out, weights 
were recorded and histopathological analyses were performed. 
6D.1.6. Hematology and clinical chemistry parameters 
Blood collected in EDTA tubes were analyzed for hematological 
parameters (Chiranthanut et al., 2013). Red blood cell (RBC), total white 
blood cell count (WBC), platelet count and hemoglobin (HGB) using a 
hematology analyzer (Model-Diatron, Wein, Austria). Total white blood cells 
were measured after diluting the blood in Turk’s fluid and counting them 
using a hemocytometer (Nelson et al., 1984). For differential counts 
(lymphocytes, eosinophills, neutrophills) blood was spread on a clean slide, 
treated with Leishman’s stain before being counted manually with a 
microscope (100 X) (Pal and Parvati, 2003). 
A part of the blood was collected in non-heparinized tubes and serum 
was separated after centrifugation at 5000 rpm for 10 min which was used for 
the following investigations: serum glutamic oxaloacetic transaminase (SGOT) 
and serum glutamic pyruvic transaminase (SGPT) were assayed according to the 
method described by Bergmeyer et al. (Bergmeyer et al., 1976). Alkaline 
phosphatase (ALP) was estimated by p-nitrophenyl phosphate (PNPP) 
hydrolysis (McComb and Bowers, 1979). Total bilirubin was determined by 
Jendrassik-Diazotized sulphanilic acid method (Jendrassik and Grof, 1938). The 
total protein concentration was determined by biuret method (Nelson and 
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Morrie, 1984). Albumin was determined based on its reaction with bromocresol 
green. Markers of kidney function such as creatinine and blood urea nitrogen 
were estimated by Jaffe-Kinetic and urease method respectively (Pearlman and 
Lee, 1974). Serum sodium, potassium and bicarbonate were estimated using 
flame photometer 129 ion selective electrolyte analyzer. Chloride was estimated 
by mercurous thiocyanate method using a kit from Raichem Lifesciences Pvt 
Ltd, India. Total cholesterol was estimated by CHOD–PAP (cholesterol 
oxidase–phenol + aminophenazone) enzymatic method (Jaffe, 2003), 
triglyceride was estimated by GPO–PAP (glycerol-3-phosphate oxidase–phenol 
+ aminophenazone) method (Cole et al., 1997), and high-density lipoprotein 
(HDL) was determined after precipitation with phosphotungistic acid. Very low-
density lipoprotein (VLDL) was estimated by the Friedewald equation (VLDL = 
triglyceride/5) and low-density lipoprotein (LDL) by calculation: LDL = total 
cholesterol–(HDL + VLDL) (Ezeja et al., 2014).  
6D.1.7 Histopathological analysis 
A portion of the selected organs (brain, kidney, liver and spleen) of 
control and treated group (high dose groups) were fixed in 10% neutral 
buffered formalin. Embedded organs tissue samples were cut into slices of 2–4 
µm and stained with hematoxylin-eosin and the sections were observed under 
light microscope (40X).  
6D.1.8 Statistical analysis 
Statistical evaluation was carried out with the Statistical Program for 
Social Sciences 13.0 (SPSS Inc, Chicago, USA, ver. 13.0). Analyses were 
carried out in triplicate, and the means of all parameters were examined for 
significance by analysis of variance (ANOVA). The values were compared 
with that of untreated control animals. 
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6D.2 Results and discussion  
The active principles in the formulation derived from green mussel P. 
viridis were competitively inhibited inflammatory cycloxygenases (COX-
1/COX-2) and lipoxygenase (5-LOX) in an inflammation and oxidative stress 
reaction, resulting in decreased production of pro-inflammatory prostaglandins 
and leukotrienes. Many of the allopathic prescriptions include NSAIDs and 
cyclooxygenase inhibitors used in controlling arthritic conditions have known 
side effects, especially with long term usage. About 25% of the users experience 
some kind of side effect and 5% develop serious health consequences such as 
stomach bleeding, stroke, and acute renal failure. The green mussel formulation 
proved to be a safer and effective alternative to these synthetic NSAIDs and 
other products available in the market.  
As it is has been observed to be slow acting, long-term use of the green 
mussel formulation may be required in treatments of arthritis related diseases. In 
this aspect, long term toxicity studies of the green mussel formulation are of 
vital importance for the assessment of its safety in mammalian systems. In order 
to provide safety evidence for the green mussel formulation as a prospective 
nutraceutical medication for joint pain and arthritis, short-term and sub-chronic 
toxicity studies were conducted on the rats to evaluate the possible toxicity. 
6D.2.1 LD50 of green mussel formulation 
The single dose administration of the green mussel formulation up to a 
concentration of 5000 mg/kg BW did not produced any mortality after 14 days 
of observation, which indicates that the mean lethal dose (LD50) of the 
formulation is greater than 5000 mg/kg BW. The oral toxicity of this 
formulation can be classified in category 5 (the lethal acute toxicity is greater 
than 5000 mg/kg) according to the Globally Harmonized Classification 
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System of OECD (Betti et al., 2012). According to the classification of 
Loomis and Hayes (Hayes, 1996), viz., a chemical substance with an LD50 
within the range of 5000–15,000 mg/kg is considered as practically non-toxic. 
The calculated LD50 for the green mussel formulation found in this range, and 
therefore, this nutraceutical formulation should be regarded as practically non-
toxic in acute ingestion. The green mussel formulation too did not cause any 
toxic symptoms, behavioral changes or mortality when acutely administered at 
5000 mg/kg to rats, and therefore, this formulation can be included under 
category 5 (low or no toxicity) in accordance with OECD guidelines. 
6D.2.2 Acute toxicity study of green mussel formulation 
Under various regulatory guidelines, changes in body weight have been 
used as an integral part of the conventional safety evaluation of test materials, 
drugs and chemicals (Schilter et al., 2003; Hilaly et al., 2004). No treatment 
related signs of mortality were observed in the animals over short-term 
administration (maximum dose of 2500 mg/kg BW). In addition, the 
administration of the green mussel formulation at different doses did not 
produce any treatment-related changes in the body weight of the animals and 
any differences in the food consumption of male and female rats when 
compared to controls. This indicates that the food conversion rate was not 
affected and growth of rats in treatment groups was comparable to that of 
control. Since, no significant changes were observed in the general behavior, 
body weight, food and water intake of rats in the treated groups as compared to 
the untreated control after the administration of the green mussel formulation 
during the short-term toxicity study spanning over 90-day period; it could be 
concluded that oral administration of this test material had no effect on the 
normal growth of rats on the concentration studied. 
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No significant changes were noticed during necropsy and there was no 
change in the organ weight. Organ weights are widely accepted in the evaluation 
of toxicity related studies (Wooley, 2008). No significant differences were 
recorded in the relative weights of kidney, brain, spleen and liver indicating that 
the acute oral administration of the green mussel formulation did not 
detrimentally affect the wet weight, organ-to-body weight ratio and the color of 
the organs. 
The haematopoietic system is one of the most sensitive targets of toxic 
compounds and is an important index to assess the toxicity of the test material 
on the physiological and pathological status in human and animals (Mukinda 
et al., 2007). No treatment-related biologically significant effects of the green 
mussel formulation treatment at dose levels of 0.5-2.5g/kg in hematology 
parameters such as haemoglobin, RBC count, platelet count, total and 
differential leukocytes counts were apparent in both genders of rats when 
compared to untreated animals. After 90 days, there were no treatment-related 
changes in hematological parameters between the untreated and the green 
mussel formulation treated groups indicating that the test material had no 
effects on the circulating blood cells, nor it interfered with their production. 
Some statistically insignificant differences were noted in WBC and differential 
counts when the control and treatment groups were compared. However, these 
changes did not appear to be related to the test article treatment since they 
were still within the limits of normal biological variation. The changes in 
WBC counts were probably due to the normal responses to foreign bodies or 
stress associated with the toxicity studies. Decreased hemoglobin and 
differential counts were found previously in the rats fed with polyunsaturated 
fatty acids, such as n-6 fatty acid arachidonic acid and n-3 fatty acid 
docosahexaenoic acid containing oils (Lina et al., 2006). However, in the 
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present study, no significant changes in these parameters were apparent. Taken 
together, the normal range of hematological indicators indicated the absence of 
hematotoxic potential of the green mussel formulation 
Biochemical determinations of blood parameters in serum serve as an 
indicator of toxicity of a test material (Schilter et al., 2003). The enzymes viz., 
serum aspartate transaminase (AST) or serum glutamic oxaloacetic 
transaminase (SGOT), serum alanine transaminase (ALT) or serum glutamic 
pyruvic transaminase (SGPT), and alkaline phosphatase (ALP) are well-
known enzymes used as good indicators of liver function and as major 
markers of hepatic injury (Hilaly et al., 2004). In general, aminotransferases 
AST and ALT are normally contained within liver cells, and their activity in 
the blood is generally low. If the liver is damaged, these enzymes diffuse 
across the damaged cell membrane due to altered plasma membrane 
permeability (Upur et al., 2009), before being entered into the circulation, 
raising the enzyme levels in the blood and signaling liver disease.The green 
mussel formulation up to a concentration of 2.5g/kg did not produce any 
change in the hepatic function parameters in serum such as SGOT, SGPT and 
ALP, These results suggest that the test material did not alter the hepatic 
function and prevent hepatocyte enzyme go into the blood. No significant 
alterations in ALP in the animal subjects treated with the green mussel 
formulation are indicative of no liver injury (Antonelli-Ushirobira et al., 
2010). Other liver enzyme activities too realized no significant decrease 
thereby suggesting that the acute administration of the test material did not 
alter the hepatocytes and consequently the metabolism of the rats. 
Albumin is synthesized by the hepatocytes, and as such, it represents a 
major synthetic plasma protein, and its determination can act as a criterion for 
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assessing the synthetic capacity of the liver (Muhammed et al., 2011). 
Decrease in plasma proteins therefore tends to reflect chronic damage. The 
common pattern seen following significant hepatocellular damage is a 
reduction in albumin accompanied by a relative increase in globulins, which 
leads to A/G ratio reduction (Woodman, 1996). Serum urea and creatinine are 
known as the usual markers of renal function (Muhammed et al., 2011). Any 
rise in their levels is only observed if there is marked damage to functional 
nephrons (Lameire et al., 2005). The renal function tests such as blood urea 
and serum creatinine did not show any variation when compared to controls. 
There was also no change in serum electrolytes sodium, potassium, chloride 
and bicarbonate indicating that the green mussel formulation did not produce 
any change in renal function. 
Acute toxicity study of the green mussel formulation did not showed 
any change in cholesterol, triglycerides, HDL, LDL, VLDL cholesterol levels. 
No significant changes were observed in cholesterol, LDL, and VLDL levels 
suggestive that the green mussel formulation had no effects on the lipid and 
carbohydrate metabolism of the rats. The liver is the site of cholesterol 
disposal, synthesis, glucose synthesis and generates free glucose into the blood 
from hepatic glycogen stores (Kaplan et al., 1995). In the present study, 
lowering of triglycerides was observed, which was not significant. 
Histopathological analysis of the brain, spleen, kidney and liver did not 
show any pathological lesions in the organs of animals treated with the green 
mussel formulation suggesting that daily oral administration of the green mussel 
formulation for 90 days caused no detrimental changes or morphological 
disturbances. 
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The above observations concluded that the green mussel formulation 
did not produce any toxicity to wistar rats when administered for two weeks. 
6D.2.3 Sub-chronic toxicity study of green mussel formulation 
6D.2.3.1 General conditions and behavior 
No treatment related signs of mortality were observed in the animals 
over the administration periods (maximum dose of 2000 mg/kg BW). The 
animal behavior, feed intake, and the normal body weight changes were not 
altered during the short-term and sub-chronic toxicity studies. In addition, the 
administration of the green mussel formulation at different doses did not 
produce any treatment-related changes in clinical signs such as mental state, 
external appearance and daily activities among the test groups when compared 
with the control. Any abnormal behavior or cases of diarrhea and soft feces were 
not observed during the period of study. No ophthalmological abnormalities 
were observed in any of the treatment groups prior to study initiation and near 
experimental completion. In general, the experimental animals from all 
treatment groups appeared healthy at the conclusion of the study period, and did 
not induce any clinical signs of toxicity in sub-chronic regimens.  
6D.2.3.2 Body weight 
The administration of the green mussel formulation during 90 days of 
long-term sub-chronic toxicity studies did not produce any abnormal change in 
the body weight of male and female rats when compared to the control (Table 
6D.1). As expected, rats gained weight with time. In male rats, the gain in mean 
body weights for the treated groups at 0.5-2.0 g/kg BW was comparable with 
those in the control group throughout the study. Similarly, the mean body weights 
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of the treated female rats were comparable with those in the control group 
throughout the study. Overall, there were no changes in body weight or body 
weight gain in the animals attributable to the administration of the green mussel 
formulation than that of the control group. Any changes observed were sporadic 
and considered incidental, unassociated with test article administration. 
Table 6D.1  Body weight, food and water consumption during sub-chronic (90 days) toxicity 
studies after the administration of green mussel formulation 
Male Female 
Days Controla 2.0 g/kgb 1.0 g/kgb 0.50 g/kgb Controla 2.0 g/kgb 1.0 g/kgb 0.50 g/kgb 
Body weight (g) 
0 230.8±1.4 254.9±2.5 263.6±14.2 284.4±0.5 185.8±1.5 218.5±15.6 195.8±1.4 190.9±5.2 
14 239.6±4.5 261.8±1.5 270.4±2.2 290.1±1.4 192.4±2.4 224.4±12.5 202.1±2.6 196.8±6.2 
42 252.4±6.6 273.9±6.5 281±18.6 300±1.5 204±2.6 232.6±11.6 212.1±3.2 206.9±2.6 
70 263.8±8.5* 283.6±1.5* 290.2±19.5 308.4±1.6* 214.2±2.6* 240.9±11.4* 220.7±1.2* 216.2±2.4* 
91 271.58±14.2* 290.8±1.6* 296.7±2.1* 314.5±1.2* 221.1±0.9* 246.6±0.5* 226.8±0.5* 222.5±2.9* 
Food consumption (g) 
0 72.4±5.6 74.4±2.5 70.6±6.5 68.7±1.2 59.5±0.6 55.4±1.6 58±2.3 62.7±0.9 
14 66.4±6.5 73.3±3.6 62.6±6.3 61.3±1.5 62.5±1.2 49.3±2.6 54.6±2.6 57.7±1.2 
42 67.3±6.9 71.6±3.9 61.4±4.2 60.6±2.5 47.6±1.1 50.6±2.7 48.3±1.5 50±1.3 
70 66.6±7.9 72.7±3.8 62.3±3.2 62.5±2.1 47.9±1.5 51.3±2.4 49±2.6 49.7±1.4 
91 68.3±8.5 74.7±3.6 63.2±2.6 65.5±2 48.7±1.3 50.8±2.1 49.7±2.8 50±1.5 
Water consumption (mL) 
0 100±4 90±2 100±2 110±3 100±2 80±2 110±4 90±2 
14 90±3 70±5 110±3 100±1 80±4 80±1 70±5 90±2 
42 90±2 110±3 90±1 100±2 100±3 80±4 90±1 90±3 
70 110±3 110±1 100±5 100±3 100±2 100±1 90±2 110±3 
91 100±4 100±2 110±1 100±4 100±1 110±2 100±2 100±3 
*Data presented as mean± standard deviation (n = 5). Significantly different from control: P < 0.05. 
aControl group received 1 mL distilled water. 
bSample group received  three doses of green mussel formulation (2.0, 1.0 and 0.5 g/kg rat). 
6D.2.3.3 Food and water consumption  
The average food intake of male rats was nearly 66-80 g/day/cage and 
female was 51-62 g/day/cage. It was observed that average food intake of 
untreated control rats decreased from about 72 g to 68 g after 90 days study. 
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The same trend was observed for medium and low dose group (1.0 and 0.5 
g/kg, respectively) of males and females. Administration of the green mussel 
formulation did not produce any significant difference in the food 
consumption of both genders of rats when compared to normal animals of the 
high dose group (P > 0.05) throughout the experimental period. The 
summarized food intake of the rats recorded after oral administration of the 
green mussel formulation to rats is shown in Table 6D.1. Similarly, the water 
consumption did not alter in male and female rats attributable to 
administration of the green mussel formulation when compared to normal 
animals during chronic and sub-chronic toxicity studies. Changes in water 
consumption during the treatment period are presented in Table 6D.1. 
Sporadic statistically significant changes in water consumption were 
considered spurious, unassociated with the test article administration. 
6D.2.3.4 Relative organ weight 
Fig.6D.1 presents the relative weights of the vital organs (in g) of rats 
(both genders). The weights of liver, kidney, spleen and brain recorded at the 
end of the sub-chronic study (day 91) did not show significant differences (P > 
0.05) in any of the treatment groups compared with the control groups 
(Fig.6D.1). Furthermore, gross examination of the vital organs of all rats 
revealed no detectable abnormalities. The evaluation of the organs weights of 
treated rats group supported the safety of the green mussel formulation. 
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Fig.6D.1  Mean organ weights (in grams) of male and female rats administered green mussel 
formulation after (A) acute and (B) sub-chronic toxicity studies 
6D.2.3.5 Hematological parameters 
The effect of the green mussel formulation on haematological parameters 
such as haemoglobin, RBC and WBC count, platelet count and differential 
counts after sub-chronic toxicity (90 days) studies are presented in Table 6D.2. 
No treatment-related biologically significant effects of the green mussel 
formulation treatment at dose levels of 0.5-2.0g/kg in these haematology 
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parameters were apparent in both genders of rats when compared to untreated 
animals (Table 6D.2) (P > 0.05), and remained within physiological range 
throughout the treatment period (90 days).  No test article-related changes in 
blood cell morphology were observed during the period of study.  
Table 6D.2 Hematology analyses data of male and female rats administered with the green 
mussel formulation after sub-chronic (90 days) toxicity studies 
  Lymphocytes Eosinophills Neutrophills HGB WBC RBC 
Treatments  (mm3) (mm3) (mm3) (g/dL) (mm3) (106/cmm) (105/cmm) 
Male 
Controla 5828.60± 159.14 998.20 ± 62.90 3213.20±17.13 15.44 ± 0.05 10040 ± 58.6 7.87 ± 0.07 
2.0g/kgb 4638.00±154.50 752.60±31.57 2329.40±83.04* 14.60 ± 0.64 7720 ±26.70 7.41 ± 0.29 
1.0g/kgb 3643.80±187.47* 618.60±33.24* 2017.60±88.02* 14.34 ± 0.73 6280 ±30.90 7.29 ± 0.58 
0.5g/kgb 4912.20±114.07 773.60±15.38 2754.20±78.98 14.64 ± 0.70 8440 ±174.70 7.27 ± 0.08 
Female 
Controla 5220.40± 231.0 888.80± 37.78 2730.80±80.31 13.38 ± 0.94 8840 ±148.9 6.37 ± 0.47 
2.0g/kgb 3856.40±167.93* 645.40±28.94 2298.20±114.25 14.12 ± 0.44 6800 ±97.7 6.97 ± 0.03 
1.0g/kgb 4975.20±269.33 770.00±31.75 1974.80± 83.87* 13.86 ± 0.83 7720±107.5 6.86 ± 0.21 
0.5g/kgb 2122.80±101.52* 321.20±14.67* 1096.00 ± 50.93* 13.54 ± 0.53 3540±101.7* 6.77 ± 0.07 
*Data presented as mean± standard deviation (n = 5). Significantly different from control: P < 0.05. 
aControl group received 1 mL distilled water. 
bSample group received  three doses of green mussel formulation (2.0, 1.0 and 0.5 g/kg rat). 
HGB: hemoglobin, WBC - total white blood cell count, RBC - red blood cell 
6D.2.3.6 Serum biochemical parameters 
Table 6D.3 summarizes the serum biochemical parameters used as the 
biomarkers of the liver and renal functioning, during the course of sub-chronic 
toxicity studies. The activity of the marker enzymes of the liver (SGOT, SGPT 
and ALP) were not significantly different (P > 0.05) in all dose groups of treated 
rats as compared to untreated control, and albumin/globulin (A/G) ratio was not 
altered in the treated animals of both genders (Table 6D.3). Sub-chronic oral 
administration of the green mussel formulation (for 90 days) did not cause any 
significant changes in hepatic function parameters such as total protein, albumin, 
total bilirubin and globulin in both sexes of rats during long term sub-chronic 
toxicity studies. However, no change in serum proteins and albumin were 
observed in the acute and sub-chronic studies, which show that the green mussel 
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formulation do not inhibit protein synthesis in the rats. This is supported by the 
microscopic examination showing the normal hepatocytes without any lesions in 
the liver. Bilirubin is a metabolic breakdown product of blood heme. Any course 
that might induce abnormally increased levels of bilirubin accumulating in human 
serum or plasma usually signify the presence of a variety of diseases with liver 
dysfunctions, ranging from jaundice to infectious hepatitis (Yao, 2004). Our 
results proved the report that long-term and high dose administration of the green 
mussel formulation did not significantly alter the bilirubin concentrations, which 
is an indication that it do not interfere with the metabolism of bilirubin in the liver. 
In liver, bilirubin also affects the protein synthesis. There was no obvious 
alteration of protein content in the liver at the experimental doses administered 
with the test material in comparison to the control group. It is of note that under 
normal circumstances, bilirubin-albumin conjugate protects the cells against the 
potential toxicity of bilirubin. Any imbalance in the formation of the conjugate 
resulting in the decreased protein content in the liver and increased total bilirubin 
in serum to have a detrimental effect leading to injury of the liver. Since, there 
was no adverse effect on plasma levels of total bilirubin, total protein and A/G 
ratio in the green mussel formulation treated animals when compared to control, it 
may be concluded that the test article did not alter the renal and hepatic function. 
The renal function parameters such as serum creatinine and blood urea 
did not show any significant variation (P > 0.05) in treated animals compared 
to controls (Table 6D.3). There were no statistically significant differences in 
the levels of serum electrolytes such as chloride, potassium, sodium and 
bicarbonate after the treatment of green mussel formulation (P > 0.05), 
indicating no expressive changes in the general metabolism after consumption 
of the green mussel formulation by rats (Table 6D.4). The green mussel 
formulation did not produce any significant changes in the total cholesterol, 
HDL, LDL and VLDL, indicating no expressive changes in the general lipid 
metabolism after consumption of the test article by rats (Table 6D.4).  
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6D.2.3.7 Histopathological analysis 
Necropsy of the treated animals after sacrifice did not show any 
morphological changes of the internal organs or any gross pathological 
abnormalities during sub-chronic toxicity studies. There were no macroscopic 
findings considered to be related to the treatment of the green mussel formulation 
(Fig. 6D.2). 
 
 
Fig. 6D.2  The cross section of the male and female rats after sub-chronic toxicity study of 90 days. (A) 
Normal male; (A1) Green mussel formulation (2.0g/kg) treated male; (B) Normal female (B1) 
Green mussel formulation (2.0 g/kg) treated female. 
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Gross examination of vital organs such as brain, kidney, spleen and 
liver of rats, and microscopic examination of tissue sections prepared from 
these organs did not observe any histopathological alteration in any treated rats 
during sub-chronic toxicity studies. The normal and treated sections of brain 
(Fig. 6D.3A & A1), kidney (Fig. 6D.3B & B1), liver (Fig. 6D.4A & A1), and 
spleen (Fig. 6D.4B & B1) showed normal appearance compared to control rats 
after sub-chronic toxicity study. The treated section of brain showed normal 
glial cells. Astrocytes, interstitial tissue of the brain and the portion of 
cerebellum also showed normal appearance compared to control rats (Fig. 
6D.3A1). The treated section of the kidney showed normal glomeruli with 
normal Bowman’s capsule. Glomeruli showed normal cellularity with renal 
tubules and interstitial tissue demonstrated the normal appearance (Fig. 
6D.3B1). The section of liver tissue showed normal portal triads and biliary 
duct. A few lymphocytic collections were seen in the portal area, which was 
normal. Central venous systems also appeared normal. Hepatocytes showed 
normal morphology and they were arranged in cords. Sinusoidal space and 
Kupffer cells also appeared normal (Fig. 6D.4A1). The section of spleen 
showed normal lymphoid follicles with germinal centers. Sinusoidal spaces 
are dilated and they were lined by normal endothelial cells. Some areas 
showed hemorrhaged congestion with many siderophages (Fig. 6D.4B1). No 
other macroscopic or microscopic lesions in organs examined were observed.  
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Fig. 6D.3  Photomicrograph of histopathological sections of the brain and kidney on day 90 of 
sub-chronic toxicity test. (A) Normal liver, (A1) brain sections from experimental rats 
after 90 days of treatment with 2.0g/kg of the green mussel formulation showing 
apparently normal glial cells, (B) photomicrograph of kidney section from 
experimental control rats, (B1) kidney sections from experimental rats after 90 days 
of treatment with 2.0g/kg of the green mussel formulation showing normal glomeruli. 
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Fig. 6D.4   Photomicrograph of histopathological sections of the liver and spleen on day 90 of 
sub-chronic toxicity test. (A) Normal liver, (A1) photomicrograph of liver sections 
from experimental rats after 90 days of treatment with 2.0g/kg of the green mussel 
formulation showing apparently normal morphology of hepatocytes, (B) 
photomicrograph of spleen section from experimental control rats, (B1) spleen 
sections from experimental rats after 90 days of treatment with 2.0g/kg of the 
green mussel formulation showing normal lymphoid follicles with germinal centers. 
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6D.3 Conclusion 
The acute and sub-chronic toxicity studies of the green mussel 
formulation using Wistar rats was carried out to understand its effect on 
various parameters such as mortality, weight change, food consumption, 
hematological, liver, and renal functions, serum electrolytes, and lipid profile. 
The results indicated that the green mussel formulation did not produce any 
change in food consumption, water consumption and body weights in rats, 
indicating that it has no toxicity to these animals. Also it did not produce any 
biochemical changes related to hepatic and renal function. This formulation 
did not produce any change in hematological and serum biochemical 
parameters. Necropsy of the treated animals showed normal appearance of 
various tissues. The no observable adverse effect level (NOAEL) was 2000 
mg/kg BW. The toxicological studies demonstrated that the green mussel 
formulation is safe to consume without any adverse effects in the body 
…………??………… 
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Mollusks contribute significantly to the total marine fish catch of the 
world. Marine bivalves are abundant in coastal and estuarine waters of India. 
The bivalve fishery is constituted mainly by clams, mussels and oysters. 
Molluskan fishery is not well-organized along the Indian coast and they are 
exploited in large quantities by traditional methods and sold live in the market 
for human consumption. Mussels, oysters and octopus form good protein food 
with considerable quantities of poly unsaturated fatty acids. Cephalopods are 
important marine organisms as a food and are the store house of many 
biologically important metabolites. Diets that include seafood on a regular 
basis may represent some health benefits regarding nutritionally relevant 
compounds, such as, minerals, n-3 fatty acids and vitamin E. Marine 
organisms are considered as unique biostore of active compounds, having 
enormous therapeutic potential which led to the growing interest in 
investigation of natural lead molecules with potential antioxidant and anti-
inflammatory characteristics.  
In the present study we have considered Perna viridis and Crassostrea 
madrasensis among the bivalves and Octopus dolffusi as the candidate 
cephalopod. These species are abundantly available at the south west coast of 
India and are the preferred food items among the people living in the Malabar 
Coast. Based on this background, the present work is focused in the isolation 
of potential anti-inflammatory and antioxidant principles from these candidate 
bivalve mollusks and cephalopods, and their characterization by different 
spectroscopic techniques. The products containing active anti-inflammatory 
and antioxidant principles with suitable stabilizers are developed from the 
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candidate bivalve mollusks and cephalopods in an attempt to deliver potent 
medication and nutraceutical supplements. 
The selected mollusks such as P. viridis, C. madrasernsis and 
O.dolffusi were evaluated for the comparative analysis of their spatial and 
seasonal disparities in the biochemical composition. The present study 
provides comprehensive knowledge of different biochemical and fatty acid 
variation of cultured and wild bivalves collected from two different locations 
of south west coast of India (Kochi and Kozhikode) during different seasons 
of the year. The higher PUFA content of the samples collected from this mussel 
harvesting area also contribute to their potential to exhibit anti-inflammatory 
activities. P. viridis, by virtue of realizing a balanced EAA/NEAA ratio with 
considerable amount of lysine and threonine, is a well-balanced and high-quality 
protein source, and a candidate species to supplement these amino acids of 
cereals. The optimum and balanced quantities of vitamins, mineral nutrients, 
and low cholesterol contents added to the good qualities of this particular 
species, and therefore, proved to be a desirable item in the human diet in the 
south-western region of India. 
The Indian edible oyster Crassostrea madrasensis is one of the most 
important and promising economic oyster species being farmed for human 
consumption. Growth conditions play vital role in physiological mechanisms of 
oysters guiding fatty acid metabolism. High levels of PUFA (21.7-36.4%) 
including n-3 PUFAs (12.5-23.2 %), low levels of n-6 PUFA (maximum of 7% 
of total fatty acids) observed in both wild and cultured oysters. The ratios of 
essential/non-essential amino acids (EAA/NEAA) indicated that both oyster 
tissues are good sources of well-balanced proteins. Octopus was found to be the 
good protein source with low in fat content, and considered as the most 
interesting inhabitants of the seas. Greater levels of EPA and DHA in the 
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lipids implied the presence of antioxidant system in the edible muscle of O. 
dolffusi. Greater levels of PUFA including n-3 PUFAs, important in the human 
diet for their platelet anti-aggregating and blood pressure-reducing properties, 
lesser levels of n-6 PUFA, and relatively high n-3/n-6 PUFA ratio values 
characterized P. viridis. The higher PUFA content also contributed to their 
potential to exhibit anti-inflammatory activities, and therefore, proved to be a 
highly desirable item for use as food and nutrceutical supplement. 
 The present study demonstrated the importance of P. viridis, C. 
madrasensis and O. dolffusi, in terms of their potential radical scavenging and 
anti-inflammatory properties. Extracts both aqueous and solvent fractions of 
different polarities were generated from these species and screened for the 
promising antioxidant and anti-inflammatory activities. The present findings 
implied that the methanolic extracts derived from these candidate bivalve 
species could be used to isolate potentially valuable antioxidative and anti-
inflammatory compounds. This forms a first comprehensive report on the 
antioxidative and anti-inflammatory properties of these seafood species as a 
novel source of antioxidants and anti-inflammatory leads.  
The crude extracts were subjected to undergo repeated purifications 
with the aid of various chromatographic techniques and a total of ten 
compounds with potential antioxidant and anti-inflammatory activities were 
isolated from these mollusks. The chemical structures of the pure compounds, 
as well as their relative stereochemistries, were established by means of 
detailed spectroscopic experiments. Chromatographic separation of P. viridis 
extract led to the isolation of six new derivatives. The molecular structures of the 
purified compounds was proposed on the basis of comprehensive analysis of the 
1H NMR, 13C NMR, including 2D-NMR experiments (1H–1H–COSY, HMQC, 
HMBC, and NOESY), and mass spectra. The chloroform partitioned methanolic 
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extract of Perna viridis was chromatographically fractionated over silica 
columns to yield 7-hydroxy-2-vinyl-1,2,3,4,4a,4b,5,6,7,8,10,10a-dodecahydro-
4-phenanthrenone (1), 1,1,4b-trimethyl-7-vinyl-1,2,3,4b,5,6,7,8,8a,9,10,10a-
dodecahydro-3-phenanthrenone (2), 10,14-dihydroxy-5,5-dimethyl-6,6a,6b,7, 
8,8a,9,10,11,12b-decahydro-5H-benzo[h]naphtho[1,2-c]chromene-8a-carbaldehyde 
(3), 8a-acetyl-10-hydroxy-5,5-dimethyl-6,6a,6b,7,8,8a,9,10,11, 12b,14,14a-
dodecahydro-5H-benzo[h]naphtho[1,2-c]chromen-14-one (4), (1,5-dimethylhexyl)-
10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H- 
cyclopenta[a]phenanthren-3-yl(3E,7E)-9-ethyl-5-hydroxy-3-methyl-3,7,9-
decatrienoate (5) and (4E)-2,3,4,7,8,9,10,11,12,13,14,15,16, 17-tetradecahydro-
10,13-dimethyl-17-(6-methylheptan-2-yl)-1H-cyclopenta[a] phenanthren-3-yl 
6-oxooct-4-enoate (6). The scavenging effect of the purified compounds 
decreased with the order: 3>4>1>2>5>6. These compounds could effectively 
inhibit COX-2 as well as LOX-5. This study established the potential of marine 
derived compounds as potential natural lead antioxidative and anti-inflammatory 
molecules for use in pharmaceutical and food industries. The knowledge on the 
structural features responsible for antioxidative and anti-inflammatory activities 
will guide us to synthesize the molecules in commercial scale for use as new 
generation antioxidant and anti-inflammatory leads. 
The ethylacetate:methanol extract of Crassostrea madrasensis was 
fractionated chromatographically to yield methyl 12-hydroxy-2,9,9-trimethyl-10-
[(2-phenylacetyl)oxy]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,14a, 14b-
icosahydro-2-picenecarboxylate (7) and methyl 1,12-dihydroxy-2,9,9-trimethyl-
10-[(2-phenylacetyl)oxy]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a, 12b,14a14b-
icosahydro-2-picenecarboxylate (8). The structures of the compounds, as well as 
their relative stereo chemistries, were established by means of spectral data 
analyses, including 2D-NMR experiments. Among the compounds isolated from 
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Crassostrea madrasensis, compound 7 showed maximum DPPH radical-
scavenging ability (72.5 percent) than 8. No significant differences in the ABTS.+ 
radical-scavenging activity, COX-2 and 5-LOX inhibition activities were 
observed for 7 and 8.The effective antioxidant property of these compounds 
indicated that they have potential as natural antioxidant lead molecules in the food 
industry.  
The  ethylacetate:methanol extract of Octopus dolffusi yielded two pure 
compounds, namely, 1-[17-(1,5-dimethylhexyl)-10,13-dimethyl-2,3,4,7,8,9,10, 
11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] 5-
methyl 3-[(E)-1-amino-3-ethyl-6-oxo-3-heptenyl]pentanedioate (9) and 4-
ethyl-6-vinyl-2,3,6,7,7a,8,9,9a-octahydroazuleno[1,8-bc]pyran-2,9-dione (10). 
The structures of the compounds, as well as their relative stereo chemistries, 
were established by means of spectral data analyses, including 2D-NMR 
experiments. Both compounds (9 and 10) isolated from Octopus dolffusi 
showed similar effect in inhibiting the DPPH and ABTS.+ radicals. The in vitro 
anti-inflammatory properties with respect to COX-2 and 5-LOX inhibitory 
activities were also found to be similar for 9 and 10.  
 Considering the importance and easy availability of P. viridis, a 
nutraceutical formulation has been formulated to inhibit 5-LOX and COX-2 
with COX-1/COX-2 ratio below the safety threshold limit leading to selective 
activity against inflammatory mediators. However, it is to be noted that the 
active ingredients of P. viridis extract are lipidic in nature, and therefore, are 
susceptible to peroxidation (or oxidation) due to the presence of olefinic bonds 
in their structure. The present study explored the natural alternatives, such as, 
different compositions of oleoresins (Rosmarinus officinalis (ROO) and 
Curcuma longa (CLO) and other natural antioxidant additives in different 
proportions were blended with the P. viridis extract (FDPE) in different 
Summary  
378 
combinations (GME1, GME2, GME3 and GME4). These experimental 
combinations were subjected to accelerated shelf life study for a period of 90 
days (d90) to find their individual and synergistic effects, which were able to 
reduce the free radicals causing oxidation reactions thereby deteriorating the 
nutritional compositions of the mussel extract. The dual inhibitory activity of 
Indian green mussel, P. viridis against pro-inflammatory enzymes 
cyclooxygenase (COX-2) and lipoxygenase (5-LOX) showed its better 
therapeutic profile and fewer side effects than synthetic NSAIDs. From the 
present study, it is revealed that different additives from natural origin like 
Curcuma longa, Rosmarinus officinalis etc., added in different combinations 
can retain the anti-inflammatory activity of P. viridis extract by stabilizing its 
active anti-inflammatory ingredients. The FT-IR spectra at various time 
intervals showed the possible degradation/retention of the anti-inflammatory 
principles of P. viridis vis a vis different combinations, in a time-dependent 
manner demonstrating that the combinations GME2 and GME4 have the 
potential to retain the active principles throughout the experimental period 
under shelf. The phenolic compounds with multiple centres of unsaturation in 
the antioxidant additives used to prepare the formulation intercepted the free 
radical chain reaction on unsaturated fatty acids during accelerated storage 
resulting in the storage stability of the long chain C20-22n-3 PUFAs. The study 
also highlights the utility of measuring pro-inflammatory prostaglandins (PGE2 
and PGF2α) as an index of antioxidant status and lipid peroxidation. The results 
obtained by HPLC were further validated using tandem LC/MS/MS and 1H 
NMR analyses to understand and compare the signal pattern and intensity of the 
PG in GME0 vis-à-vis the samples fortified with antioxidant additives after 90 
days of accelerated shelf-life study. 
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The present work involved the extraction and isolation of different anti-
inflammatory principles from P. viridis for the enrichment of the potentanti-
inflammatory formulation GME2. Specifically the anti-inflammatory lecithin 
and polysaccharides along with glycolipoprotein and n-3 polyunsaturated fatty 
acids were isolated from this bivalve mollusk in an attempt to enrich the anti-
inflammatory activity of the formulations.  
The oligosaccharide (compound 11) was characterized as di-(N-acetyl-β-
D-mannosamine) -(1→4)-2-N-acetyl-β-D-galactosamine-(1→) - (4-N-acetyl p-
phenoxyl) motifs. IR spectrum of (→4)-2, 4 di-(N-acetyl-β-D-mannosamine) -
(1→4)-2-N-acetyl- β -D-galactosamine-(1→) - (4-N-acetyl p-phenoxyl) unit 
revealed the broad and  intense stretching at 3400 cm−1 is characteristic of 
hydroxyl groups and the weak stretching at 2930 cm−1 is attributed to the C–H 
bond. The fraction also exhibited an obvious characteristic absorption at 925 and 
800 cm−1 corresponding to the existence of mannose. The characteristic 
absorptions at 850 cm−1 in the IR spectra indicated the presence of α-glycosidic 
linkages. The 1H NMR spectrum (500 MHz) showed anomeric proton signals at δ 
5.28-5.35  and δ 4.5 in a molar ratio of about 2:1, which were assigned to the two 
types of sugar units. The structure characteristics of oligosaccharide, especially 
the chain linkage and conformation of the sugar units, were completed and 
confirmed by 1D and 2D NMR. The in vitro anti-inflammatory activities were 
studied by using indomethacin and aspirin as positive controls and polysaccharide 
fraction registered significantly greater COX-2 inhibition (74.8%) than aspirin 
and indomethacin (58.6% and 59%, respectively, 5mg/mL). 
The compound 12 contain C-28 carbon lysolecithin isolated from the 
green mussel, whereas the ultraviolet absorbance at λmax (log ε) 244 (3.11) nm 
(in MeOH) has been assigned to the choline and glycerol systems. Its mass 
spectrum exhibited a molecular ion peak at m/z 550 (C28H57NO7P). 1H NMR 
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in conjugation with 13C NMR recorded the signature peaks of choline, glycerol 
and fatty acid portion of the lysolecithin. 13C NMR spectra displayed three 
close peaks at δ 54.31(C-1), δ 54.21(C-2) and δ 53.56(C-3) that were attached 
to the nitrogen represented singlet at δ 3.19 (s) with an integral value of 9. The 
lysolecithin fraction (68.9 %) exhibited strong, concentration dependent 
inhibition of COX-2, and was greater inhibition than the traditional NSAID 
COX inhibitor, indomethacin, at comparable concentrations. 
 The isolated naturally derived anti-inflammatory components, such as, 
lecithin and polysaccharides along with glycolipoprotein and n-3 polyunsaturated 
fatty acids were added in various compositions to the said anti-inflammatory 
combination GME2 to prepare different experimental combinations (Q1 to Q2). 
These enriched combinations (Q1 through Q2) of the freeze dried P. viridis extract 
(FDPE) supplemented with the antioxidative oleoresins for stabilizing its active 
anti-inflammatory ingredients. Among the different treatments of enriched green 
mussel extracts Q1 exhibited significant inhibition of pro-inflammatory COX-1, 
COX-2 and 5-LOX enzymes, indicating their potential for use as effective green 
alternatives to the synthetic drugs with multiple adverse effects on human health. 
Significant in vivo activities also indicated better therapeutic profile and fewer 
side effects of the anti-inflammatory formulation Q1 as compared to the synthetic 
non-steroidal anti-inflammatory drugs. Therefore, Q1 proved to be the effective 
new generation green alternatives to the synthetic non-steroidal anti-inflammatory 
drugs for use against a cascade of mammalian inflammatory diseases. 
The acute and sub-chronic toxicity studies of the potential green mussel 
formulation using wistar rats was carried out to understand its effect on 
various parameters such as mortality, weight change, food consumption, 
haematological, liver, and renal functions, serum electrolytes, and lipid profile. 
The results indicated that the green mussel formulation did not produce any 
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change in food consumption, water consumption and body weights in rats, 
indicating that it has no toxicity to these animals. Also it did not produce any 
biochemical changes related to hepatic and renal function. This formulation 
did not produce any change in haematological and serum biochemical 
parameters. Necropsy of the treated animals showed normal appearance of 
various tissues. The no observable adverse effect level (NOAEL) was 2000 
mg/kg BW. The toxicological studies demonstrated that the green mussel 
formulation is safe to consume without any adverse effects in the body. 
In recent years, the use of antioxidants and anti-inflammatory agents of 
natural origin is considerably enhanced, by the concern about the adverse side 
effects of these popularly used synthetic antioxidants and NSAIDS. Presently 
the anti-inflammatory concentrates of natural origin, available in the market are 
mostly imported and highly priced. Therefore it is not cost-effective to use them 
as health food additives. The anti-inflammatory combination enriched product, 
might be a cheaper alternative to the imported supplements, and has been used 
as nutraceuticals. Hence, the enriched anti-inflammatory formulations are 
effective new generation green alternatives to the synthetic NSAIDs for use 
against a cascade of mammalian inflammatory diseases. The optimized 
procedure to prepare the stabilized anti-inflammatory combinations developed 
in the present study would contribute to the commercial application to produce 
the stabilized anti-inflammatory as nutraceuticals and dietary supplements. 
…………??………… 
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